data_2kut_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kut _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.56 1.355 0 CA-C-O 118.529 -0.748 . . . . 1.0 110.911 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.5 -28.64 45.88 Favored 'Trans proline' 0 N--CA 1.517 2.855 0 C-N-CA 121.592 1.528 . . . . 1.0 112.361 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.15 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.762 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.5 p -131.93 120.22 22.2 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.955 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 9' ' ' LYS . 60.4 mt -102.66 145.48 29.61 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.225 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.8 t -78.88 31.17 0.2 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.6 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 7' ' ' LEU . 80.8 tttt -72.98 49.35 0.24 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.584 0.707 . . . . 1.0 110.16 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -61.08 -40.49 93.89 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -117.17 89.86 31.94 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.708 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.47 111.13 0.33 Allowed 'Trans proline' 0 N--CA 1.523 3.221 0 C-N-CA 121.052 1.168 . . . . 1.0 113.256 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -162.48 109.37 1.27 Allowed 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.265 0.555 . . . . 1.0 110.432 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -55.68 142.68 33.22 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.112 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.1 18.23 63.37 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -107.28 143.62 35.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.663 0.385 . . . . 1.0 110.233 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.17 130.95 40.07 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.15 144.68 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.987 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -89.3 112.96 24.16 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -96.22 115.51 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.1 p -129.53 134.83 47.97 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.371 0.605 . . . . 1.0 110.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.0 127.18 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.831 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -84.03 116.26 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.81 126.51 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.135 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -96.18 126.91 41.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 120.677 0.275 . . . . 1.0 110.284 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.7 t30 . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 1.0 109.749 179.794 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.25 0.548 . . . . 1.0 110.613 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.05 119.33 6.6 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.363 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.08 149.74 21.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.888 0.375 . . . . 1.0 110.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -137.13 162.75 32.53 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 122.435 1.112 . . . . 1.0 109.797 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 53.83 67.57 0.99 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.604 -1.18 . . . . 1.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.43 82.58 24.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.273 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.17 175.27 10.49 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.75 0.966 . . . . 1.0 111.16 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.51 138.69 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.677 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.26 114.25 17.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.379 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 t -107.59 140.56 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.519 0.676 . . . . 1.0 109.233 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -145.56 130.24 18.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.048 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.31 125.59 32.41 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.99 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -159.65 17.06 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -108.59 143.32 27.26 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.467 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.12 -21.19 27.63 Favored 'Trans proline' 0 N--CA 1.516 2.812 0 C-N-CA 120.5 0.8 . . . . 1.0 111.789 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.3 -45.88 89.33 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.934 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -72.38 -69.59 0.39 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.136 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.02 77.42 0.03 OUTLIER Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.32 165.84 21.6 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.54 141.8 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.089 0.471 . . . . 1.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -73.83 134.17 43.29 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.757 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -98.51 -42.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.7 168.75 39.37 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -153.96 166.19 33.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.506 0.67 . . . . 1.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -154.65 114.89 3.85 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.047 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -76.0 132.71 40.34 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.6 mt -86.46 148.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -62.24 -49.85 74.06 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.36 0.6 . . . . 1.0 110.465 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -176.25 146.77 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.293 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -118.31 124.16 28.8 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-O 117.924 -1.036 . . . . 1.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.04 163.15 39.07 Favored 'Trans proline' 0 N--CA 1.519 2.999 0 CA-C-N 119.844 0.98 . . . . 1.0 111.984 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -71.61 142.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.717 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.18 6.33 56.83 Favored Glycine 0 N--CA 1.465 0.627 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.9 -166.74 21.54 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 110.481 -1.048 . . . . 1.0 110.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 p -146.2 152.42 39.19 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.274 0.559 . . . . 1.0 110.14 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.55 157.75 19.84 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.39 113.72 7.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.501 0.667 . . . . 1.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.98 159.47 15.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.513 -0.767 . . . . 1.0 110.002 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -126.38 122.22 34.74 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.868 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.71 146.37 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.9 0.857 . . . . 1.0 109.55 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -119.84 142.29 48.77 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.216 -0.902 . . . . 1.0 110.033 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -144.5 145.2 31.73 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.012 0.911 . . . . 1.0 109.712 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -91.19 121.19 32.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.942 -1.026 . . . . 1.0 109.676 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.38 132.64 42.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.951 0.405 . . . . 1.0 110.181 179.056 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.072 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.42 64.98 5.93 Favored Pre-proline 0 N--CA 1.48 1.047 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -68.81 175.45 7.27 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.983 1.789 . . . . 1.0 111.357 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.43 135.73 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.868 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -135.22 146.78 48.98 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.862 0.839 . . . . 1.0 109.721 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.72 143.02 28.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.929 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.42 140.13 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.652 0.739 . . . . 1.0 109.728 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.06 140.63 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.255 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 CA--C 1.561 1.387 0 CA-C-O 118.143 -0.932 . . . . 1.0 111.767 179.792 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.28 46.6 1.11 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.364 0.666 . . . . 1.0 110.234 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 13.1 p -105.68 139.01 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.428 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 55.3 m-85 -145.33 143.24 30.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.146 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.4 p -170.54 143.36 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.74 147.28 33.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.6 mp -92.48 144.59 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.57 140.12 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.927 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.38 143.94 38.26 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.873 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.1 m -109.58 135.79 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.826 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.676 0.751 . . . . 1.0 109.063 -179.713 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.557 1.224 0 CA-C-O 119.225 -0.417 . . . . 1.0 110.735 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.26 -23.51 38.74 Favored 'Trans proline' 0 N--CA 1.51 2.451 0 C-N-CA 121.551 1.501 . . . . 1.0 111.737 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.24 132.16 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.334 0.588 . . . . 1.0 110.269 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.3 m -133.62 121.95 22.78 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.047 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.07 147.61 26.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.477 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.9 p -85.82 34.55 0.6 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.297 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -71.77 54.92 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.936 0.398 . . . . 1.0 110.261 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -52.14 -32.6 36.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.311 0.577 . . . . 1.0 110.434 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.9 p -134.85 139.26 31.72 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.638 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -79.33 115.62 3.48 Favored 'Trans proline' 0 N--CA 1.515 2.771 0 C-N-CA 120.522 0.815 . . . . 1.0 111.779 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -167.13 102.93 0.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.805 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -52.58 146.41 10.08 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.018 0.437 . . . . 1.0 110.642 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.91 -23.6 22.6 Favored Glycine 0 N--CA 1.476 1.301 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -67.66 141.09 56.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.887 0.375 . . . . 1.0 110.014 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.94 133.85 47.74 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.1 pt -119.65 144.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.976 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.7 m -96.25 110.46 22.76 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.559 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.4 t -93.82 117.71 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -128.38 137.73 52.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.266 0.555 . . . . 1.0 110.286 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.56 123.51 40.75 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.253 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -77.63 116.05 17.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.22 121.86 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.6 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.1 m -108.72 122.73 47.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 120.993 0.425 . . . . 1.0 110.078 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.472 0.627 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.859 179.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 121.34 0.59 . . . . 1.0 110.584 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.96 121.18 14.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.89 154.0 18.47 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.115 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -142.71 171.0 14.64 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.484 0.659 . . . . 1.0 110.131 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 51.13 63.68 2.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.613 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.56 84.25 6.22 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 115.45 -0.796 . . . . 1.0 109.953 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -79.21 158.77 26.52 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 121.365 1.377 . . . . 1.0 111.518 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.51 135.99 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.358 -0.837 . . . . 1.0 109.842 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.05 115.09 17.94 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.47 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 m -107.83 140.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.796 0.807 . . . . 1.0 109.489 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.67 130.28 17.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.205 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.65 125.94 32.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.96 -162.33 18.04 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -93.66 146.68 32.22 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 119.1 -0.476 . . . . 1.0 111.039 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.12 -12.18 29.95 Favored 'Trans proline' 0 N--CA 1.511 2.55 0 C-N-CA 120.679 0.919 . . . . 1.0 111.606 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.29 86.59 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.02 0.438 . . . . 1.0 110.699 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -81.64 7.37 12.49 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.09 -9.35 47.2 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.31 177.77 0.21 Allowed Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.74 135.92 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.921 0.391 . . . . 1.0 110.345 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.17 132.23 44.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.871 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.27 -42.67 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.48 155.72 26.11 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -148.18 161.58 41.17 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.472 0.653 . . . . 1.0 110.48 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -160.99 114.11 1.97 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.111 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.9 m -82.62 140.55 33.12 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.14 147.73 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.657 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -64.49 -46.28 83.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 1.0 110.54 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -166.5 137.07 3.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.657 -0.702 . . . . 1.0 110.596 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.92 118.83 32.78 Favored Pre-proline 0 N--CA 1.494 1.739 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.69 162.73 37.21 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 CA-C-N 119.78 0.957 . . . . 1.0 111.693 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.11 137.71 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.41 16.44 77.36 Favored Glycine 0 CA--C 1.511 -0.204 0 N-CA-C 110.144 -1.182 . . . . 1.0 110.144 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.08 17.52 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 p -140.17 -170.57 3.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.498 0.666 . . . . 1.0 110.634 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.63 147.2 18.72 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.6 114.66 19.66 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.631 . . . . 1.0 109.81 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.67 154.01 22.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.52 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -126.18 121.66 33.42 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.81 131.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.549 0.69 . . . . 1.0 109.49 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -110.73 138.66 46.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.93 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -138.73 133.71 32.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.912 0.863 . . . . 1.0 109.983 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.38 121.01 30.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 1.0 109.73 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.27 122.94 20.48 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.467 0.404 0 CA-C-O 121.1 0.476 . . . . 1.0 110.429 -179.669 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.623 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -117.05 82.29 13.53 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-O 118.474 -0.774 . . . . 1.0 109.234 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.82 160.81 33.93 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 121.848 1.698 . . . . 1.0 111.236 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.36 158.53 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.063 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.55 149.47 35.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.804 0.811 . . . . 1.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.05 136.39 20.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.06 144.15 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.702 0.763 . . . . 1.0 109.683 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -94.94 139.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.819 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 t70 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 118.59 -0.719 . . . . 1.0 109.696 179.849 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -161.46 42.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.178 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.9 146.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.156 0.503 . . . . 1.0 109.65 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -147.76 154.19 40.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.7 t -160.55 145.92 14.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.174 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.88 130.71 34.27 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.272 0.558 . . . . 1.0 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.5 mp -80.95 128.42 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.6 t -132.21 138.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.742 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -130.63 110.22 11.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.006 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -89.83 137.22 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.732 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 121.309 0.576 . . . . 1.0 109.486 -179.591 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 CA--C 1.552 1.032 0 CA-C-O 118.359 -0.829 . . . . 1.0 111.005 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.74 -21.51 5.79 Favored 'Trans proline' 0 N--CA 1.512 2.587 0 C-N-CA 121.831 1.687 . . . . 1.0 112.562 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.51 132.74 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.077 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.7 p -134.51 122.3 22.23 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.266 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.86 147.14 30.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.418 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.0 t -81.81 36.39 0.44 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.404 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HZ1' ' CZ ' ' A' ' 110' ' ' ARG . 58.8 pttt -71.43 50.72 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.047 0.451 . . . . 1.0 110.714 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.19 -39.27 72.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.588 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -124.41 84.33 56.68 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.875 -0.583 . . . . 1.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.13 112.91 0.58 Allowed 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.9 1.734 . . . . 1.0 112.56 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -167.08 123.96 1.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.961 0.41 . . . . 1.0 110.592 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.68 147.19 33.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 1.0 110.448 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.58 -31.64 4.48 Favored Glycine 0 N--CA 1.474 1.212 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.79 133.6 50.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.863 0.363 . . . . 1.0 110.052 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -68.19 136.54 53.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.792 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 pt -126.0 146.67 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.454 0.645 . . . . 1.0 110.426 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -92.79 112.26 24.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.616 -0.72 . . . . 1.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 69' ' ' VAL . 22.0 t -93.09 117.75 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.848 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -129.42 136.79 50.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.349 0.595 . . . . 1.0 110.29 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.08 125.96 46.17 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.02 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -81.19 113.72 19.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.66 124.66 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.867 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.8 m -101.25 122.04 42.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.118 0.485 . . . . 1.0 110.015 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.559 0.695 . . . . 1.0 109.76 179.472 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.49 0.662 . . . . 1.0 110.52 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -61.1 117.14 5.16 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.175 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.43 22.85 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.049 0.452 . . . . 1.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -137.96 159.79 41.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.114 0.959 . . . . 1.0 109.817 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 53.46 65.79 1.41 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.474 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -113.32 83.34 6.53 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.91 176.37 10.21 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 120.909 1.072 . . . . 1.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -150.34 145.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.025 -0.988 . . . . 1.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.97 132.57 43.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.507 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.07 144.93 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.43 0.633 . . . . 1.0 109.335 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.19 150.14 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.262 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 tp -99.47 127.21 45.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.046 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.96 -154.75 16.45 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -116.35 143.86 31.93 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.112 -0.471 . . . . 1.0 111.257 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.58 -10.85 23.99 Favored 'Trans proline' 0 N--CA 1.511 2.508 0 C-N-CA 120.725 0.95 . . . . 1.0 111.58 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.828 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -80.69 -76.13 0.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.86 78.2 0.05 OUTLIER Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.39 168.26 26.43 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 p -132.77 139.34 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 120.952 0.406 . . . . 1.0 110.487 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -74.71 136.97 41.8 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.096 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -95.02 -41.74 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.72 171.08 42.28 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -150.32 162.63 40.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.761 0.791 . . . . 1.0 110.253 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -152.46 113.93 4.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.147 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -78.08 132.9 37.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.8 mt -89.57 150.77 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.33 -51.34 66.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -169.79 141.79 2.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.505 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mt -113.97 124.03 31.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 117.978 -1.011 . . . . 1.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.16 160.17 45.9 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 120.87 1.047 . . . . 1.0 111.705 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.09 143.27 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.19 10.65 66.06 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.83 -167.75 16.37 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.0 p -145.64 150.44 36.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.439 -0.38 . . . . 1.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.4 148.93 19.23 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.46 109.79 16.65 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.602 0.715 . . . . 1.0 109.75 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 154.35 18.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.893 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -132.45 123.03 25.87 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 20' ' ' VAL . 40.8 t -137.08 135.11 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.457 -0.792 . . . . 1.0 109.506 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -103.41 138.8 39.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.031 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -139.77 132.46 28.94 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.627 0.727 . . . . 1.0 110.248 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -86.41 124.62 32.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.784 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 100.61 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 121.196 0.522 . . . . 1.0 110.26 -179.664 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.965 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -119.14 65.03 7.38 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 118.818 -0.61 . . . . 1.0 109.524 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.96 147.85 94.12 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.228 1.952 . . . . 1.0 111.431 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.46 141.63 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.901 0.857 . . . . 1.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.68 151.83 51.86 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.317 1.055 . . . . 1.0 109.882 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.13 139.93 26.32 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.669 -1.15 . . . . 1.0 109.919 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.7 t -133.04 141.95 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 121.82 0.819 . . . . 1.0 110.034 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.11 136.61 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.697 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 118.182 -0.913 . . . . 1.0 111.729 -179.603 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -95.01 35.26 1.28 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.12 0.568 . . . . 1.0 110.36 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.21 137.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -146.23 147.99 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.273 0.558 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.9 p -164.26 149.66 10.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.701 -0.681 . . . . 1.0 109.839 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.491 ' CZ ' ' HZ1' ' A' ' 9' ' ' LYS . 77.6 ttt180 -134.32 126.31 29.44 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.883 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.0 mm -85.1 101.6 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 m -86.87 144.25 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -119.58 132.62 55.77 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.618 0.723 . . . . 1.0 110.034 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.27 135.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.175 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 115.606 -0.724 . . . . 1.0 109.287 -179.713 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.566 1.572 0 CA-C-O 118.402 -0.809 . . . . 1.0 111.069 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.14 -27.98 23.99 Favored 'Trans proline' 0 N--CA 1.519 2.984 0 C-N-CA 121.092 1.195 . . . . 1.0 112.775 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -109.99 134.48 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.195 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 p -143.7 137.8 28.43 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.341 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.17 157.32 47.21 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.276 0.56 . . . . 1.0 110.396 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 m -84.02 113.42 21.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.702 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -145.9 52.1 1.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.032 0.444 . . . . 1.0 110.72 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.61 -43.18 84.54 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.463 0.649 . . . . 1.0 110.487 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.0 p -124.01 84.38 54.98 Favored Pre-proline 0 N--CA 1.485 1.323 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.169 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.43 122.06 7.2 Favored 'Trans proline' 0 N--CA 1.515 2.74 0 C-N-CA 121.348 1.365 . . . . 1.0 112.705 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -167.88 123.01 1.0 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.667 -0.242 . . . . 1.0 110.675 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -56.19 145.16 27.17 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.611 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.21 -26.7 6.69 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 111.357 -0.697 . . . . 1.0 111.357 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -69.63 140.4 53.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -73.73 137.28 43.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -132.31 147.94 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.161 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -94.64 141.4 28.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.418 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.0 126.89 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -137.0 128.53 28.5 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.496 0.665 . . . . 1.0 109.953 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.86 131.48 56.92 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.487 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -89.22 118.15 28.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.495 0.664 . . . . 1.0 109.498 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.32 132.97 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.784 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.2 m -100.66 127.81 46.93 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.124 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 . . . . . 0 N--CA 1.478 0.939 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.636 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.291 0.567 . . . . 1.0 110.422 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 24.7 mp0 -59.81 118.81 6.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.923 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.2 154.66 17.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.99 0.424 . . . . 1.0 110.082 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -144.94 175.1 10.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.752 0.787 . . . . 1.0 110.067 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 50.93 64.08 1.98 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.978 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.7 t -116.21 84.52 14.17 Favored Pre-proline 0 N--CA 1.489 1.486 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.473 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.66 120.35 3.5 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.626 0.884 . . . . 1.0 111.579 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 t -87.35 141.33 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.647 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 115.65 17.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.61 144.15 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.62 0.724 . . . . 1.0 109.227 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -152.16 143.28 23.18 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -95.61 128.29 42.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.237 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.57 -158.36 17.23 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 110.784 -0.926 . . . . 1.0 110.784 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -103.32 144.23 28.21 Favored Pre-proline 0 N--CA 1.487 1.408 0 CA-C-O 118.404 -0.808 . . . . 1.0 111.461 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.54 -29.68 16.0 Favored 'Trans proline' 0 N--CA 1.516 2.824 0 C-N-CA 120.796 0.997 . . . . 1.0 111.808 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.32 90.29 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -67.55 -70.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.238 0.542 . . . . 1.0 110.166 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 85.85 0.06 OUTLIER Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.47 141.7 47.22 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -113.47 123.98 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-O 121.124 0.488 . . . . 1.0 109.821 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.36 125.08 24.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.643 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.36 -42.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.58 163.34 32.39 Favored Glycine 0 N--CA 1.462 0.417 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -150.35 163.98 36.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.508 0.67 . . . . 1.0 110.528 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.95 116.87 1.03 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.139 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -75.23 139.15 42.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.3 mm -78.55 148.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.698 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -63.84 -47.9 78.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.31 0.576 . . . . 1.0 110.418 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -168.51 136.26 2.1 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.385 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.13 119.21 37.12 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-O 117.785 -1.102 . . . . 1.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.86 165.62 29.68 Favored 'Trans proline' 0 N--CA 1.518 2.966 0 CA-C-N 120.009 1.039 . . . . 1.0 111.993 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.73 139.89 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.003 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.83 73.11 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.83 -171.15 18.12 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.8 p -143.68 149.81 37.77 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.806 0.336 . . . . 1.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.97 157.14 18.03 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.1 tp -150.46 139.33 20.89 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.932 0.872 . . . . 1.0 110.039 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.71 160.37 26.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.024 -0.989 . . . . 1.0 109.866 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -122.2 124.14 43.13 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.493 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.0 142.84 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.761 0.791 . . . . 1.0 109.587 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -103.44 140.81 36.97 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -141.01 132.49 26.91 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.319 0.581 . . . . 1.0 109.931 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -88.04 124.54 33.85 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.695 -0.684 . . . . 1.0 109.388 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.06 130.22 42.28 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 121.373 0.606 . . . . 1.0 110.345 -179.82 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.951 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.19 63.64 17.8 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.22 -177.91 0.56 Allowed 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.676 1.584 . . . . 1.0 111.837 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.89 158.38 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.331 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -153.11 148.0 26.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.026 0.917 . . . . 1.0 109.817 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.57 145.03 31.59 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.017 -0.992 . . . . 1.0 109.973 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -141.25 142.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.419 0.628 . . . . 1.0 110.206 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.01 136.53 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.706 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 CA--C 1.555 1.135 0 CA-C-O 117.666 -1.159 . . . . 1.0 111.404 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.0 t30 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.072 -0.344 . . . . 1.0 110.072 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.75 46.35 1.23 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.495 0.718 . . . . 1.0 110.999 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.62 136.08 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.336 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -143.99 145.47 32.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.832 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 t -165.42 147.82 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.576 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -134.02 128.15 33.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.477 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.09 132.61 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.27 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.18 142.91 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.989 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.73 149.45 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.502 0.668 . . . . 1.0 109.698 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.43 136.7 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.785 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.87 0.843 . . . . 1.0 110.042 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 118.925 -0.559 . . . . 1.0 111.373 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 -27.46 13.92 Favored 'Trans proline' 0 N--CA 1.51 2.47 0 C-N-CA 121.766 1.644 . . . . 1.0 111.742 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.85 130.96 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.221 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -132.66 122.69 25.04 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.941 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.0 mt -104.33 144.2 31.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.232 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.3 m -80.07 44.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.627 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -75.89 51.84 0.66 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.564 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.55 -45.25 92.37 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.238 0.542 . . . . 1.0 110.331 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.2 p -119.19 85.94 31.39 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.378 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.43 116.37 1.54 Allowed 'Trans proline' 0 N--CA 1.514 2.685 0 C-N-CA 121.524 1.483 . . . . 1.0 112.804 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -167.09 117.2 0.87 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.621 0.248 . . . . 1.0 110.508 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -55.95 146.32 22.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.03 0.443 . . . . 1.0 110.354 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.26 -26.19 8.2 Favored Glycine 0 N--CA 1.475 1.293 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.34 146.93 53.59 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.41 132.96 37.55 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.398 0.618 . . . . 1.0 109.651 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.31 145.29 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -91.25 115.96 28.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.899 -0.592 . . . . 1.0 109.522 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.88 112.89 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.4 p -123.56 138.24 54.6 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.556 0.693 . . . . 1.0 110.18 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.16 124.67 47.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.033 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.76 113.22 21.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.719 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -92.71 117.85 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.616 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.7 m -89.75 125.31 35.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.903 0.859 . . . . 1.0 109.665 179.197 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.477 0.656 . . . . 1.0 110.699 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.25 116.4 3.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.286 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.88 152.27 20.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -142.44 169.83 16.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.696 0.76 . . . . 1.0 110.049 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 49.48 62.25 2.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.716 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -113.47 82.69 6.25 Favored Pre-proline 0 N--CA 1.485 1.297 0 CA-C-N 115.749 -0.659 . . . . 1.0 109.381 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -80.35 112.39 2.75 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 121.201 1.267 . . . . 1.0 111.395 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.92 146.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.831 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.81 122.13 28.14 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -117.0 143.48 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.466 0.651 . . . . 1.0 109.704 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -156.14 132.6 10.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 mp -87.13 127.86 35.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.606 0.717 . . . . 1.0 109.697 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.31 -154.6 16.51 Favored Glycine 0 N--CA 1.469 0.879 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -122.21 143.01 38.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.175 -0.916 . . . . 1.0 111.721 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.6 -39.57 46.23 Favored 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 120.782 0.988 . . . . 1.0 113.069 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . -60.78 -42.37 97.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.931 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.04 8.65 1.48 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.104 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 66.77 72.89 0.7 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.98 163.35 25.22 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 141.4 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.233 0.539 . . . . 1.0 110.481 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.85 135.81 40.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.811 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -103.15 -42.84 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.533 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.93 160.36 30.26 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 110.576 -1.01 . . . . 1.0 110.576 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -151.6 164.48 36.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.667 0.746 . . . . 1.0 110.406 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -154.51 115.94 4.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.358 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -77.0 133.91 39.0 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 mm -79.76 145.82 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.531 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -63.5 -49.33 73.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.693 0.759 . . . . 1.0 110.687 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -173.06 142.22 1.04 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.302 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.5 mt -122.98 120.45 27.53 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 118.03 -0.986 . . . . 1.0 111.145 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.12 166.82 28.53 Favored 'Trans proline' 0 N--CA 1.509 2.438 0 C-N-CA 120.85 1.033 . . . . 1.0 111.648 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.74 139.13 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.412 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.51 22.65 76.6 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.54 -172.32 15.91 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -139.9 -169.19 2.67 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.528 0.68 . . . . 1.0 110.672 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.44 150.91 22.27 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.89 114.92 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.847 0.832 . . . . 1.0 110.206 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.82 155.75 19.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.705 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -126.12 122.27 35.26 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.705 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 t -136.75 136.06 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.87 0.843 . . . . 1.0 109.323 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -108.4 140.66 41.37 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.946 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -141.67 135.76 30.21 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.95 0.881 . . . . 1.0 109.837 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -89.64 123.0 33.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.635 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.51 35.72 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 1.0 110.318 179.655 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.097 0 N-CA-C 110.893 -0.883 . . . . 1.0 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.44 68.93 1.37 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.57 -169.22 0.51 Allowed 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.081 1.187 . . . . 1.0 111.654 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -147.83 142.98 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.324 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.28 140.14 33.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.652 0.739 . . . . 1.0 109.747 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.7 141.6 26.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.32 -0.854 . . . . 1.0 109.95 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.4 t -140.75 143.72 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.996 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.98 142.71 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.533 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.558 1.272 0 CA-C-O 119.055 -0.497 . . . . 1.0 110.213 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.555 ' N ' HD21 ' A' ' 105' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -171.77 48.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.05 139.66 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 121.235 0.54 . . . . 1.0 109.868 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -144.9 143.81 30.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.243 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 t -171.18 137.04 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.414 0.626 . . . . 1.0 110.039 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -135.08 155.37 50.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.661 -0.699 . . . . 1.0 110.479 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.0 mm -83.36 123.12 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.089 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.21 103.87 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.44 102.7 15.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -106.9 127.91 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 1.0 109.82 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 121.72 0.771 . . . . 1.0 109.136 179.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 CA--C 1.552 1.033 0 CA-C-O 118.678 -0.677 . . . . 1.0 111.087 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.94 -27.32 20.98 Favored 'Trans proline' 0 N--CA 1.515 2.753 0 C-N-CA 121.492 1.461 . . . . 1.0 111.992 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.25 132.7 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.067 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 t -133.15 127.83 34.73 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.229 0.538 . . . . 1.0 110.227 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 9' ' ' LYS . 16.2 mt -108.61 144.04 36.86 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.275 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -76.74 36.15 0.16 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.844 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 7' ' ' LEU . 36.8 tttp -74.05 48.74 0.32 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.672 0.749 . . . . 1.0 110.235 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.14 -41.61 93.08 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.451 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -116.06 87.49 19.3 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.477 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.03 115.31 1.44 Allowed 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 121.051 1.167 . . . . 1.0 113.076 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -169.09 116.42 0.63 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.627 -0.26 . . . . 1.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -55.8 145.71 23.61 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.52 -25.98 8.71 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -65.77 144.03 57.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.77 137.04 38.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.48 0.657 . . . . 1.0 109.516 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.5 pt -124.05 145.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.399 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -87.56 113.62 23.41 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.07 113.24 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -130.1 135.19 47.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.576 0.703 . . . . 1.0 110.141 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 126.2 48.88 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.02 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -81.87 111.4 18.05 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 p -89.62 124.99 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.3 m -98.09 124.52 42.66 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 121.358 0.599 . . . . 1.0 109.647 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.3 0.571 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -62.1 126.95 29.11 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.579 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.54 135.88 37.42 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.532 ' O ' ' C ' ' A' ' 34' ' ' ASN . 33.6 m170 -105.9 169.71 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.087 0.946 . . . . 1.0 109.73 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 33' ' ' HIS . 4.3 p30 16.73 84.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.906 -1.043 . . . . 1.0 111.454 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 t -112.44 80.9 3.75 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.109 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -83.57 102.8 1.04 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 120.386 0.724 . . . . 1.0 111.352 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.46 149.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.46 40.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -121.37 143.98 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.5 0.667 . . . . 1.0 109.501 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -152.86 128.39 10.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.52 127.64 33.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.12 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.79 -155.33 17.12 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 110.714 -0.955 . . . . 1.0 110.714 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -121.34 143.72 38.21 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.325 -0.845 . . . . 1.0 111.503 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.59 -30.11 15.57 Favored 'Trans proline' 0 N--CA 1.517 2.904 0 CA-C-N 119.684 0.923 . . . . 1.0 113.166 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.37 87.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.729 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.16 -52.36 64.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.324 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.49 -4.08 0.26 Allowed Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.34 98.84 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -81.41 114.43 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.417 ' OE2' ' NH1' ' A' ' 53' ' ' ARG . 63.5 tt0 -74.46 112.69 10.89 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.9 -46.2 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 176.24 42.47 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.734 -0.947 . . . . 1.0 110.734 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.417 ' NH1' ' OE2' ' A' ' 50' ' ' GLU . 9.5 ptp85 -147.85 160.88 42.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.726 0.774 . . . . 1.0 110.457 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -146.07 113.7 6.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.893 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -84.98 130.25 34.66 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.7 145.77 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.079 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.558 ' HG ' ' H ' ' A' ' 58' ' ' ARG . 82.9 p -62.42 -46.58 87.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.121 0.486 . . . . 1.0 110.421 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.558 ' H ' ' HG ' ' A' ' 57' ' ' SER . 40.4 ttm180 -169.09 137.53 2.0 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.472 0.653 . . . . 1.0 109.9 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.0 mt -115.91 119.14 37.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 CA-C-O 118.393 -0.813 . . . . 1.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.43 168.71 24.18 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 CA-C-N 119.592 0.89 . . . . 1.0 112.302 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.12 141.23 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.91 13.5 59.51 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.597 -1.001 . . . . 1.0 110.597 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.95 -175.44 19.4 Favored Glycine 0 N--CA 1.477 1.393 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 p -143.09 150.91 40.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.882 -0.159 . . . . 1.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.82 158.19 21.32 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.21 -1.156 . . . . 1.0 110.21 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.24 110.84 16.64 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.9 0.857 . . . . 1.0 109.906 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.47 154.81 18.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.088 -0.96 . . . . 1.0 110.339 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -141.47 123.59 15.53 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.842 0.829 . . . . 1.0 110.594 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.05 135.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.428 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -92.6 137.1 32.66 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.597 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -139.65 131.02 26.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 1.0 109.639 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -97.26 123.9 41.19 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.003 -0.999 . . . . 1.0 109.482 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 147.09 53.25 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.484 1.235 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.433 -179.193 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.67 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.8 p -165.44 60.47 0.69 Allowed Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.98 163.34 31.09 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.943 1.762 . . . . 1.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.24 134.33 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 121.433 0.635 . . . . 1.0 109.787 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -128.46 148.23 50.72 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.996 0.903 . . . . 1.0 109.937 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.98 146.75 31.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.969 -1.014 . . . . 1.0 110.102 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.42 141.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.512 0.672 . . . . 1.0 110.156 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -86.83 137.5 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.547 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 117.951 -1.023 . . . . 1.0 111.547 -179.607 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.745 0.307 . . . . 1.0 110.673 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -90.56 51.58 2.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.155 0.502 . . . . 1.0 110.661 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.87 134.88 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.716 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -142.84 136.4 28.7 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.426 0.631 . . . . 1.0 109.736 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.6 m -158.48 145.14 17.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.527 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -144.11 127.2 16.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.974 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.445 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.9 mp -88.75 147.24 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.671 -0.863 . . . . 1.0 108.671 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.32 140.9 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 115.202 -0.908 . . . . 1.0 109.842 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -95.51 142.49 27.8 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.798 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.7 136.32 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-O 121.324 0.583 . . . . 1.0 110.203 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.484 1.264 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.707 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 mp . . . . . 0 CA--C 1.558 1.282 0 CA-C-O 118.336 -0.84 . . . . 1.0 111.115 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.47 -29.33 77.63 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.643 1.562 . . . . 1.0 112.339 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.9 mt -111.99 135.94 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.209 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 t -148.23 138.98 23.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.382 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.07 163.27 33.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.72 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.3 t -84.02 114.69 21.9 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.971 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.86 50.19 1.19 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.834 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -56.77 -43.79 81.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.717 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 p -123.19 84.93 51.52 Favored Pre-proline 0 N--CA 1.485 1.285 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.251 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -49.27 123.33 9.98 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 121.584 1.523 . . . . 1.0 112.2 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -168.15 123.7 1.0 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.397 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -56.85 146.21 27.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.599 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.16 -27.54 6.09 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 110.994 -0.843 . . . . 1.0 110.994 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.54 141.25 55.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.881 -0.415 . . . . 1.0 109.881 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -74.76 143.28 44.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.681 0.753 . . . . 1.0 109.745 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.046 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -89.35 112.51 23.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.366 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.02 118.33 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -130.79 133.99 46.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.442 0.639 . . . . 1.0 110.479 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.57 128.26 53.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.109 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.43 119.72 26.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.573 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.74 126.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.765 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -88.81 125.17 34.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.02 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.6 t30 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 121.239 0.542 . . . . 1.0 110.133 179.746 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 121.386 0.612 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -56.63 120.19 7.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.462 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.84 152.95 18.2 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.101 0.476 . . . . 1.0 109.828 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.438 ' CG ' ' H ' ' A' ' 34' ' ' ASN . 32.3 t-80 -146.15 173.31 12.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.876 0.846 . . . . 1.0 109.836 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.438 ' H ' ' CG ' ' A' ' 33' ' ' HIS . 31.4 m120 48.63 59.45 4.36 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.086 -0.961 . . . . 1.0 110.857 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.44 87.33 7.64 Favored Pre-proline 0 N--CA 1.488 1.457 0 CA-C-O 118.578 -0.725 . . . . 1.0 109.749 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.52 173.4 14.54 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 120.836 1.024 . . . . 1.0 111.478 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.58 144.42 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.92 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.1 133.06 43.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.528 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.1 146.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.635 0.731 . . . . 1.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -154.95 141.89 19.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.822 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tt -96.62 130.22 43.87 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.545 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.94 -153.04 17.09 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 110.498 -1.041 . . . . 1.0 110.498 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -126.01 140.03 35.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-O 118.175 -0.917 . . . . 1.0 111.575 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.04 -36.15 53.25 Favored 'Trans proline' 0 N--CA 1.517 2.888 0 C-N-CA 120.74 0.96 . . . . 1.0 112.923 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.48 89.49 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.885 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -65.77 -75.32 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.193 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.42 67.79 0.04 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.64 51.16 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.72 138.0 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.286 0.565 . . . . 1.0 110.403 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.93 136.13 53.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.766 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.0 mt -101.52 -38.95 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.531 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.01 164.16 34.04 Favored Glycine 0 N--CA 1.462 0.433 0 N-CA-C 110.654 -0.978 . . . . 1.0 110.654 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -149.35 162.17 40.6 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.967 0.889 . . . . 1.0 110.264 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -155.05 118.79 4.55 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.036 -0.983 . . . . 1.0 110.162 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.1 m -79.1 133.3 36.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.23 0.538 . . . . 1.0 109.591 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.8 mt -108.52 145.57 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.47 -56.35 2.31 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.628 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -64.92 79.28 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.316 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.3 mt -122.85 86.9 50.36 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 118.237 -0.887 . . . . 1.0 110.558 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.66 163.7 35.29 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.59 1.526 . . . . 1.0 111.746 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -69.09 142.7 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.445 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.41 68.9 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.04 -167.68 18.91 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -146.33 151.06 36.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.255 0.55 . . . . 1.0 110.253 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.64 151.85 19.81 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.062 -1.215 . . . . 1.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.52 116.52 16.04 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.746 0.784 . . . . 1.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 156.0 18.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.837 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -125.54 124.17 40.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.944 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.21 140.64 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.482 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -106.3 140.21 39.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.709 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -141.64 134.23 28.39 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.974 0.893 . . . . 1.0 109.839 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -102.34 127.56 49.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.986 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 141.88 53.27 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 N--CA 1.484 1.265 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.204 -179.734 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.668 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.5 m -119.45 65.26 8.45 Favored Pre-proline 0 N--CA 1.481 1.089 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.4 -179.55 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.129 1.886 . . . . 1.0 110.94 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.66 157.59 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.077 -0.965 . . . . 1.0 110.173 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -147.11 145.77 29.71 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.925 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.18 142.36 32.69 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.13 136.54 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.64 0.734 . . . . 1.0 110.088 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.63 138.37 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.666 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 CA--C 1.558 1.278 0 CA-C-O 117.917 -1.04 . . . . 1.0 111.184 -179.691 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -93.29 47.53 1.26 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.392 0.615 . . . . 1.0 110.737 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 58.7 t -100.38 135.76 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 121.723 0.773 . . . . 1.0 109.423 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 53.4 m-85 -144.68 146.3 32.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.245 -0.889 . . . . 1.0 109.929 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.9 t -163.05 150.02 12.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.437 -0.802 . . . . 1.0 109.8 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -145.25 132.58 20.62 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.088 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.7 mp -83.0 118.63 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.45 107.05 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.8 122.3 29.69 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.5 t -129.08 134.98 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 1.0 109.902 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 122.06 0.933 . . . . 1.0 109.931 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.554 1.113 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.21 -39.17 3.16 Favored 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 120.881 1.054 . . . . 1.0 112.417 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -100.51 133.83 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.588 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.9 p -137.26 123.06 20.0 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.4 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 9' ' ' LYS . 56.6 mt -112.27 150.7 30.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.48 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.3 p -81.09 28.35 0.37 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.37 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 7' ' ' LEU . 56.0 tttp -73.95 48.91 0.31 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -55.15 -26.24 37.31 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.193 0.52 . . . . 1.0 110.396 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -133.34 138.45 31.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-O 118.247 -0.883 . . . . 1.0 111.4 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -78.42 113.54 3.37 Favored 'Trans proline' 0 N--CA 1.51 2.468 0 CA-C-N 119.596 0.891 . . . . 1.0 111.642 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -166.96 99.39 0.54 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.78 146.83 16.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.733 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.93 -23.01 25.84 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -68.78 138.15 54.59 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.47 136.32 54.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.31 0.576 . . . . 1.0 109.622 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.84 148.1 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.234 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.5 m -96.35 114.11 25.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.816 -0.629 . . . . 1.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.24 122.77 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 m -128.63 132.66 48.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.33 0.586 . . . . 1.0 109.984 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.08 123.41 40.27 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.734 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -79.28 144.64 34.1 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.202 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.03 135.64 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -101.34 123.99 46.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.429 0.633 . . . . 1.0 110.103 179.677 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.183 0.516 . . . . 1.0 110.77 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -58.08 125.84 24.88 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.533 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.08 152.91 22.18 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.201 0.524 . . . . 1.0 110.107 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -147.22 -178.88 6.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.097 0.951 . . . . 1.0 109.741 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 47.83 59.24 4.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.832 -1.076 . . . . 1.0 111.223 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.86 84.66 2.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 CA-C-O 118.395 -0.812 . . . . 1.0 109.783 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.83 160.69 30.73 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 120.638 0.892 . . . . 1.0 111.724 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.82 141.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.031 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.43 129.09 42.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.499 -0.773 . . . . 1.0 109.536 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.51 146.32 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.724 0.773 . . . . 1.0 109.224 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -152.12 150.03 29.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.992 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tp -97.33 130.85 44.45 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.114 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.79 -153.55 17.45 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -118.72 143.63 33.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.36 -37.11 40.1 Favored 'Trans proline' 0 N--CA 1.521 3.142 0 CA-C-N 119.559 0.878 . . . . 1.0 113.275 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . -63.21 -42.57 99.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.783 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.91 8.69 1.42 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.235 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 66.31 74.2 0.55 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.89 163.99 13.98 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.125 -0.79 . . . . 1.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.79 132.97 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.211 0.529 . . . . 1.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.04 134.84 48.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.684 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -98.69 -36.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.577 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.84 172.84 41.01 Favored Glycine 0 N--CA 1.463 0.437 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.16 166.77 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.754 0.787 . . . . 1.0 110.294 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -161.17 117.14 2.18 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.95 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -76.62 136.52 39.2 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.9 mt -107.56 142.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.727 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 59' ' ' ILE . 95.8 p -105.02 -54.95 2.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.578 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -63.51 75.3 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.15 0.976 . . . . 1.0 110.967 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' SER . 49.7 mm -121.91 82.23 42.88 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 114.748 -1.115 . . . . 1.0 109.529 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 167.7 24.49 Favored 'Trans proline' 0 N--CA 1.506 2.219 0 C-N-CA 121.191 1.26 . . . . 1.0 111.844 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.95 137.73 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.323 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.23 13.84 73.64 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.93 -167.27 22.36 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.5 p -143.15 -174.32 4.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.297 0.57 . . . . 1.0 110.616 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.73 149.52 21.37 Favored Glycine 0 N--CA 1.477 1.382 0 N-CA-C 110.929 -0.869 . . . . 1.0 110.929 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.7 mt -138.68 124.61 19.95 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.278 1.037 . . . . 1.0 110.025 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.91 160.6 15.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.421 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -126.18 122.34 35.37 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.843 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.13 135.4 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 122.004 0.907 . . . . 1.0 109.043 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -99.77 139.09 35.93 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -143.01 143.37 31.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.143 0.973 . . . . 1.0 109.932 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -113.43 127.28 56.06 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.181 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 118.18 13.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.661 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 121.21 0.529 . . . . 1.0 109.916 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.705 0 N-CA-C 110.621 -0.991 . . . . 1.0 110.621 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.55 63.14 13.82 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.66 166.54 19.69 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.888 1.726 . . . . 1.0 111.245 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.5 158.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 114.898 -1.047 . . . . 1.0 110.144 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -152.95 146.54 25.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.872 0.844 . . . . 1.0 109.746 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.49 144.33 34.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.886 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.3 t -131.74 138.63 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.66 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.59 135.17 28.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 118.785 -0.626 . . . . 1.0 110.17 179.253 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.2 m120 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -159.61 46.53 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.71 104.43 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -110.27 132.04 54.53 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.03 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 t -164.36 144.09 7.67 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.331 0.586 . . . . 1.0 110.139 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -133.55 132.23 40.67 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.514 0.673 . . . . 1.0 110.136 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.5 mp -80.68 137.72 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.68 142.92 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.771 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.26 143.68 49.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.137 0.97 . . . . 1.0 110.061 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.43 137.83 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.293 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.753 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 CA--C 1.562 1.429 0 CA-C-O 119.478 -0.296 . . . . 1.0 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.84 -24.14 40.64 Favored 'Trans proline' 0 N--CA 1.515 2.75 0 C-N-CA 121.976 1.784 . . . . 1.0 111.957 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.4 mt -124.27 130.93 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.328 0.585 . . . . 1.0 110.2 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.2 m -134.87 123.46 23.52 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.856 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.47 147.64 28.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.369 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.9 p -81.06 34.41 0.35 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -70.79 50.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.974 0.51 . . . . 1.0 110.209 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -51.83 -30.33 23.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.658 0.742 . . . . 1.0 110.523 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.5 p -137.16 140.7 31.9 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.261 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.97 113.95 3.52 Favored 'Trans proline' 0 N--CA 1.514 2.728 0 CA-C-N 119.231 0.761 . . . . 1.0 111.392 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.92 101.45 0.55 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.86 0.362 . . . . 1.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 1.4 pm0 -53.9 148.8 9.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.948 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.14 -23.7 16.85 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -69.68 144.1 52.95 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.46 137.55 46.49 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.561 0.696 . . . . 1.0 109.508 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.14 146.55 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.915 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -97.7 114.51 26.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.7 119.7 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -129.09 132.99 47.48 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.265 0.555 . . . . 1.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.06 128.22 55.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.152 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -84.5 119.34 25.05 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 t -108.26 113.21 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.497 0.665 . . . . 1.0 109.215 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 m -86.27 131.92 34.11 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.557 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.006 0.431 . . . . 1.0 109.844 -179.841 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 121.495 0.664 . . . . 1.0 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -66.01 117.22 8.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.738 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.14 152.65 22.16 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.534 ' HD1' ' ND2' ' A' ' 34' ' ' ASN . 44.1 t-80 -139.91 169.04 18.44 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.518 0.675 . . . . 1.0 110.04 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.534 ' ND2' ' HD1' ' A' ' 33' ' ' HIS . 80.0 m-20 50.24 62.52 2.63 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.738 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 t -113.97 82.81 7.17 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -80.39 169.5 17.12 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.638 1.559 . . . . 1.0 111.322 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.13 136.61 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.547 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.38 114.91 18.83 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.275 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 t -104.44 137.48 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.526 0.679 . . . . 1.0 109.307 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -146.71 127.11 14.0 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.131 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tp -85.93 124.33 32.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 -158.75 15.68 Favored Glycine 0 N--CA 1.476 1.348 0 N-CA-C 110.762 -0.935 . . . . 1.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.5 142.68 28.56 Favored Pre-proline 0 N--CA 1.491 1.62 0 CA-C-O 117.788 -1.101 . . . . 1.0 111.528 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 46' ' ' GLN . 85.8 Cg_exo -48.8 -38.8 38.42 Favored 'Trans proline' 0 N--CA 1.519 2.992 0 CA-C-N 120.079 1.064 . . . . 1.0 113.108 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.51 22.89 0.23 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.981 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 44' ' ' PRO . 58.7 tt0 -166.71 -73.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.921 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.63 -97.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.1 90.86 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.1 115.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.24 133.07 45.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.67 -46.11 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.64 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.15 165.8 35.45 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -155.49 167.43 30.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.367 0.603 . . . . 1.0 110.629 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -161.25 119.82 2.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.404 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 m -75.11 131.4 40.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -80.81 155.51 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.541 ' HG ' ' N ' ' A' ' 58' ' ' ARG . 79.4 p -65.42 -51.96 56.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.602 0.715 . . . . 1.0 110.072 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.541 ' N ' ' HG ' ' A' ' 57' ' ' SER . 14.8 ptp180 -177.29 145.47 0.45 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.039 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.5 mt -114.56 117.29 42.85 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 117.571 -1.205 . . . . 1.0 110.686 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.13 162.25 41.19 Favored 'Trans proline' 0 N--CA 1.519 2.971 0 CA-C-N 120.286 1.138 . . . . 1.0 112.157 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.17 137.31 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.557 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.55 77.48 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.82 -167.9 14.69 Favored Glycine 0 N--CA 1.472 1.068 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -132.92 176.23 8.66 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.896 0.855 . . . . 1.0 110.364 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.41 124.42 0.94 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 115.098 -0.955 . . . . 1.0 110.783 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.76 160.15 37.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.05 0.929 . . . . 1.0 110.127 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.67 161.91 13.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.246 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.854 -1.066 . . . . 1.0 109.895 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -140.03 156.32 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.28 1.038 . . . . 1.0 109.169 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -123.32 141.72 51.69 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.956 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -140.8 137.56 33.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.991 0.9 . . . . 1.0 109.691 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -100.31 123.84 45.04 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.557 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.44 138.39 49.02 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.47 0.57 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.436 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -119.14 64.71 7.21 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -60.6 141.46 95.28 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.755 1.637 . . . . 1.0 111.734 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.7 t -98.49 147.02 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 115.349 -0.841 . . . . 1.0 109.862 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -135.38 138.88 43.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.037 0.923 . . . . 1.0 109.821 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.92 135.03 22.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.033 -0.985 . . . . 1.0 109.632 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 t -139.67 144.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.996 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.4 145.79 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.538 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 118.437 -0.792 . . . . 1.0 110.143 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 110.23 -0.285 . . . . 1.0 110.23 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -167.32 44.38 0.05 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.873 0.368 . . . . 1.0 110.547 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.45 139.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.222 0.534 . . . . 1.0 109.789 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -147.9 153.39 39.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.123 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -165.09 147.04 7.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.125 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -142.14 133.01 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.8 mp -81.28 123.35 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.63 136.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.376 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -131.95 125.19 30.99 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.317 0.58 . . . . 1.0 109.927 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.09 137.05 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.771 0.796 . . . . 1.0 110.039 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.481 1.088 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.952 -179.689 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 CA--C 1.563 1.447 0 CA-C-O 118.314 -0.851 . . . . 1.0 110.918 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.47 -32.16 61.58 Favored 'Trans proline' 0 N--CA 1.516 2.806 0 C-N-CA 121.099 1.2 . . . . 1.0 112.603 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.95 130.1 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.202 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -134.22 121.76 21.81 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.475 0.655 . . . . 1.0 109.921 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.04 147.29 27.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.445 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -94.03 78.03 4.09 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.603 0.716 . . . . 1.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.44 58.89 0.69 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.444 1.098 . . . . 1.0 110.693 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.67 -33.72 56.26 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.743 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -126.93 132.74 24.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.903 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -81.13 105.78 1.68 Allowed 'Trans proline' 0 N--CA 1.511 2.518 0 CA-C-N 119.914 1.005 . . . . 1.0 111.438 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -169.42 117.32 0.62 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.206 0.527 . . . . 1.0 110.454 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.76 150.81 9.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.065 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.3 34.56 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -72.82 126.33 29.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.217 0.532 . . . . 1.0 109.815 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -65.03 131.54 46.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.662 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.8 pt -119.69 147.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.271 0.558 . . . . 1.0 109.741 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.9 m -94.5 121.14 35.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.701 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.4 t -100.27 121.59 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -123.99 134.5 53.45 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.603 0.716 . . . . 1.0 109.808 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.09 120.67 33.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.08 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.81 123.25 30.96 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.997 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -107.62 129.26 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.216 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 m -90.94 123.75 34.68 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.305 0.574 . . . . 1.0 110.856 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -67.04 125.78 27.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.909 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.74 160.35 18.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 1.0 110.432 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -161.09 94.22 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 122.572 1.177 . . . . 1.0 109.33 178.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER 157.4 58.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.414 -1.266 . . . . 1.0 110.394 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.63 86.01 12.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.09 100.85 0.96 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.016 1.144 . . . . 1.0 111.269 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.97 143.02 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.759 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.15 120.21 26.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.935 0.494 . . . . 1.0 109.82 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.9 t -112.01 143.14 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.324 0.583 . . . . 1.0 109.582 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -151.98 126.01 9.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.102 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.55 128.54 34.95 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.643 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.61 -160.38 15.99 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -117.45 142.35 30.22 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.144 -0.932 . . . . 1.0 111.457 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.64 -40.95 46.48 Favored 'Trans proline' 0 N--CA 1.522 3.171 0 CA-C-N 119.688 0.924 . . . . 1.0 113.323 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.41 93.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.968 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -59.21 4.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.122 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.67 83.16 0.04 OUTLIER Glycine 0 N--CA 1.476 1.361 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.6 130.7 40.44 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.92 126.0 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.224 0.535 . . . . 1.0 109.786 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -68.48 122.14 17.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.824 -0.626 . . . . 1.0 109.926 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.16 -44.91 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.213 0.53 . . . . 1.0 109.94 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.56 168.53 37.98 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -158.16 169.99 23.27 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.618 0.723 . . . . 1.0 110.334 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -163.45 114.66 1.41 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.005 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -75.22 140.51 43.3 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.9 mm -78.63 142.09 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -66.62 -50.13 64.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.229 0.538 . . . . 1.0 110.579 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -147.3 130.33 16.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.759 0.79 . . . . 1.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 mt -117.71 108.47 42.88 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.982 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.95 159.88 44.08 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 CA-C-N 119.934 1.012 . . . . 1.0 111.667 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -70.57 145.52 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.499 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.26 1.86 29.95 Favored Glycine 0 N--CA 1.461 0.321 0 N-CA-C 110.385 -1.086 . . . . 1.0 110.385 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.95 -165.35 26.92 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -139.74 -173.42 3.62 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.388 0.613 . . . . 1.0 110.648 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.01 151.18 22.65 Favored Glycine 0 N--CA 1.477 1.408 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mt -132.54 152.59 51.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.291 1.043 . . . . 1.0 109.641 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.04 154.74 45.19 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.706 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -117.9 120.4 37.75 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.35 128.76 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.632 0.73 . . . . 1.0 109.269 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -99.29 140.04 34.05 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.848 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -137.98 121.88 17.71 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.981 0.896 . . . . 1.0 109.981 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -92.37 127.04 37.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.107 -0.951 . . . . 1.0 109.788 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.88 138.52 50.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.487 -0.485 . . . . 1.0 109.749 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.714 -179.373 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.823 0 N-CA-C 110.594 -1.003 . . . . 1.0 110.594 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.79 62.79 27.0 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.25 149.62 89.89 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.731 1.621 . . . . 1.0 111.309 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.6 t -103.75 114.33 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.72 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.61 147.32 30.79 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.852 0.834 . . . . 1.0 109.474 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.99 142.69 27.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.041 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.1 138.87 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.082 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -84.65 135.91 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.284 0 CA-C-O 117.759 -1.115 . . . . 1.0 111.558 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -155.06 26.39 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.418 0.287 . . . . 1.0 110.556 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.83 136.73 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -141.63 138.66 32.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.0 m -165.62 140.04 4.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.086 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -134.84 150.31 50.47 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.083 0.468 . . . . 1.0 110.444 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.5 mp -88.76 133.05 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.53 138.61 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.84 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.33 155.99 48.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.779 0.799 . . . . 1.0 109.535 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.55 133.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 mt . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.6 t0 52.91 84.3 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.332 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.81 156.58 72.13 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 118.529 -0.748 . . . . 1.0 110.911 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.5 -28.64 45.88 Favored 'Trans proline' 0 N--CA 1.517 2.855 0 C-N-CA 121.592 1.528 . . . . 1.0 112.361 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.15 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.762 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.5 p -131.93 120.22 22.2 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.955 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 9' ' ' LYS . 60.4 mt -102.66 145.48 29.61 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.225 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.8 t -78.88 31.17 0.2 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.6 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' H ' ' C ' ' A' ' 7' ' ' LEU . 80.8 tttt -72.98 49.35 0.24 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.584 0.707 . . . . 1.0 110.16 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -61.08 -40.49 93.89 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -117.17 89.86 31.94 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.708 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.47 111.13 0.33 Allowed 'Trans proline' 0 N--CA 1.523 3.221 0 C-N-CA 121.052 1.168 . . . . 1.0 113.256 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -162.48 109.37 1.27 Allowed 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.265 0.555 . . . . 1.0 110.432 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -55.68 142.68 33.22 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.112 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.1 18.23 63.37 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -107.28 143.62 35.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.663 0.385 . . . . 1.0 110.233 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.17 130.95 40.07 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.15 144.68 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.987 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -89.3 112.96 24.16 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -96.22 115.51 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.1 p -129.53 134.83 47.97 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.371 0.605 . . . . 1.0 110.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.0 127.18 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.831 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -84.03 116.26 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.81 126.51 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.135 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -96.18 126.91 41.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 120.677 0.275 . . . . 1.0 110.284 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -82.81 108.06 15.89 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 1.0 109.749 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -98.33 -168.17 1.61 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.238 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.27 -122.79 6.87 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.774 -0.93 . . . . 1.0 110.774 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.39 12.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.553 0.216 . . . . 1.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.41 156.06 44.04 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.25 0.548 . . . . 1.0 110.613 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.05 119.33 6.6 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.363 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.08 149.74 21.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.888 0.375 . . . . 1.0 110.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -137.13 162.75 32.53 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 122.435 1.112 . . . . 1.0 109.797 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 53.83 67.57 0.99 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.604 -1.18 . . . . 1.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.43 82.58 24.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.273 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.17 175.27 10.49 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.75 0.966 . . . . 1.0 111.16 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.51 138.69 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.677 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.26 114.25 17.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.379 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 t -107.59 140.56 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.519 0.676 . . . . 1.0 109.233 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -145.56 130.24 18.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.048 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.31 125.59 32.41 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.99 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -159.65 17.06 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -108.59 143.32 27.26 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.467 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.12 -21.19 27.63 Favored 'Trans proline' 0 N--CA 1.516 2.812 0 C-N-CA 120.5 0.8 . . . . 1.0 111.789 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.3 -45.88 89.33 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.934 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -72.38 -69.59 0.39 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.136 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.02 77.42 0.03 OUTLIER Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.32 165.84 21.6 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.54 141.8 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.089 0.471 . . . . 1.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -73.83 134.17 43.29 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.757 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -98.51 -42.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.7 168.75 39.37 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -153.96 166.19 33.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.506 0.67 . . . . 1.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -154.65 114.89 3.85 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.047 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -76.0 132.71 40.34 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.6 mt -86.46 148.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -62.24 -49.85 74.06 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.36 0.6 . . . . 1.0 110.465 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -176.25 146.77 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.293 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -118.31 124.16 28.8 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-O 117.924 -1.036 . . . . 1.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.04 163.15 39.07 Favored 'Trans proline' 0 N--CA 1.519 2.999 0 CA-C-N 119.844 0.98 . . . . 1.0 111.984 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -71.61 142.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.717 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.18 6.33 56.83 Favored Glycine 0 N--CA 1.465 0.627 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.9 -166.74 21.54 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 110.481 -1.048 . . . . 1.0 110.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 p -146.2 152.42 39.19 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.274 0.559 . . . . 1.0 110.14 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.55 157.75 19.84 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.39 113.72 7.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.501 0.667 . . . . 1.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.98 159.47 15.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.513 -0.767 . . . . 1.0 110.002 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -126.38 122.22 34.74 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.868 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.71 146.37 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.9 0.857 . . . . 1.0 109.55 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -119.84 142.29 48.77 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.216 -0.902 . . . . 1.0 110.033 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -144.5 145.2 31.73 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.012 0.911 . . . . 1.0 109.712 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -91.19 121.19 32.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.942 -1.026 . . . . 1.0 109.676 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.38 132.64 42.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t -170.82 119.64 0.53 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.951 0.405 . . . . 1.0 110.181 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -168.58 12.57 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.063 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -62.88 154.67 29.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.125 0.488 . . . . 1.0 110.461 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.39 13.21 1.22 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.261 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 53.07 46.71 26.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.535 0.683 . . . . 1.0 110.675 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.52 145.1 5.91 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 55.33 67.55 1.0 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.652 0.263 . . . . 1.0 110.824 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 83' ' ' ASN . . . -87.54 -17.39 32.14 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.332 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.03 37.16 0.24 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.917 0.389 . . . . 1.0 110.658 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 81' ' ' ALA . 4.9 t30 -167.58 130.25 1.34 Allowed Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 118.087 -0.958 . . . . 1.0 111.418 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.437 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 73.1 Cg_endo -71.26 -83.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.512 2.592 0 CA-C-N 119.831 0.975 . . . . 1.0 112.097 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.437 ' H ' ' HG2' ' A' ' 84' ' ' PRO . . . 83.72 11.96 78.56 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.9 p -118.42 64.98 5.93 Favored Pre-proline 0 N--CA 1.48 1.047 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -68.81 175.45 7.27 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.983 1.789 . . . . 1.0 111.357 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.43 135.73 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.868 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -135.22 146.78 48.98 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.862 0.839 . . . . 1.0 109.721 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.72 143.02 28.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.929 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.42 140.13 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.652 0.739 . . . . 1.0 109.728 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.06 140.63 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.255 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -40.69 146.66 0.44 Allowed Pre-proline 0 CA--C 1.561 1.387 0 CA-C-O 118.143 -0.932 . . . . 1.0 111.767 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.81 109.59 2.55 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 120.8 1.0 . . . . 1.0 112.231 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -85.24 8.74 17.32 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -149.84 49.54 0.93 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.954 0.407 . . . . 1.0 110.61 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 52.82 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.127 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.82 125.19 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-O 121.79 0.805 . . . . 1.0 109.87 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.87 100.29 0.22 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.073 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -70.31 -60.81 2.06 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.852 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.5 t -44.66 -47.37 10.54 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.505 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.85 -72.42 0.12 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 120.993 -0.283 . . . . 1.0 110.406 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 105' ' ' ASN . 22.9 mtpp -42.75 -45.53 4.81 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 120.962 0.41 . . . . 1.0 111.222 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.03 -6.7 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.511 0.672 . . . . 1.0 111.745 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.492 ' H ' ' C ' ' A' ' 103' ' ' LYS . 6.6 m120 -84.4 -38.22 20.52 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.935 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.28 46.6 1.11 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.364 0.666 . . . . 1.0 110.234 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 13.1 p -105.68 139.01 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.428 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 55.3 m-85 -145.33 143.24 30.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.146 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.4 p -170.54 143.36 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.74 147.28 33.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.418 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.6 mp -92.48 144.59 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.57 140.12 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.927 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.38 143.94 38.26 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.873 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.1 m -109.58 135.79 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.826 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.52 133.03 35.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.676 0.751 . . . . 1.0 109.063 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.17 101.73 5.92 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.342 -0.844 . . . . 1.0 109.671 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.478 ' N ' ' HD1' ' A' ' 117' ' ' HIS . 3.2 p-80 -165.63 171.66 12.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.226 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -149.53 152.32 35.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.182 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -69.07 123.1 20.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.622 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 122' ' ' HIS . 64.0 m80 -79.53 -157.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 1.0 109.926 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 55.49 -82.89 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.992 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.54 ' N ' ' HD1' ' A' ' 122' ' ' HIS . 2.5 p-80 . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 118.045 -0.979 . . . . 1.0 110.199 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' H2 ' ' H ' ' A' ' 2' ' ' ASP . 22.7 ptt? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.415 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 68.8 m-20 -81.44 76.18 8.38 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.235 0.54 . . . . 1.0 109.874 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.32 151.72 81.13 Favored Pre-proline 0 CA--C 1.557 1.224 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.735 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.26 -23.51 38.74 Favored 'Trans proline' 0 N--CA 1.51 2.451 0 C-N-CA 121.551 1.501 . . . . 1.0 111.737 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.24 132.16 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.334 0.588 . . . . 1.0 110.269 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.3 m -133.62 121.95 22.78 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.047 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.07 147.61 26.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.477 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.9 p -85.82 34.55 0.6 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.297 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -71.77 54.92 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.936 0.398 . . . . 1.0 110.261 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -52.14 -32.6 36.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.311 0.577 . . . . 1.0 110.434 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.9 p -134.85 139.26 31.72 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.638 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -79.33 115.62 3.48 Favored 'Trans proline' 0 N--CA 1.515 2.771 0 C-N-CA 120.522 0.815 . . . . 1.0 111.779 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -167.13 102.93 0.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.805 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -52.58 146.41 10.08 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.018 0.437 . . . . 1.0 110.642 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.91 -23.6 22.6 Favored Glycine 0 N--CA 1.476 1.301 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -67.66 141.09 56.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.887 0.375 . . . . 1.0 110.014 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.94 133.85 47.74 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.1 pt -119.65 144.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.976 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.7 m -96.25 110.46 22.76 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.559 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.4 t -93.82 117.71 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -128.38 137.73 52.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.266 0.555 . . . . 1.0 110.286 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.56 123.51 40.75 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.253 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -77.63 116.05 17.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.22 121.86 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.6 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.1 m -108.72 122.73 47.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 120.993 0.425 . . . . 1.0 110.078 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -89.47 127.55 35.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.859 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -129.52 130.58 45.97 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.536 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.56 -109.82 0.32 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.68 3.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.466 0.174 . . . . 1.0 110.846 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.39 163.26 36.18 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.34 0.59 . . . . 1.0 110.584 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.96 121.18 14.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.89 154.0 18.47 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.115 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -142.71 171.0 14.64 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.484 0.659 . . . . 1.0 110.131 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 51.13 63.68 2.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.613 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.56 84.25 6.22 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 115.45 -0.796 . . . . 1.0 109.953 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -79.21 158.77 26.52 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 121.365 1.377 . . . . 1.0 111.518 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.51 135.99 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.358 -0.837 . . . . 1.0 109.842 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.05 115.09 17.94 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.47 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 m -107.83 140.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.796 0.807 . . . . 1.0 109.489 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.67 130.28 17.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.205 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.65 125.94 32.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.96 -162.33 18.04 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -93.66 146.68 32.22 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 119.1 -0.476 . . . . 1.0 111.039 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.12 -12.18 29.95 Favored 'Trans proline' 0 N--CA 1.511 2.55 0 C-N-CA 120.679 0.919 . . . . 1.0 111.606 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.29 86.59 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.02 0.438 . . . . 1.0 110.699 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -81.64 7.37 12.49 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.09 -9.35 47.2 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.31 177.77 0.21 Allowed Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.74 135.92 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.921 0.391 . . . . 1.0 110.345 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.17 132.23 44.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.871 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.27 -42.67 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.48 155.72 26.11 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -148.18 161.58 41.17 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.472 0.653 . . . . 1.0 110.48 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -160.99 114.11 1.97 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.111 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.9 m -82.62 140.55 33.12 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.14 147.73 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.657 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -64.49 -46.28 83.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 1.0 110.54 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -166.5 137.07 3.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.657 -0.702 . . . . 1.0 110.596 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.92 118.83 32.78 Favored Pre-proline 0 N--CA 1.494 1.739 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.69 162.73 37.21 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 CA-C-N 119.78 0.957 . . . . 1.0 111.693 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.11 137.71 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.41 16.44 77.36 Favored Glycine 0 CA--C 1.511 -0.204 0 N-CA-C 110.144 -1.182 . . . . 1.0 110.144 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.08 17.52 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 p -140.17 -170.57 3.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.498 0.666 . . . . 1.0 110.634 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.63 147.2 18.72 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.6 114.66 19.66 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.631 . . . . 1.0 109.81 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.67 154.01 22.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.52 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -126.18 121.66 33.42 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.81 131.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.549 0.69 . . . . 1.0 109.49 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -110.73 138.66 46.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.93 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -138.73 133.71 32.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.912 0.863 . . . . 1.0 109.983 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.38 121.01 30.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 1.0 109.73 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.27 122.94 20.48 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -168.82 -167.36 0.75 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.1 0.476 . . . . 1.0 110.429 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 57.74 50.27 10.97 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.319 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.412 ' HZ2' ' CA ' ' A' ' 84' ' ' PRO . 86.1 tttt -168.27 88.92 0.25 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -67.53 -32.34 73.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.401 0.62 . . . . 1.0 110.121 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 54.66 73.8 0.38 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.567 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.52 84.84 0.05 OUTLIER Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 51.53 88.37 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.812 0.339 . . . . 1.0 110.726 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.77 102.65 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.12 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.05 -169.96 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.871 -0.418 . . . . 1.0 109.871 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 39.1 71.07 1.2 Allowed Pre-proline 0 N--CA 1.486 1.348 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.255 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.412 ' CA ' ' HZ2' ' A' ' 76' ' ' LYS . 96.6 Cg_exo -50.14 -45.18 34.54 Favored 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 121.978 1.785 . . . . 1.0 112.834 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.65 80.38 0.14 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -117.05 82.29 13.53 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-O 118.474 -0.774 . . . . 1.0 109.234 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.82 160.81 33.93 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 121.848 1.698 . . . . 1.0 111.236 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.36 158.53 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.063 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.55 149.47 35.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.804 0.811 . . . . 1.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.05 136.39 20.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.06 144.15 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.702 0.763 . . . . 1.0 109.683 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -94.94 139.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.819 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -120.37 81.6 30.68 Favored Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 118.59 -0.719 . . . . 1.0 109.696 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 96' ' ' ASN . 58.1 Cg_endo -80.15 162.44 23.03 Favored 'Trans proline' 0 N--CA 1.503 2.063 0 C-N-CA 121.765 1.643 . . . . 1.0 111.346 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.39 21.08 0.5 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.284 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 94' ' ' PRO . 21.3 t-20 -144.07 40.89 1.38 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.593 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -55.9 96.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.461 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.2 -55.58 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.208 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.29 -176.33 2.5 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.465 0.65 . . . . 1.0 110.387 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.17 -64.17 0.91 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.086 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.9 t -47.38 -44.54 24.33 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.228 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.21 -70.39 0.2 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.315 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.575 ' C ' ' H ' ' A' ' 105' ' ' ASN . 36.7 ttpt -44.77 -40.71 6.29 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.273 0.559 . . . . 1.0 111.054 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.7 3.33 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.556 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 103' ' ' LYS . 67.4 m-20 -94.9 32.6 1.63 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.615 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -161.46 42.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.178 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.9 146.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.156 0.503 . . . . 1.0 109.65 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -147.76 154.19 40.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.7 t -160.55 145.92 14.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.174 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.88 130.71 34.27 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.272 0.558 . . . . 1.0 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.5 mp -80.95 128.42 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.6 t -132.21 138.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.742 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -130.63 110.22 11.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.006 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -89.83 137.22 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.732 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.95 133.89 35.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.309 0.576 . . . . 1.0 109.486 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -65.7 -35.66 81.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.955 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -150.67 155.85 40.16 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.34 0.59 . . . . 1.0 110.577 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' ' 120' ' ' HIS . 60.2 t-80 -167.52 -13.6 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.392 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -80.73 24.85 0.46 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.405 ' H ' ' C ' ' A' ' 118' ' ' HIS . 59.7 t-80 -62.08 -47.27 85.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.412 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -75.17 71.52 2.21 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.072 0.463 . . . . 1.0 110.105 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 117.957 -1.02 . . . . 1.0 110.273 -179.93 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.23 104.19 1.41 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.87 151.4 93.06 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 118.359 -0.829 . . . . 1.0 111.005 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.74 -21.51 5.79 Favored 'Trans proline' 0 N--CA 1.512 2.587 0 C-N-CA 121.831 1.687 . . . . 1.0 112.562 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.51 132.74 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.077 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.7 p -134.51 122.3 22.23 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.266 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.86 147.14 30.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.418 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.0 t -81.81 36.39 0.44 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.404 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HZ1' ' CZ ' ' A' ' 110' ' ' ARG . 58.8 pttt -71.43 50.72 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.047 0.451 . . . . 1.0 110.714 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.19 -39.27 72.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.588 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -124.41 84.33 56.68 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.875 -0.583 . . . . 1.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.13 112.91 0.58 Allowed 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.9 1.734 . . . . 1.0 112.56 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -167.08 123.96 1.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.961 0.41 . . . . 1.0 110.592 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.68 147.19 33.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 1.0 110.448 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.58 -31.64 4.48 Favored Glycine 0 N--CA 1.474 1.212 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.79 133.6 50.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.863 0.363 . . . . 1.0 110.052 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -68.19 136.54 53.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.792 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 pt -126.0 146.67 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.454 0.645 . . . . 1.0 110.426 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -92.79 112.26 24.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.616 -0.72 . . . . 1.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 69' ' ' VAL . 22.0 t -93.09 117.75 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.848 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -129.42 136.79 50.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.349 0.595 . . . . 1.0 110.29 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.08 125.96 46.17 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.02 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -81.19 113.72 19.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.66 124.66 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.867 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.8 m -101.25 122.04 42.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.118 0.485 . . . . 1.0 110.015 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -91.77 122.56 34.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.559 0.695 . . . . 1.0 109.76 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.569 ' NH2' HD22 ' A' ' 106' ' ' ASN . 87.1 mtm180 -111.02 126.06 54.4 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.261 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.41 -137.37 4.07 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.16 10.98 0.21 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.983 -0.128 . . . . 1.0 110.668 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.22 158.47 43.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.49 0.662 . . . . 1.0 110.52 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -61.1 117.14 5.16 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.175 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.43 22.85 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.049 0.452 . . . . 1.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -137.96 159.79 41.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.114 0.959 . . . . 1.0 109.817 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 53.46 65.79 1.41 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.474 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -113.32 83.34 6.53 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.91 176.37 10.21 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 120.909 1.072 . . . . 1.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -150.34 145.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.025 -0.988 . . . . 1.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.97 132.57 43.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.507 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.07 144.93 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.43 0.633 . . . . 1.0 109.335 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.19 150.14 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.262 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 tp -99.47 127.21 45.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.046 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.96 -154.75 16.45 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -116.35 143.86 31.93 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.112 -0.471 . . . . 1.0 111.257 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.58 -10.85 23.99 Favored 'Trans proline' 0 N--CA 1.511 2.508 0 C-N-CA 120.725 0.95 . . . . 1.0 111.58 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.828 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -80.69 -76.13 0.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.86 78.2 0.05 OUTLIER Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.39 168.26 26.43 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 p -132.77 139.34 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 120.952 0.406 . . . . 1.0 110.487 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -74.71 136.97 41.8 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.096 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -95.02 -41.74 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.72 171.08 42.28 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -150.32 162.63 40.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.761 0.791 . . . . 1.0 110.253 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -152.46 113.93 4.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.147 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -78.08 132.9 37.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.8 mt -89.57 150.77 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.33 -51.34 66.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -169.79 141.79 2.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.505 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mt -113.97 124.03 31.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 117.978 -1.011 . . . . 1.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.16 160.17 45.9 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 120.87 1.047 . . . . 1.0 111.705 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.09 143.27 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.19 10.65 66.06 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.83 -167.75 16.37 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.0 p -145.64 150.44 36.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.439 -0.38 . . . . 1.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.4 148.93 19.23 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.46 109.79 16.65 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.602 0.715 . . . . 1.0 109.75 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 154.35 18.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.893 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -132.45 123.03 25.87 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 20' ' ' VAL . 40.8 t -137.08 135.11 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.457 -0.792 . . . . 1.0 109.506 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -103.41 138.8 39.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.031 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -139.77 132.46 28.94 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.627 0.727 . . . . 1.0 110.248 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -86.41 124.62 32.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.784 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 100.61 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 t -105.55 178.43 4.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.196 0.522 . . . . 1.0 110.26 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -156.23 170.0 23.25 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.519 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -151.12 141.29 22.23 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.324 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.87 107.57 9.29 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.278 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -169.17 104.21 0.38 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.44 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.25 106.87 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -64.31 140.75 58.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.809 -0.441 . . . . 1.0 109.809 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -157.12 153.72 28.24 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.38 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.55 -76.7 0.08 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.086 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.1 144.47 71.74 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.542 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.69 -37.6 2.18 Favored 'Trans proline' 0 N--CA 1.511 2.552 0 C-N-CA 120.635 0.89 . . . . 1.0 111.661 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.07 79.29 0.14 Allowed Glycine 0 N--CA 1.47 0.965 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -119.14 65.03 7.38 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 118.818 -0.61 . . . . 1.0 109.524 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.96 147.85 94.12 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.228 1.952 . . . . 1.0 111.431 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.46 141.63 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.901 0.857 . . . . 1.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.68 151.83 51.86 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.317 1.055 . . . . 1.0 109.882 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.13 139.93 26.32 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.669 -1.15 . . . . 1.0 109.919 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.7 t -133.04 141.95 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 121.82 0.819 . . . . 1.0 110.034 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.11 136.61 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.697 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -46.85 143.49 4.31 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-O 118.182 -0.913 . . . . 1.0 111.729 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.62 140.87 30.2 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.612 1.542 . . . . 1.0 111.547 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -74.01 -42.41 60.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.355 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -171.2 76.31 0.06 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.312 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 50.59 60.93 3.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.144 0.497 . . . . 1.0 111.033 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.87 146.33 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.139 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.32 158.48 34.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.87 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -66.28 -65.0 0.73 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.045 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.1 p -43.28 -37.54 2.23 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.092 -0.503 . . . . 1.0 111.126 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.64 -56.51 5.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.585 ' C ' ' H ' ' A' ' 105' ' ' ASN . 88.3 tttt -44.07 -38.39 3.58 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.298 0.57 . . . . 1.0 110.995 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.52 2.56 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.528 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.585 ' H ' ' C ' ' A' ' 103' ' ' LYS . 86.7 m-20 -91.88 -34.62 14.45 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.002 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.569 HD22 ' NH2' ' A' ' 27' ' ' ARG . 80.8 m-20 -95.01 35.26 1.28 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.12 0.568 . . . . 1.0 110.36 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.21 137.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -146.23 147.99 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.273 0.558 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.9 p -164.26 149.66 10.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.701 -0.681 . . . . 1.0 109.839 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.491 ' CZ ' ' HZ1' ' A' ' 9' ' ' LYS . 77.6 ttt180 -134.32 126.31 29.44 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.883 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.0 mm -85.1 101.6 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 m -86.87 144.25 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -119.58 132.62 55.77 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.618 0.723 . . . . 1.0 110.034 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.27 135.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.175 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 mp -83.99 130.34 34.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.606 -0.724 . . . . 1.0 109.287 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -62.73 143.39 57.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.221 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -70.78 106.05 3.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.697 -0.482 . . . . 1.0 109.697 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -65.58 133.23 50.75 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -167.17 -42.5 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 53.7 98.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.692 -0.231 . . . . 1.0 110.648 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -56.93 116.45 3.2 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.672 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 13.9 p80 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.643 -179.719 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' NH1' ' A' ' 23' ' ' ARG . 66.1 mtt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 55.43 177.03 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.772 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mp -73.81 153.34 89.18 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 118.402 -0.809 . . . . 1.0 111.069 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.14 -27.98 23.99 Favored 'Trans proline' 0 N--CA 1.519 2.984 0 C-N-CA 121.092 1.195 . . . . 1.0 112.775 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -109.99 134.48 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.195 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 p -143.7 137.8 28.43 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.341 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.17 157.32 47.21 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.276 0.56 . . . . 1.0 110.396 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 m -84.02 113.42 21.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.702 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -145.9 52.1 1.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.032 0.444 . . . . 1.0 110.72 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.61 -43.18 84.54 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.463 0.649 . . . . 1.0 110.487 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.0 p -124.01 84.38 54.98 Favored Pre-proline 0 N--CA 1.485 1.323 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.169 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.43 122.06 7.2 Favored 'Trans proline' 0 N--CA 1.515 2.74 0 C-N-CA 121.348 1.365 . . . . 1.0 112.705 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -167.88 123.01 1.0 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.667 -0.242 . . . . 1.0 110.675 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -56.19 145.16 27.17 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.611 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.21 -26.7 6.69 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 111.357 -0.697 . . . . 1.0 111.357 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -69.63 140.4 53.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -73.73 137.28 43.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -132.31 147.94 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.161 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -94.64 141.4 28.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.418 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.0 126.89 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -137.0 128.53 28.5 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.496 0.665 . . . . 1.0 109.953 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.86 131.48 56.92 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.487 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' NH1' ' O ' ' A' ' 1' ' ' MET . 99.9 mtt180 -89.22 118.15 28.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.495 0.664 . . . . 1.0 109.498 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.32 132.97 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.784 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.2 m -100.66 127.81 46.93 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.124 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -88.92 121.05 30.89 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.636 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -113.83 132.46 55.87 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.193 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.51 -125.13 1.25 Allowed Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.712 -0.955 . . . . 1.0 110.712 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.67 5.83 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.787 0.327 . . . . 1.0 110.871 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.26 162.68 39.0 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.291 0.567 . . . . 1.0 110.422 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 24.7 mp0 -59.81 118.81 6.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.923 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.2 154.66 17.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.99 0.424 . . . . 1.0 110.082 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -144.94 175.1 10.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.752 0.787 . . . . 1.0 110.067 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 50.93 64.08 1.98 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.978 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.7 t -116.21 84.52 14.17 Favored Pre-proline 0 N--CA 1.489 1.486 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.473 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.66 120.35 3.5 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.626 0.884 . . . . 1.0 111.579 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 t -87.35 141.33 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.647 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 115.65 17.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.61 144.15 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.62 0.724 . . . . 1.0 109.227 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -152.16 143.28 23.18 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -95.61 128.29 42.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.237 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.57 -158.36 17.23 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 110.784 -0.926 . . . . 1.0 110.784 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -103.32 144.23 28.21 Favored Pre-proline 0 N--CA 1.487 1.408 0 CA-C-O 118.404 -0.808 . . . . 1.0 111.461 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.54 -29.68 16.0 Favored 'Trans proline' 0 N--CA 1.516 2.824 0 C-N-CA 120.796 0.997 . . . . 1.0 111.808 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.32 90.29 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -67.55 -70.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.238 0.542 . . . . 1.0 110.166 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 85.85 0.06 OUTLIER Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.47 141.7 47.22 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -113.47 123.98 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-O 121.124 0.488 . . . . 1.0 109.821 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.36 125.08 24.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.643 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.36 -42.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.58 163.34 32.39 Favored Glycine 0 N--CA 1.462 0.417 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -150.35 163.98 36.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.508 0.67 . . . . 1.0 110.528 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.95 116.87 1.03 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.139 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -75.23 139.15 42.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.3 mm -78.55 148.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.698 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -63.84 -47.9 78.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.31 0.576 . . . . 1.0 110.418 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -168.51 136.26 2.1 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.385 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.13 119.21 37.12 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-O 117.785 -1.102 . . . . 1.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.86 165.62 29.68 Favored 'Trans proline' 0 N--CA 1.518 2.966 0 CA-C-N 120.009 1.039 . . . . 1.0 111.993 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.73 139.89 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.003 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.83 73.11 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.83 -171.15 18.12 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.8 p -143.68 149.81 37.77 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.806 0.336 . . . . 1.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.97 157.14 18.03 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.1 tp -150.46 139.33 20.89 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.932 0.872 . . . . 1.0 110.039 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.71 160.37 26.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.024 -0.989 . . . . 1.0 109.866 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -122.2 124.14 43.13 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.493 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.0 142.84 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.761 0.791 . . . . 1.0 109.587 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -103.44 140.81 36.97 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -141.01 132.49 26.91 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.319 0.581 . . . . 1.0 109.931 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -88.04 124.54 33.85 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.695 -0.684 . . . . 1.0 109.388 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.06 130.22 42.28 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 t -158.67 173.87 15.92 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.373 0.606 . . . . 1.0 110.345 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -150.93 85.19 1.35 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.985 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -67.36 131.98 46.78 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.854 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tp 54.23 94.28 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 O-C-N 123.087 0.242 . . . . 1.0 110.635 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.1 -163.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.699 0.285 . . . . 1.0 110.417 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.13 -139.55 21.29 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 55.08 76.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 117.177 0.489 . . . . 1.0 110.122 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 56.61 170.52 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.484 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.39 178.67 7.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.806 0.336 . . . . 1.0 110.18 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 60.53 145.53 0.06 OUTLIER Pre-proline 0 CA--C 1.564 1.49 0 CA-C-O 118.599 -0.715 . . . . 1.0 111.489 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -70.76 -55.0 0.16 Allowed 'Trans proline' 0 N--CA 1.516 2.832 0 CA-C-N 119.288 0.782 . . . . 1.0 111.997 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.38 78.34 0.15 Allowed Glycine 0 N--CA 1.47 0.951 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.19 63.64 17.8 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.22 -177.91 0.56 Allowed 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.676 1.584 . . . . 1.0 111.837 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.89 158.38 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.331 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -153.11 148.0 26.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.026 0.917 . . . . 1.0 109.817 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.57 145.03 31.59 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.017 -0.992 . . . . 1.0 109.973 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -141.25 142.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.419 0.628 . . . . 1.0 110.206 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.01 136.53 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.706 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -47.17 130.01 9.49 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 117.666 -1.159 . . . . 1.0 111.404 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.85 153.19 37.65 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 CA-C-N 120.27 1.132 . . . . 1.0 112.03 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -93.57 18.85 9.3 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.673 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.5 t30 58.57 12.04 1.97 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.835 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -145.25 -10.96 0.55 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.87 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.7 p -66.27 -27.4 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 120.893 0.378 . . . . 1.0 110.057 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 74.46 161.47 0.24 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.847 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -81.01 -57.11 3.68 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.556 0.693 . . . . 1.0 110.518 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.1 p -40.82 -40.74 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.448 -0.797 . . . . 1.0 111.446 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -74.83 -50.41 17.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.966 0.413 . . . . 1.0 109.888 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.617 ' C ' ' H ' ' A' ' 105' ' ' ASN . 34.2 ttmt -45.04 -44.48 10.18 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.161 0.505 . . . . 1.0 110.636 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.69 -0.11 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.76 0 CA-C-O 121.486 0.66 . . . . 1.0 111.752 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.617 ' H ' ' C ' ' A' ' 103' ' ' LYS . 57.0 t30 -89.53 -36.2 15.5 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.527 -0.76 . . . . 1.0 110.072 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.75 46.35 1.23 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.495 0.718 . . . . 1.0 110.999 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.62 136.08 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.336 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -143.99 145.47 32.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.832 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 t -165.42 147.82 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.576 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -134.02 128.15 33.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.477 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.09 132.61 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.27 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.18 142.91 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.989 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.73 149.45 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.502 0.668 . . . . 1.0 109.698 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.43 136.7 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.785 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -151.83 134.83 15.74 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.87 0.843 . . . . 1.0 110.042 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.578 ' C ' ' H ' ' A' ' 118' ' ' HIS . 47.5 tp10 -167.78 92.7 0.37 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.076 -0.965 . . . . 1.0 109.371 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 66.31 -17.44 0.12 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.858 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.578 ' H ' ' C ' ' A' ' 116' ' ' GLU . 49.9 t-80 56.2 177.65 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.365 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.553 ' H ' ' CG ' ' A' ' 118' ' ' HIS . 86.9 m-70 59.28 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.967 0.413 . . . . 1.0 110.69 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 118' ' ' HIS . 81.4 t60 54.33 102.35 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.499 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 122' ' ' HIS . 82.4 t60 56.94 170.42 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.753 -0.203 . . . . 1.0 110.498 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.447 ' N ' ' CG ' ' A' ' 121' ' ' HIS . 57.0 t-80 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 118.037 -0.982 . . . . 1.0 111.135 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' H3 ' ' H ' ' A' ' 2' ' ' ASP . 63.5 mtm . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.411 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 62.9 m-20 -153.47 173.53 15.57 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.698 0.761 . . . . 1.0 109.986 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.25 147.21 98.97 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.279 -0.873 . . . . 1.0 111.373 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 -27.46 13.92 Favored 'Trans proline' 0 N--CA 1.51 2.47 0 C-N-CA 121.766 1.644 . . . . 1.0 111.742 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.85 130.96 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.221 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -132.66 122.69 25.04 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.941 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.0 mt -104.33 144.2 31.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.232 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.3 m -80.07 44.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.627 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -75.89 51.84 0.66 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.564 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.55 -45.25 92.37 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.238 0.542 . . . . 1.0 110.331 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.2 p -119.19 85.94 31.39 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.378 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.43 116.37 1.54 Allowed 'Trans proline' 0 N--CA 1.514 2.685 0 C-N-CA 121.524 1.483 . . . . 1.0 112.804 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -167.09 117.2 0.87 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.621 0.248 . . . . 1.0 110.508 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -55.95 146.32 22.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.03 0.443 . . . . 1.0 110.354 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.26 -26.19 8.2 Favored Glycine 0 N--CA 1.475 1.293 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.34 146.93 53.59 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.41 132.96 37.55 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.398 0.618 . . . . 1.0 109.651 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.31 145.29 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -91.25 115.96 28.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.899 -0.592 . . . . 1.0 109.522 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.88 112.89 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.4 p -123.56 138.24 54.6 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.556 0.693 . . . . 1.0 110.18 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.16 124.67 47.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.033 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.76 113.22 21.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.719 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -92.71 117.85 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.616 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.7 m -89.75 125.31 35.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -103.34 111.66 24.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.903 0.859 . . . . 1.0 109.665 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -59.76 137.8 57.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.171 -0.922 . . . . 1.0 110.158 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.14 119.81 18.63 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.774 -0.93 . . . . 1.0 110.774 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -172.54 -78.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.905 -0.648 . . . . 1.0 109.796 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.59 149.21 40.44 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.477 0.656 . . . . 1.0 110.699 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.25 116.4 3.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.286 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.88 152.27 20.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -142.44 169.83 16.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.696 0.76 . . . . 1.0 110.049 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 49.48 62.25 2.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.716 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -113.47 82.69 6.25 Favored Pre-proline 0 N--CA 1.485 1.297 0 CA-C-N 115.749 -0.659 . . . . 1.0 109.381 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -80.35 112.39 2.75 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 121.201 1.267 . . . . 1.0 111.395 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.92 146.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.831 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.81 122.13 28.14 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -117.0 143.48 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.466 0.651 . . . . 1.0 109.704 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -156.14 132.6 10.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 mp -87.13 127.86 35.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.606 0.717 . . . . 1.0 109.697 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.31 -154.6 16.51 Favored Glycine 0 N--CA 1.469 0.879 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -122.21 143.01 38.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.175 -0.916 . . . . 1.0 111.721 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.6 -39.57 46.23 Favored 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 120.782 0.988 . . . . 1.0 113.069 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . -60.78 -42.37 97.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.931 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.04 8.65 1.48 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.104 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 66.77 72.89 0.7 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.98 163.35 25.22 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 141.4 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.233 0.539 . . . . 1.0 110.481 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.85 135.81 40.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.811 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -103.15 -42.84 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.533 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.93 160.36 30.26 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 110.576 -1.01 . . . . 1.0 110.576 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -151.6 164.48 36.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.667 0.746 . . . . 1.0 110.406 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -154.51 115.94 4.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.358 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -77.0 133.91 39.0 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 mm -79.76 145.82 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.531 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -63.5 -49.33 73.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.693 0.759 . . . . 1.0 110.687 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -173.06 142.22 1.04 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.302 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.5 mt -122.98 120.45 27.53 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 118.03 -0.986 . . . . 1.0 111.145 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.12 166.82 28.53 Favored 'Trans proline' 0 N--CA 1.509 2.438 0 C-N-CA 120.85 1.033 . . . . 1.0 111.648 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.74 139.13 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.412 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.51 22.65 76.6 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.54 -172.32 15.91 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -139.9 -169.19 2.67 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.528 0.68 . . . . 1.0 110.672 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.44 150.91 22.27 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.89 114.92 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.847 0.832 . . . . 1.0 110.206 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.82 155.75 19.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.705 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -126.12 122.27 35.26 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.705 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 t -136.75 136.06 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.87 0.843 . . . . 1.0 109.323 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -108.4 140.66 41.37 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.946 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -141.67 135.76 30.21 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.95 0.881 . . . . 1.0 109.837 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -89.64 123.0 33.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.635 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.51 35.72 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 t -167.78 131.5 1.7 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 1.0 110.318 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -147.1 -70.98 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.343 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' ALA . 1.3 ttmp? -164.53 151.18 11.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.332 0.587 . . . . 1.0 110.566 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mp -62.4 80.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.997 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 76' ' ' LYS . . . -84.98 177.04 8.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.848 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.83 136.8 2.81 Favored Glycine 0 N--CA 1.463 0.477 0 N-CA-C 110.615 -0.994 . . . . 1.0 110.615 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 53.73 97.67 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.609 0.242 . . . . 1.0 110.759 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.47 -171.12 1.6 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.283 0.563 . . . . 1.0 110.244 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.04 65.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.719 0.771 . . . . 1.0 110.408 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -165.92 96.13 0.78 Allowed Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.24 -0.891 . . . . 1.0 110.243 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -44.98 -83.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.513 2.632 0 C-N-CA 120.679 0.919 . . . . 1.0 113.336 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.77 11.01 78.01 Favored Glycine 0 N--CA 1.472 1.097 0 N-CA-C 110.893 -0.883 . . . . 1.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.44 68.93 1.37 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.57 -169.22 0.51 Allowed 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.081 1.187 . . . . 1.0 111.654 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -147.83 142.98 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.324 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.28 140.14 33.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.652 0.739 . . . . 1.0 109.747 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.7 141.6 26.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.32 -0.854 . . . . 1.0 109.95 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.4 t -140.75 143.72 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.996 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.98 142.71 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.533 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.2 146.31 97.97 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 119.055 -0.497 . . . . 1.0 110.213 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 96' ' ' ASN . 88.7 Cg_endo -74.47 170.63 19.82 Favored 'Trans proline' 0 N--CA 1.511 2.557 0 C-N-CA 121.13 1.22 . . . . 1.0 111.733 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -73.98 24.23 0.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.435 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 94' ' ' PRO . 41.4 t30 67.87 42.67 1.87 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.521 0.676 . . . . 1.0 110.499 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 67.7 mtp85 -133.97 -0.47 3.09 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.528 -0.76 . . . . 1.0 111.023 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t 54.74 102.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 116.673 -0.239 . . . . 1.0 110.563 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.483 ' C ' ' H ' ' A' ' 101' ' ' SER . . . -158.26 107.98 2.07 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.023 0.44 . . . . 1.0 110.385 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -72.46 13.11 0.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.237 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 99' ' ' ALA . 53.1 m -87.56 -55.15 3.91 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.305 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.45 -41.54 89.91 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.511 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.0 -60.84 3.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.328 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.44 -38.8 30.79 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.113 0.482 . . . . 1.0 110.864 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.555 ' N ' HD21 ' A' ' 105' ' ' ASN . 0.9 OUTLIER -86.16 34.28 0.62 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.959 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -171.77 48.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.05 139.66 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 121.235 0.54 . . . . 1.0 109.868 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -144.9 143.81 30.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.243 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 t -171.18 137.04 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.414 0.626 . . . . 1.0 110.039 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -135.08 155.37 50.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.661 -0.699 . . . . 1.0 110.479 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.0 mm -83.36 123.12 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.089 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.21 103.87 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.44 102.7 15.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -106.9 127.91 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 1.0 109.82 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.18 176.73 6.84 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.72 0.771 . . . . 1.0 109.136 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -169.32 43.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.303 -0.862 . . . . 1.0 110.164 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -164.1 108.14 0.97 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.339 0.59 . . . . 1.0 110.151 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -149.54 159.59 44.18 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.096 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.599 ' CG ' ' H ' ' A' ' 120' ' ' HIS . 51.0 t60 -167.25 -138.06 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.269 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.599 ' H ' ' CG ' ' A' ' 119' ' ' HIS . 90.4 m-70 52.16 67.75 0.92 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.462 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -167.36 11.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.632 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 118.065 -0.969 . . . . 1.0 111.404 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 ttm . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -67.73 126.74 30.35 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.2 mt -65.63 144.39 98.89 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.678 -0.677 . . . . 1.0 111.087 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.94 -27.32 20.98 Favored 'Trans proline' 0 N--CA 1.515 2.753 0 C-N-CA 121.492 1.461 . . . . 1.0 111.992 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.25 132.7 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.067 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 t -133.15 127.83 34.73 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.229 0.538 . . . . 1.0 110.227 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 9' ' ' LYS . 16.2 mt -108.61 144.04 36.86 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.275 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -76.74 36.15 0.16 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.844 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' A' ' 7' ' ' LEU . 36.8 tttp -74.05 48.74 0.32 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.672 0.749 . . . . 1.0 110.235 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.14 -41.61 93.08 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.451 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -116.06 87.49 19.3 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.477 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.03 115.31 1.44 Allowed 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 121.051 1.167 . . . . 1.0 113.076 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -169.09 116.42 0.63 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.627 -0.26 . . . . 1.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -55.8 145.71 23.61 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.52 -25.98 8.71 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -65.77 144.03 57.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.77 137.04 38.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.48 0.657 . . . . 1.0 109.516 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.5 pt -124.05 145.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.399 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -87.56 113.62 23.41 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.07 113.24 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -130.1 135.19 47.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.576 0.703 . . . . 1.0 110.141 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 126.2 48.88 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.02 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -81.87 111.4 18.05 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 p -89.62 124.99 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.3 m -98.09 124.52 42.66 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -75.61 106.38 7.14 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.358 0.599 . . . . 1.0 109.647 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -122.5 119.0 29.63 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.128 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.76 -99.5 0.13 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.45 -6.34 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.658 0.266 . . . . 1.0 111.016 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.07 174.6 13.49 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.3 0.571 . . . . 1.0 110.549 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -62.1 126.95 29.11 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.579 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.54 135.88 37.42 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.532 ' O ' ' C ' ' A' ' 34' ' ' ASN . 33.6 m170 -105.9 169.71 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.087 0.946 . . . . 1.0 109.73 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 33' ' ' HIS . 4.3 p30 16.73 84.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.906 -1.043 . . . . 1.0 111.454 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 t -112.44 80.9 3.75 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.109 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -83.57 102.8 1.04 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 120.386 0.724 . . . . 1.0 111.352 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.46 149.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.46 40.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -121.37 143.98 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.5 0.667 . . . . 1.0 109.501 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -152.86 128.39 10.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.52 127.64 33.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.12 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.79 -155.33 17.12 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 110.714 -0.955 . . . . 1.0 110.714 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -121.34 143.72 38.21 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.325 -0.845 . . . . 1.0 111.503 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.59 -30.11 15.57 Favored 'Trans proline' 0 N--CA 1.517 2.904 0 CA-C-N 119.684 0.923 . . . . 1.0 113.166 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.37 87.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.729 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.16 -52.36 64.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.324 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.49 -4.08 0.26 Allowed Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.34 98.84 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -81.41 114.43 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.417 ' OE2' ' NH1' ' A' ' 53' ' ' ARG . 63.5 tt0 -74.46 112.69 10.89 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.9 -46.2 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 176.24 42.47 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.734 -0.947 . . . . 1.0 110.734 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.417 ' NH1' ' OE2' ' A' ' 50' ' ' GLU . 9.5 ptp85 -147.85 160.88 42.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.726 0.774 . . . . 1.0 110.457 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -146.07 113.7 6.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.893 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -84.98 130.25 34.66 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.7 145.77 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.079 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.558 ' HG ' ' H ' ' A' ' 58' ' ' ARG . 82.9 p -62.42 -46.58 87.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.121 0.486 . . . . 1.0 110.421 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.558 ' H ' ' HG ' ' A' ' 57' ' ' SER . 40.4 ttm180 -169.09 137.53 2.0 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.472 0.653 . . . . 1.0 109.9 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.0 mt -115.91 119.14 37.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 CA-C-O 118.393 -0.813 . . . . 1.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.43 168.71 24.18 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 CA-C-N 119.592 0.89 . . . . 1.0 112.302 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.12 141.23 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.91 13.5 59.51 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.597 -1.001 . . . . 1.0 110.597 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.95 -175.44 19.4 Favored Glycine 0 N--CA 1.477 1.393 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 p -143.09 150.91 40.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.882 -0.159 . . . . 1.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.82 158.19 21.32 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.21 -1.156 . . . . 1.0 110.21 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.24 110.84 16.64 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.9 0.857 . . . . 1.0 109.906 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.47 154.81 18.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.088 -0.96 . . . . 1.0 110.339 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -141.47 123.59 15.53 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.842 0.829 . . . . 1.0 110.594 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.05 135.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.428 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -92.6 137.1 32.66 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.597 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -139.65 131.02 26.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 1.0 109.639 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -97.26 123.9 41.19 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.003 -0.999 . . . . 1.0 109.482 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 147.09 53.25 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.0 p -139.18 -162.85 1.38 Allowed 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.433 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 53.72 83.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.875 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.57 129.05 34.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.08 0.467 . . . . 1.0 109.945 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 tt -165.66 116.66 1.07 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.619 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.11 138.71 42.33 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.5 -106.81 0.23 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.294 -0.722 . . . . 1.0 111.294 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.81 -33.6 75.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.94 0.4 . . . . 1.0 110.331 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 52.95 36.82 22.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.332 0.587 . . . . 1.0 110.977 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.78 -30.23 71.3 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.665 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -152.09 145.42 17.59 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.321 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.417 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 71.1 Cg_endo -69.42 -67.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.516 2.828 0 CA-C-N 118.798 0.606 . . . . 1.0 112.316 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' A' ' 84' ' ' PRO . . . 79.05 73.82 1.1 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.8 p -165.44 60.47 0.69 Allowed Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.98 163.34 31.09 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.943 1.762 . . . . 1.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.24 134.33 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 121.433 0.635 . . . . 1.0 109.787 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -128.46 148.23 50.72 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.996 0.903 . . . . 1.0 109.937 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.98 146.75 31.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.969 -1.014 . . . . 1.0 110.102 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.42 141.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.512 0.672 . . . . 1.0 110.156 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -86.83 137.5 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.547 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -41.55 145.56 0.64 Allowed Pre-proline 0 N--CA 1.484 1.229 0 CA-C-O 117.951 -1.023 . . . . 1.0 111.547 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.18 129.21 14.76 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 120.997 1.132 . . . . 1.0 111.913 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.37 -34.98 79.19 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.284 0.564 . . . . 1.0 110.161 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 98' ' ' VAL . 52.8 t30 -161.75 78.11 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.65 -0.705 . . . . 1.0 110.084 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 58.74 -74.38 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.617 -0.719 . . . . 1.0 110.862 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 96' ' ' ASN . 40.9 t -55.92 144.12 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.393 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -166.71 -4.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.376 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -52.77 -22.45 5.32 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.554 0.216 . . . . 1.0 110.475 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.0 t -89.17 -56.24 3.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.605 0.362 . . . . 1.0 110.024 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.22 -33.83 71.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.393 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.16 -60.62 3.58 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.13 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.25 -44.42 79.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.629 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -63.61 -53.4 52.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.673 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -90.56 51.58 2.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.155 0.502 . . . . 1.0 110.661 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.87 134.88 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.716 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -142.84 136.4 28.7 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.426 0.631 . . . . 1.0 109.736 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.6 m -158.48 145.14 17.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.527 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -144.11 127.2 16.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.974 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.445 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.9 mp -88.75 147.24 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.671 -0.863 . . . . 1.0 108.671 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.32 140.9 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 115.202 -0.908 . . . . 1.0 109.842 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -95.51 142.49 27.8 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.798 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.7 136.32 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-O 121.324 0.583 . . . . 1.0 110.203 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tp -105.42 133.43 50.19 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.707 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -160.33 91.33 0.92 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.795 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -168.15 96.44 0.42 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.882 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.503 ' N ' ' HD1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -164.27 170.84 15.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.295 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -65.02 111.57 2.94 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.101 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -67.09 142.29 57.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.879 0.371 . . . . 1.0 110.072 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -65.97 -39.36 90.3 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.128 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.8 m80 . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 118.058 -0.972 . . . . 1.0 109.719 -179.834 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtt . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.24 151.86 39.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.172 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.48 151.83 82.01 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 118.336 -0.84 . . . . 1.0 111.115 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.47 -29.33 77.63 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.643 1.562 . . . . 1.0 112.339 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.9 mt -111.99 135.94 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.209 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 t -148.23 138.98 23.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.382 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.07 163.27 33.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.72 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.3 t -84.02 114.69 21.9 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.971 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.86 50.19 1.19 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.834 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -56.77 -43.79 81.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.717 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 p -123.19 84.93 51.52 Favored Pre-proline 0 N--CA 1.485 1.285 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.251 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -49.27 123.33 9.98 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 121.584 1.523 . . . . 1.0 112.2 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -168.15 123.7 1.0 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.397 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -56.85 146.21 27.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.599 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.16 -27.54 6.09 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 110.994 -0.843 . . . . 1.0 110.994 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.54 141.25 55.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.881 -0.415 . . . . 1.0 109.881 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -74.76 143.28 44.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.681 0.753 . . . . 1.0 109.745 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.046 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -89.35 112.51 23.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.366 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.02 118.33 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -130.79 133.99 46.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.442 0.639 . . . . 1.0 110.479 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.57 128.26 53.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.109 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.43 119.72 26.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.573 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.74 126.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.765 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -88.81 125.17 34.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.02 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -83.24 115.0 21.76 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.239 0.542 . . . . 1.0 110.133 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.43 104.59 13.97 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.056 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.39 143.88 6.93 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.758 -0.937 . . . . 1.0 110.758 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.75 8.44 6.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.802 0.334 . . . . 1.0 110.246 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.93 31.73 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.386 0.612 . . . . 1.0 110.556 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -56.63 120.19 7.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.462 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.84 152.95 18.2 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.101 0.476 . . . . 1.0 109.828 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.438 ' CG ' ' H ' ' A' ' 34' ' ' ASN . 32.3 t-80 -146.15 173.31 12.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.876 0.846 . . . . 1.0 109.836 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.438 ' H ' ' CG ' ' A' ' 33' ' ' HIS . 31.4 m120 48.63 59.45 4.36 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.086 -0.961 . . . . 1.0 110.857 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.44 87.33 7.64 Favored Pre-proline 0 N--CA 1.488 1.457 0 CA-C-O 118.578 -0.725 . . . . 1.0 109.749 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.52 173.4 14.54 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 120.836 1.024 . . . . 1.0 111.478 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.58 144.42 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.92 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.1 133.06 43.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.528 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.1 146.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.635 0.731 . . . . 1.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -154.95 141.89 19.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.822 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tt -96.62 130.22 43.87 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.545 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.94 -153.04 17.09 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 110.498 -1.041 . . . . 1.0 110.498 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -126.01 140.03 35.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-O 118.175 -0.917 . . . . 1.0 111.575 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.04 -36.15 53.25 Favored 'Trans proline' 0 N--CA 1.517 2.888 0 C-N-CA 120.74 0.96 . . . . 1.0 112.923 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.48 89.49 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.885 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -65.77 -75.32 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.193 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.42 67.79 0.04 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.64 51.16 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.72 138.0 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.286 0.565 . . . . 1.0 110.403 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.93 136.13 53.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.766 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.0 mt -101.52 -38.95 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.531 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.01 164.16 34.04 Favored Glycine 0 N--CA 1.462 0.433 0 N-CA-C 110.654 -0.978 . . . . 1.0 110.654 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -149.35 162.17 40.6 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.967 0.889 . . . . 1.0 110.264 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -155.05 118.79 4.55 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.036 -0.983 . . . . 1.0 110.162 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.1 m -79.1 133.3 36.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.23 0.538 . . . . 1.0 109.591 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.8 mt -108.52 145.57 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.47 -56.35 2.31 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.628 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -64.92 79.28 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.316 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.3 mt -122.85 86.9 50.36 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 118.237 -0.887 . . . . 1.0 110.558 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.66 163.7 35.29 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.59 1.526 . . . . 1.0 111.746 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -69.09 142.7 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.445 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.41 68.9 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.04 -167.68 18.91 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -146.33 151.06 36.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.255 0.55 . . . . 1.0 110.253 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.64 151.85 19.81 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.062 -1.215 . . . . 1.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.52 116.52 16.04 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.746 0.784 . . . . 1.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 156.0 18.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.837 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -125.54 124.17 40.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.944 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.21 140.64 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.482 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -106.3 140.21 39.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.709 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -141.64 134.23 28.39 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.974 0.893 . . . . 1.0 109.839 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -102.34 127.56 49.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.986 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 141.88 53.27 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -119.1 138.4 52.91 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.204 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -167.62 43.57 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.934 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -75.55 138.91 41.81 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.585 0.707 . . . . 1.0 109.227 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 47.17 79.24 0.06 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.382 -0.826 . . . . 1.0 110.951 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' A' ' 80' ' ' ARG . . . -71.21 146.45 49.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.213 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.12 29.34 1.63 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 78' ' ' ALA . 77.3 mtm-85 52.73 16.78 0.72 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.57 0.7 . . . . 1.0 110.811 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.28 -169.89 2.77 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.45 -0.796 . . . . 1.0 109.996 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.01 85.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.168 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' PRO . 34.5 m120 -151.57 76.51 7.51 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.603 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 83' ' ' ASN . 74.2 Cg_exo -52.8 -146.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.185 1.924 . . . . 1.0 112.459 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.82 82.08 1.4 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.5 m -119.45 65.26 8.45 Favored Pre-proline 0 N--CA 1.481 1.089 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.4 -179.55 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.129 1.886 . . . . 1.0 110.94 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.66 157.59 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.077 -0.965 . . . . 1.0 110.173 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -147.11 145.77 29.71 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.925 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.18 142.36 32.69 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.13 136.54 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.64 0.734 . . . . 1.0 110.088 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.63 138.37 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.666 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -49.81 134.04 20.75 Favored Pre-proline 0 CA--C 1.558 1.278 0 CA-C-O 117.917 -1.04 . . . . 1.0 111.184 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.42 148.47 48.62 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 C-N-CA 121.16 1.24 . . . . 1.0 111.668 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.49 -42.39 64.91 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.178 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -168.81 47.14 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.773 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 50.16 70.42 0.51 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.34 -79.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.148 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.83 161.27 8.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.12 0.486 . . . . 1.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -62.84 -66.38 0.55 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.3 p -46.32 -39.78 10.71 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.098 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.64 -71.53 0.15 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.243 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.612 ' C ' ' H ' ' A' ' 105' ' ' ASN . 90.7 mttt -45.64 -41.54 10.37 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.793 0.33 . . . . 1.0 110.642 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.8 3.92 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 121.182 0.515 . . . . 1.0 111.586 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.612 ' H ' ' C ' ' A' ' 103' ' ' LYS . 90.2 m-20 -89.06 -35.44 16.34 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.832 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -93.29 47.53 1.26 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.392 0.615 . . . . 1.0 110.737 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 58.7 t -100.38 135.76 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 121.723 0.773 . . . . 1.0 109.423 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 53.4 m-85 -144.68 146.3 32.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.245 -0.889 . . . . 1.0 109.929 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.9 t -163.05 150.02 12.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.437 -0.802 . . . . 1.0 109.8 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -145.25 132.58 20.62 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.088 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.452 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.7 mp -83.0 118.63 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.45 107.05 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.8 122.3 29.69 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.5 t -129.08 134.98 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 1.0 109.902 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.06 179.48 7.71 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.06 0.933 . . . . 1.0 109.931 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -140.88 147.81 39.5 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.018 -0.992 . . . . 1.0 110.352 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -74.38 90.98 2.18 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.701 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.97 -48.76 80.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.367 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -64.63 80.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.135 0.493 . . . . 1.0 110.057 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -60.75 -40.47 92.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.125 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -67.01 119.13 11.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.101 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.8 m80 . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.283 179.781 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mmm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 54.22 -177.87 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.781 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp -64.65 144.31 98.75 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.92 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.21 -39.17 3.16 Favored 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 120.881 1.054 . . . . 1.0 112.417 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -100.51 133.83 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.588 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.9 p -137.26 123.06 20.0 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.4 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 9' ' ' LYS . 56.6 mt -112.27 150.7 30.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.48 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.3 p -81.09 28.35 0.37 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.37 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 7' ' ' LEU . 56.0 tttp -73.95 48.91 0.31 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -55.15 -26.24 37.31 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.193 0.52 . . . . 1.0 110.396 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -133.34 138.45 31.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-O 118.247 -0.883 . . . . 1.0 111.4 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -78.42 113.54 3.37 Favored 'Trans proline' 0 N--CA 1.51 2.468 0 CA-C-N 119.596 0.891 . . . . 1.0 111.642 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -166.96 99.39 0.54 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.78 146.83 16.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.733 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.93 -23.01 25.84 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -68.78 138.15 54.59 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.47 136.32 54.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.31 0.576 . . . . 1.0 109.622 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.84 148.1 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.234 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.5 m -96.35 114.11 25.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.816 -0.629 . . . . 1.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.24 122.77 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 m -128.63 132.66 48.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.33 0.586 . . . . 1.0 109.984 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.08 123.41 40.27 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.734 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -79.28 144.64 34.1 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.202 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.03 135.64 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -101.34 123.99 46.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -82.06 119.79 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.429 0.633 . . . . 1.0 110.103 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -108.95 95.9 5.95 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.523 -0.762 . . . . 1.0 109.981 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 30' ' ' ALA . . . -171.91 137.13 4.14 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.87 11.27 1.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.723 0.297 . . . . 1.0 110.446 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 28' ' ' GLY . . . -147.9 165.48 30.52 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.183 0.516 . . . . 1.0 110.77 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -58.08 125.84 24.88 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.533 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.08 152.91 22.18 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.201 0.524 . . . . 1.0 110.107 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -147.22 -178.88 6.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.097 0.951 . . . . 1.0 109.741 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 47.83 59.24 4.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.832 -1.076 . . . . 1.0 111.223 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.86 84.66 2.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 CA-C-O 118.395 -0.812 . . . . 1.0 109.783 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.83 160.69 30.73 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 120.638 0.892 . . . . 1.0 111.724 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.82 141.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.031 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.43 129.09 42.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.499 -0.773 . . . . 1.0 109.536 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.51 146.32 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.724 0.773 . . . . 1.0 109.224 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -152.12 150.03 29.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.992 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tp -97.33 130.85 44.45 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.114 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.79 -153.55 17.45 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -118.72 143.63 33.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.36 -37.11 40.1 Favored 'Trans proline' 0 N--CA 1.521 3.142 0 CA-C-N 119.559 0.878 . . . . 1.0 113.275 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.417 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . -63.21 -42.57 99.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.783 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.91 8.69 1.42 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.235 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 66.31 74.2 0.55 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.89 163.99 13.98 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.125 -0.79 . . . . 1.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.79 132.97 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.211 0.529 . . . . 1.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.04 134.84 48.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.684 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -98.69 -36.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.577 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.84 172.84 41.01 Favored Glycine 0 N--CA 1.463 0.437 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.16 166.77 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.754 0.787 . . . . 1.0 110.294 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -161.17 117.14 2.18 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.95 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -76.62 136.52 39.2 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.9 mt -107.56 142.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.727 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 59' ' ' ILE . 95.8 p -105.02 -54.95 2.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.578 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -63.51 75.3 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.15 0.976 . . . . 1.0 110.967 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' SER . 49.7 mm -121.91 82.23 42.88 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 114.748 -1.115 . . . . 1.0 109.529 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 167.7 24.49 Favored 'Trans proline' 0 N--CA 1.506 2.219 0 C-N-CA 121.191 1.26 . . . . 1.0 111.844 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.95 137.73 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.323 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.23 13.84 73.64 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.93 -167.27 22.36 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.5 p -143.15 -174.32 4.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.297 0.57 . . . . 1.0 110.616 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.73 149.52 21.37 Favored Glycine 0 N--CA 1.477 1.382 0 N-CA-C 110.929 -0.869 . . . . 1.0 110.929 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.7 mt -138.68 124.61 19.95 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.278 1.037 . . . . 1.0 110.025 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.91 160.6 15.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.421 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -126.18 122.34 35.37 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.843 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.13 135.4 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 122.004 0.907 . . . . 1.0 109.043 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -99.77 139.09 35.93 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -143.01 143.37 31.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.143 0.973 . . . . 1.0 109.932 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -113.43 127.28 56.06 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.181 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 118.18 13.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.661 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p -105.23 119.19 38.45 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.21 0.529 . . . . 1.0 109.916 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.498 HH12 ' CB ' ' A' ' 84' ' ' PRO . 41.5 ttm180 -170.61 116.3 0.48 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.089 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -133.89 93.85 3.17 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.263 0.554 . . . . 1.0 110.062 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.8 mt -105.18 -161.33 0.81 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.97 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.0 65.84 0.19 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.637 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.1 -159.89 25.78 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -63.58 172.41 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.792 0.33 . . . . 1.0 110.559 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.3 126.93 1.41 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.64 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.07 20.14 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.646 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -152.69 55.75 1.56 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.498 ' CB ' HH12 ' A' ' 75' ' ' ARG . 53.2 Cg_endo -64.71 -67.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 121.356 1.371 . . . . 1.0 111.719 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.21 79.71 0.16 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.621 -0.991 . . . . 1.0 110.621 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.55 63.14 13.82 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.66 166.54 19.69 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.888 1.726 . . . . 1.0 111.245 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.5 158.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 114.898 -1.047 . . . . 1.0 110.144 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -152.95 146.54 25.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.872 0.844 . . . . 1.0 109.746 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.49 144.33 34.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.886 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.3 t -131.74 138.63 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.66 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.59 135.17 28.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -125.37 80.47 65.3 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-O 118.785 -0.626 . . . . 1.0 110.17 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.5 178.3 0.47 Allowed 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 121.803 1.669 . . . . 1.0 111.847 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.7 -40.05 94.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.093 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -110.13 66.17 0.63 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.034 0.533 . . . . 1.0 110.659 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -64.37 97.74 0.21 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.006 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.2 160.17 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 121.789 0.804 . . . . 1.0 110.078 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.95 107.25 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.151 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -71.1 -64.32 0.93 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.52 0.676 . . . . 1.0 110.072 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.5 p -41.48 -32.18 0.32 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 115.617 -0.72 . . . . 1.0 111.269 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.35 -63.05 1.14 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.564 ' C ' ' H ' ' A' ' 105' ' ' ASN . 23.4 ttpp -43.33 -41.73 4.19 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.125 0.488 . . . . 1.0 111.025 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.46 0.17 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.89 -0.595 . . . . 1.0 111.564 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.564 ' H ' ' C ' ' A' ' 103' ' ' LYS . 9.2 m120 -95.36 32.58 1.73 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.679 -0.692 . . . . 1.0 109.671 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -159.61 46.53 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.71 104.43 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -110.27 132.04 54.53 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.03 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 t -164.36 144.09 7.67 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.331 0.586 . . . . 1.0 110.139 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -133.55 132.23 40.67 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.514 0.673 . . . . 1.0 110.136 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.414 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.5 mp -80.68 137.72 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.68 142.92 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.771 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.26 143.68 49.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.137 0.97 . . . . 1.0 110.061 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.43 137.83 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.293 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -149.54 136.28 19.45 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.753 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -166.57 141.42 4.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.928 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -75.92 131.99 39.99 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -66.74 127.03 30.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 52.04 90.4 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.637 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -60.95 -42.14 97.66 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.134 0.492 . . . . 1.0 110.289 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.443 ' CG ' ' H ' ' A' ' 122' ' ' HIS . 81.0 t60 56.51 170.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.652 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.443 ' H ' ' CG ' ' A' ' 121' ' ' HIS . 50.9 t-80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.192 -0.909 . . . . 1.0 109.508 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.2 mpt? . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 108.69 -0.855 . . . . 1.0 108.69 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 63.65 23.87 13.71 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.228 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.04 152.28 68.19 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.875 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.84 -24.14 40.64 Favored 'Trans proline' 0 N--CA 1.515 2.75 0 C-N-CA 121.976 1.784 . . . . 1.0 111.957 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.4 mt -124.27 130.93 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.328 0.585 . . . . 1.0 110.2 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.2 m -134.87 123.46 23.52 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.856 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.47 147.64 28.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.369 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.9 p -81.06 34.41 0.35 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -70.79 50.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.974 0.51 . . . . 1.0 110.209 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -51.83 -30.33 23.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.658 0.742 . . . . 1.0 110.523 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.5 p -137.16 140.7 31.9 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.261 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.97 113.95 3.52 Favored 'Trans proline' 0 N--CA 1.514 2.728 0 CA-C-N 119.231 0.761 . . . . 1.0 111.392 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.92 101.45 0.55 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.86 0.362 . . . . 1.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 1.4 pm0 -53.9 148.8 9.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.948 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.14 -23.7 16.85 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -69.68 144.1 52.95 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.46 137.55 46.49 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.561 0.696 . . . . 1.0 109.508 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.14 146.55 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.915 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -97.7 114.51 26.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.7 119.7 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -129.09 132.99 47.48 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.265 0.555 . . . . 1.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.06 128.22 55.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.152 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -84.5 119.34 25.05 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 t -108.26 113.21 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.497 0.665 . . . . 1.0 109.215 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 m -86.27 131.92 34.11 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.557 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -86.79 107.18 18.16 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.006 0.431 . . . . 1.0 109.844 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -97.72 -159.34 0.73 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.319 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.47 -130.69 11.41 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.557 -1.017 . . . . 1.0 110.557 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.47 21.18 0.06 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.864 0.364 . . . . 1.0 110.684 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.44 154.66 44.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.495 0.664 . . . . 1.0 110.598 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -66.01 117.22 8.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.738 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.14 152.65 22.16 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.534 ' HD1' ' ND2' ' A' ' 34' ' ' ASN . 44.1 t-80 -139.91 169.04 18.44 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.518 0.675 . . . . 1.0 110.04 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.534 ' ND2' ' HD1' ' A' ' 33' ' ' HIS . 80.0 m-20 50.24 62.52 2.63 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.738 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 t -113.97 82.81 7.17 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -80.39 169.5 17.12 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.638 1.559 . . . . 1.0 111.322 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.13 136.61 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.547 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.38 114.91 18.83 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.275 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 t -104.44 137.48 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.526 0.679 . . . . 1.0 109.307 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -146.71 127.11 14.0 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.131 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tp -85.93 124.33 32.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 -158.75 15.68 Favored Glycine 0 N--CA 1.476 1.348 0 N-CA-C 110.762 -0.935 . . . . 1.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.5 142.68 28.56 Favored Pre-proline 0 N--CA 1.491 1.62 0 CA-C-O 117.788 -1.101 . . . . 1.0 111.528 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' C ' ' H ' ' A' ' 46' ' ' GLN . 85.8 Cg_exo -48.8 -38.8 38.42 Favored 'Trans proline' 0 N--CA 1.519 2.992 0 CA-C-N 120.079 1.064 . . . . 1.0 113.108 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.51 22.89 0.23 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.981 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 44' ' ' PRO . 58.7 tt0 -166.71 -73.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.921 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.63 -97.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.1 90.86 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.1 115.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.24 133.07 45.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.67 -46.11 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.64 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.15 165.8 35.45 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -155.49 167.43 30.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.367 0.603 . . . . 1.0 110.629 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -161.25 119.82 2.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.404 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 m -75.11 131.4 40.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -80.81 155.51 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.541 ' HG ' ' N ' ' A' ' 58' ' ' ARG . 79.4 p -65.42 -51.96 56.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.602 0.715 . . . . 1.0 110.072 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.541 ' N ' ' HG ' ' A' ' 57' ' ' SER . 14.8 ptp180 -177.29 145.47 0.45 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.039 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.5 mt -114.56 117.29 42.85 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 117.571 -1.205 . . . . 1.0 110.686 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.13 162.25 41.19 Favored 'Trans proline' 0 N--CA 1.519 2.971 0 CA-C-N 120.286 1.138 . . . . 1.0 112.157 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.17 137.31 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.557 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.55 77.48 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.82 -167.9 14.69 Favored Glycine 0 N--CA 1.472 1.068 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -132.92 176.23 8.66 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.896 0.855 . . . . 1.0 110.364 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.41 124.42 0.94 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 115.098 -0.955 . . . . 1.0 110.783 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.76 160.15 37.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.05 0.929 . . . . 1.0 110.127 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.67 161.91 13.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.246 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.854 -1.066 . . . . 1.0 109.895 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -140.03 156.32 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.28 1.038 . . . . 1.0 109.169 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -123.32 141.72 51.69 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.956 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -140.8 137.56 33.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.991 0.9 . . . . 1.0 109.691 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -100.31 123.84 45.04 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.557 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.44 138.39 49.02 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -166.36 150.23 7.48 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -167.77 84.21 0.21 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.879 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -70.82 126.51 29.79 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.703 -0.481 . . . . 1.0 109.703 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 tp -162.72 120.98 2.09 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.319 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.16 96.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.129 -0.323 . . . . 1.0 110.129 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.48 156.46 48.58 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.796 -0.922 . . . . 1.0 110.796 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -62.53 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.951 0.405 . . . . 1.0 110.68 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -163.69 156.0 17.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.431 0.634 . . . . 1.0 110.399 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.32 26.63 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.631 0.729 . . . . 1.0 110.714 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -165.61 97.44 0.79 Allowed Pre-proline 0 CA--C 1.556 1.211 0 CA-C-O 117.577 -1.201 . . . . 1.0 110.065 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.69 -80.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.512 2.575 0 CA-C-N 120.283 1.137 . . . . 1.0 112.065 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.83 79.58 0.13 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.282 -0.961 . . . . 1.0 111.047 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -119.14 64.71 7.21 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -60.6 141.46 95.28 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.755 1.637 . . . . 1.0 111.734 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.7 t -98.49 147.02 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 115.349 -0.841 . . . . 1.0 109.862 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -135.38 138.88 43.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.037 0.923 . . . . 1.0 109.821 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.92 135.03 22.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.033 -0.985 . . . . 1.0 109.632 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 t -139.67 144.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.996 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.4 145.79 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.538 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -136.35 87.33 22.51 Favored Pre-proline 0 N--CA 1.482 1.162 0 CA-C-O 118.437 -0.792 . . . . 1.0 110.143 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.51 -60.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.511 2.528 0 C-N-CA 121.936 1.757 . . . . 1.0 112.35 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -91.83 21.12 5.06 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.343 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.21 97.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.209 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 54.46 88.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.668 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.1 t -78.75 -76.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.005 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' A' ' 101' ' ' SER . . . -168.58 158.29 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.413 0.625 . . . . 1.0 110.49 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.79 -4.87 1.08 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.683 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 99' ' ' ALA . 47.3 t -87.16 -56.51 3.34 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.831 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -62.52 -44.31 96.67 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.611 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -54.82 -59.62 4.48 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.394 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 106' ' ' ASN . . . -52.21 -36.17 51.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.537 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -79.01 23.94 0.33 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.23 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' H ' ' C ' ' A' ' 104' ' ' ALA . 28.0 t30 -167.32 44.38 0.05 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.873 0.368 . . . . 1.0 110.547 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.45 139.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.222 0.534 . . . . 1.0 109.789 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -147.9 153.39 39.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.123 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -165.09 147.04 7.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.125 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -142.14 133.01 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.8 mp -81.28 123.35 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.63 136.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.376 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -131.95 125.19 30.99 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.317 0.58 . . . . 1.0 109.927 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.09 137.05 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.771 0.796 . . . . 1.0 110.039 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt -125.06 126.32 45.2 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.952 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -81.38 -27.59 34.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.121 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -69.79 164.22 24.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.64 0.733 . . . . 1.0 109.808 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.46 ' C ' ' H ' ' A' ' 120' ' ' HIS . 1.1 t60 54.68 86.58 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.291 -0.868 . . . . 1.0 110.533 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -75.53 15.66 0.45 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.176 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.46 ' H ' ' C ' ' A' ' 118' ' ' HIS . 94.0 m-70 53.34 -173.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.495 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 54.44 16.63 1.33 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.164 0.507 . . . . 1.0 111.051 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 117.979 -1.01 . . . . 1.0 110.517 -179.712 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.777 -0.823 . . . . 1.0 108.777 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -169.2 77.15 0.1 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.99 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.59 139.97 89.32 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 118.314 -0.851 . . . . 1.0 110.918 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.47 -32.16 61.58 Favored 'Trans proline' 0 N--CA 1.516 2.806 0 C-N-CA 121.099 1.2 . . . . 1.0 112.603 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.95 130.1 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.202 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -134.22 121.76 21.81 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.475 0.655 . . . . 1.0 109.921 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.04 147.29 27.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.445 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -94.03 78.03 4.09 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.603 0.716 . . . . 1.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.44 58.89 0.69 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.444 1.098 . . . . 1.0 110.693 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.67 -33.72 56.26 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.743 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -126.93 132.74 24.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.903 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -81.13 105.78 1.68 Allowed 'Trans proline' 0 N--CA 1.511 2.518 0 CA-C-N 119.914 1.005 . . . . 1.0 111.438 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -169.42 117.32 0.62 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.206 0.527 . . . . 1.0 110.454 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.76 150.81 9.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.065 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.3 34.56 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -72.82 126.33 29.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.217 0.532 . . . . 1.0 109.815 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -65.03 131.54 46.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.662 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.8 pt -119.69 147.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.271 0.558 . . . . 1.0 109.741 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.9 m -94.5 121.14 35.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.701 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.4 t -100.27 121.59 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -123.99 134.5 53.45 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.603 0.716 . . . . 1.0 109.808 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.09 120.67 33.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.08 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.81 123.25 30.96 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.997 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -107.62 129.26 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.216 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 m -90.94 123.75 34.68 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -74.0 115.43 13.46 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -114.3 96.75 5.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.028 0.442 . . . . 1.0 110.05 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.86 152.97 21.86 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.75 2.0 27.97 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.572 -0.314 . . . . 1.0 110.301 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.51 169.82 20.04 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.305 0.574 . . . . 1.0 110.856 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -67.04 125.78 27.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.909 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.74 160.35 18.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 1.0 110.432 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -161.09 94.22 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 122.572 1.177 . . . . 1.0 109.33 178.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER 157.4 58.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.414 -1.266 . . . . 1.0 110.394 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.63 86.01 12.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.09 100.85 0.96 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.016 1.144 . . . . 1.0 111.269 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.97 143.02 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.759 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.15 120.21 26.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.935 0.494 . . . . 1.0 109.82 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.9 t -112.01 143.14 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.324 0.583 . . . . 1.0 109.582 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -151.98 126.01 9.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.102 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.55 128.54 34.95 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.643 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.61 -160.38 15.99 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -117.45 142.35 30.22 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.144 -0.932 . . . . 1.0 111.457 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.64 -40.95 46.48 Favored 'Trans proline' 0 N--CA 1.522 3.171 0 CA-C-N 119.688 0.924 . . . . 1.0 113.323 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.41 93.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.968 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -59.21 4.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.122 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.67 83.16 0.04 OUTLIER Glycine 0 N--CA 1.476 1.361 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.6 130.7 40.44 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.92 126.0 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.224 0.535 . . . . 1.0 109.786 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -68.48 122.14 17.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.824 -0.626 . . . . 1.0 109.926 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.16 -44.91 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.213 0.53 . . . . 1.0 109.94 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.56 168.53 37.98 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -158.16 169.99 23.27 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.618 0.723 . . . . 1.0 110.334 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -163.45 114.66 1.41 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.005 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -75.22 140.51 43.3 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.9 mm -78.63 142.09 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -66.62 -50.13 64.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.229 0.538 . . . . 1.0 110.579 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -147.3 130.33 16.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.759 0.79 . . . . 1.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 mt -117.71 108.47 42.88 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.982 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.95 159.88 44.08 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 CA-C-N 119.934 1.012 . . . . 1.0 111.667 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -70.57 145.52 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.499 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.26 1.86 29.95 Favored Glycine 0 N--CA 1.461 0.321 0 N-CA-C 110.385 -1.086 . . . . 1.0 110.385 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.95 -165.35 26.92 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -139.74 -173.42 3.62 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.388 0.613 . . . . 1.0 110.648 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.01 151.18 22.65 Favored Glycine 0 N--CA 1.477 1.408 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mt -132.54 152.59 51.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.291 1.043 . . . . 1.0 109.641 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.04 154.74 45.19 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.706 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -117.9 120.4 37.75 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.35 128.76 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.632 0.73 . . . . 1.0 109.269 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -99.29 140.04 34.05 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.848 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -137.98 121.88 17.71 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.981 0.896 . . . . 1.0 109.981 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -92.37 127.04 37.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.107 -0.951 . . . . 1.0 109.788 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.88 138.52 50.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.487 -0.485 . . . . 1.0 109.749 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 75' ' ' ARG . 4.4 t -147.56 -174.68 4.6 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.714 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.408 ' N ' ' OG1' ' A' ' 74' ' ' THR . 21.9 mmt85 56.26 12.68 1.04 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.416 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.4 145.23 35.07 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.789 0.805 . . . . 1.0 110.455 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.8 tp -169.11 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.12 -0.945 . . . . 1.0 109.851 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -47.52 76.8 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.832 0.348 . . . . 1.0 110.984 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.55 44.04 90.88 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -64.4 -38.03 89.6 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.116 0.484 . . . . 1.0 110.451 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.41 37.91 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.43 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.47 -160.02 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.597 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -130.57 86.02 54.3 Favored Pre-proline 0 N--CA 1.483 1.182 0 CA-C-O 118.758 -0.639 . . . . 1.0 110.053 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.62 -174.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.508 2.345 0 C-N-CA 122.076 1.85 . . . . 1.0 112.486 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.3 81.24 1.45 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.594 -1.003 . . . . 1.0 110.594 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.79 62.79 27.0 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.25 149.62 89.89 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.731 1.621 . . . . 1.0 111.309 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.6 t -103.75 114.33 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.72 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.61 147.32 30.79 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.852 0.834 . . . . 1.0 109.474 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.99 142.69 27.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.041 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.1 138.87 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.082 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -84.65 135.91 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.03 163.7 0.17 Allowed Pre-proline 0 CA--C 1.558 1.284 0 CA-C-O 117.759 -1.115 . . . . 1.0 111.558 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.57 129.59 32.84 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 120.935 1.09 . . . . 1.0 112.296 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 97' ' ' ARG . 21.4 p-10 -88.68 25.54 1.71 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.068 0.547 . . . . 1.0 110.1 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 71.38 -4.37 1.86 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.561 0.696 . . . . 1.0 110.455 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 95' ' ' ASP . 70.4 mmt-85 -133.15 81.24 1.92 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.303 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.43 119.95 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.883 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.28 140.62 1.15 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.217 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -68.58 -61.1 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.944 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 m -41.82 -48.99 4.43 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.585 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -65.96 -63.31 1.11 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 110.173 -0.306 . . . . 1.0 110.173 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' C ' ' H ' ' A' ' 105' ' ' ASN . 37.8 ttpt -46.24 -49.8 16.76 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.222 0.534 . . . . 1.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.74 -11.29 0.05 Allowed 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.734 -0.667 . . . . 1.0 111.635 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.455 ' H ' ' C ' ' A' ' 103' ' ' LYS . 27.1 m-20 -102.23 26.39 7.78 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.824 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -155.06 26.39 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.418 0.287 . . . . 1.0 110.556 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.83 136.73 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -141.63 138.66 32.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.0 m -165.62 140.04 4.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.086 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -134.84 150.31 50.47 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.083 0.468 . . . . 1.0 110.444 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.431 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.5 mp -88.76 133.05 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.53 138.61 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.84 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.33 155.99 48.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.779 0.799 . . . . 1.0 109.535 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.55 133.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.3 115.82 28.34 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -76.87 -65.38 0.95 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.946 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -77.85 152.76 33.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.019 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -64.58 133.09 51.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.138 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -65.62 -42.53 91.46 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.992 0.425 . . . . 1.0 110.017 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -62.52 98.33 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.377 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -65.37 -43.11 91.8 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.087 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 118.04 -0.981 . . . . 1.0 110.601 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.56 1.355 0 CA-C-O 118.529 -0.748 . . . . 1.0 110.911 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.5 -28.64 45.88 Favored 'Trans proline' 0 N--CA 1.517 2.855 0 C-N-CA 121.592 1.528 . . . . 1.0 112.361 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.15 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.762 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.5 p -131.93 120.22 22.2 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.955 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 9' ' ' LYS . 60.4 mt -102.66 145.48 29.61 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.225 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.8 t -78.88 31.17 0.2 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.6 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 7' ' ' LEU . 80.8 tttt -72.98 49.35 0.24 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.584 0.707 . . . . 1.0 110.16 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -61.08 -40.49 93.89 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -117.17 89.86 31.94 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.708 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.47 111.13 0.33 Allowed 'Trans proline' 0 N--CA 1.523 3.221 0 C-N-CA 121.052 1.168 . . . . 1.0 113.256 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -162.48 109.37 1.27 Allowed 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.265 0.555 . . . . 1.0 110.432 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -55.68 142.68 33.22 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.112 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.1 18.23 63.37 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -107.28 143.62 35.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.663 0.385 . . . . 1.0 110.233 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.17 130.95 40.07 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.15 144.68 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.987 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -89.3 112.96 24.16 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -96.22 115.51 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.1 p -129.53 134.83 47.97 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.371 0.605 . . . . 1.0 110.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.0 127.18 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.831 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -84.03 116.26 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.81 126.51 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.135 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -96.18 126.91 41.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 120.677 0.275 . . . . 1.0 110.284 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.7 t30 . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 1.0 109.749 179.794 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.25 0.548 . . . . 1.0 110.613 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.05 119.33 6.6 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.363 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.08 149.74 21.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.888 0.375 . . . . 1.0 110.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -137.13 162.75 32.53 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 122.435 1.112 . . . . 1.0 109.797 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 53.83 67.57 0.99 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.604 -1.18 . . . . 1.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.43 82.58 24.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.273 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.17 175.27 10.49 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.75 0.966 . . . . 1.0 111.16 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.51 138.69 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.677 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.26 114.25 17.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.379 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 t -107.59 140.56 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.519 0.676 . . . . 1.0 109.233 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -145.56 130.24 18.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.048 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.31 125.59 32.41 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.99 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -159.65 17.06 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -108.59 143.32 27.26 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.467 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.12 -21.19 27.63 Favored 'Trans proline' 0 N--CA 1.516 2.812 0 C-N-CA 120.5 0.8 . . . . 1.0 111.789 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.3 -45.88 89.33 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.934 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -72.38 -69.59 0.39 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.136 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.02 77.42 0.03 OUTLIER Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.32 165.84 21.6 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.54 141.8 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.089 0.471 . . . . 1.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -73.83 134.17 43.29 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.757 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -98.51 -42.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.7 168.75 39.37 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -153.96 166.19 33.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.506 0.67 . . . . 1.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -154.65 114.89 3.85 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.047 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -76.0 132.71 40.34 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.6 mt -86.46 148.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -62.24 -49.85 74.06 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.36 0.6 . . . . 1.0 110.465 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -176.25 146.77 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.293 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -118.31 124.16 28.8 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-O 117.924 -1.036 . . . . 1.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.04 163.15 39.07 Favored 'Trans proline' 0 N--CA 1.519 2.999 0 CA-C-N 119.844 0.98 . . . . 1.0 111.984 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -71.61 142.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.717 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.18 6.33 56.83 Favored Glycine 0 N--CA 1.465 0.627 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.9 -166.74 21.54 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 110.481 -1.048 . . . . 1.0 110.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 p -146.2 152.42 39.19 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.274 0.559 . . . . 1.0 110.14 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.55 157.75 19.84 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.39 113.72 7.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.501 0.667 . . . . 1.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.98 159.47 15.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.513 -0.767 . . . . 1.0 110.002 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -126.38 122.22 34.74 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.868 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.71 146.37 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.9 0.857 . . . . 1.0 109.55 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -119.84 142.29 48.77 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.216 -0.902 . . . . 1.0 110.033 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -144.5 145.2 31.73 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.012 0.911 . . . . 1.0 109.712 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -91.19 121.19 32.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.942 -1.026 . . . . 1.0 109.676 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.38 132.64 42.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.951 0.405 . . . . 1.0 110.181 179.056 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.072 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.9 p -118.42 64.98 5.93 Favored Pre-proline 0 N--CA 1.48 1.047 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -68.81 175.45 7.27 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.983 1.789 . . . . 1.0 111.357 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.43 135.73 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.868 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -135.22 146.78 48.98 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.862 0.839 . . . . 1.0 109.721 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.72 143.02 28.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.929 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.42 140.13 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.652 0.739 . . . . 1.0 109.728 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.06 140.63 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.255 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 CA--C 1.561 1.387 0 CA-C-O 118.143 -0.932 . . . . 1.0 111.767 179.792 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.28 46.6 1.11 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.364 0.666 . . . . 1.0 110.234 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 13.1 p -105.68 139.01 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.428 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 55.3 m-85 -145.33 143.24 30.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.146 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.4 p -170.54 143.36 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.74 147.28 33.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.6 mp -92.48 144.59 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.57 140.12 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.927 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.38 143.94 38.26 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.873 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.1 m -109.58 135.79 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.826 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.676 0.751 . . . . 1.0 109.063 -179.713 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.557 1.224 0 CA-C-O 119.225 -0.417 . . . . 1.0 110.735 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.26 -23.51 38.74 Favored 'Trans proline' 0 N--CA 1.51 2.451 0 C-N-CA 121.551 1.501 . . . . 1.0 111.737 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.24 132.16 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.334 0.588 . . . . 1.0 110.269 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.3 m -133.62 121.95 22.78 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.047 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.07 147.61 26.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.477 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.9 p -85.82 34.55 0.6 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.297 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -71.77 54.92 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.936 0.398 . . . . 1.0 110.261 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -52.14 -32.6 36.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.311 0.577 . . . . 1.0 110.434 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.9 p -134.85 139.26 31.72 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.638 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -79.33 115.62 3.48 Favored 'Trans proline' 0 N--CA 1.515 2.771 0 C-N-CA 120.522 0.815 . . . . 1.0 111.779 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -167.13 102.93 0.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.805 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -52.58 146.41 10.08 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.018 0.437 . . . . 1.0 110.642 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.91 -23.6 22.6 Favored Glycine 0 N--CA 1.476 1.301 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -67.66 141.09 56.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.887 0.375 . . . . 1.0 110.014 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.94 133.85 47.74 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.1 pt -119.65 144.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.976 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.7 m -96.25 110.46 22.76 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.559 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.4 t -93.82 117.71 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -128.38 137.73 52.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.266 0.555 . . . . 1.0 110.286 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.56 123.51 40.75 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.253 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -77.63 116.05 17.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.22 121.86 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.6 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.1 m -108.72 122.73 47.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 120.993 0.425 . . . . 1.0 110.078 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.472 0.627 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.859 179.777 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 121.34 0.59 . . . . 1.0 110.584 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.96 121.18 14.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.89 154.0 18.47 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.115 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -142.71 171.0 14.64 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.484 0.659 . . . . 1.0 110.131 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 51.13 63.68 2.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.613 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.56 84.25 6.22 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 115.45 -0.796 . . . . 1.0 109.953 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -79.21 158.77 26.52 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 121.365 1.377 . . . . 1.0 111.518 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.51 135.99 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.358 -0.837 . . . . 1.0 109.842 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.05 115.09 17.94 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.47 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 m -107.83 140.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.796 0.807 . . . . 1.0 109.489 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.67 130.28 17.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.205 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.65 125.94 32.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.96 -162.33 18.04 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -93.66 146.68 32.22 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 119.1 -0.476 . . . . 1.0 111.039 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.12 -12.18 29.95 Favored 'Trans proline' 0 N--CA 1.511 2.55 0 C-N-CA 120.679 0.919 . . . . 1.0 111.606 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.29 86.59 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.02 0.438 . . . . 1.0 110.699 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -81.64 7.37 12.49 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.09 -9.35 47.2 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.31 177.77 0.21 Allowed Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.74 135.92 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.921 0.391 . . . . 1.0 110.345 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.17 132.23 44.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.871 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.27 -42.67 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.48 155.72 26.11 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -148.18 161.58 41.17 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.472 0.653 . . . . 1.0 110.48 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -160.99 114.11 1.97 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.111 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.9 m -82.62 140.55 33.12 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.14 147.73 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.657 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -64.49 -46.28 83.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 1.0 110.54 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -166.5 137.07 3.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.657 -0.702 . . . . 1.0 110.596 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.92 118.83 32.78 Favored Pre-proline 0 N--CA 1.494 1.739 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.69 162.73 37.21 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 CA-C-N 119.78 0.957 . . . . 1.0 111.693 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.11 137.71 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.41 16.44 77.36 Favored Glycine 0 CA--C 1.511 -0.204 0 N-CA-C 110.144 -1.182 . . . . 1.0 110.144 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.08 17.52 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 p -140.17 -170.57 3.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.498 0.666 . . . . 1.0 110.634 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.63 147.2 18.72 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.6 114.66 19.66 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.631 . . . . 1.0 109.81 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.67 154.01 22.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.52 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -126.18 121.66 33.42 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.81 131.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.549 0.69 . . . . 1.0 109.49 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -110.73 138.66 46.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.93 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -138.73 133.71 32.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.912 0.863 . . . . 1.0 109.983 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.38 121.01 30.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 1.0 109.73 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.27 122.94 20.48 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.467 0.404 0 CA-C-O 121.1 0.476 . . . . 1.0 110.429 -179.669 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.623 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -117.05 82.29 13.53 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-O 118.474 -0.774 . . . . 1.0 109.234 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.82 160.81 33.93 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 121.848 1.698 . . . . 1.0 111.236 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.36 158.53 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.063 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.55 149.47 35.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.804 0.811 . . . . 1.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.05 136.39 20.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.06 144.15 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.702 0.763 . . . . 1.0 109.683 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -94.94 139.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.819 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 t70 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 118.59 -0.719 . . . . 1.0 109.696 179.849 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -161.46 42.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.178 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.9 146.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.156 0.503 . . . . 1.0 109.65 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -147.76 154.19 40.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.7 t -160.55 145.92 14.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.174 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.88 130.71 34.27 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.272 0.558 . . . . 1.0 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -80.95 128.42 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.6 t -132.21 138.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.742 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -130.63 110.22 11.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.006 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -89.83 137.22 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.732 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 121.309 0.576 . . . . 1.0 109.486 -179.591 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 CA--C 1.552 1.032 0 CA-C-O 118.359 -0.829 . . . . 1.0 111.005 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.74 -21.51 5.79 Favored 'Trans proline' 0 N--CA 1.512 2.587 0 C-N-CA 121.831 1.687 . . . . 1.0 112.562 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.51 132.74 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.077 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.7 p -134.51 122.3 22.23 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.266 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.86 147.14 30.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.418 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.0 t -81.81 36.39 0.44 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.404 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -71.43 50.72 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.047 0.451 . . . . 1.0 110.714 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.19 -39.27 72.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.588 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -124.41 84.33 56.68 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.875 -0.583 . . . . 1.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.13 112.91 0.58 Allowed 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.9 1.734 . . . . 1.0 112.56 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -167.08 123.96 1.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.961 0.41 . . . . 1.0 110.592 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.68 147.19 33.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 1.0 110.448 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.58 -31.64 4.48 Favored Glycine 0 N--CA 1.474 1.212 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.79 133.6 50.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.863 0.363 . . . . 1.0 110.052 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -68.19 136.54 53.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.792 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 pt -126.0 146.67 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.454 0.645 . . . . 1.0 110.426 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -92.79 112.26 24.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.616 -0.72 . . . . 1.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.09 117.75 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.848 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -129.42 136.79 50.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.349 0.595 . . . . 1.0 110.29 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.08 125.96 46.17 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.02 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -81.19 113.72 19.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.66 124.66 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.867 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.8 m -101.25 122.04 42.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.118 0.485 . . . . 1.0 110.015 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.559 0.695 . . . . 1.0 109.76 179.472 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.49 0.662 . . . . 1.0 110.52 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -61.1 117.14 5.16 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.175 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.43 22.85 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.049 0.452 . . . . 1.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -137.96 159.79 41.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.114 0.959 . . . . 1.0 109.817 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 53.46 65.79 1.41 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.474 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -113.32 83.34 6.53 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.91 176.37 10.21 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 120.909 1.072 . . . . 1.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -150.34 145.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.025 -0.988 . . . . 1.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.97 132.57 43.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.507 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.07 144.93 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.43 0.633 . . . . 1.0 109.335 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.19 150.14 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.262 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 tp -99.47 127.21 45.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.046 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.96 -154.75 16.45 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -116.35 143.86 31.93 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.112 -0.471 . . . . 1.0 111.257 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.58 -10.85 23.99 Favored 'Trans proline' 0 N--CA 1.511 2.508 0 C-N-CA 120.725 0.95 . . . . 1.0 111.58 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.828 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -80.69 -76.13 0.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.86 78.2 0.05 OUTLIER Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.39 168.26 26.43 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 p -132.77 139.34 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 120.952 0.406 . . . . 1.0 110.487 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -74.71 136.97 41.8 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.096 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -95.02 -41.74 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.72 171.08 42.28 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -150.32 162.63 40.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.761 0.791 . . . . 1.0 110.253 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -152.46 113.93 4.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.147 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -78.08 132.9 37.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.8 mt -89.57 150.77 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.33 -51.34 66.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -169.79 141.79 2.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.505 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mt -113.97 124.03 31.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 117.978 -1.011 . . . . 1.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.16 160.17 45.9 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 120.87 1.047 . . . . 1.0 111.705 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.09 143.27 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.19 10.65 66.06 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.83 -167.75 16.37 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.0 p -145.64 150.44 36.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.439 -0.38 . . . . 1.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.4 148.93 19.23 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.46 109.79 16.65 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.602 0.715 . . . . 1.0 109.75 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 154.35 18.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.893 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -132.45 123.03 25.87 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.08 135.11 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.457 -0.792 . . . . 1.0 109.506 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -103.41 138.8 39.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.031 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -139.77 132.46 28.94 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.627 0.727 . . . . 1.0 110.248 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -86.41 124.62 32.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.784 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 100.61 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 121.196 0.522 . . . . 1.0 110.26 -179.664 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.965 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -119.14 65.03 7.38 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 118.818 -0.61 . . . . 1.0 109.524 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.96 147.85 94.12 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.228 1.952 . . . . 1.0 111.431 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.46 141.63 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.901 0.857 . . . . 1.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.68 151.83 51.86 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.317 1.055 . . . . 1.0 109.882 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.13 139.93 26.32 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.669 -1.15 . . . . 1.0 109.919 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.7 t -133.04 141.95 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 121.82 0.819 . . . . 1.0 110.034 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.11 136.61 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.697 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 118.182 -0.913 . . . . 1.0 111.729 -179.603 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -95.01 35.26 1.28 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.12 0.568 . . . . 1.0 110.36 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.21 137.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -146.23 147.99 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.273 0.558 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.9 p -164.26 149.66 10.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.701 -0.681 . . . . 1.0 109.839 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -134.32 126.31 29.44 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.883 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.0 mm -85.1 101.6 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 m -86.87 144.25 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -119.58 132.62 55.77 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.618 0.723 . . . . 1.0 110.034 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.27 135.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.175 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 115.606 -0.724 . . . . 1.0 109.287 -179.713 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.566 1.572 0 CA-C-O 118.402 -0.809 . . . . 1.0 111.069 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.14 -27.98 23.99 Favored 'Trans proline' 0 N--CA 1.519 2.984 0 C-N-CA 121.092 1.195 . . . . 1.0 112.775 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -109.99 134.48 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.195 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 p -143.7 137.8 28.43 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.341 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.17 157.32 47.21 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.276 0.56 . . . . 1.0 110.396 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 m -84.02 113.42 21.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.702 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -145.9 52.1 1.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.032 0.444 . . . . 1.0 110.72 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.61 -43.18 84.54 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.463 0.649 . . . . 1.0 110.487 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.0 p -124.01 84.38 54.98 Favored Pre-proline 0 N--CA 1.485 1.323 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.169 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.43 122.06 7.2 Favored 'Trans proline' 0 N--CA 1.515 2.74 0 C-N-CA 121.348 1.365 . . . . 1.0 112.705 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -167.88 123.01 1.0 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.667 -0.242 . . . . 1.0 110.675 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -56.19 145.16 27.17 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.611 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.21 -26.7 6.69 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 111.357 -0.697 . . . . 1.0 111.357 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -69.63 140.4 53.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -73.73 137.28 43.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -132.31 147.94 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.161 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -94.64 141.4 28.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.418 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.0 126.89 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -137.0 128.53 28.5 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.496 0.665 . . . . 1.0 109.953 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.86 131.48 56.92 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.487 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -89.22 118.15 28.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.495 0.664 . . . . 1.0 109.498 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.32 132.97 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.784 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.2 m -100.66 127.81 46.93 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.124 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 . . . . . 0 N--CA 1.478 0.939 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.636 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.291 0.567 . . . . 1.0 110.422 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 24.7 mp0 -59.81 118.81 6.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.923 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.2 154.66 17.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.99 0.424 . . . . 1.0 110.082 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -144.94 175.1 10.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.752 0.787 . . . . 1.0 110.067 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 50.93 64.08 1.98 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.978 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.7 t -116.21 84.52 14.17 Favored Pre-proline 0 N--CA 1.489 1.486 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.473 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.66 120.35 3.5 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.626 0.884 . . . . 1.0 111.579 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 t -87.35 141.33 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.647 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 115.65 17.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.61 144.15 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.62 0.724 . . . . 1.0 109.227 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -152.16 143.28 23.18 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -95.61 128.29 42.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.237 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.57 -158.36 17.23 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 110.784 -0.926 . . . . 1.0 110.784 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -103.32 144.23 28.21 Favored Pre-proline 0 N--CA 1.487 1.408 0 CA-C-O 118.404 -0.808 . . . . 1.0 111.461 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.54 -29.68 16.0 Favored 'Trans proline' 0 N--CA 1.516 2.824 0 C-N-CA 120.796 0.997 . . . . 1.0 111.808 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.32 90.29 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -67.55 -70.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.238 0.542 . . . . 1.0 110.166 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 85.85 0.06 OUTLIER Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.47 141.7 47.22 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -113.47 123.98 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-O 121.124 0.488 . . . . 1.0 109.821 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.36 125.08 24.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.643 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.36 -42.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.58 163.34 32.39 Favored Glycine 0 N--CA 1.462 0.417 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -150.35 163.98 36.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.508 0.67 . . . . 1.0 110.528 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.95 116.87 1.03 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.139 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -75.23 139.15 42.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.3 mm -78.55 148.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.698 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -63.84 -47.9 78.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.31 0.576 . . . . 1.0 110.418 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -168.51 136.26 2.1 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.385 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.13 119.21 37.12 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-O 117.785 -1.102 . . . . 1.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.86 165.62 29.68 Favored 'Trans proline' 0 N--CA 1.518 2.966 0 CA-C-N 120.009 1.039 . . . . 1.0 111.993 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.73 139.89 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.003 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.83 73.11 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.83 -171.15 18.12 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.8 p -143.68 149.81 37.77 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.806 0.336 . . . . 1.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.97 157.14 18.03 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.1 tp -150.46 139.33 20.89 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.932 0.872 . . . . 1.0 110.039 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.71 160.37 26.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.024 -0.989 . . . . 1.0 109.866 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -122.2 124.14 43.13 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.493 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.0 142.84 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.761 0.791 . . . . 1.0 109.587 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -103.44 140.81 36.97 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -141.01 132.49 26.91 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.319 0.581 . . . . 1.0 109.931 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -88.04 124.54 33.85 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.695 -0.684 . . . . 1.0 109.388 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.06 130.22 42.28 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 121.373 0.606 . . . . 1.0 110.345 -179.82 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.951 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.19 63.64 17.8 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.22 -177.91 0.56 Allowed 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.676 1.584 . . . . 1.0 111.837 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.89 158.38 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.331 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -153.11 148.0 26.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.026 0.917 . . . . 1.0 109.817 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.57 145.03 31.59 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.017 -0.992 . . . . 1.0 109.973 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -141.25 142.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.419 0.628 . . . . 1.0 110.206 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.01 136.53 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.706 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 CA--C 1.555 1.135 0 CA-C-O 117.666 -1.159 . . . . 1.0 111.404 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.0 t30 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.072 -0.344 . . . . 1.0 110.072 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.75 46.35 1.23 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.495 0.718 . . . . 1.0 110.999 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.62 136.08 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.336 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -143.99 145.47 32.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.832 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 t -165.42 147.82 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.576 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -134.02 128.15 33.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.477 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.09 132.61 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.27 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.18 142.91 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.989 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.73 149.45 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.502 0.668 . . . . 1.0 109.698 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.43 136.7 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.785 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.87 0.843 . . . . 1.0 110.042 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 118.925 -0.559 . . . . 1.0 111.373 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 -27.46 13.92 Favored 'Trans proline' 0 N--CA 1.51 2.47 0 C-N-CA 121.766 1.644 . . . . 1.0 111.742 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.85 130.96 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.221 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -132.66 122.69 25.04 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.941 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.0 mt -104.33 144.2 31.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.232 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.3 m -80.07 44.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.627 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -75.89 51.84 0.66 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.564 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.55 -45.25 92.37 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.238 0.542 . . . . 1.0 110.331 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.2 p -119.19 85.94 31.39 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.378 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.43 116.37 1.54 Allowed 'Trans proline' 0 N--CA 1.514 2.685 0 C-N-CA 121.524 1.483 . . . . 1.0 112.804 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -167.09 117.2 0.87 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.621 0.248 . . . . 1.0 110.508 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -55.95 146.32 22.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.03 0.443 . . . . 1.0 110.354 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.26 -26.19 8.2 Favored Glycine 0 N--CA 1.475 1.293 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.34 146.93 53.59 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.41 132.96 37.55 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.398 0.618 . . . . 1.0 109.651 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.31 145.29 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -91.25 115.96 28.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.899 -0.592 . . . . 1.0 109.522 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.88 112.89 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.4 p -123.56 138.24 54.6 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.556 0.693 . . . . 1.0 110.18 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.16 124.67 47.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.033 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.76 113.22 21.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.719 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -92.71 117.85 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.616 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.7 m -89.75 125.31 35.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.903 0.859 . . . . 1.0 109.665 179.197 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.477 0.656 . . . . 1.0 110.699 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.25 116.4 3.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.286 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.88 152.27 20.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -142.44 169.83 16.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.696 0.76 . . . . 1.0 110.049 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 49.48 62.25 2.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.716 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -113.47 82.69 6.25 Favored Pre-proline 0 N--CA 1.485 1.297 0 CA-C-N 115.749 -0.659 . . . . 1.0 109.381 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -80.35 112.39 2.75 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 121.201 1.267 . . . . 1.0 111.395 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.92 146.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.831 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.81 122.13 28.14 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -117.0 143.48 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.466 0.651 . . . . 1.0 109.704 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -156.14 132.6 10.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 mp -87.13 127.86 35.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.606 0.717 . . . . 1.0 109.697 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.31 -154.6 16.51 Favored Glycine 0 N--CA 1.469 0.879 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -122.21 143.01 38.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.175 -0.916 . . . . 1.0 111.721 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.6 -39.57 46.23 Favored 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 120.782 0.988 . . . . 1.0 113.069 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . -60.78 -42.37 97.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.931 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.04 8.65 1.48 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.104 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 66.77 72.89 0.7 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.98 163.35 25.22 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 141.4 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.233 0.539 . . . . 1.0 110.481 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.85 135.81 40.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.811 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -103.15 -42.84 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.533 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.93 160.36 30.26 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 110.576 -1.01 . . . . 1.0 110.576 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -151.6 164.48 36.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.667 0.746 . . . . 1.0 110.406 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -154.51 115.94 4.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.358 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -77.0 133.91 39.0 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 mm -79.76 145.82 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.531 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -63.5 -49.33 73.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.693 0.759 . . . . 1.0 110.687 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -173.06 142.22 1.04 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.302 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.5 mt -122.98 120.45 27.53 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 118.03 -0.986 . . . . 1.0 111.145 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.12 166.82 28.53 Favored 'Trans proline' 0 N--CA 1.509 2.438 0 C-N-CA 120.85 1.033 . . . . 1.0 111.648 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.74 139.13 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.412 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.51 22.65 76.6 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.54 -172.32 15.91 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -139.9 -169.19 2.67 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.528 0.68 . . . . 1.0 110.672 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.44 150.91 22.27 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.89 114.92 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.847 0.832 . . . . 1.0 110.206 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.82 155.75 19.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.705 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -126.12 122.27 35.26 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.705 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 t -136.75 136.06 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.87 0.843 . . . . 1.0 109.323 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -108.4 140.66 41.37 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.946 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -141.67 135.76 30.21 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.95 0.881 . . . . 1.0 109.837 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -89.64 123.0 33.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.635 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.51 35.72 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 1.0 110.318 179.655 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.097 0 N-CA-C 110.893 -0.883 . . . . 1.0 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.44 68.93 1.37 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.57 -169.22 0.51 Allowed 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.081 1.187 . . . . 1.0 111.654 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -147.83 142.98 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.324 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.28 140.14 33.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.652 0.739 . . . . 1.0 109.747 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.7 141.6 26.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.32 -0.854 . . . . 1.0 109.95 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.4 t -140.75 143.72 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.996 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.98 142.71 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.533 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.558 1.272 0 CA-C-O 119.055 -0.497 . . . . 1.0 110.213 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.575 HD22 ' N ' ' A' ' 105' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -171.77 48.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.05 139.66 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 121.235 0.54 . . . . 1.0 109.868 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -144.9 143.81 30.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.243 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 t -171.18 137.04 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.414 0.626 . . . . 1.0 110.039 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -135.08 155.37 50.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.661 -0.699 . . . . 1.0 110.479 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.0 mm -83.36 123.12 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.089 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.21 103.87 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.44 102.7 15.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -106.9 127.91 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 1.0 109.82 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 121.72 0.771 . . . . 1.0 109.136 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 CA--C 1.552 1.033 0 CA-C-O 118.678 -0.677 . . . . 1.0 111.087 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.94 -27.32 20.98 Favored 'Trans proline' 0 N--CA 1.515 2.753 0 C-N-CA 121.492 1.461 . . . . 1.0 111.992 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.25 132.7 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.067 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 t -133.15 127.83 34.73 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.229 0.538 . . . . 1.0 110.227 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.487 HD22 HD12 ' A' ' 18' ' ' ILE . 16.2 mt -108.61 144.04 36.86 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.275 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -76.74 36.15 0.16 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.844 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 7' ' ' LEU . 36.8 tttp -74.05 48.74 0.32 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.672 0.749 . . . . 1.0 110.235 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.14 -41.61 93.08 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.451 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -116.06 87.49 19.3 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.477 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.03 115.31 1.44 Allowed 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 121.051 1.167 . . . . 1.0 113.076 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -169.09 116.42 0.63 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.627 -0.26 . . . . 1.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -55.8 145.71 23.61 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.52 -25.98 8.71 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -65.77 144.03 57.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.77 137.04 38.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.48 0.657 . . . . 1.0 109.516 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.487 HD12 HD22 ' A' ' 7' ' ' LEU . 33.5 pt -124.05 145.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.399 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -87.56 113.62 23.41 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.07 113.24 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -130.1 135.19 47.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.576 0.703 . . . . 1.0 110.141 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 126.2 48.88 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.02 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -81.87 111.4 18.05 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 p -89.62 124.99 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.3 m -98.09 124.52 42.66 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 121.358 0.599 . . . . 1.0 109.647 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.3 0.571 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -62.1 126.95 29.11 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.579 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.54 135.88 37.42 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.532 ' O ' ' C ' ' A' ' 34' ' ' ASN . 33.6 m170 -105.9 169.71 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.087 0.946 . . . . 1.0 109.73 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 33' ' ' HIS . 4.3 p30 16.73 84.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.906 -1.043 . . . . 1.0 111.454 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 t -112.44 80.9 3.75 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.109 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -83.57 102.8 1.04 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 120.386 0.724 . . . . 1.0 111.352 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.46 149.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.46 40.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -121.37 143.98 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.5 0.667 . . . . 1.0 109.501 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -152.86 128.39 10.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.52 127.64 33.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.12 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.79 -155.33 17.12 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 110.714 -0.955 . . . . 1.0 110.714 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -121.34 143.72 38.21 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.325 -0.845 . . . . 1.0 111.503 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.59 -30.11 15.57 Favored 'Trans proline' 0 N--CA 1.517 2.904 0 CA-C-N 119.684 0.923 . . . . 1.0 113.166 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.37 87.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.729 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.16 -52.36 64.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.324 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.49 -4.08 0.26 Allowed Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.34 98.84 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -81.41 114.43 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' CD ' HH22 ' A' ' 53' ' ' ARG . 63.5 tt0 -74.46 112.69 10.89 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.9 -46.2 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 176.24 42.47 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.734 -0.947 . . . . 1.0 110.734 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.428 HH22 ' CD ' ' A' ' 50' ' ' GLU . 9.5 ptp85 -147.85 160.88 42.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.726 0.774 . . . . 1.0 110.457 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -146.07 113.7 6.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.893 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -84.98 130.25 34.66 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.7 145.77 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.079 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.9 p -62.42 -46.58 87.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.121 0.486 . . . . 1.0 110.421 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -169.09 137.53 2.0 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.472 0.653 . . . . 1.0 109.9 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.0 mt -115.91 119.14 37.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 CA-C-O 118.393 -0.813 . . . . 1.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.43 168.71 24.18 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 CA-C-N 119.592 0.89 . . . . 1.0 112.302 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.12 141.23 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.91 13.5 59.51 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.597 -1.001 . . . . 1.0 110.597 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.95 -175.44 19.4 Favored Glycine 0 N--CA 1.477 1.393 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 p -143.09 150.91 40.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.882 -0.159 . . . . 1.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.82 158.19 21.32 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.21 -1.156 . . . . 1.0 110.21 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.24 110.84 16.64 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.9 0.857 . . . . 1.0 109.906 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.47 154.81 18.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.088 -0.96 . . . . 1.0 110.339 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -141.47 123.59 15.53 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.842 0.829 . . . . 1.0 110.594 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.05 135.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.428 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -92.6 137.1 32.66 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.597 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -139.65 131.02 26.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 1.0 109.639 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -97.26 123.9 41.19 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.003 -0.999 . . . . 1.0 109.482 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 147.09 53.25 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.484 1.235 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.433 -179.193 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.67 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 86' ' ' VAL . 11.8 p -165.44 60.47 0.69 Allowed Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.98 163.34 31.09 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.943 1.762 . . . . 1.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.24 134.33 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 121.433 0.635 . . . . 1.0 109.787 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -128.46 148.23 50.72 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.996 0.903 . . . . 1.0 109.937 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.98 146.75 31.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.969 -1.014 . . . . 1.0 110.102 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.42 141.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.512 0.672 . . . . 1.0 110.156 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -86.83 137.5 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.547 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 117.951 -1.023 . . . . 1.0 111.547 -179.607 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.745 0.307 . . . . 1.0 110.673 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -90.56 51.58 2.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.155 0.502 . . . . 1.0 110.661 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.87 134.88 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.716 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -142.84 136.4 28.7 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.426 0.631 . . . . 1.0 109.736 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.6 m -158.48 145.14 17.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.527 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -144.11 127.2 16.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.974 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.9 mp -88.75 147.24 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.671 -0.863 . . . . 1.0 108.671 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.32 140.9 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 115.202 -0.908 . . . . 1.0 109.842 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -95.51 142.49 27.8 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.798 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.7 136.32 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-O 121.324 0.583 . . . . 1.0 110.203 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.484 1.264 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.707 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 mp . . . . . 0 CA--C 1.558 1.282 0 CA-C-O 118.336 -0.84 . . . . 1.0 111.115 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.47 -29.33 77.63 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.643 1.562 . . . . 1.0 112.339 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.9 mt -111.99 135.94 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.209 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 t -148.23 138.98 23.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.382 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.07 163.27 33.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.72 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.3 t -84.02 114.69 21.9 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.971 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.86 50.19 1.19 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.834 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -56.77 -43.79 81.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.717 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 p -123.19 84.93 51.52 Favored Pre-proline 0 N--CA 1.485 1.285 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.251 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -49.27 123.33 9.98 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 121.584 1.523 . . . . 1.0 112.2 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -168.15 123.7 1.0 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.397 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -56.85 146.21 27.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.599 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.16 -27.54 6.09 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 110.994 -0.843 . . . . 1.0 110.994 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.54 141.25 55.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.881 -0.415 . . . . 1.0 109.881 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -74.76 143.28 44.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.681 0.753 . . . . 1.0 109.745 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.046 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -89.35 112.51 23.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.366 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.02 118.33 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -130.79 133.99 46.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.442 0.639 . . . . 1.0 110.479 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.57 128.26 53.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.109 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.43 119.72 26.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.573 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.74 126.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.765 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -88.81 125.17 34.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.02 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.6 t30 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 121.239 0.542 . . . . 1.0 110.133 179.746 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 121.386 0.612 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -56.63 120.19 7.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.462 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.84 152.95 18.2 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.101 0.476 . . . . 1.0 109.828 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -146.15 173.31 12.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.876 0.846 . . . . 1.0 109.836 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 m120 48.63 59.45 4.36 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.086 -0.961 . . . . 1.0 110.857 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.44 87.33 7.64 Favored Pre-proline 0 N--CA 1.488 1.457 0 CA-C-O 118.578 -0.725 . . . . 1.0 109.749 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.52 173.4 14.54 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 120.836 1.024 . . . . 1.0 111.478 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.58 144.42 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.92 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.1 133.06 43.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.528 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.1 146.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.635 0.731 . . . . 1.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -154.95 141.89 19.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.822 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 42' ' ' GLY . 1.6 tt -96.62 130.22 43.87 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.545 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.592 ' N ' HD23 ' A' ' 41' ' ' LEU . . . 118.94 -153.04 17.09 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 110.498 -1.041 . . . . 1.0 110.498 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -126.01 140.03 35.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-O 118.175 -0.917 . . . . 1.0 111.575 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.04 -36.15 53.25 Favored 'Trans proline' 0 N--CA 1.517 2.888 0 C-N-CA 120.74 0.96 . . . . 1.0 112.923 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.48 89.49 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.885 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -65.77 -75.32 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.193 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.42 67.79 0.04 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.64 51.16 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.72 138.0 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.286 0.565 . . . . 1.0 110.403 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.93 136.13 53.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.766 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.0 mt -101.52 -38.95 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.531 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.01 164.16 34.04 Favored Glycine 0 N--CA 1.462 0.433 0 N-CA-C 110.654 -0.978 . . . . 1.0 110.654 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -149.35 162.17 40.6 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.967 0.889 . . . . 1.0 110.264 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -155.05 118.79 4.55 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.036 -0.983 . . . . 1.0 110.162 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.1 m -79.1 133.3 36.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.23 0.538 . . . . 1.0 109.591 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 59' ' ' ILE . 60.8 mt -108.52 145.57 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.47 -56.35 2.31 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.628 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -64.92 79.28 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.316 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' A' ' 56' ' ' ILE . 30.3 mt -122.85 86.9 50.36 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 118.237 -0.887 . . . . 1.0 110.558 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.66 163.7 35.29 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.59 1.526 . . . . 1.0 111.746 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -69.09 142.7 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.445 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.41 68.9 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.04 -167.68 18.91 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -146.33 151.06 36.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.255 0.55 . . . . 1.0 110.253 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.64 151.85 19.81 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.062 -1.215 . . . . 1.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.52 116.52 16.04 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.746 0.784 . . . . 1.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 156.0 18.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.837 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -125.54 124.17 40.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.944 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.21 140.64 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.482 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -106.3 140.21 39.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.709 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -141.64 134.23 28.39 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.974 0.893 . . . . 1.0 109.839 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -102.34 127.56 49.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.986 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 141.88 53.27 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 N--CA 1.484 1.265 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.204 -179.734 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.668 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.5 m -119.45 65.26 8.45 Favored Pre-proline 0 N--CA 1.481 1.089 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.4 -179.55 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.129 1.886 . . . . 1.0 110.94 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.66 157.59 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.077 -0.965 . . . . 1.0 110.173 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -147.11 145.77 29.71 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.925 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.18 142.36 32.69 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.13 136.54 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.64 0.734 . . . . 1.0 110.088 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.63 138.37 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.666 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 CA--C 1.558 1.278 0 CA-C-O 117.917 -1.04 . . . . 1.0 111.184 -179.691 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -93.29 47.53 1.26 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.392 0.615 . . . . 1.0 110.737 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 58.7 t -100.38 135.76 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 121.723 0.773 . . . . 1.0 109.423 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 53.4 m-85 -144.68 146.3 32.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.245 -0.889 . . . . 1.0 109.929 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.9 t -163.05 150.02 12.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.437 -0.802 . . . . 1.0 109.8 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -145.25 132.58 20.62 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.088 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.7 mp -83.0 118.63 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.45 107.05 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.8 122.3 29.69 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.5 t -129.08 134.98 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 1.0 109.902 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 122.06 0.933 . . . . 1.0 109.931 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.554 1.113 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.21 -39.17 3.16 Favored 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 120.881 1.054 . . . . 1.0 112.417 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -100.51 133.83 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.588 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.9 p -137.26 123.06 20.0 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.4 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.6 mt -112.27 150.7 30.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.48 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.3 p -81.09 28.35 0.37 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.37 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -73.95 48.91 0.31 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -55.15 -26.24 37.31 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.193 0.52 . . . . 1.0 110.396 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -133.34 138.45 31.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-O 118.247 -0.883 . . . . 1.0 111.4 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -78.42 113.54 3.37 Favored 'Trans proline' 0 N--CA 1.51 2.468 0 CA-C-N 119.596 0.891 . . . . 1.0 111.642 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -166.96 99.39 0.54 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.78 146.83 16.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.733 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.93 -23.01 25.84 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -68.78 138.15 54.59 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.47 136.32 54.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.31 0.576 . . . . 1.0 109.622 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.84 148.1 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.234 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.5 m -96.35 114.11 25.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.816 -0.629 . . . . 1.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.24 122.77 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 m -128.63 132.66 48.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.33 0.586 . . . . 1.0 109.984 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.08 123.41 40.27 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.734 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -79.28 144.64 34.1 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.202 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.03 135.64 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -101.34 123.99 46.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.1 t30 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.429 0.633 . . . . 1.0 110.103 179.677 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.183 0.516 . . . . 1.0 110.77 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -58.08 125.84 24.88 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.533 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.08 152.91 22.18 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.201 0.524 . . . . 1.0 110.107 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -147.22 -178.88 6.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.097 0.951 . . . . 1.0 109.741 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 47.83 59.24 4.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.832 -1.076 . . . . 1.0 111.223 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.86 84.66 2.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 CA-C-O 118.395 -0.812 . . . . 1.0 109.783 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.83 160.69 30.73 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 120.638 0.892 . . . . 1.0 111.724 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.82 141.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.031 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.43 129.09 42.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.499 -0.773 . . . . 1.0 109.536 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.51 146.32 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.724 0.773 . . . . 1.0 109.224 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -152.12 150.03 29.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.992 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tp -97.33 130.85 44.45 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.114 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.79 -153.55 17.45 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -118.72 143.63 33.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.36 -37.11 40.1 Favored 'Trans proline' 0 N--CA 1.521 3.142 0 CA-C-N 119.559 0.878 . . . . 1.0 113.275 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.57 99.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.783 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.91 8.69 1.42 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.235 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.31 74.2 0.55 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.89 163.99 13.98 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.125 -0.79 . . . . 1.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.79 132.97 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.211 0.529 . . . . 1.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.04 134.84 48.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.684 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -98.69 -36.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.577 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.84 172.84 41.01 Favored Glycine 0 N--CA 1.463 0.437 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.16 166.77 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.754 0.787 . . . . 1.0 110.294 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -161.17 117.14 2.18 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.95 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -76.62 136.52 39.2 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.9 mt -107.56 142.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.727 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 59' ' ' ILE . 95.8 p -105.02 -54.95 2.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.578 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -63.51 75.3 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.15 0.976 . . . . 1.0 110.967 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' SER . 49.7 mm -121.91 82.23 42.88 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 114.748 -1.115 . . . . 1.0 109.529 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 167.7 24.49 Favored 'Trans proline' 0 N--CA 1.506 2.219 0 C-N-CA 121.191 1.26 . . . . 1.0 111.844 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.95 137.73 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.323 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.23 13.84 73.64 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.93 -167.27 22.36 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.5 p -143.15 -174.32 4.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.297 0.57 . . . . 1.0 110.616 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.73 149.52 21.37 Favored Glycine 0 N--CA 1.477 1.382 0 N-CA-C 110.929 -0.869 . . . . 1.0 110.929 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.7 mt -138.68 124.61 19.95 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.278 1.037 . . . . 1.0 110.025 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.91 160.6 15.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.421 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -126.18 122.34 35.37 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.843 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.13 135.4 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 122.004 0.907 . . . . 1.0 109.043 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -99.77 139.09 35.93 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -143.01 143.37 31.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.143 0.973 . . . . 1.0 109.932 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -113.43 127.28 56.06 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.181 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 118.18 13.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.661 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 121.21 0.529 . . . . 1.0 109.916 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.705 0 N-CA-C 110.621 -0.991 . . . . 1.0 110.621 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.55 63.14 13.82 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.66 166.54 19.69 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.888 1.726 . . . . 1.0 111.245 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.5 158.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 114.898 -1.047 . . . . 1.0 110.144 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -152.95 146.54 25.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.872 0.844 . . . . 1.0 109.746 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.49 144.33 34.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.886 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.3 t -131.74 138.63 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.66 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.59 135.17 28.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 118.785 -0.626 . . . . 1.0 110.17 179.253 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -159.61 46.53 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.71 104.43 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -110.27 132.04 54.53 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.03 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 t -164.36 144.09 7.67 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.331 0.586 . . . . 1.0 110.139 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -133.55 132.23 40.67 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.514 0.673 . . . . 1.0 110.136 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -80.68 137.72 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.68 142.92 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.771 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.26 143.68 49.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.137 0.97 . . . . 1.0 110.061 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.43 137.83 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.293 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.753 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 CA--C 1.562 1.429 0 CA-C-O 119.478 -0.296 . . . . 1.0 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.84 -24.14 40.64 Favored 'Trans proline' 0 N--CA 1.515 2.75 0 C-N-CA 121.976 1.784 . . . . 1.0 111.957 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.4 mt -124.27 130.93 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.328 0.585 . . . . 1.0 110.2 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.2 m -134.87 123.46 23.52 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.856 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.47 147.64 28.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.369 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.9 p -81.06 34.41 0.35 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -70.79 50.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.974 0.51 . . . . 1.0 110.209 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -51.83 -30.33 23.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.658 0.742 . . . . 1.0 110.523 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.5 p -137.16 140.7 31.9 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.261 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.97 113.95 3.52 Favored 'Trans proline' 0 N--CA 1.514 2.728 0 CA-C-N 119.231 0.761 . . . . 1.0 111.392 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.92 101.45 0.55 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.86 0.362 . . . . 1.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 1.4 pm0 -53.9 148.8 9.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.948 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.14 -23.7 16.85 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -69.68 144.1 52.95 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.46 137.55 46.49 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.561 0.696 . . . . 1.0 109.508 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.14 146.55 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.915 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -97.7 114.51 26.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.7 119.7 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -129.09 132.99 47.48 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.265 0.555 . . . . 1.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.06 128.22 55.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.152 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -84.5 119.34 25.05 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 t -108.26 113.21 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.497 0.665 . . . . 1.0 109.215 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 m -86.27 131.92 34.11 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.557 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.006 0.431 . . . . 1.0 109.844 -179.841 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 121.495 0.664 . . . . 1.0 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -66.01 117.22 8.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.738 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.14 152.65 22.16 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 34' ' ' ASN . 44.1 t-80 -139.91 169.04 18.44 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.518 0.675 . . . . 1.0 110.04 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.418 ' N ' ' CG ' ' A' ' 33' ' ' HIS . 80.0 m-20 50.24 62.52 2.63 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.738 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 t -113.97 82.81 7.17 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -80.39 169.5 17.12 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.638 1.559 . . . . 1.0 111.322 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.13 136.61 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.547 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.38 114.91 18.83 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.275 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 t -104.44 137.48 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.526 0.679 . . . . 1.0 109.307 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -146.71 127.11 14.0 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.131 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tp -85.93 124.33 32.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 -158.75 15.68 Favored Glycine 0 N--CA 1.476 1.348 0 N-CA-C 110.762 -0.935 . . . . 1.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.5 142.68 28.56 Favored Pre-proline 0 N--CA 1.491 1.62 0 CA-C-O 117.788 -1.101 . . . . 1.0 111.528 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.8 -38.8 38.42 Favored 'Trans proline' 0 N--CA 1.519 2.992 0 CA-C-N 120.079 1.064 . . . . 1.0 113.108 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.51 22.89 0.23 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.981 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -166.71 -73.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.921 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.63 -97.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.1 90.86 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.1 115.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.24 133.07 45.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.67 -46.11 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.64 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.15 165.8 35.45 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -155.49 167.43 30.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.367 0.603 . . . . 1.0 110.629 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -161.25 119.82 2.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.404 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 m -75.11 131.4 40.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -80.81 155.51 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.4 p -65.42 -51.96 56.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.602 0.715 . . . . 1.0 110.072 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -177.29 145.47 0.45 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.039 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.5 mt -114.56 117.29 42.85 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 117.571 -1.205 . . . . 1.0 110.686 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.13 162.25 41.19 Favored 'Trans proline' 0 N--CA 1.519 2.971 0 CA-C-N 120.286 1.138 . . . . 1.0 112.157 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.17 137.31 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.557 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.55 77.48 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.82 -167.9 14.69 Favored Glycine 0 N--CA 1.472 1.068 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -132.92 176.23 8.66 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.896 0.855 . . . . 1.0 110.364 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.41 124.42 0.94 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 115.098 -0.955 . . . . 1.0 110.783 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.76 160.15 37.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.05 0.929 . . . . 1.0 110.127 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.67 161.91 13.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.246 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.854 -1.066 . . . . 1.0 109.895 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -140.03 156.32 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.28 1.038 . . . . 1.0 109.169 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.32 141.72 51.69 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.956 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -140.8 137.56 33.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.991 0.9 . . . . 1.0 109.691 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -100.31 123.84 45.04 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.557 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.44 138.39 49.02 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.47 0.57 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.436 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -119.14 64.71 7.21 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -60.6 141.46 95.28 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.755 1.637 . . . . 1.0 111.734 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.7 t -98.49 147.02 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 115.349 -0.841 . . . . 1.0 109.862 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -135.38 138.88 43.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.037 0.923 . . . . 1.0 109.821 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.92 135.03 22.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.033 -0.985 . . . . 1.0 109.632 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 t -139.67 144.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.996 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.4 145.79 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.538 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 118.437 -0.792 . . . . 1.0 110.143 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 110.23 -0.285 . . . . 1.0 110.23 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -167.32 44.38 0.05 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.873 0.368 . . . . 1.0 110.547 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.45 139.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.222 0.534 . . . . 1.0 109.789 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -147.9 153.39 39.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.123 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -165.09 147.04 7.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.125 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -142.14 133.01 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.8 mp -81.28 123.35 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.63 136.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.376 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -131.95 125.19 30.99 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.317 0.58 . . . . 1.0 109.927 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.09 137.05 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.771 0.796 . . . . 1.0 110.039 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.481 1.088 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.952 -179.689 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 CA--C 1.563 1.447 0 CA-C-O 118.314 -0.851 . . . . 1.0 110.918 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.47 -32.16 61.58 Favored 'Trans proline' 0 N--CA 1.516 2.806 0 C-N-CA 121.099 1.2 . . . . 1.0 112.603 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.95 130.1 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.202 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -134.22 121.76 21.81 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.475 0.655 . . . . 1.0 109.921 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.04 147.29 27.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.445 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -94.03 78.03 4.09 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.603 0.716 . . . . 1.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.44 58.89 0.69 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.444 1.098 . . . . 1.0 110.693 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.67 -33.72 56.26 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.743 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -126.93 132.74 24.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.903 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -81.13 105.78 1.68 Allowed 'Trans proline' 0 N--CA 1.511 2.518 0 CA-C-N 119.914 1.005 . . . . 1.0 111.438 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -169.42 117.32 0.62 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.206 0.527 . . . . 1.0 110.454 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.76 150.81 9.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.065 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.3 34.56 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -72.82 126.33 29.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.217 0.532 . . . . 1.0 109.815 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -65.03 131.54 46.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.662 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.8 pt -119.69 147.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.271 0.558 . . . . 1.0 109.741 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.9 m -94.5 121.14 35.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.701 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.4 t -100.27 121.59 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -123.99 134.5 53.45 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.603 0.716 . . . . 1.0 109.808 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.09 120.67 33.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.08 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.81 123.25 30.96 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.997 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -107.62 129.26 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.216 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 m -90.94 123.75 34.68 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.305 0.574 . . . . 1.0 110.856 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 19.1 mp0 -67.04 125.78 27.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.909 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.74 160.35 18.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 1.0 110.432 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -161.09 94.22 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 122.572 1.177 . . . . 1.0 109.33 178.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER 157.4 58.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.414 -1.266 . . . . 1.0 110.394 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.63 86.01 12.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.09 100.85 0.96 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.016 1.144 . . . . 1.0 111.269 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.97 143.02 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.759 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.15 120.21 26.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.935 0.494 . . . . 1.0 109.82 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.9 t -112.01 143.14 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.324 0.583 . . . . 1.0 109.582 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -151.98 126.01 9.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.102 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.55 128.54 34.95 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.643 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.61 -160.38 15.99 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -117.45 142.35 30.22 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.144 -0.932 . . . . 1.0 111.457 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.64 -40.95 46.48 Favored 'Trans proline' 0 N--CA 1.522 3.171 0 CA-C-N 119.688 0.924 . . . . 1.0 113.323 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.41 93.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.968 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -59.21 4.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.122 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.67 83.16 0.04 OUTLIER Glycine 0 N--CA 1.476 1.361 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.6 130.7 40.44 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.92 126.0 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.224 0.535 . . . . 1.0 109.786 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -68.48 122.14 17.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.824 -0.626 . . . . 1.0 109.926 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.16 -44.91 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.213 0.53 . . . . 1.0 109.94 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.56 168.53 37.98 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -158.16 169.99 23.27 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.618 0.723 . . . . 1.0 110.334 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -163.45 114.66 1.41 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.005 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -75.22 140.51 43.3 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.9 mm -78.63 142.09 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -66.62 -50.13 64.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.229 0.538 . . . . 1.0 110.579 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -147.3 130.33 16.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.759 0.79 . . . . 1.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 mt -117.71 108.47 42.88 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.982 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.95 159.88 44.08 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 CA-C-N 119.934 1.012 . . . . 1.0 111.667 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -70.57 145.52 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.499 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.26 1.86 29.95 Favored Glycine 0 N--CA 1.461 0.321 0 N-CA-C 110.385 -1.086 . . . . 1.0 110.385 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.95 -165.35 26.92 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -139.74 -173.42 3.62 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.388 0.613 . . . . 1.0 110.648 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.01 151.18 22.65 Favored Glycine 0 N--CA 1.477 1.408 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mt -132.54 152.59 51.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.291 1.043 . . . . 1.0 109.641 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.04 154.74 45.19 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.706 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -117.9 120.4 37.75 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.35 128.76 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.632 0.73 . . . . 1.0 109.269 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -99.29 140.04 34.05 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.848 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -137.98 121.88 17.71 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.981 0.896 . . . . 1.0 109.981 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -92.37 127.04 37.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.107 -0.951 . . . . 1.0 109.788 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.88 138.52 50.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.487 -0.485 . . . . 1.0 109.749 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.714 -179.373 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.823 0 N-CA-C 110.594 -1.003 . . . . 1.0 110.594 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.79 62.79 27.0 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.25 149.62 89.89 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.731 1.621 . . . . 1.0 111.309 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.6 t -103.75 114.33 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.72 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.61 147.32 30.79 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.852 0.834 . . . . 1.0 109.474 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.99 142.69 27.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.041 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.1 138.87 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.082 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -84.65 135.91 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.284 0 CA-C-O 117.759 -1.115 . . . . 1.0 111.558 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -155.06 26.39 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.418 0.287 . . . . 1.0 110.556 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.83 136.73 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -141.63 138.66 32.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.0 m -165.62 140.04 4.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.086 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -134.84 150.31 50.47 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.083 0.468 . . . . 1.0 110.444 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -88.76 133.05 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.53 138.61 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.84 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.33 155.99 48.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.779 0.799 . . . . 1.0 109.535 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.55 133.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 mt . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.6 t0 52.91 84.3 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.332 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.81 156.58 72.13 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 118.529 -0.748 . . . . 1.0 110.911 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.5 -28.64 45.88 Favored 'Trans proline' 0 N--CA 1.517 2.855 0 C-N-CA 121.592 1.528 . . . . 1.0 112.361 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.15 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.762 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.5 p -131.93 120.22 22.2 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.955 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 9' ' ' LYS . 60.4 mt -102.66 145.48 29.61 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.225 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.8 t -78.88 31.17 0.2 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.6 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 7' ' ' LEU . 80.8 tttt -72.98 49.35 0.24 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.584 0.707 . . . . 1.0 110.16 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -61.08 -40.49 93.89 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -117.17 89.86 31.94 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.708 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.47 111.13 0.33 Allowed 'Trans proline' 0 N--CA 1.523 3.221 0 C-N-CA 121.052 1.168 . . . . 1.0 113.256 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -162.48 109.37 1.27 Allowed 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.265 0.555 . . . . 1.0 110.432 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -55.68 142.68 33.22 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.112 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.1 18.23 63.37 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -107.28 143.62 35.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.663 0.385 . . . . 1.0 110.233 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.17 130.95 40.07 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.15 144.68 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.987 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -89.3 112.96 24.16 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -96.22 115.51 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.1 p -129.53 134.83 47.97 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.371 0.605 . . . . 1.0 110.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.0 127.18 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.831 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -84.03 116.26 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.81 126.51 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.135 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -96.18 126.91 41.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 120.677 0.275 . . . . 1.0 110.284 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -82.81 108.06 15.89 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 1.0 109.749 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -98.33 -168.17 1.61 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.238 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.27 -122.79 6.87 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.774 -0.93 . . . . 1.0 110.774 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.39 12.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.553 0.216 . . . . 1.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.41 156.06 44.04 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.25 0.548 . . . . 1.0 110.613 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.05 119.33 6.6 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.363 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.08 149.74 21.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.888 0.375 . . . . 1.0 110.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -137.13 162.75 32.53 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 122.435 1.112 . . . . 1.0 109.797 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 53.83 67.57 0.99 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.604 -1.18 . . . . 1.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.43 82.58 24.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.273 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.17 175.27 10.49 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.75 0.966 . . . . 1.0 111.16 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.51 138.69 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.677 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.26 114.25 17.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.379 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 t -107.59 140.56 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.519 0.676 . . . . 1.0 109.233 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -145.56 130.24 18.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.048 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.31 125.59 32.41 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.99 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -159.65 17.06 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -108.59 143.32 27.26 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.467 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.12 -21.19 27.63 Favored 'Trans proline' 0 N--CA 1.516 2.812 0 C-N-CA 120.5 0.8 . . . . 1.0 111.789 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.3 -45.88 89.33 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.934 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -72.38 -69.59 0.39 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.136 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.02 77.42 0.03 OUTLIER Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.32 165.84 21.6 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.54 141.8 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.089 0.471 . . . . 1.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -73.83 134.17 43.29 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.757 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -98.51 -42.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.7 168.75 39.37 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -153.96 166.19 33.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.506 0.67 . . . . 1.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -154.65 114.89 3.85 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.047 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -76.0 132.71 40.34 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.6 mt -86.46 148.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -62.24 -49.85 74.06 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.36 0.6 . . . . 1.0 110.465 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -176.25 146.77 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.293 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -118.31 124.16 28.8 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-O 117.924 -1.036 . . . . 1.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.04 163.15 39.07 Favored 'Trans proline' 0 N--CA 1.519 2.999 0 CA-C-N 119.844 0.98 . . . . 1.0 111.984 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -71.61 142.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.717 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.18 6.33 56.83 Favored Glycine 0 N--CA 1.465 0.627 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.9 -166.74 21.54 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 110.481 -1.048 . . . . 1.0 110.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 p -146.2 152.42 39.19 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.274 0.559 . . . . 1.0 110.14 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.55 157.75 19.84 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.39 113.72 7.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.501 0.667 . . . . 1.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.98 159.47 15.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.513 -0.767 . . . . 1.0 110.002 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -126.38 122.22 34.74 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.868 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.71 146.37 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.9 0.857 . . . . 1.0 109.55 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -119.84 142.29 48.77 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.216 -0.902 . . . . 1.0 110.033 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -144.5 145.2 31.73 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.012 0.911 . . . . 1.0 109.712 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -91.19 121.19 32.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.942 -1.026 . . . . 1.0 109.676 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.38 132.64 42.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t -170.82 119.64 0.53 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.951 0.405 . . . . 1.0 110.181 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -168.58 12.57 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.063 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -62.88 154.67 29.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.125 0.488 . . . . 1.0 110.461 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.39 13.21 1.22 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.261 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 53.07 46.71 26.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.535 0.683 . . . . 1.0 110.675 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.52 145.1 5.91 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 55.33 67.55 1.0 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.652 0.263 . . . . 1.0 110.824 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.54 -17.39 32.14 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.332 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.03 37.16 0.24 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.917 0.389 . . . . 1.0 110.658 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -167.58 130.25 1.34 Allowed Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 118.087 -0.958 . . . . 1.0 111.418 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 73.1 Cg_endo -71.26 -83.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.512 2.592 0 CA-C-N 119.831 0.975 . . . . 1.0 112.097 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.422 ' H ' ' HG2' ' A' ' 84' ' ' PRO . . . 83.72 11.96 78.56 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.9 p -118.42 64.98 5.93 Favored Pre-proline 0 N--CA 1.48 1.047 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -68.81 175.45 7.27 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.983 1.789 . . . . 1.0 111.357 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.43 135.73 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.868 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -135.22 146.78 48.98 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.862 0.839 . . . . 1.0 109.721 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.72 143.02 28.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.929 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.42 140.13 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.652 0.739 . . . . 1.0 109.728 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.06 140.63 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.255 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -40.69 146.66 0.44 Allowed Pre-proline 0 CA--C 1.561 1.387 0 CA-C-O 118.143 -0.932 . . . . 1.0 111.767 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.81 109.59 2.55 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 120.8 1.0 . . . . 1.0 112.231 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -85.24 8.74 17.32 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -149.84 49.54 0.93 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.954 0.407 . . . . 1.0 110.61 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 52.82 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.127 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.82 125.19 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-O 121.79 0.805 . . . . 1.0 109.87 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.87 100.29 0.22 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.073 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -70.31 -60.81 2.06 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.852 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.5 t -44.66 -47.37 10.54 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.505 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.85 -72.42 0.12 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 120.993 -0.283 . . . . 1.0 110.406 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 105' ' ' ASN . 22.9 mtpp -42.75 -45.53 4.81 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 120.962 0.41 . . . . 1.0 111.222 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.03 -6.7 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.511 0.672 . . . . 1.0 111.745 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 103' ' ' LYS . 48.2 m-20 -84.4 -38.22 20.52 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.935 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.28 46.6 1.11 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.364 0.666 . . . . 1.0 110.234 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 13.1 p -105.68 139.01 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.428 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 55.3 m-85 -145.33 143.24 30.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.146 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.4 p -170.54 143.36 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.74 147.28 33.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.6 mp -92.48 144.59 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.57 140.12 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.927 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.38 143.94 38.26 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.873 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.1 m -109.58 135.79 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.826 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.52 133.03 35.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.676 0.751 . . . . 1.0 109.063 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.17 101.73 5.92 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.342 -0.844 . . . . 1.0 109.671 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 117' ' ' HIS . 3.2 p-80 -165.63 171.66 12.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.226 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -149.53 152.32 35.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.182 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -69.07 123.1 20.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.622 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 122' ' ' HIS . 64.0 m80 -79.53 -157.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 1.0 109.926 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 55.49 -82.89 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.992 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 2.5 p-80 . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 118.045 -0.979 . . . . 1.0 110.199 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -81.44 76.18 8.38 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.235 0.54 . . . . 1.0 109.874 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.32 151.72 81.13 Favored Pre-proline 0 CA--C 1.557 1.224 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.735 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.26 -23.51 38.74 Favored 'Trans proline' 0 N--CA 1.51 2.451 0 C-N-CA 121.551 1.501 . . . . 1.0 111.737 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.24 132.16 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.334 0.588 . . . . 1.0 110.269 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.3 m -133.62 121.95 22.78 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.047 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.07 147.61 26.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.477 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.9 p -85.82 34.55 0.6 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.297 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -71.77 54.92 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.936 0.398 . . . . 1.0 110.261 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -52.14 -32.6 36.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.311 0.577 . . . . 1.0 110.434 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.9 p -134.85 139.26 31.72 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.638 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -79.33 115.62 3.48 Favored 'Trans proline' 0 N--CA 1.515 2.771 0 C-N-CA 120.522 0.815 . . . . 1.0 111.779 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -167.13 102.93 0.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.805 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -52.58 146.41 10.08 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.018 0.437 . . . . 1.0 110.642 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.91 -23.6 22.6 Favored Glycine 0 N--CA 1.476 1.301 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -67.66 141.09 56.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.887 0.375 . . . . 1.0 110.014 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.94 133.85 47.74 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.1 pt -119.65 144.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.976 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.7 m -96.25 110.46 22.76 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.559 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.4 t -93.82 117.71 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -128.38 137.73 52.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.266 0.555 . . . . 1.0 110.286 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.56 123.51 40.75 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.253 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -77.63 116.05 17.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.22 121.86 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.6 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.1 m -108.72 122.73 47.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 120.993 0.425 . . . . 1.0 110.078 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -89.47 127.55 35.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.859 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -129.52 130.58 45.97 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.536 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.56 -109.82 0.32 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 30' ' ' ALA . . . -167.68 3.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.466 0.174 . . . . 1.0 110.846 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 29' ' ' ALA . . . -146.39 163.26 36.18 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.34 0.59 . . . . 1.0 110.584 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.96 121.18 14.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.89 154.0 18.47 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.115 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -142.71 171.0 14.64 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.484 0.659 . . . . 1.0 110.131 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 51.13 63.68 2.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.613 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.56 84.25 6.22 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 115.45 -0.796 . . . . 1.0 109.953 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -79.21 158.77 26.52 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 121.365 1.377 . . . . 1.0 111.518 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.51 135.99 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.358 -0.837 . . . . 1.0 109.842 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.05 115.09 17.94 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.47 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 m -107.83 140.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.796 0.807 . . . . 1.0 109.489 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.67 130.28 17.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.205 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.65 125.94 32.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.96 -162.33 18.04 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -93.66 146.68 32.22 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 119.1 -0.476 . . . . 1.0 111.039 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.12 -12.18 29.95 Favored 'Trans proline' 0 N--CA 1.511 2.55 0 C-N-CA 120.679 0.919 . . . . 1.0 111.606 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.29 86.59 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.02 0.438 . . . . 1.0 110.699 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -81.64 7.37 12.49 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.09 -9.35 47.2 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.31 177.77 0.21 Allowed Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.74 135.92 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.921 0.391 . . . . 1.0 110.345 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.17 132.23 44.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.871 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.27 -42.67 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.48 155.72 26.11 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -148.18 161.58 41.17 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.472 0.653 . . . . 1.0 110.48 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -160.99 114.11 1.97 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.111 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.9 m -82.62 140.55 33.12 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.14 147.73 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.657 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -64.49 -46.28 83.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 1.0 110.54 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -166.5 137.07 3.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.657 -0.702 . . . . 1.0 110.596 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.92 118.83 32.78 Favored Pre-proline 0 N--CA 1.494 1.739 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.69 162.73 37.21 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 CA-C-N 119.78 0.957 . . . . 1.0 111.693 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.11 137.71 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.41 16.44 77.36 Favored Glycine 0 CA--C 1.511 -0.204 0 N-CA-C 110.144 -1.182 . . . . 1.0 110.144 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.08 17.52 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 p -140.17 -170.57 3.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.498 0.666 . . . . 1.0 110.634 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.63 147.2 18.72 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.6 114.66 19.66 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.631 . . . . 1.0 109.81 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.67 154.01 22.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.52 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -126.18 121.66 33.42 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.81 131.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.549 0.69 . . . . 1.0 109.49 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -110.73 138.66 46.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.93 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -138.73 133.71 32.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.912 0.863 . . . . 1.0 109.983 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.38 121.01 30.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 1.0 109.73 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.27 122.94 20.48 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -168.82 -167.36 0.75 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.1 0.476 . . . . 1.0 110.429 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 57.74 50.27 10.97 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.319 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -168.27 88.92 0.25 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.143 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -67.53 -32.34 73.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.401 0.62 . . . . 1.0 110.121 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 54.66 73.8 0.38 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.567 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.52 84.84 0.05 OUTLIER Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 51.53 88.37 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.812 0.339 . . . . 1.0 110.726 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.77 102.65 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.12 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.05 -169.96 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.871 -0.418 . . . . 1.0 109.871 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 39.1 71.07 1.2 Allowed Pre-proline 0 N--CA 1.486 1.348 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.255 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -50.14 -45.18 34.54 Favored 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 121.978 1.785 . . . . 1.0 112.834 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.65 80.38 0.14 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -117.05 82.29 13.53 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-O 118.474 -0.774 . . . . 1.0 109.234 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.82 160.81 33.93 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 121.848 1.698 . . . . 1.0 111.236 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.36 158.53 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.063 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.55 149.47 35.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.804 0.811 . . . . 1.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.05 136.39 20.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.06 144.15 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.702 0.763 . . . . 1.0 109.683 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -94.94 139.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.819 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -120.37 81.6 30.68 Favored Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 118.59 -0.719 . . . . 1.0 109.696 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.15 162.44 23.03 Favored 'Trans proline' 0 N--CA 1.503 2.063 0 C-N-CA 121.765 1.643 . . . . 1.0 111.346 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.39 21.08 0.5 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.284 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -144.07 40.89 1.38 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.593 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -55.9 96.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.461 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.2 -55.58 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.208 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.29 -176.33 2.5 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.465 0.65 . . . . 1.0 110.387 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.17 -64.17 0.91 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.086 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.9 t -47.38 -44.54 24.33 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.228 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.21 -70.39 0.2 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.315 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.541 ' C ' ' H ' ' A' ' 105' ' ' ASN . 36.7 ttpt -44.77 -40.71 6.29 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.273 0.559 . . . . 1.0 111.054 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.7 3.33 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.556 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 103' ' ' LYS . 67.4 m-20 -94.9 32.6 1.63 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.615 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -161.46 42.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.178 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.9 146.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.156 0.503 . . . . 1.0 109.65 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -147.76 154.19 40.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.7 t -160.55 145.92 14.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.174 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.88 130.71 34.27 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.272 0.558 . . . . 1.0 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -80.95 128.42 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.6 t -132.21 138.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.742 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -130.63 110.22 11.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.006 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -89.83 137.22 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.732 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.95 133.89 35.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.309 0.576 . . . . 1.0 109.486 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -65.7 -35.66 81.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.955 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -150.67 155.85 40.16 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.34 0.59 . . . . 1.0 110.577 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -167.52 -13.6 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.392 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -80.73 24.85 0.46 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -62.08 -47.27 85.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.412 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -75.17 71.52 2.21 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.072 0.463 . . . . 1.0 110.105 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 117.957 -1.02 . . . . 1.0 110.273 -179.93 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.23 104.19 1.41 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.87 151.4 93.06 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 118.359 -0.829 . . . . 1.0 111.005 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.74 -21.51 5.79 Favored 'Trans proline' 0 N--CA 1.512 2.587 0 C-N-CA 121.831 1.687 . . . . 1.0 112.562 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.51 132.74 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.077 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.7 p -134.51 122.3 22.23 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.266 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.86 147.14 30.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.418 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.0 t -81.81 36.39 0.44 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.404 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -71.43 50.72 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.047 0.451 . . . . 1.0 110.714 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.19 -39.27 72.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.588 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -124.41 84.33 56.68 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.875 -0.583 . . . . 1.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.13 112.91 0.58 Allowed 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.9 1.734 . . . . 1.0 112.56 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -167.08 123.96 1.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.961 0.41 . . . . 1.0 110.592 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.68 147.19 33.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 1.0 110.448 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.58 -31.64 4.48 Favored Glycine 0 N--CA 1.474 1.212 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.79 133.6 50.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.863 0.363 . . . . 1.0 110.052 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -68.19 136.54 53.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.792 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 pt -126.0 146.67 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.454 0.645 . . . . 1.0 110.426 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -92.79 112.26 24.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.616 -0.72 . . . . 1.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.09 117.75 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.848 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -129.42 136.79 50.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.349 0.595 . . . . 1.0 110.29 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.08 125.96 46.17 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.02 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -81.19 113.72 19.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.66 124.66 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.867 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.8 m -101.25 122.04 42.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.118 0.485 . . . . 1.0 110.015 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -91.77 122.56 34.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.559 0.695 . . . . 1.0 109.76 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.1 mtm180 -111.02 126.06 54.4 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.261 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.41 -137.37 4.07 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.16 10.98 0.21 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.983 -0.128 . . . . 1.0 110.668 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.22 158.47 43.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.49 0.662 . . . . 1.0 110.52 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -61.1 117.14 5.16 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.175 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.43 22.85 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.049 0.452 . . . . 1.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -137.96 159.79 41.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.114 0.959 . . . . 1.0 109.817 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 53.46 65.79 1.41 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.474 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -113.32 83.34 6.53 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.91 176.37 10.21 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 120.909 1.072 . . . . 1.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -150.34 145.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.025 -0.988 . . . . 1.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.97 132.57 43.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.507 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.07 144.93 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.43 0.633 . . . . 1.0 109.335 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.19 150.14 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.262 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 tp -99.47 127.21 45.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.046 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.96 -154.75 16.45 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -116.35 143.86 31.93 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.112 -0.471 . . . . 1.0 111.257 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.58 -10.85 23.99 Favored 'Trans proline' 0 N--CA 1.511 2.508 0 C-N-CA 120.725 0.95 . . . . 1.0 111.58 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.828 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -80.69 -76.13 0.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.86 78.2 0.05 OUTLIER Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.39 168.26 26.43 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 p -132.77 139.34 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 120.952 0.406 . . . . 1.0 110.487 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -74.71 136.97 41.8 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.096 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -95.02 -41.74 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.72 171.08 42.28 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -150.32 162.63 40.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.761 0.791 . . . . 1.0 110.253 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -152.46 113.93 4.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.147 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -78.08 132.9 37.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.8 mt -89.57 150.77 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.33 -51.34 66.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -169.79 141.79 2.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.505 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mt -113.97 124.03 31.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 117.978 -1.011 . . . . 1.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.16 160.17 45.9 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 120.87 1.047 . . . . 1.0 111.705 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.09 143.27 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.19 10.65 66.06 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.83 -167.75 16.37 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.0 p -145.64 150.44 36.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.439 -0.38 . . . . 1.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.4 148.93 19.23 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.46 109.79 16.65 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.602 0.715 . . . . 1.0 109.75 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 154.35 18.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.893 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -132.45 123.03 25.87 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.08 135.11 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.457 -0.792 . . . . 1.0 109.506 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -103.41 138.8 39.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.031 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -139.77 132.46 28.94 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.627 0.727 . . . . 1.0 110.248 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -86.41 124.62 32.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.784 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 100.61 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 t -105.55 178.43 4.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.196 0.522 . . . . 1.0 110.26 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -156.23 170.0 23.25 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.519 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -151.12 141.29 22.23 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.324 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.87 107.57 9.29 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.278 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -169.17 104.21 0.38 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.44 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.25 106.87 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -64.31 140.75 58.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.809 -0.441 . . . . 1.0 109.809 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -157.12 153.72 28.24 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.38 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.55 -76.7 0.08 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.086 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -77.1 144.47 71.74 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.542 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.69 -37.6 2.18 Favored 'Trans proline' 0 N--CA 1.511 2.552 0 C-N-CA 120.635 0.89 . . . . 1.0 111.661 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.07 79.29 0.14 Allowed Glycine 0 N--CA 1.47 0.965 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -119.14 65.03 7.38 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 118.818 -0.61 . . . . 1.0 109.524 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.96 147.85 94.12 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.228 1.952 . . . . 1.0 111.431 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.46 141.63 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.901 0.857 . . . . 1.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.68 151.83 51.86 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.317 1.055 . . . . 1.0 109.882 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.13 139.93 26.32 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.669 -1.15 . . . . 1.0 109.919 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.7 t -133.04 141.95 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 121.82 0.819 . . . . 1.0 110.034 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.11 136.61 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.697 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -46.85 143.49 4.31 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-O 118.182 -0.913 . . . . 1.0 111.729 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.62 140.87 30.2 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.612 1.542 . . . . 1.0 111.547 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -74.01 -42.41 60.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.355 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -171.2 76.31 0.06 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.312 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 50.59 60.93 3.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.144 0.497 . . . . 1.0 111.033 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.87 146.33 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.139 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.32 158.48 34.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.87 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -66.28 -65.0 0.73 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.045 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.1 p -43.28 -37.54 2.23 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.092 -0.503 . . . . 1.0 111.126 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.64 -56.51 5.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 105' ' ' ASN . 88.3 tttt -44.07 -38.39 3.58 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.298 0.57 . . . . 1.0 110.995 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.52 2.56 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.528 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.548 ' H ' ' C ' ' A' ' 103' ' ' LYS . 86.7 m-20 -91.88 -34.62 14.45 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.002 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -95.01 35.26 1.28 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.12 0.568 . . . . 1.0 110.36 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.21 137.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -146.23 147.99 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.273 0.558 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.9 p -164.26 149.66 10.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.701 -0.681 . . . . 1.0 109.839 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -134.32 126.31 29.44 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.883 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.0 mm -85.1 101.6 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 m -86.87 144.25 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -119.58 132.62 55.77 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.618 0.723 . . . . 1.0 110.034 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.27 135.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.175 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 mp -83.99 130.34 34.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.606 -0.724 . . . . 1.0 109.287 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -62.73 143.39 57.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.221 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -70.78 106.05 3.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.697 -0.482 . . . . 1.0 109.697 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -65.58 133.23 50.75 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -167.17 -42.5 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 53.7 98.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.692 -0.231 . . . . 1.0 110.648 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -56.93 116.45 3.2 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.672 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.643 -179.719 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' NH1' ' A' ' 23' ' ' ARG . 66.1 mtt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 55.43 177.03 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.772 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mp -73.81 153.34 89.18 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 118.402 -0.809 . . . . 1.0 111.069 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.14 -27.98 23.99 Favored 'Trans proline' 0 N--CA 1.519 2.984 0 C-N-CA 121.092 1.195 . . . . 1.0 112.775 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -109.99 134.48 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.195 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 p -143.7 137.8 28.43 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.341 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.17 157.32 47.21 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.276 0.56 . . . . 1.0 110.396 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 m -84.02 113.42 21.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.702 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -145.9 52.1 1.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.032 0.444 . . . . 1.0 110.72 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.61 -43.18 84.54 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.463 0.649 . . . . 1.0 110.487 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.0 p -124.01 84.38 54.98 Favored Pre-proline 0 N--CA 1.485 1.323 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.169 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.43 122.06 7.2 Favored 'Trans proline' 0 N--CA 1.515 2.74 0 C-N-CA 121.348 1.365 . . . . 1.0 112.705 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -167.88 123.01 1.0 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.667 -0.242 . . . . 1.0 110.675 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -56.19 145.16 27.17 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.611 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.21 -26.7 6.69 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 111.357 -0.697 . . . . 1.0 111.357 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -69.63 140.4 53.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -73.73 137.28 43.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -132.31 147.94 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.161 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -94.64 141.4 28.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.418 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.0 126.89 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -137.0 128.53 28.5 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.496 0.665 . . . . 1.0 109.953 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.86 131.48 56.92 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.487 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' NH1' ' O ' ' A' ' 1' ' ' MET . 99.9 mtt180 -89.22 118.15 28.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.495 0.664 . . . . 1.0 109.498 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.32 132.97 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.784 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.431 HG21 ' HE ' ' A' ' 27' ' ' ARG . 90.2 m -100.66 127.81 46.93 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.124 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -88.92 121.05 30.89 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.636 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HE ' HG21 ' A' ' 25' ' ' THR . 23.4 mmt85 -113.83 132.46 55.87 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.193 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.51 -125.13 1.25 Allowed Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.712 -0.955 . . . . 1.0 110.712 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.67 5.83 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.787 0.327 . . . . 1.0 110.871 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.26 162.68 39.0 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.291 0.567 . . . . 1.0 110.422 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 24.7 mp0 -59.81 118.81 6.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.923 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.2 154.66 17.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.99 0.424 . . . . 1.0 110.082 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -144.94 175.1 10.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.752 0.787 . . . . 1.0 110.067 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 50.93 64.08 1.98 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.978 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.7 t -116.21 84.52 14.17 Favored Pre-proline 0 N--CA 1.489 1.486 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.473 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.66 120.35 3.5 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.626 0.884 . . . . 1.0 111.579 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 t -87.35 141.33 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.647 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 115.65 17.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.61 144.15 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.62 0.724 . . . . 1.0 109.227 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -152.16 143.28 23.18 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -95.61 128.29 42.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.237 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.57 -158.36 17.23 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 110.784 -0.926 . . . . 1.0 110.784 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -103.32 144.23 28.21 Favored Pre-proline 0 N--CA 1.487 1.408 0 CA-C-O 118.404 -0.808 . . . . 1.0 111.461 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.54 -29.68 16.0 Favored 'Trans proline' 0 N--CA 1.516 2.824 0 C-N-CA 120.796 0.997 . . . . 1.0 111.808 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.32 90.29 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -67.55 -70.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.238 0.542 . . . . 1.0 110.166 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 85.85 0.06 OUTLIER Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.47 141.7 47.22 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -113.47 123.98 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-O 121.124 0.488 . . . . 1.0 109.821 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.36 125.08 24.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.643 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.36 -42.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.58 163.34 32.39 Favored Glycine 0 N--CA 1.462 0.417 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -150.35 163.98 36.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.508 0.67 . . . . 1.0 110.528 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.95 116.87 1.03 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.139 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -75.23 139.15 42.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.3 mm -78.55 148.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.698 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -63.84 -47.9 78.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.31 0.576 . . . . 1.0 110.418 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -168.51 136.26 2.1 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.385 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.13 119.21 37.12 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-O 117.785 -1.102 . . . . 1.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.86 165.62 29.68 Favored 'Trans proline' 0 N--CA 1.518 2.966 0 CA-C-N 120.009 1.039 . . . . 1.0 111.993 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.73 139.89 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.003 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.83 73.11 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.83 -171.15 18.12 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.8 p -143.68 149.81 37.77 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.806 0.336 . . . . 1.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.97 157.14 18.03 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.1 tp -150.46 139.33 20.89 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.932 0.872 . . . . 1.0 110.039 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.71 160.37 26.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.024 -0.989 . . . . 1.0 109.866 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -122.2 124.14 43.13 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.493 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.0 142.84 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.761 0.791 . . . . 1.0 109.587 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -103.44 140.81 36.97 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -141.01 132.49 26.91 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.319 0.581 . . . . 1.0 109.931 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -88.04 124.54 33.85 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.695 -0.684 . . . . 1.0 109.388 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.06 130.22 42.28 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 t -158.67 173.87 15.92 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.373 0.606 . . . . 1.0 110.345 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -150.93 85.19 1.35 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.985 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -67.36 131.98 46.78 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.854 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tp 54.23 94.28 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 O-C-N 123.087 0.242 . . . . 1.0 110.635 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.1 -163.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.699 0.285 . . . . 1.0 110.417 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.13 -139.55 21.29 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 55.08 76.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 117.177 0.489 . . . . 1.0 110.122 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 56.61 170.52 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.484 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.39 178.67 7.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.806 0.336 . . . . 1.0 110.18 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.6 m120 60.53 145.53 0.06 OUTLIER Pre-proline 0 CA--C 1.564 1.49 0 CA-C-O 118.599 -0.715 . . . . 1.0 111.489 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -70.76 -55.0 0.16 Allowed 'Trans proline' 0 N--CA 1.516 2.832 0 CA-C-N 119.288 0.782 . . . . 1.0 111.997 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.38 78.34 0.15 Allowed Glycine 0 N--CA 1.47 0.951 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.19 63.64 17.8 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.22 -177.91 0.56 Allowed 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.676 1.584 . . . . 1.0 111.837 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.89 158.38 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.331 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -153.11 148.0 26.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.026 0.917 . . . . 1.0 109.817 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.57 145.03 31.59 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.017 -0.992 . . . . 1.0 109.973 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -141.25 142.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.419 0.628 . . . . 1.0 110.206 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.01 136.53 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.706 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -47.17 130.01 9.49 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 117.666 -1.159 . . . . 1.0 111.404 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.85 153.19 37.65 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 CA-C-N 120.27 1.132 . . . . 1.0 112.03 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -93.57 18.85 9.3 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.673 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.5 t30 58.57 12.04 1.97 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.835 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -145.25 -10.96 0.55 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.87 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 11.7 p -66.27 -27.4 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 120.893 0.378 . . . . 1.0 110.057 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 98' ' ' VAL . . . 74.46 161.47 0.24 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.847 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -81.01 -57.11 3.68 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.556 0.693 . . . . 1.0 110.518 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.1 p -40.82 -40.74 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.448 -0.797 . . . . 1.0 111.446 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -74.83 -50.41 17.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.966 0.413 . . . . 1.0 109.888 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.577 ' C ' ' H ' ' A' ' 105' ' ' ASN . 34.2 ttmt -45.04 -44.48 10.18 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.161 0.505 . . . . 1.0 110.636 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.69 -0.11 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.76 0 CA-C-O 121.486 0.66 . . . . 1.0 111.752 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.577 ' H ' ' C ' ' A' ' 103' ' ' LYS . 57.0 t30 -89.53 -36.2 15.5 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.527 -0.76 . . . . 1.0 110.072 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.75 46.35 1.23 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.495 0.718 . . . . 1.0 110.999 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.62 136.08 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.336 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -143.99 145.47 32.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.832 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 t -165.42 147.82 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.576 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -134.02 128.15 33.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.477 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.09 132.61 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.27 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.18 142.91 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.989 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.73 149.45 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.502 0.668 . . . . 1.0 109.698 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.43 136.7 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.785 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -151.83 134.83 15.74 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.87 0.843 . . . . 1.0 110.042 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 118' ' ' HIS . 47.5 tp10 -167.78 92.7 0.37 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.076 -0.965 . . . . 1.0 109.371 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 66.31 -17.44 0.12 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.858 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.568 ' H ' ' C ' ' A' ' 116' ' ' GLU . 49.9 t-80 56.2 177.65 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.365 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.529 ' H ' ' CG ' ' A' ' 118' ' ' HIS . 86.9 m-70 59.28 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.967 0.413 . . . . 1.0 110.69 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 118' ' ' HIS . 81.4 t60 54.33 102.35 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.499 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 122' ' ' HIS . 82.4 t60 56.94 170.42 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.753 -0.203 . . . . 1.0 110.498 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.447 ' N ' ' CG ' ' A' ' 121' ' ' HIS . 57.0 t-80 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 118.037 -0.982 . . . . 1.0 111.135 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtm . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -153.47 173.53 15.57 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.698 0.761 . . . . 1.0 109.986 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.25 147.21 98.97 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.279 -0.873 . . . . 1.0 111.373 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 -27.46 13.92 Favored 'Trans proline' 0 N--CA 1.51 2.47 0 C-N-CA 121.766 1.644 . . . . 1.0 111.742 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.85 130.96 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.221 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -132.66 122.69 25.04 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.941 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.0 mt -104.33 144.2 31.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.232 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.3 m -80.07 44.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.627 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -75.89 51.84 0.66 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.564 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.55 -45.25 92.37 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.238 0.542 . . . . 1.0 110.331 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.2 p -119.19 85.94 31.39 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.378 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.43 116.37 1.54 Allowed 'Trans proline' 0 N--CA 1.514 2.685 0 C-N-CA 121.524 1.483 . . . . 1.0 112.804 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -167.09 117.2 0.87 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.621 0.248 . . . . 1.0 110.508 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -55.95 146.32 22.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.03 0.443 . . . . 1.0 110.354 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.26 -26.19 8.2 Favored Glycine 0 N--CA 1.475 1.293 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.34 146.93 53.59 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.41 132.96 37.55 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.398 0.618 . . . . 1.0 109.651 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.31 145.29 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -91.25 115.96 28.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.899 -0.592 . . . . 1.0 109.522 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.88 112.89 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.4 p -123.56 138.24 54.6 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.556 0.693 . . . . 1.0 110.18 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.16 124.67 47.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.033 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.76 113.22 21.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.719 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -92.71 117.85 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.616 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.7 m -89.75 125.31 35.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -103.34 111.66 24.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.903 0.859 . . . . 1.0 109.665 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -59.76 137.8 57.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.171 -0.922 . . . . 1.0 110.158 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.14 119.81 18.63 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.774 -0.93 . . . . 1.0 110.774 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -172.54 -78.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.905 -0.648 . . . . 1.0 109.796 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.59 149.21 40.44 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.477 0.656 . . . . 1.0 110.699 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.25 116.4 3.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.286 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.88 152.27 20.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -142.44 169.83 16.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.696 0.76 . . . . 1.0 110.049 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 49.48 62.25 2.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.716 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -113.47 82.69 6.25 Favored Pre-proline 0 N--CA 1.485 1.297 0 CA-C-N 115.749 -0.659 . . . . 1.0 109.381 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -80.35 112.39 2.75 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 121.201 1.267 . . . . 1.0 111.395 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.92 146.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.831 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.81 122.13 28.14 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -117.0 143.48 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.466 0.651 . . . . 1.0 109.704 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -156.14 132.6 10.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 mp -87.13 127.86 35.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.606 0.717 . . . . 1.0 109.697 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.31 -154.6 16.51 Favored Glycine 0 N--CA 1.469 0.879 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -122.21 143.01 38.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.175 -0.916 . . . . 1.0 111.721 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.6 -39.57 46.23 Favored 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 120.782 0.988 . . . . 1.0 113.069 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . -60.78 -42.37 97.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.931 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.04 8.65 1.48 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.104 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 66.77 72.89 0.7 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.98 163.35 25.22 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 141.4 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.233 0.539 . . . . 1.0 110.481 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.85 135.81 40.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.811 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -103.15 -42.84 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.533 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.93 160.36 30.26 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 110.576 -1.01 . . . . 1.0 110.576 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -151.6 164.48 36.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.667 0.746 . . . . 1.0 110.406 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -154.51 115.94 4.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.358 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -77.0 133.91 39.0 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 mm -79.76 145.82 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.531 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -63.5 -49.33 73.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.693 0.759 . . . . 1.0 110.687 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -173.06 142.22 1.04 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.302 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.5 mt -122.98 120.45 27.53 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 118.03 -0.986 . . . . 1.0 111.145 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.12 166.82 28.53 Favored 'Trans proline' 0 N--CA 1.509 2.438 0 C-N-CA 120.85 1.033 . . . . 1.0 111.648 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.74 139.13 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.412 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.51 22.65 76.6 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.54 -172.32 15.91 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -139.9 -169.19 2.67 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.528 0.68 . . . . 1.0 110.672 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.44 150.91 22.27 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.89 114.92 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.847 0.832 . . . . 1.0 110.206 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.82 155.75 19.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.705 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -126.12 122.27 35.26 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.705 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 t -136.75 136.06 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.87 0.843 . . . . 1.0 109.323 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -108.4 140.66 41.37 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.946 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -141.67 135.76 30.21 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.95 0.881 . . . . 1.0 109.837 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -89.64 123.0 33.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.635 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.51 35.72 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 t -167.78 131.5 1.7 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 1.0 110.318 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -147.1 -70.98 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.343 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' ALA . 1.3 ttmp? -164.53 151.18 11.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.332 0.587 . . . . 1.0 110.566 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 77' ' ' LEU . 9.6 mp -62.4 80.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.997 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 76' ' ' LYS . . . -84.98 177.04 8.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.848 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.83 136.8 2.81 Favored Glycine 0 N--CA 1.463 0.477 0 N-CA-C 110.615 -0.994 . . . . 1.0 110.615 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 53.73 97.67 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.609 0.242 . . . . 1.0 110.759 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.47 -171.12 1.6 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.283 0.563 . . . . 1.0 110.244 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.04 65.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.719 0.771 . . . . 1.0 110.408 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -165.92 96.13 0.78 Allowed Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.24 -0.891 . . . . 1.0 110.243 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -44.98 -83.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.513 2.632 0 C-N-CA 120.679 0.919 . . . . 1.0 113.336 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.77 11.01 78.01 Favored Glycine 0 N--CA 1.472 1.097 0 N-CA-C 110.893 -0.883 . . . . 1.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.44 68.93 1.37 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.57 -169.22 0.51 Allowed 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.081 1.187 . . . . 1.0 111.654 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -147.83 142.98 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.324 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.28 140.14 33.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.652 0.739 . . . . 1.0 109.747 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.7 141.6 26.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.32 -0.854 . . . . 1.0 109.95 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.4 t -140.75 143.72 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.996 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.98 142.71 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.533 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.2 146.31 97.97 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 119.055 -0.497 . . . . 1.0 110.213 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 96' ' ' ASN . 88.7 Cg_endo -74.47 170.63 19.82 Favored 'Trans proline' 0 N--CA 1.511 2.557 0 C-N-CA 121.13 1.22 . . . . 1.0 111.733 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -73.98 24.23 0.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.435 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 94' ' ' PRO . 41.4 t30 67.87 42.67 1.87 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.521 0.676 . . . . 1.0 110.499 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 67.7 mtp85 -133.97 -0.47 3.09 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.528 -0.76 . . . . 1.0 111.023 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t 54.74 102.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 116.673 -0.239 . . . . 1.0 110.563 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 101' ' ' SER . . . -158.26 107.98 2.07 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.023 0.44 . . . . 1.0 110.385 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -72.46 13.11 0.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.237 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 99' ' ' ALA . 53.1 m -87.56 -55.15 3.91 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.305 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.45 -41.54 89.91 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.511 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.0 -60.84 3.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.328 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.44 -38.8 30.79 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.113 0.482 . . . . 1.0 110.864 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -86.16 34.28 0.62 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.959 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -171.77 48.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.05 139.66 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 121.235 0.54 . . . . 1.0 109.868 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -144.9 143.81 30.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.243 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 t -171.18 137.04 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.414 0.626 . . . . 1.0 110.039 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -135.08 155.37 50.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.661 -0.699 . . . . 1.0 110.479 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.0 mm -83.36 123.12 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.089 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.21 103.87 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.44 102.7 15.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -106.9 127.91 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 1.0 109.82 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.0 mp -89.18 176.73 6.84 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.72 0.771 . . . . 1.0 109.136 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -169.32 43.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.303 -0.862 . . . . 1.0 110.164 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -164.1 108.14 0.97 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.339 0.59 . . . . 1.0 110.151 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -149.54 159.59 44.18 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.096 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.565 ' CG ' ' H ' ' A' ' 120' ' ' HIS . 11.8 t-80 -167.25 -138.06 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.269 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.565 ' H ' ' CG ' ' A' ' 119' ' ' HIS . 90.4 m-70 52.16 67.75 0.92 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.462 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -167.36 11.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.632 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 118.065 -0.969 . . . . 1.0 111.404 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 ttm . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -67.73 126.74 30.35 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.2 mt -65.63 144.39 98.89 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.678 -0.677 . . . . 1.0 111.087 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.94 -27.32 20.98 Favored 'Trans proline' 0 N--CA 1.515 2.753 0 C-N-CA 121.492 1.461 . . . . 1.0 111.992 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.25 132.7 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.067 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 t -133.15 127.83 34.73 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.229 0.538 . . . . 1.0 110.227 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.487 HD22 HD12 ' A' ' 18' ' ' ILE . 16.2 mt -108.61 144.04 36.86 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.275 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -76.74 36.15 0.16 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.844 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 7' ' ' LEU . 36.8 tttp -74.05 48.74 0.32 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.672 0.749 . . . . 1.0 110.235 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.14 -41.61 93.08 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.451 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -116.06 87.49 19.3 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.477 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.03 115.31 1.44 Allowed 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 121.051 1.167 . . . . 1.0 113.076 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -169.09 116.42 0.63 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.627 -0.26 . . . . 1.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -55.8 145.71 23.61 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.52 -25.98 8.71 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -65.77 144.03 57.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.77 137.04 38.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.48 0.657 . . . . 1.0 109.516 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.487 HD12 HD22 ' A' ' 7' ' ' LEU . 33.5 pt -124.05 145.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.399 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -87.56 113.62 23.41 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.07 113.24 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -130.1 135.19 47.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.576 0.703 . . . . 1.0 110.141 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 126.2 48.88 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.02 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -81.87 111.4 18.05 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 p -89.62 124.99 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.3 m -98.09 124.52 42.66 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -75.61 106.38 7.14 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.358 0.599 . . . . 1.0 109.647 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -122.5 119.0 29.63 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.128 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.76 -99.5 0.13 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 30' ' ' ALA . . . -169.45 -6.34 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.658 0.266 . . . . 1.0 111.016 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 29' ' ' ALA . . . -152.07 174.6 13.49 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.3 0.571 . . . . 1.0 110.549 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -62.1 126.95 29.11 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.579 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.54 135.88 37.42 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.532 ' O ' ' C ' ' A' ' 34' ' ' ASN . 33.6 m170 -105.9 169.71 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.087 0.946 . . . . 1.0 109.73 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 33' ' ' HIS . 4.3 p30 16.73 84.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.906 -1.043 . . . . 1.0 111.454 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 t -112.44 80.9 3.75 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.109 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -83.57 102.8 1.04 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 120.386 0.724 . . . . 1.0 111.352 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.46 149.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.46 40.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -121.37 143.98 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.5 0.667 . . . . 1.0 109.501 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -152.86 128.39 10.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.52 127.64 33.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.12 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.79 -155.33 17.12 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 110.714 -0.955 . . . . 1.0 110.714 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -121.34 143.72 38.21 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.325 -0.845 . . . . 1.0 111.503 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.59 -30.11 15.57 Favored 'Trans proline' 0 N--CA 1.517 2.904 0 CA-C-N 119.684 0.923 . . . . 1.0 113.166 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.37 87.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.729 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.16 -52.36 64.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.324 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.49 -4.08 0.26 Allowed Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.34 98.84 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -81.41 114.43 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' CD ' HH22 ' A' ' 53' ' ' ARG . 63.5 tt0 -74.46 112.69 10.89 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.9 -46.2 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 176.24 42.47 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.734 -0.947 . . . . 1.0 110.734 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.428 HH22 ' CD ' ' A' ' 50' ' ' GLU . 9.5 ptp85 -147.85 160.88 42.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.726 0.774 . . . . 1.0 110.457 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -146.07 113.7 6.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.893 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -84.98 130.25 34.66 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.7 145.77 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.079 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.9 p -62.42 -46.58 87.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.121 0.486 . . . . 1.0 110.421 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -169.09 137.53 2.0 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.472 0.653 . . . . 1.0 109.9 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.0 mt -115.91 119.14 37.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 CA-C-O 118.393 -0.813 . . . . 1.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.43 168.71 24.18 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 CA-C-N 119.592 0.89 . . . . 1.0 112.302 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.12 141.23 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.91 13.5 59.51 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.597 -1.001 . . . . 1.0 110.597 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.95 -175.44 19.4 Favored Glycine 0 N--CA 1.477 1.393 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 p -143.09 150.91 40.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.882 -0.159 . . . . 1.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.82 158.19 21.32 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.21 -1.156 . . . . 1.0 110.21 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.24 110.84 16.64 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.9 0.857 . . . . 1.0 109.906 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.47 154.81 18.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.088 -0.96 . . . . 1.0 110.339 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -141.47 123.59 15.53 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.842 0.829 . . . . 1.0 110.594 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.05 135.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.428 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -92.6 137.1 32.66 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.597 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -139.65 131.02 26.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 1.0 109.639 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -97.26 123.9 41.19 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.003 -0.999 . . . . 1.0 109.482 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 147.09 53.25 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.0 p -139.18 -162.85 1.38 Allowed 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.433 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 53.72 83.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.875 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.57 129.05 34.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.08 0.467 . . . . 1.0 109.945 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 tt -165.66 116.66 1.07 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.619 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.11 138.71 42.33 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.5 -106.81 0.23 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.294 -0.722 . . . . 1.0 111.294 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.81 -33.6 75.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.94 0.4 . . . . 1.0 110.331 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 52.95 36.82 22.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.332 0.587 . . . . 1.0 110.977 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.78 -30.23 71.3 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.665 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -152.09 145.42 17.59 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.321 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 71.1 Cg_endo -69.42 -67.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.516 2.828 0 CA-C-N 118.798 0.606 . . . . 1.0 112.316 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 84' ' ' PRO . . . 79.05 73.82 1.1 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 86' ' ' VAL . 11.8 p -165.44 60.47 0.69 Allowed Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.98 163.34 31.09 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.943 1.762 . . . . 1.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.24 134.33 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 121.433 0.635 . . . . 1.0 109.787 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -128.46 148.23 50.72 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.996 0.903 . . . . 1.0 109.937 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.98 146.75 31.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.969 -1.014 . . . . 1.0 110.102 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.42 141.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.512 0.672 . . . . 1.0 110.156 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -86.83 137.5 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.547 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -41.55 145.56 0.64 Allowed Pre-proline 0 N--CA 1.484 1.229 0 CA-C-O 117.951 -1.023 . . . . 1.0 111.547 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.18 129.21 14.76 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 120.997 1.132 . . . . 1.0 111.913 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.37 -34.98 79.19 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.284 0.564 . . . . 1.0 110.161 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 98' ' ' VAL . 52.8 t30 -161.75 78.11 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.65 -0.705 . . . . 1.0 110.084 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 58.74 -74.38 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.617 -0.719 . . . . 1.0 110.862 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 96' ' ' ASN . 40.9 t -55.92 144.12 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.393 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -166.71 -4.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.376 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -52.77 -22.45 5.32 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.554 0.216 . . . . 1.0 110.475 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.0 t -89.17 -56.24 3.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.605 0.362 . . . . 1.0 110.024 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.22 -33.83 71.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.393 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.16 -60.62 3.58 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.13 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.25 -44.42 79.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.629 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -63.61 -53.4 52.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.673 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -90.56 51.58 2.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.155 0.502 . . . . 1.0 110.661 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.87 134.88 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.716 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -142.84 136.4 28.7 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.426 0.631 . . . . 1.0 109.736 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.6 m -158.48 145.14 17.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.527 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -144.11 127.2 16.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.974 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.9 mp -88.75 147.24 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.671 -0.863 . . . . 1.0 108.671 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.32 140.9 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 115.202 -0.908 . . . . 1.0 109.842 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -95.51 142.49 27.8 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.798 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.7 136.32 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-O 121.324 0.583 . . . . 1.0 110.203 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tp -105.42 133.43 50.19 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.707 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -160.33 91.33 0.92 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.795 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -168.15 96.44 0.42 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.882 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.415 ' N ' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -164.27 170.84 15.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.295 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -65.02 111.57 2.94 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.101 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -67.09 142.29 57.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.879 0.371 . . . . 1.0 110.072 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -65.97 -39.36 90.3 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.128 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.8 m80 . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 118.058 -0.972 . . . . 1.0 109.719 -179.834 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtt . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.24 151.86 39.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.172 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.48 151.83 82.01 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 118.336 -0.84 . . . . 1.0 111.115 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.47 -29.33 77.63 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.643 1.562 . . . . 1.0 112.339 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.9 mt -111.99 135.94 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.209 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 t -148.23 138.98 23.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.382 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.07 163.27 33.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.72 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.3 t -84.02 114.69 21.9 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.971 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.86 50.19 1.19 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.834 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -56.77 -43.79 81.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.717 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 p -123.19 84.93 51.52 Favored Pre-proline 0 N--CA 1.485 1.285 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.251 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -49.27 123.33 9.98 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 121.584 1.523 . . . . 1.0 112.2 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -168.15 123.7 1.0 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.397 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -56.85 146.21 27.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.599 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.16 -27.54 6.09 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 110.994 -0.843 . . . . 1.0 110.994 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.54 141.25 55.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.881 -0.415 . . . . 1.0 109.881 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -74.76 143.28 44.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.681 0.753 . . . . 1.0 109.745 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.046 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -89.35 112.51 23.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.366 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.02 118.33 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -130.79 133.99 46.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.442 0.639 . . . . 1.0 110.479 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.57 128.26 53.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.109 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.43 119.72 26.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.573 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.74 126.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.765 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -88.81 125.17 34.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.02 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -83.24 115.0 21.76 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.239 0.542 . . . . 1.0 110.133 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.43 104.59 13.97 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.056 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.39 143.88 6.93 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.758 -0.937 . . . . 1.0 110.758 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.75 8.44 6.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.802 0.334 . . . . 1.0 110.246 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.93 31.73 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.386 0.612 . . . . 1.0 110.556 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -56.63 120.19 7.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.462 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.84 152.95 18.2 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.101 0.476 . . . . 1.0 109.828 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -146.15 173.31 12.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.876 0.846 . . . . 1.0 109.836 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 m120 48.63 59.45 4.36 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.086 -0.961 . . . . 1.0 110.857 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.44 87.33 7.64 Favored Pre-proline 0 N--CA 1.488 1.457 0 CA-C-O 118.578 -0.725 . . . . 1.0 109.749 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.52 173.4 14.54 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 120.836 1.024 . . . . 1.0 111.478 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.58 144.42 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.92 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.1 133.06 43.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.528 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.1 146.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.635 0.731 . . . . 1.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -154.95 141.89 19.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.822 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 42' ' ' GLY . 1.6 tt -96.62 130.22 43.87 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.545 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.592 ' N ' HD23 ' A' ' 41' ' ' LEU . . . 118.94 -153.04 17.09 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 110.498 -1.041 . . . . 1.0 110.498 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -126.01 140.03 35.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-O 118.175 -0.917 . . . . 1.0 111.575 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.04 -36.15 53.25 Favored 'Trans proline' 0 N--CA 1.517 2.888 0 C-N-CA 120.74 0.96 . . . . 1.0 112.923 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.48 89.49 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.885 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -65.77 -75.32 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.193 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.42 67.79 0.04 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.64 51.16 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.72 138.0 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.286 0.565 . . . . 1.0 110.403 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.93 136.13 53.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.766 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.0 mt -101.52 -38.95 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.531 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.01 164.16 34.04 Favored Glycine 0 N--CA 1.462 0.433 0 N-CA-C 110.654 -0.978 . . . . 1.0 110.654 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -149.35 162.17 40.6 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.967 0.889 . . . . 1.0 110.264 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -155.05 118.79 4.55 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.036 -0.983 . . . . 1.0 110.162 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.1 m -79.1 133.3 36.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.23 0.538 . . . . 1.0 109.591 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 59' ' ' ILE . 60.8 mt -108.52 145.57 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.47 -56.35 2.31 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.628 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -64.92 79.28 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.316 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' A' ' 56' ' ' ILE . 30.3 mt -122.85 86.9 50.36 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 118.237 -0.887 . . . . 1.0 110.558 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.66 163.7 35.29 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.59 1.526 . . . . 1.0 111.746 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -69.09 142.7 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.445 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.41 68.9 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.04 -167.68 18.91 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -146.33 151.06 36.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.255 0.55 . . . . 1.0 110.253 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.64 151.85 19.81 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.062 -1.215 . . . . 1.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.52 116.52 16.04 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.746 0.784 . . . . 1.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 156.0 18.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.837 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -125.54 124.17 40.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.944 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.21 140.64 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.482 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -106.3 140.21 39.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.709 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -141.64 134.23 28.39 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.974 0.893 . . . . 1.0 109.839 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -102.34 127.56 49.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.986 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 141.88 53.27 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -119.1 138.4 52.91 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.204 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -167.62 43.57 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.934 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -75.55 138.91 41.81 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.585 0.707 . . . . 1.0 109.227 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 47.17 79.24 0.06 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.382 -0.826 . . . . 1.0 110.951 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 80' ' ' ARG . . . -71.21 146.45 49.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.213 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.12 29.34 1.63 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 78' ' ' ALA . 77.3 mtm-85 52.73 16.78 0.72 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.57 0.7 . . . . 1.0 110.811 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.28 -169.89 2.77 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.45 -0.796 . . . . 1.0 109.996 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.01 85.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.168 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' PRO . 75.7 m-20 -151.57 76.51 7.51 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.603 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 83' ' ' ASN . 74.2 Cg_exo -52.8 -146.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.185 1.924 . . . . 1.0 112.459 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.82 82.08 1.4 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.5 m -119.45 65.26 8.45 Favored Pre-proline 0 N--CA 1.481 1.089 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.4 -179.55 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.129 1.886 . . . . 1.0 110.94 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.66 157.59 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.077 -0.965 . . . . 1.0 110.173 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -147.11 145.77 29.71 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.925 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.18 142.36 32.69 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.13 136.54 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.64 0.734 . . . . 1.0 110.088 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.63 138.37 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.666 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -49.81 134.04 20.75 Favored Pre-proline 0 CA--C 1.558 1.278 0 CA-C-O 117.917 -1.04 . . . . 1.0 111.184 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.42 148.47 48.62 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 C-N-CA 121.16 1.24 . . . . 1.0 111.668 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.49 -42.39 64.91 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.178 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -168.81 47.14 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.773 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 50.16 70.42 0.51 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.34 -79.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.148 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.83 161.27 8.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.12 0.486 . . . . 1.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -62.84 -66.38 0.55 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.3 p -46.32 -39.78 10.71 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.098 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.64 -71.53 0.15 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.243 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 105' ' ' ASN . 90.7 mttt -45.64 -41.54 10.37 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.793 0.33 . . . . 1.0 110.642 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.8 3.92 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 121.182 0.515 . . . . 1.0 111.586 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 103' ' ' LYS . 90.2 m-20 -89.06 -35.44 16.34 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.832 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -93.29 47.53 1.26 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.392 0.615 . . . . 1.0 110.737 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 58.7 t -100.38 135.76 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 121.723 0.773 . . . . 1.0 109.423 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 53.4 m-85 -144.68 146.3 32.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.245 -0.889 . . . . 1.0 109.929 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.9 t -163.05 150.02 12.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.437 -0.802 . . . . 1.0 109.8 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -145.25 132.58 20.62 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.088 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.7 mp -83.0 118.63 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.45 107.05 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.8 122.3 29.69 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.5 t -129.08 134.98 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 1.0 109.902 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.06 179.48 7.71 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.06 0.933 . . . . 1.0 109.931 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -140.88 147.81 39.5 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.018 -0.992 . . . . 1.0 110.352 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -74.38 90.98 2.18 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.701 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.97 -48.76 80.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.367 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -64.63 80.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.135 0.493 . . . . 1.0 110.057 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -60.75 -40.47 92.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.125 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -67.01 119.13 11.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.101 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.8 m80 . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.283 179.781 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mmm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 54.22 -177.87 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.781 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp -64.65 144.31 98.75 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.92 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.21 -39.17 3.16 Favored 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 120.881 1.054 . . . . 1.0 112.417 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -100.51 133.83 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.588 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.9 p -137.26 123.06 20.0 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.4 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.6 mt -112.27 150.7 30.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.48 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.3 p -81.09 28.35 0.37 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.37 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -73.95 48.91 0.31 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -55.15 -26.24 37.31 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.193 0.52 . . . . 1.0 110.396 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -133.34 138.45 31.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-O 118.247 -0.883 . . . . 1.0 111.4 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -78.42 113.54 3.37 Favored 'Trans proline' 0 N--CA 1.51 2.468 0 CA-C-N 119.596 0.891 . . . . 1.0 111.642 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -166.96 99.39 0.54 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.78 146.83 16.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.733 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.93 -23.01 25.84 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -68.78 138.15 54.59 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.47 136.32 54.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.31 0.576 . . . . 1.0 109.622 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.84 148.1 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.234 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.5 m -96.35 114.11 25.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.816 -0.629 . . . . 1.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.24 122.77 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 m -128.63 132.66 48.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.33 0.586 . . . . 1.0 109.984 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.08 123.41 40.27 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.734 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -79.28 144.64 34.1 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.202 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.03 135.64 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -101.34 123.99 46.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -82.06 119.79 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.429 0.633 . . . . 1.0 110.103 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -108.95 95.9 5.95 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.523 -0.762 . . . . 1.0 109.981 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.91 137.13 4.14 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.87 11.27 1.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.723 0.297 . . . . 1.0 110.446 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.9 165.48 30.52 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.183 0.516 . . . . 1.0 110.77 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -58.08 125.84 24.88 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.533 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -105.08 152.91 22.18 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.201 0.524 . . . . 1.0 110.107 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -147.22 -178.88 6.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.097 0.951 . . . . 1.0 109.741 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 47.83 59.24 4.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.832 -1.076 . . . . 1.0 111.223 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.86 84.66 2.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 CA-C-O 118.395 -0.812 . . . . 1.0 109.783 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.83 160.69 30.73 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 120.638 0.892 . . . . 1.0 111.724 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.82 141.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.031 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.43 129.09 42.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.499 -0.773 . . . . 1.0 109.536 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.51 146.32 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.724 0.773 . . . . 1.0 109.224 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -152.12 150.03 29.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.992 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tp -97.33 130.85 44.45 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.114 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.79 -153.55 17.45 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -118.72 143.63 33.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.36 -37.11 40.1 Favored 'Trans proline' 0 N--CA 1.521 3.142 0 CA-C-N 119.559 0.878 . . . . 1.0 113.275 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.57 99.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.783 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.91 8.69 1.42 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.235 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.31 74.2 0.55 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.89 163.99 13.98 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.125 -0.79 . . . . 1.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.79 132.97 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.211 0.529 . . . . 1.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.04 134.84 48.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.684 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -98.69 -36.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.577 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.84 172.84 41.01 Favored Glycine 0 N--CA 1.463 0.437 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.16 166.77 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.754 0.787 . . . . 1.0 110.294 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -161.17 117.14 2.18 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.95 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -76.62 136.52 39.2 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.9 mt -107.56 142.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.727 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 59' ' ' ILE . 95.8 p -105.02 -54.95 2.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.578 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -63.51 75.3 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.15 0.976 . . . . 1.0 110.967 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' SER . 49.7 mm -121.91 82.23 42.88 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 114.748 -1.115 . . . . 1.0 109.529 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 167.7 24.49 Favored 'Trans proline' 0 N--CA 1.506 2.219 0 C-N-CA 121.191 1.26 . . . . 1.0 111.844 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.95 137.73 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.323 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.23 13.84 73.64 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.93 -167.27 22.36 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.5 p -143.15 -174.32 4.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.297 0.57 . . . . 1.0 110.616 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.73 149.52 21.37 Favored Glycine 0 N--CA 1.477 1.382 0 N-CA-C 110.929 -0.869 . . . . 1.0 110.929 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.7 mt -138.68 124.61 19.95 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.278 1.037 . . . . 1.0 110.025 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.91 160.6 15.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.421 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -126.18 122.34 35.37 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.843 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.13 135.4 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 122.004 0.907 . . . . 1.0 109.043 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -99.77 139.09 35.93 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -143.01 143.37 31.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.143 0.973 . . . . 1.0 109.932 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -113.43 127.28 56.06 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.181 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 118.18 13.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.661 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p -105.23 119.19 38.45 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.21 0.529 . . . . 1.0 109.916 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.513 HH12 ' CB ' ' A' ' 84' ' ' PRO . 41.5 ttm180 -170.61 116.3 0.48 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.089 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -133.89 93.85 3.17 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.263 0.554 . . . . 1.0 110.062 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.8 mt -105.18 -161.33 0.81 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.97 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.0 65.84 0.19 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.637 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.1 -159.89 25.78 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -63.58 172.41 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.792 0.33 . . . . 1.0 110.559 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.3 126.93 1.41 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.64 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.07 20.14 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.646 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -152.69 55.75 1.56 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.513 ' CB ' HH12 ' A' ' 75' ' ' ARG . 53.2 Cg_endo -64.71 -67.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 121.356 1.371 . . . . 1.0 111.719 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.21 79.71 0.16 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.621 -0.991 . . . . 1.0 110.621 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.55 63.14 13.82 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.66 166.54 19.69 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.888 1.726 . . . . 1.0 111.245 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.5 158.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 114.898 -1.047 . . . . 1.0 110.144 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -152.95 146.54 25.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.872 0.844 . . . . 1.0 109.746 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.49 144.33 34.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.886 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.3 t -131.74 138.63 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.66 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.59 135.17 28.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -125.37 80.47 65.3 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-O 118.785 -0.626 . . . . 1.0 110.17 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.5 178.3 0.47 Allowed 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 121.803 1.669 . . . . 1.0 111.847 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.7 -40.05 94.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.093 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -110.13 66.17 0.63 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.034 0.533 . . . . 1.0 110.659 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -64.37 97.74 0.21 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.006 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.2 160.17 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 121.789 0.804 . . . . 1.0 110.078 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.95 107.25 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.151 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -71.1 -64.32 0.93 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.52 0.676 . . . . 1.0 110.072 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.5 p -41.48 -32.18 0.32 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 115.617 -0.72 . . . . 1.0 111.269 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.35 -63.05 1.14 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.543 ' C ' ' H ' ' A' ' 105' ' ' ASN . 23.4 ttpp -43.33 -41.73 4.19 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.125 0.488 . . . . 1.0 111.025 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.46 0.17 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.89 -0.595 . . . . 1.0 111.564 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 103' ' ' LYS . 63.8 m-20 -95.36 32.58 1.73 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.679 -0.692 . . . . 1.0 109.671 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -159.61 46.53 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.71 104.43 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -110.27 132.04 54.53 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.03 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 t -164.36 144.09 7.67 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.331 0.586 . . . . 1.0 110.139 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -133.55 132.23 40.67 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.514 0.673 . . . . 1.0 110.136 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -80.68 137.72 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.68 142.92 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.771 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.26 143.68 49.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.137 0.97 . . . . 1.0 110.061 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.43 137.83 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.293 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -149.54 136.28 19.45 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.753 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -166.57 141.42 4.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.928 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -75.92 131.99 39.99 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -66.74 127.03 30.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 52.04 90.4 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.637 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -60.95 -42.14 97.66 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.134 0.492 . . . . 1.0 110.289 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.432 ' CG ' ' N ' ' A' ' 122' ' ' HIS . 81.0 t60 56.51 170.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.652 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.432 ' N ' ' CG ' ' A' ' 121' ' ' HIS . 50.9 t-80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.192 -0.909 . . . . 1.0 109.508 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 108.69 -0.855 . . . . 1.0 108.69 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 63.65 23.87 13.71 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.228 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.04 152.28 68.19 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.875 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.84 -24.14 40.64 Favored 'Trans proline' 0 N--CA 1.515 2.75 0 C-N-CA 121.976 1.784 . . . . 1.0 111.957 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.4 mt -124.27 130.93 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.328 0.585 . . . . 1.0 110.2 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.2 m -134.87 123.46 23.52 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.856 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.47 147.64 28.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.369 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.9 p -81.06 34.41 0.35 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -70.79 50.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.974 0.51 . . . . 1.0 110.209 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -51.83 -30.33 23.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.658 0.742 . . . . 1.0 110.523 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.5 p -137.16 140.7 31.9 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.261 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.97 113.95 3.52 Favored 'Trans proline' 0 N--CA 1.514 2.728 0 CA-C-N 119.231 0.761 . . . . 1.0 111.392 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.92 101.45 0.55 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.86 0.362 . . . . 1.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 1.4 pm0 -53.9 148.8 9.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.948 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.14 -23.7 16.85 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -69.68 144.1 52.95 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.46 137.55 46.49 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.561 0.696 . . . . 1.0 109.508 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.14 146.55 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.915 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -97.7 114.51 26.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.7 119.7 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -129.09 132.99 47.48 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.265 0.555 . . . . 1.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.06 128.22 55.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.152 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -84.5 119.34 25.05 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 t -108.26 113.21 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.497 0.665 . . . . 1.0 109.215 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 m -86.27 131.92 34.11 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.557 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -86.79 107.18 18.16 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.006 0.431 . . . . 1.0 109.844 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -97.72 -159.34 0.73 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.319 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.47 -130.69 11.41 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.557 -1.017 . . . . 1.0 110.557 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.47 21.18 0.06 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.864 0.364 . . . . 1.0 110.684 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.44 154.66 44.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.495 0.664 . . . . 1.0 110.598 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -66.01 117.22 8.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.738 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.14 152.65 22.16 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 34' ' ' ASN . 44.1 t-80 -139.91 169.04 18.44 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.518 0.675 . . . . 1.0 110.04 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.418 ' N ' ' CG ' ' A' ' 33' ' ' HIS . 80.0 m-20 50.24 62.52 2.63 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.738 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 t -113.97 82.81 7.17 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -80.39 169.5 17.12 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.638 1.559 . . . . 1.0 111.322 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.13 136.61 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.547 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.38 114.91 18.83 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.275 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 t -104.44 137.48 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.526 0.679 . . . . 1.0 109.307 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -146.71 127.11 14.0 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.131 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tp -85.93 124.33 32.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 -158.75 15.68 Favored Glycine 0 N--CA 1.476 1.348 0 N-CA-C 110.762 -0.935 . . . . 1.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.5 142.68 28.56 Favored Pre-proline 0 N--CA 1.491 1.62 0 CA-C-O 117.788 -1.101 . . . . 1.0 111.528 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.8 -38.8 38.42 Favored 'Trans proline' 0 N--CA 1.519 2.992 0 CA-C-N 120.079 1.064 . . . . 1.0 113.108 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.51 22.89 0.23 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.981 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -166.71 -73.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.921 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.63 -97.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.1 90.86 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.1 115.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.24 133.07 45.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.67 -46.11 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.64 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.15 165.8 35.45 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -155.49 167.43 30.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.367 0.603 . . . . 1.0 110.629 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -161.25 119.82 2.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.404 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 m -75.11 131.4 40.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -80.81 155.51 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.4 p -65.42 -51.96 56.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.602 0.715 . . . . 1.0 110.072 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -177.29 145.47 0.45 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.039 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.5 mt -114.56 117.29 42.85 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 117.571 -1.205 . . . . 1.0 110.686 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.13 162.25 41.19 Favored 'Trans proline' 0 N--CA 1.519 2.971 0 CA-C-N 120.286 1.138 . . . . 1.0 112.157 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.17 137.31 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.557 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.55 77.48 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.82 -167.9 14.69 Favored Glycine 0 N--CA 1.472 1.068 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -132.92 176.23 8.66 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.896 0.855 . . . . 1.0 110.364 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.41 124.42 0.94 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 115.098 -0.955 . . . . 1.0 110.783 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.76 160.15 37.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.05 0.929 . . . . 1.0 110.127 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.67 161.91 13.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.246 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.854 -1.066 . . . . 1.0 109.895 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -140.03 156.32 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.28 1.038 . . . . 1.0 109.169 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -123.32 141.72 51.69 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.956 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -140.8 137.56 33.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.991 0.9 . . . . 1.0 109.691 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -100.31 123.84 45.04 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.557 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.44 138.39 49.02 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -166.36 150.23 7.48 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -167.77 84.21 0.21 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.879 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -70.82 126.51 29.79 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.703 -0.481 . . . . 1.0 109.703 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 tp -162.72 120.98 2.09 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.319 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.16 96.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.129 -0.323 . . . . 1.0 110.129 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.48 156.46 48.58 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.796 -0.922 . . . . 1.0 110.796 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -62.53 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.951 0.405 . . . . 1.0 110.68 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -163.69 156.0 17.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.431 0.634 . . . . 1.0 110.399 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.32 26.63 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.631 0.729 . . . . 1.0 110.714 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -165.61 97.44 0.79 Allowed Pre-proline 0 CA--C 1.556 1.211 0 CA-C-O 117.577 -1.201 . . . . 1.0 110.065 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.69 -80.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.512 2.575 0 CA-C-N 120.283 1.137 . . . . 1.0 112.065 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.83 79.58 0.13 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.282 -0.961 . . . . 1.0 111.047 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -119.14 64.71 7.21 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -60.6 141.46 95.28 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.755 1.637 . . . . 1.0 111.734 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.7 t -98.49 147.02 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 115.349 -0.841 . . . . 1.0 109.862 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -135.38 138.88 43.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.037 0.923 . . . . 1.0 109.821 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.92 135.03 22.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.033 -0.985 . . . . 1.0 109.632 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 t -139.67 144.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.996 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.4 145.79 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.538 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -136.35 87.33 22.51 Favored Pre-proline 0 N--CA 1.482 1.162 0 CA-C-O 118.437 -0.792 . . . . 1.0 110.143 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.51 -60.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.511 2.528 0 C-N-CA 121.936 1.757 . . . . 1.0 112.35 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -91.83 21.12 5.06 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.343 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.21 97.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.209 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 54.46 88.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.668 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.1 t -78.75 -76.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.005 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -168.58 158.29 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.413 0.625 . . . . 1.0 110.49 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.79 -4.87 1.08 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.683 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -87.16 -56.51 3.34 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.831 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -62.52 -44.31 96.67 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.611 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -54.82 -59.62 4.48 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.394 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.21 -36.17 51.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.537 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -79.01 23.94 0.33 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.23 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -167.32 44.38 0.05 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.873 0.368 . . . . 1.0 110.547 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.45 139.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.222 0.534 . . . . 1.0 109.789 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -147.9 153.39 39.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.123 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -165.09 147.04 7.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.125 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -142.14 133.01 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.8 mp -81.28 123.35 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.63 136.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.376 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -131.95 125.19 30.99 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.317 0.58 . . . . 1.0 109.927 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.09 137.05 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.771 0.796 . . . . 1.0 110.039 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt -125.06 126.32 45.2 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.952 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -81.38 -27.59 34.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.121 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -69.79 164.22 24.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.64 0.733 . . . . 1.0 109.808 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 120' ' ' HIS . 1.1 t60 54.68 86.58 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.291 -0.868 . . . . 1.0 110.533 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -75.53 15.66 0.45 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.176 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.433 ' H ' ' C ' ' A' ' 118' ' ' HIS . 94.0 m-70 53.34 -173.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.495 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 54.44 16.63 1.33 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.164 0.507 . . . . 1.0 111.051 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 117.979 -1.01 . . . . 1.0 110.517 -179.712 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.777 -0.823 . . . . 1.0 108.777 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -169.2 77.15 0.1 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.99 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.59 139.97 89.32 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 118.314 -0.851 . . . . 1.0 110.918 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.47 -32.16 61.58 Favored 'Trans proline' 0 N--CA 1.516 2.806 0 C-N-CA 121.099 1.2 . . . . 1.0 112.603 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.95 130.1 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.202 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -134.22 121.76 21.81 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.475 0.655 . . . . 1.0 109.921 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.04 147.29 27.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.445 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -94.03 78.03 4.09 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.603 0.716 . . . . 1.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.44 58.89 0.69 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.444 1.098 . . . . 1.0 110.693 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.67 -33.72 56.26 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.743 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -126.93 132.74 24.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.903 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -81.13 105.78 1.68 Allowed 'Trans proline' 0 N--CA 1.511 2.518 0 CA-C-N 119.914 1.005 . . . . 1.0 111.438 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -169.42 117.32 0.62 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.206 0.527 . . . . 1.0 110.454 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.76 150.81 9.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.065 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.3 34.56 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -72.82 126.33 29.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.217 0.532 . . . . 1.0 109.815 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -65.03 131.54 46.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.662 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.8 pt -119.69 147.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.271 0.558 . . . . 1.0 109.741 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.9 m -94.5 121.14 35.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.701 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.4 t -100.27 121.59 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -123.99 134.5 53.45 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.603 0.716 . . . . 1.0 109.808 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.09 120.67 33.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.08 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.81 123.25 30.96 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.997 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -107.62 129.26 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.216 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 m -90.94 123.75 34.68 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -74.0 115.43 13.46 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -114.3 96.75 5.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.028 0.442 . . . . 1.0 110.05 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.86 152.97 21.86 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.75 2.0 27.97 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.572 -0.314 . . . . 1.0 110.301 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.51 169.82 20.04 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.305 0.574 . . . . 1.0 110.856 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 19.1 mp0 -67.04 125.78 27.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.909 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.74 160.35 18.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 1.0 110.432 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -161.09 94.22 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 122.572 1.177 . . . . 1.0 109.33 178.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER 157.4 58.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.414 -1.266 . . . . 1.0 110.394 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.63 86.01 12.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.09 100.85 0.96 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.016 1.144 . . . . 1.0 111.269 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.97 143.02 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.759 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.15 120.21 26.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.935 0.494 . . . . 1.0 109.82 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.9 t -112.01 143.14 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.324 0.583 . . . . 1.0 109.582 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -151.98 126.01 9.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.102 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.55 128.54 34.95 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.643 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.61 -160.38 15.99 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -117.45 142.35 30.22 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.144 -0.932 . . . . 1.0 111.457 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.64 -40.95 46.48 Favored 'Trans proline' 0 N--CA 1.522 3.171 0 CA-C-N 119.688 0.924 . . . . 1.0 113.323 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.41 93.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.968 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -59.21 4.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.122 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.67 83.16 0.04 OUTLIER Glycine 0 N--CA 1.476 1.361 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.6 130.7 40.44 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.92 126.0 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.224 0.535 . . . . 1.0 109.786 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -68.48 122.14 17.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.824 -0.626 . . . . 1.0 109.926 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.16 -44.91 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.213 0.53 . . . . 1.0 109.94 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.56 168.53 37.98 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -158.16 169.99 23.27 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.618 0.723 . . . . 1.0 110.334 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -163.45 114.66 1.41 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.005 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -75.22 140.51 43.3 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.9 mm -78.63 142.09 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -66.62 -50.13 64.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.229 0.538 . . . . 1.0 110.579 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -147.3 130.33 16.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.759 0.79 . . . . 1.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 mt -117.71 108.47 42.88 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.982 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.95 159.88 44.08 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 CA-C-N 119.934 1.012 . . . . 1.0 111.667 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -70.57 145.52 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.499 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.26 1.86 29.95 Favored Glycine 0 N--CA 1.461 0.321 0 N-CA-C 110.385 -1.086 . . . . 1.0 110.385 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.95 -165.35 26.92 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -139.74 -173.42 3.62 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.388 0.613 . . . . 1.0 110.648 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.01 151.18 22.65 Favored Glycine 0 N--CA 1.477 1.408 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mt -132.54 152.59 51.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.291 1.043 . . . . 1.0 109.641 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.04 154.74 45.19 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.706 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -117.9 120.4 37.75 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.35 128.76 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.632 0.73 . . . . 1.0 109.269 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -99.29 140.04 34.05 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.848 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -137.98 121.88 17.71 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.981 0.896 . . . . 1.0 109.981 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -92.37 127.04 37.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.107 -0.951 . . . . 1.0 109.788 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.88 138.52 50.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.487 -0.485 . . . . 1.0 109.749 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 75' ' ' ARG . 4.4 t -147.56 -174.68 4.6 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.714 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.408 ' N ' ' OG1' ' A' ' 74' ' ' THR . 21.9 mmt85 56.26 12.68 1.04 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.416 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.4 145.23 35.07 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.789 0.805 . . . . 1.0 110.455 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.8 tp -169.11 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.12 -0.945 . . . . 1.0 109.851 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -47.52 76.8 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.832 0.348 . . . . 1.0 110.984 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.55 44.04 90.88 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -64.4 -38.03 89.6 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.116 0.484 . . . . 1.0 110.451 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.41 37.91 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.43 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.47 -160.02 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.597 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -130.57 86.02 54.3 Favored Pre-proline 0 N--CA 1.483 1.182 0 CA-C-O 118.758 -0.639 . . . . 1.0 110.053 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.62 -174.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.508 2.345 0 C-N-CA 122.076 1.85 . . . . 1.0 112.486 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.3 81.24 1.45 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.594 -1.003 . . . . 1.0 110.594 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.79 62.79 27.0 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.25 149.62 89.89 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.731 1.621 . . . . 1.0 111.309 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.6 t -103.75 114.33 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.72 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.61 147.32 30.79 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.852 0.834 . . . . 1.0 109.474 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.99 142.69 27.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.041 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.1 138.87 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.082 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -84.65 135.91 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.03 163.7 0.17 Allowed Pre-proline 0 CA--C 1.558 1.284 0 CA-C-O 117.759 -1.115 . . . . 1.0 111.558 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.57 129.59 32.84 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 120.935 1.09 . . . . 1.0 112.296 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -88.68 25.54 1.71 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.068 0.547 . . . . 1.0 110.1 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 71.38 -4.37 1.86 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.561 0.696 . . . . 1.0 110.455 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 70.4 mmt-85 -133.15 81.24 1.92 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.303 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.43 119.95 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.883 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.28 140.62 1.15 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.217 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -68.58 -61.1 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.944 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 m -41.82 -48.99 4.43 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.585 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -65.96 -63.31 1.11 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 110.173 -0.306 . . . . 1.0 110.173 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 105' ' ' ASN . 37.8 ttpt -46.24 -49.8 16.76 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.222 0.534 . . . . 1.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.74 -11.29 0.05 Allowed 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.734 -0.667 . . . . 1.0 111.635 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 103' ' ' LYS . 27.1 m-20 -102.23 26.39 7.78 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.824 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -155.06 26.39 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.418 0.287 . . . . 1.0 110.556 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.83 136.73 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -141.63 138.66 32.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.0 m -165.62 140.04 4.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.086 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -134.84 150.31 50.47 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.083 0.468 . . . . 1.0 110.444 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -88.76 133.05 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.53 138.61 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.84 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.33 155.99 48.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.779 0.799 . . . . 1.0 109.535 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.55 133.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.3 115.82 28.34 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -76.87 -65.38 0.95 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.946 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -77.85 152.76 33.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.019 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -64.58 133.09 51.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.138 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -65.62 -42.53 91.46 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.992 0.425 . . . . 1.0 110.017 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -62.52 98.33 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.377 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -65.37 -43.11 91.8 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.087 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 118.04 -0.981 . . . . 1.0 110.601 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.56 1.355 0 CA-C-O 118.529 -0.748 . . . . 1.0 110.911 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.5 -28.64 45.88 Favored 'Trans proline' 0 N--CA 1.517 2.855 0 C-N-CA 121.592 1.528 . . . . 1.0 112.361 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.15 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.762 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.5 p -131.93 120.22 22.2 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.955 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 9' ' ' LYS . 60.4 mt -102.66 145.48 29.61 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.225 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.8 t -78.88 31.17 0.2 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.6 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 7' ' ' LEU . 80.8 tttt -72.98 49.35 0.24 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.584 0.707 . . . . 1.0 110.16 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -61.08 -40.49 93.89 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -117.17 89.86 31.94 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.708 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.47 111.13 0.33 Allowed 'Trans proline' 0 N--CA 1.523 3.221 0 C-N-CA 121.052 1.168 . . . . 1.0 113.256 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -162.48 109.37 1.27 Allowed 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.265 0.555 . . . . 1.0 110.432 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -55.68 142.68 33.22 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.112 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.1 18.23 63.37 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -107.28 143.62 35.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.663 0.385 . . . . 1.0 110.233 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.17 130.95 40.07 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.15 144.68 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.987 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -89.3 112.96 24.16 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -96.22 115.51 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.1 p -129.53 134.83 47.97 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.371 0.605 . . . . 1.0 110.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.0 127.18 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.831 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -84.03 116.26 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.81 126.51 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.135 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -96.18 126.91 41.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 120.677 0.275 . . . . 1.0 110.284 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.7 t30 . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 1.0 109.749 179.794 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.25 0.548 . . . . 1.0 110.613 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.05 119.33 6.6 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.363 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.08 149.74 21.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.888 0.375 . . . . 1.0 110.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -137.13 162.75 32.53 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 122.435 1.112 . . . . 1.0 109.797 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 53.83 67.57 0.99 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.604 -1.18 . . . . 1.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.43 82.58 24.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.273 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.17 175.27 10.49 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.75 0.966 . . . . 1.0 111.16 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.51 138.69 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.677 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.26 114.25 17.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.379 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 t -107.59 140.56 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.519 0.676 . . . . 1.0 109.233 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -145.56 130.24 18.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.048 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.31 125.59 32.41 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.99 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -159.65 17.06 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -108.59 143.32 27.26 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.467 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.12 -21.19 27.63 Favored 'Trans proline' 0 N--CA 1.516 2.812 0 C-N-CA 120.5 0.8 . . . . 1.0 111.789 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.3 -45.88 89.33 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.934 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -72.38 -69.59 0.39 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.136 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.02 77.42 0.03 OUTLIER Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.32 165.84 21.6 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.54 141.8 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.089 0.471 . . . . 1.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -73.83 134.17 43.29 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.757 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -98.51 -42.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.7 168.75 39.37 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -153.96 166.19 33.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.506 0.67 . . . . 1.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -154.65 114.89 3.85 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.047 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -76.0 132.71 40.34 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.6 mt -86.46 148.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -62.24 -49.85 74.06 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.36 0.6 . . . . 1.0 110.465 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -176.25 146.77 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.293 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -118.31 124.16 28.8 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-O 117.924 -1.036 . . . . 1.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.04 163.15 39.07 Favored 'Trans proline' 0 N--CA 1.519 2.999 0 CA-C-N 119.844 0.98 . . . . 1.0 111.984 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -71.61 142.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.717 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.18 6.33 56.83 Favored Glycine 0 N--CA 1.465 0.627 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.9 -166.74 21.54 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 110.481 -1.048 . . . . 1.0 110.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 p -146.2 152.42 39.19 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.274 0.559 . . . . 1.0 110.14 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.55 157.75 19.84 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.39 113.72 7.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.501 0.667 . . . . 1.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.98 159.47 15.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.513 -0.767 . . . . 1.0 110.002 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -126.38 122.22 34.74 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.868 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.71 146.37 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.9 0.857 . . . . 1.0 109.55 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -119.84 142.29 48.77 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.216 -0.902 . . . . 1.0 110.033 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -144.5 145.2 31.73 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.012 0.911 . . . . 1.0 109.712 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -91.19 121.19 32.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.942 -1.026 . . . . 1.0 109.676 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.38 132.64 42.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.951 0.405 . . . . 1.0 110.181 179.056 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.072 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 86' ' ' VAL . 3.9 p -118.42 64.98 5.93 Favored Pre-proline 0 N--CA 1.48 1.047 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -68.81 175.45 7.27 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.983 1.789 . . . . 1.0 111.357 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.43 135.73 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.868 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -135.22 146.78 48.98 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.862 0.839 . . . . 1.0 109.721 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.72 143.02 28.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.929 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.42 140.13 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.652 0.739 . . . . 1.0 109.728 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.06 140.63 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.255 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 CA--C 1.561 1.387 0 CA-C-O 118.143 -0.932 . . . . 1.0 111.767 179.792 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.6 m120 . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.28 46.6 1.11 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.364 0.666 . . . . 1.0 110.234 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 13.1 p -105.68 139.01 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.428 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 55.3 m-85 -145.33 143.24 30.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.146 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.4 p -170.54 143.36 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.74 147.28 33.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.6 mp -92.48 144.59 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.57 140.12 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.927 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.38 143.94 38.26 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.873 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.1 m -109.58 135.79 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.826 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.676 0.751 . . . . 1.0 109.063 -179.713 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 CA--C 1.557 1.224 0 CA-C-O 119.225 -0.417 . . . . 1.0 110.735 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.26 -23.51 38.74 Favored 'Trans proline' 0 N--CA 1.51 2.451 0 C-N-CA 121.551 1.501 . . . . 1.0 111.737 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.24 132.16 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.334 0.588 . . . . 1.0 110.269 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.3 m -133.62 121.95 22.78 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.047 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.07 147.61 26.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.477 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.9 p -85.82 34.55 0.6 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.297 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -71.77 54.92 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.936 0.398 . . . . 1.0 110.261 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -52.14 -32.6 36.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.311 0.577 . . . . 1.0 110.434 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.9 p -134.85 139.26 31.72 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.638 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -79.33 115.62 3.48 Favored 'Trans proline' 0 N--CA 1.515 2.771 0 C-N-CA 120.522 0.815 . . . . 1.0 111.779 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -167.13 102.93 0.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.805 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -52.58 146.41 10.08 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.018 0.437 . . . . 1.0 110.642 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.91 -23.6 22.6 Favored Glycine 0 N--CA 1.476 1.301 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -67.66 141.09 56.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.887 0.375 . . . . 1.0 110.014 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.94 133.85 47.74 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.1 pt -119.65 144.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.976 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.7 m -96.25 110.46 22.76 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.559 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.4 t -93.82 117.71 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -128.38 137.73 52.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.266 0.555 . . . . 1.0 110.286 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.56 123.51 40.75 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.253 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -77.63 116.05 17.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.22 121.86 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.6 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.1 m -108.72 122.73 47.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 120.993 0.425 . . . . 1.0 110.078 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.472 0.627 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.859 179.777 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.894 0 CA-C-O 121.34 0.59 . . . . 1.0 110.584 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.96 121.18 14.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.89 154.0 18.47 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.115 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -142.71 171.0 14.64 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.484 0.659 . . . . 1.0 110.131 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 51.13 63.68 2.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.613 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.56 84.25 6.22 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 115.45 -0.796 . . . . 1.0 109.953 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -79.21 158.77 26.52 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 121.365 1.377 . . . . 1.0 111.518 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.51 135.99 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.358 -0.837 . . . . 1.0 109.842 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.05 115.09 17.94 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.47 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 m -107.83 140.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.796 0.807 . . . . 1.0 109.489 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.67 130.28 17.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.205 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.65 125.94 32.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.96 -162.33 18.04 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -93.66 146.68 32.22 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 119.1 -0.476 . . . . 1.0 111.039 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.12 -12.18 29.95 Favored 'Trans proline' 0 N--CA 1.511 2.55 0 C-N-CA 120.679 0.919 . . . . 1.0 111.606 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.29 86.59 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.02 0.438 . . . . 1.0 110.699 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -81.64 7.37 12.49 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.09 -9.35 47.2 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.31 177.77 0.21 Allowed Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.74 135.92 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.921 0.391 . . . . 1.0 110.345 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.17 132.23 44.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.871 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.27 -42.67 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.48 155.72 26.11 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -148.18 161.58 41.17 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.472 0.653 . . . . 1.0 110.48 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -160.99 114.11 1.97 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.111 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.9 m -82.62 140.55 33.12 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.14 147.73 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.657 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -64.49 -46.28 83.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 1.0 110.54 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -166.5 137.07 3.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.657 -0.702 . . . . 1.0 110.596 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.92 118.83 32.78 Favored Pre-proline 0 N--CA 1.494 1.739 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.69 162.73 37.21 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 CA-C-N 119.78 0.957 . . . . 1.0 111.693 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.11 137.71 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.41 16.44 77.36 Favored Glycine 0 CA--C 1.511 -0.204 0 N-CA-C 110.144 -1.182 . . . . 1.0 110.144 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.08 17.52 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 p -140.17 -170.57 3.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.498 0.666 . . . . 1.0 110.634 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.63 147.2 18.72 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.6 114.66 19.66 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.631 . . . . 1.0 109.81 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.67 154.01 22.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.52 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -126.18 121.66 33.42 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.81 131.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.549 0.69 . . . . 1.0 109.49 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -110.73 138.66 46.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.93 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -138.73 133.71 32.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.912 0.863 . . . . 1.0 109.983 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.38 121.01 30.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 1.0 109.73 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.27 122.94 20.48 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.467 0.404 0 CA-C-O 121.1 0.476 . . . . 1.0 110.429 -179.669 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.623 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -117.05 82.29 13.53 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-O 118.474 -0.774 . . . . 1.0 109.234 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.82 160.81 33.93 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 121.848 1.698 . . . . 1.0 111.236 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.36 158.53 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.063 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.55 149.47 35.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.804 0.811 . . . . 1.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.05 136.39 20.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.06 144.15 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.702 0.763 . . . . 1.0 109.683 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -94.94 139.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.819 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 t70 . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 118.59 -0.719 . . . . 1.0 109.696 179.849 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -161.46 42.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.178 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.9 146.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.156 0.503 . . . . 1.0 109.65 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -147.76 154.19 40.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.7 t -160.55 145.92 14.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.174 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.88 130.71 34.27 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.272 0.558 . . . . 1.0 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -80.95 128.42 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.6 t -132.21 138.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.742 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -130.63 110.22 11.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.006 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -89.83 137.22 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.732 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 121.309 0.576 . . . . 1.0 109.486 -179.591 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 CA--C 1.552 1.032 0 CA-C-O 118.359 -0.829 . . . . 1.0 111.005 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.74 -21.51 5.79 Favored 'Trans proline' 0 N--CA 1.512 2.587 0 C-N-CA 121.831 1.687 . . . . 1.0 112.562 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.51 132.74 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.077 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.7 p -134.51 122.3 22.23 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.266 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.86 147.14 30.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.418 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.0 t -81.81 36.39 0.44 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.404 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -71.43 50.72 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.047 0.451 . . . . 1.0 110.714 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.19 -39.27 72.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.588 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -124.41 84.33 56.68 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.875 -0.583 . . . . 1.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.13 112.91 0.58 Allowed 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.9 1.734 . . . . 1.0 112.56 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -167.08 123.96 1.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.961 0.41 . . . . 1.0 110.592 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.68 147.19 33.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 1.0 110.448 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.58 -31.64 4.48 Favored Glycine 0 N--CA 1.474 1.212 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.79 133.6 50.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.863 0.363 . . . . 1.0 110.052 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -68.19 136.54 53.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.792 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 pt -126.0 146.67 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.454 0.645 . . . . 1.0 110.426 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -92.79 112.26 24.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.616 -0.72 . . . . 1.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.09 117.75 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.848 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -129.42 136.79 50.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.349 0.595 . . . . 1.0 110.29 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.08 125.96 46.17 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.02 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -81.19 113.72 19.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.66 124.66 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.867 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.8 m -101.25 122.04 42.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.118 0.485 . . . . 1.0 110.015 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 m120 . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.559 0.695 . . . . 1.0 109.76 179.472 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.49 0.662 . . . . 1.0 110.52 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -61.1 117.14 5.16 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.175 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.43 22.85 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.049 0.452 . . . . 1.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -137.96 159.79 41.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.114 0.959 . . . . 1.0 109.817 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 53.46 65.79 1.41 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.474 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -113.32 83.34 6.53 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.91 176.37 10.21 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 120.909 1.072 . . . . 1.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -150.34 145.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.025 -0.988 . . . . 1.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.97 132.57 43.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.507 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.07 144.93 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.43 0.633 . . . . 1.0 109.335 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.19 150.14 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.262 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 tp -99.47 127.21 45.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.046 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.96 -154.75 16.45 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -116.35 143.86 31.93 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.112 -0.471 . . . . 1.0 111.257 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.58 -10.85 23.99 Favored 'Trans proline' 0 N--CA 1.511 2.508 0 C-N-CA 120.725 0.95 . . . . 1.0 111.58 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.828 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -80.69 -76.13 0.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.86 78.2 0.05 OUTLIER Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.39 168.26 26.43 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 p -132.77 139.34 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 120.952 0.406 . . . . 1.0 110.487 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -74.71 136.97 41.8 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.096 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -95.02 -41.74 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.72 171.08 42.28 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -150.32 162.63 40.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.761 0.791 . . . . 1.0 110.253 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -152.46 113.93 4.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.147 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -78.08 132.9 37.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.8 mt -89.57 150.77 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.33 -51.34 66.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -169.79 141.79 2.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.505 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mt -113.97 124.03 31.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 117.978 -1.011 . . . . 1.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.16 160.17 45.9 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 120.87 1.047 . . . . 1.0 111.705 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.09 143.27 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.19 10.65 66.06 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.83 -167.75 16.37 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.0 p -145.64 150.44 36.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.439 -0.38 . . . . 1.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.4 148.93 19.23 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.46 109.79 16.65 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.602 0.715 . . . . 1.0 109.75 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 154.35 18.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.893 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -132.45 123.03 25.87 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.08 135.11 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.457 -0.792 . . . . 1.0 109.506 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -103.41 138.8 39.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.031 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -139.77 132.46 28.94 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.627 0.727 . . . . 1.0 110.248 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -86.41 124.62 32.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.784 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 100.61 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 121.196 0.522 . . . . 1.0 110.26 -179.664 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.965 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -119.14 65.03 7.38 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 118.818 -0.61 . . . . 1.0 109.524 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.96 147.85 94.12 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.228 1.952 . . . . 1.0 111.431 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.46 141.63 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.901 0.857 . . . . 1.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.68 151.83 51.86 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.317 1.055 . . . . 1.0 109.882 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.13 139.93 26.32 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.669 -1.15 . . . . 1.0 109.919 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.7 t -133.04 141.95 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 121.82 0.819 . . . . 1.0 110.034 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.11 136.61 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.697 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 CA--C 1.557 1.234 0 CA-C-O 118.182 -0.913 . . . . 1.0 111.729 -179.603 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -95.01 35.26 1.28 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.12 0.568 . . . . 1.0 110.36 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.21 137.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -146.23 147.99 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.273 0.558 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.9 p -164.26 149.66 10.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.701 -0.681 . . . . 1.0 109.839 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -134.32 126.31 29.44 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.883 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.0 mm -85.1 101.6 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 m -86.87 144.25 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -119.58 132.62 55.77 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.618 0.723 . . . . 1.0 110.034 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.27 135.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.175 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 115.606 -0.724 . . . . 1.0 109.287 -179.713 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.566 1.572 0 CA-C-O 118.402 -0.809 . . . . 1.0 111.069 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.14 -27.98 23.99 Favored 'Trans proline' 0 N--CA 1.519 2.984 0 C-N-CA 121.092 1.195 . . . . 1.0 112.775 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -109.99 134.48 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.195 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 p -143.7 137.8 28.43 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.341 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.17 157.32 47.21 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.276 0.56 . . . . 1.0 110.396 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 m -84.02 113.42 21.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.702 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -145.9 52.1 1.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.032 0.444 . . . . 1.0 110.72 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.61 -43.18 84.54 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.463 0.649 . . . . 1.0 110.487 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.0 p -124.01 84.38 54.98 Favored Pre-proline 0 N--CA 1.485 1.323 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.169 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.43 122.06 7.2 Favored 'Trans proline' 0 N--CA 1.515 2.74 0 C-N-CA 121.348 1.365 . . . . 1.0 112.705 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -167.88 123.01 1.0 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.667 -0.242 . . . . 1.0 110.675 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -56.19 145.16 27.17 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.611 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.21 -26.7 6.69 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 111.357 -0.697 . . . . 1.0 111.357 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -69.63 140.4 53.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -73.73 137.28 43.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -132.31 147.94 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.161 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -94.64 141.4 28.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.418 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.0 126.89 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -137.0 128.53 28.5 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.496 0.665 . . . . 1.0 109.953 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.86 131.48 56.92 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.487 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -89.22 118.15 28.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.495 0.664 . . . . 1.0 109.498 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.32 132.97 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.784 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.2 m -100.66 127.81 46.93 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.124 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 . . . . . 0 N--CA 1.478 0.939 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.636 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.291 0.567 . . . . 1.0 110.422 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 24.7 mp0 -59.81 118.81 6.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.923 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.2 154.66 17.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.99 0.424 . . . . 1.0 110.082 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -144.94 175.1 10.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.752 0.787 . . . . 1.0 110.067 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 50.93 64.08 1.98 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.978 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.7 t -116.21 84.52 14.17 Favored Pre-proline 0 N--CA 1.489 1.486 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.473 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.66 120.35 3.5 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.626 0.884 . . . . 1.0 111.579 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 t -87.35 141.33 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.647 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 115.65 17.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.61 144.15 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.62 0.724 . . . . 1.0 109.227 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -152.16 143.28 23.18 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -95.61 128.29 42.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.237 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.57 -158.36 17.23 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 110.784 -0.926 . . . . 1.0 110.784 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -103.32 144.23 28.21 Favored Pre-proline 0 N--CA 1.487 1.408 0 CA-C-O 118.404 -0.808 . . . . 1.0 111.461 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.54 -29.68 16.0 Favored 'Trans proline' 0 N--CA 1.516 2.824 0 C-N-CA 120.796 0.997 . . . . 1.0 111.808 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.32 90.29 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -67.55 -70.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.238 0.542 . . . . 1.0 110.166 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 85.85 0.06 OUTLIER Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.47 141.7 47.22 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -113.47 123.98 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-O 121.124 0.488 . . . . 1.0 109.821 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.36 125.08 24.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.643 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.36 -42.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.58 163.34 32.39 Favored Glycine 0 N--CA 1.462 0.417 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -150.35 163.98 36.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.508 0.67 . . . . 1.0 110.528 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.95 116.87 1.03 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.139 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -75.23 139.15 42.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.3 mm -78.55 148.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.698 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -63.84 -47.9 78.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.31 0.576 . . . . 1.0 110.418 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -168.51 136.26 2.1 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.385 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.13 119.21 37.12 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-O 117.785 -1.102 . . . . 1.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.86 165.62 29.68 Favored 'Trans proline' 0 N--CA 1.518 2.966 0 CA-C-N 120.009 1.039 . . . . 1.0 111.993 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.73 139.89 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.003 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.83 73.11 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.83 -171.15 18.12 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.8 p -143.68 149.81 37.77 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.806 0.336 . . . . 1.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.97 157.14 18.03 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.1 tp -150.46 139.33 20.89 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.932 0.872 . . . . 1.0 110.039 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.71 160.37 26.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.024 -0.989 . . . . 1.0 109.866 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -122.2 124.14 43.13 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.493 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.0 142.84 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.761 0.791 . . . . 1.0 109.587 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -103.44 140.81 36.97 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -141.01 132.49 26.91 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.319 0.581 . . . . 1.0 109.931 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -88.04 124.54 33.85 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.695 -0.684 . . . . 1.0 109.388 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.06 130.22 42.28 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.468 0.448 0 CA-C-O 121.373 0.606 . . . . 1.0 110.345 -179.82 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.951 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.19 63.64 17.8 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.22 -177.91 0.56 Allowed 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.676 1.584 . . . . 1.0 111.837 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.89 158.38 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.331 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -153.11 148.0 26.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.026 0.917 . . . . 1.0 109.817 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.57 145.03 31.59 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.017 -0.992 . . . . 1.0 109.973 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -141.25 142.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.419 0.628 . . . . 1.0 110.206 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.01 136.53 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.706 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 . . . . . 0 CA--C 1.555 1.135 0 CA-C-O 117.666 -1.159 . . . . 1.0 111.404 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.0 t30 . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 110.072 -0.344 . . . . 1.0 110.072 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.75 46.35 1.23 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.495 0.718 . . . . 1.0 110.999 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.62 136.08 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.336 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -143.99 145.47 32.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.832 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 t -165.42 147.82 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.576 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -134.02 128.15 33.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.477 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.09 132.61 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.27 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.18 142.91 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.989 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.73 149.45 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.502 0.668 . . . . 1.0 109.698 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.43 136.7 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.785 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.87 0.843 . . . . 1.0 110.042 -179.895 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 118.925 -0.559 . . . . 1.0 111.373 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 -27.46 13.92 Favored 'Trans proline' 0 N--CA 1.51 2.47 0 C-N-CA 121.766 1.644 . . . . 1.0 111.742 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.85 130.96 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.221 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -132.66 122.69 25.04 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.941 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.0 mt -104.33 144.2 31.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.232 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.3 m -80.07 44.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.627 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -75.89 51.84 0.66 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.564 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.55 -45.25 92.37 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.238 0.542 . . . . 1.0 110.331 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.2 p -119.19 85.94 31.39 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.378 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.43 116.37 1.54 Allowed 'Trans proline' 0 N--CA 1.514 2.685 0 C-N-CA 121.524 1.483 . . . . 1.0 112.804 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -167.09 117.2 0.87 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.621 0.248 . . . . 1.0 110.508 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -55.95 146.32 22.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.03 0.443 . . . . 1.0 110.354 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.26 -26.19 8.2 Favored Glycine 0 N--CA 1.475 1.293 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.34 146.93 53.59 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.41 132.96 37.55 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.398 0.618 . . . . 1.0 109.651 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.31 145.29 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -91.25 115.96 28.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.899 -0.592 . . . . 1.0 109.522 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.88 112.89 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.4 p -123.56 138.24 54.6 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.556 0.693 . . . . 1.0 110.18 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.16 124.67 47.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.033 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.76 113.22 21.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.719 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -92.71 117.85 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.616 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.7 m -89.75 125.31 35.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.903 0.859 . . . . 1.0 109.665 179.197 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 121.477 0.656 . . . . 1.0 110.699 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.25 116.4 3.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.286 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.88 152.27 20.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -142.44 169.83 16.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.696 0.76 . . . . 1.0 110.049 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 49.48 62.25 2.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.716 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -113.47 82.69 6.25 Favored Pre-proline 0 N--CA 1.485 1.297 0 CA-C-N 115.749 -0.659 . . . . 1.0 109.381 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -80.35 112.39 2.75 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 121.201 1.267 . . . . 1.0 111.395 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.92 146.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.831 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.81 122.13 28.14 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -117.0 143.48 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.466 0.651 . . . . 1.0 109.704 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -156.14 132.6 10.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 mp -87.13 127.86 35.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.606 0.717 . . . . 1.0 109.697 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.31 -154.6 16.51 Favored Glycine 0 N--CA 1.469 0.879 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -122.21 143.01 38.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.175 -0.916 . . . . 1.0 111.721 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.6 -39.57 46.23 Favored 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 120.782 0.988 . . . . 1.0 113.069 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . -60.78 -42.37 97.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.931 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.04 8.65 1.48 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.104 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 66.77 72.89 0.7 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.98 163.35 25.22 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 141.4 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.233 0.539 . . . . 1.0 110.481 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.85 135.81 40.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.811 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -103.15 -42.84 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.533 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.93 160.36 30.26 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 110.576 -1.01 . . . . 1.0 110.576 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -151.6 164.48 36.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.667 0.746 . . . . 1.0 110.406 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -154.51 115.94 4.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.358 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -77.0 133.91 39.0 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 mm -79.76 145.82 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.531 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -63.5 -49.33 73.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.693 0.759 . . . . 1.0 110.687 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -173.06 142.22 1.04 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.302 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.5 mt -122.98 120.45 27.53 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 118.03 -0.986 . . . . 1.0 111.145 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.12 166.82 28.53 Favored 'Trans proline' 0 N--CA 1.509 2.438 0 C-N-CA 120.85 1.033 . . . . 1.0 111.648 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.74 139.13 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.412 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.51 22.65 76.6 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.54 -172.32 15.91 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -139.9 -169.19 2.67 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.528 0.68 . . . . 1.0 110.672 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.44 150.91 22.27 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.89 114.92 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.847 0.832 . . . . 1.0 110.206 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.82 155.75 19.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.705 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -126.12 122.27 35.26 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.705 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 t -136.75 136.06 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.87 0.843 . . . . 1.0 109.323 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -108.4 140.66 41.37 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.946 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -141.67 135.76 30.21 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.95 0.881 . . . . 1.0 109.837 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -89.64 123.0 33.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.635 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.51 35.72 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 1.0 110.318 179.655 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.097 0 N-CA-C 110.893 -0.883 . . . . 1.0 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.44 68.93 1.37 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.57 -169.22 0.51 Allowed 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.081 1.187 . . . . 1.0 111.654 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -147.83 142.98 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.324 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.28 140.14 33.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.652 0.739 . . . . 1.0 109.747 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.7 141.6 26.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.32 -0.854 . . . . 1.0 109.95 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.4 t -140.75 143.72 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.996 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.98 142.71 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.533 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.558 1.272 0 CA-C-O 119.055 -0.497 . . . . 1.0 110.213 179.991 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.575 HD22 ' N ' ' A' ' 105' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -171.77 48.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.05 139.66 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 121.235 0.54 . . . . 1.0 109.868 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -144.9 143.81 30.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.243 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 t -171.18 137.04 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.414 0.626 . . . . 1.0 110.039 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -135.08 155.37 50.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.661 -0.699 . . . . 1.0 110.479 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.0 mm -83.36 123.12 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.089 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.21 103.87 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.44 102.7 15.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -106.9 127.91 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 1.0 109.82 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 115' ' ' LEU . 10.0 mp . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 121.72 0.771 . . . . 1.0 109.136 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.2 mt . . . . . 0 CA--C 1.552 1.033 0 CA-C-O 118.678 -0.677 . . . . 1.0 111.087 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.94 -27.32 20.98 Favored 'Trans proline' 0 N--CA 1.515 2.753 0 C-N-CA 121.492 1.461 . . . . 1.0 111.992 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.25 132.7 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.067 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 t -133.15 127.83 34.73 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.229 0.538 . . . . 1.0 110.227 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.487 HD22 HD12 ' A' ' 18' ' ' ILE . 16.2 mt -108.61 144.04 36.86 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.275 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -76.74 36.15 0.16 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.844 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 7' ' ' LEU . 36.8 tttp -74.05 48.74 0.32 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.672 0.749 . . . . 1.0 110.235 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.14 -41.61 93.08 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.451 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -116.06 87.49 19.3 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.477 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.03 115.31 1.44 Allowed 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 121.051 1.167 . . . . 1.0 113.076 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -169.09 116.42 0.63 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.627 -0.26 . . . . 1.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -55.8 145.71 23.61 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.52 -25.98 8.71 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -65.77 144.03 57.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.77 137.04 38.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.48 0.657 . . . . 1.0 109.516 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.487 HD12 HD22 ' A' ' 7' ' ' LEU . 33.5 pt -124.05 145.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.399 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -87.56 113.62 23.41 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.07 113.24 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -130.1 135.19 47.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.576 0.703 . . . . 1.0 110.141 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 126.2 48.88 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.02 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -81.87 111.4 18.05 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 p -89.62 124.99 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.3 m -98.09 124.52 42.66 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 121.358 0.599 . . . . 1.0 109.647 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.3 0.571 . . . . 1.0 110.549 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -62.1 126.95 29.11 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.579 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.54 135.88 37.42 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.532 ' O ' ' C ' ' A' ' 34' ' ' ASN . 33.6 m170 -105.9 169.71 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.087 0.946 . . . . 1.0 109.73 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 33' ' ' HIS . 4.3 p30 16.73 84.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.906 -1.043 . . . . 1.0 111.454 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 t -112.44 80.9 3.75 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.109 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -83.57 102.8 1.04 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 120.386 0.724 . . . . 1.0 111.352 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.46 149.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.46 40.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -121.37 143.98 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.5 0.667 . . . . 1.0 109.501 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -152.86 128.39 10.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.52 127.64 33.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.12 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.79 -155.33 17.12 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 110.714 -0.955 . . . . 1.0 110.714 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -121.34 143.72 38.21 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.325 -0.845 . . . . 1.0 111.503 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.59 -30.11 15.57 Favored 'Trans proline' 0 N--CA 1.517 2.904 0 CA-C-N 119.684 0.923 . . . . 1.0 113.166 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.37 87.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.729 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.16 -52.36 64.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.324 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.49 -4.08 0.26 Allowed Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.34 98.84 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -81.41 114.43 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' CD ' HH22 ' A' ' 53' ' ' ARG . 63.5 tt0 -74.46 112.69 10.89 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.9 -46.2 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 176.24 42.47 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.734 -0.947 . . . . 1.0 110.734 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.428 HH22 ' CD ' ' A' ' 50' ' ' GLU . 9.5 ptp85 -147.85 160.88 42.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.726 0.774 . . . . 1.0 110.457 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -146.07 113.7 6.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.893 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -84.98 130.25 34.66 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.7 145.77 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.079 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.9 p -62.42 -46.58 87.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.121 0.486 . . . . 1.0 110.421 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -169.09 137.53 2.0 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.472 0.653 . . . . 1.0 109.9 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.0 mt -115.91 119.14 37.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 CA-C-O 118.393 -0.813 . . . . 1.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.43 168.71 24.18 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 CA-C-N 119.592 0.89 . . . . 1.0 112.302 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.12 141.23 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.91 13.5 59.51 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.597 -1.001 . . . . 1.0 110.597 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.95 -175.44 19.4 Favored Glycine 0 N--CA 1.477 1.393 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 p -143.09 150.91 40.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.882 -0.159 . . . . 1.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.82 158.19 21.32 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.21 -1.156 . . . . 1.0 110.21 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.24 110.84 16.64 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.9 0.857 . . . . 1.0 109.906 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.47 154.81 18.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.088 -0.96 . . . . 1.0 110.339 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -141.47 123.59 15.53 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.842 0.829 . . . . 1.0 110.594 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.05 135.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.428 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -92.6 137.1 32.66 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.597 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -139.65 131.02 26.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 1.0 109.639 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -97.26 123.9 41.19 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.003 -0.999 . . . . 1.0 109.482 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 147.09 53.25 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.484 1.235 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.433 -179.193 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.67 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 86' ' ' VAL . 11.8 p -165.44 60.47 0.69 Allowed Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.98 163.34 31.09 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.943 1.762 . . . . 1.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.24 134.33 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 121.433 0.635 . . . . 1.0 109.787 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -128.46 148.23 50.72 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.996 0.903 . . . . 1.0 109.937 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.98 146.75 31.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.969 -1.014 . . . . 1.0 110.102 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.42 141.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.512 0.672 . . . . 1.0 110.156 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -86.83 137.5 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.547 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 p30 . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 117.951 -1.023 . . . . 1.0 111.547 -179.607 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.745 0.307 . . . . 1.0 110.673 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -90.56 51.58 2.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.155 0.502 . . . . 1.0 110.661 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.87 134.88 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.716 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -142.84 136.4 28.7 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.426 0.631 . . . . 1.0 109.736 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.6 m -158.48 145.14 17.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.527 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -144.11 127.2 16.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.974 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.9 mp -88.75 147.24 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.671 -0.863 . . . . 1.0 108.671 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.32 140.9 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 115.202 -0.908 . . . . 1.0 109.842 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -95.51 142.49 27.8 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.798 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.7 136.32 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-O 121.324 0.583 . . . . 1.0 110.203 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.484 1.264 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.707 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 mp . . . . . 0 CA--C 1.558 1.282 0 CA-C-O 118.336 -0.84 . . . . 1.0 111.115 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.47 -29.33 77.63 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.643 1.562 . . . . 1.0 112.339 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.9 mt -111.99 135.94 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.209 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 t -148.23 138.98 23.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.382 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.07 163.27 33.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.72 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.3 t -84.02 114.69 21.9 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.971 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.86 50.19 1.19 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.834 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -56.77 -43.79 81.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.717 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 p -123.19 84.93 51.52 Favored Pre-proline 0 N--CA 1.485 1.285 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.251 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -49.27 123.33 9.98 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 121.584 1.523 . . . . 1.0 112.2 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -168.15 123.7 1.0 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.397 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -56.85 146.21 27.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.599 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.16 -27.54 6.09 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 110.994 -0.843 . . . . 1.0 110.994 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.54 141.25 55.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.881 -0.415 . . . . 1.0 109.881 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -74.76 143.28 44.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.681 0.753 . . . . 1.0 109.745 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.046 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -89.35 112.51 23.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.366 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.02 118.33 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -130.79 133.99 46.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.442 0.639 . . . . 1.0 110.479 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.57 128.26 53.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.109 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.43 119.72 26.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.573 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.74 126.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.765 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -88.81 125.17 34.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.02 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.6 t30 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 121.239 0.542 . . . . 1.0 110.133 179.746 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 121.386 0.612 . . . . 1.0 110.556 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -56.63 120.19 7.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.462 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.84 152.95 18.2 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.101 0.476 . . . . 1.0 109.828 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -146.15 173.31 12.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.876 0.846 . . . . 1.0 109.836 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 m120 48.63 59.45 4.36 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.086 -0.961 . . . . 1.0 110.857 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.44 87.33 7.64 Favored Pre-proline 0 N--CA 1.488 1.457 0 CA-C-O 118.578 -0.725 . . . . 1.0 109.749 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.52 173.4 14.54 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 120.836 1.024 . . . . 1.0 111.478 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.58 144.42 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.92 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.1 133.06 43.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.528 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.1 146.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.635 0.731 . . . . 1.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -154.95 141.89 19.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.822 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 42' ' ' GLY . 1.6 tt -96.62 130.22 43.87 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.545 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.592 ' N ' HD23 ' A' ' 41' ' ' LEU . . . 118.94 -153.04 17.09 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 110.498 -1.041 . . . . 1.0 110.498 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -126.01 140.03 35.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-O 118.175 -0.917 . . . . 1.0 111.575 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.04 -36.15 53.25 Favored 'Trans proline' 0 N--CA 1.517 2.888 0 C-N-CA 120.74 0.96 . . . . 1.0 112.923 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.48 89.49 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.885 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -65.77 -75.32 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.193 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.42 67.79 0.04 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.64 51.16 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.72 138.0 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.286 0.565 . . . . 1.0 110.403 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.93 136.13 53.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.766 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.0 mt -101.52 -38.95 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.531 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.01 164.16 34.04 Favored Glycine 0 N--CA 1.462 0.433 0 N-CA-C 110.654 -0.978 . . . . 1.0 110.654 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -149.35 162.17 40.6 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.967 0.889 . . . . 1.0 110.264 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -155.05 118.79 4.55 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.036 -0.983 . . . . 1.0 110.162 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.1 m -79.1 133.3 36.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.23 0.538 . . . . 1.0 109.591 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 59' ' ' ILE . 60.8 mt -108.52 145.57 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.47 -56.35 2.31 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.628 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -64.92 79.28 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.316 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' A' ' 56' ' ' ILE . 30.3 mt -122.85 86.9 50.36 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 118.237 -0.887 . . . . 1.0 110.558 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.66 163.7 35.29 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.59 1.526 . . . . 1.0 111.746 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -69.09 142.7 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.445 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.41 68.9 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.04 -167.68 18.91 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -146.33 151.06 36.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.255 0.55 . . . . 1.0 110.253 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.64 151.85 19.81 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.062 -1.215 . . . . 1.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.52 116.52 16.04 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.746 0.784 . . . . 1.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 156.0 18.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.837 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -125.54 124.17 40.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.944 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.21 140.64 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.482 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -106.3 140.21 39.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.709 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -141.64 134.23 28.39 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.974 0.893 . . . . 1.0 109.839 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -102.34 127.56 49.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.986 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 141.88 53.27 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 N--CA 1.484 1.265 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.204 -179.734 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.668 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.5 m -119.45 65.26 8.45 Favored Pre-proline 0 N--CA 1.481 1.089 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.4 -179.55 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.129 1.886 . . . . 1.0 110.94 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.66 157.59 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.077 -0.965 . . . . 1.0 110.173 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -147.11 145.77 29.71 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.925 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.18 142.36 32.69 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.13 136.54 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.64 0.734 . . . . 1.0 110.088 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.63 138.37 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.666 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 CA--C 1.558 1.278 0 CA-C-O 117.917 -1.04 . . . . 1.0 111.184 -179.691 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.832 -0.433 . . . . 1.0 109.832 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -93.29 47.53 1.26 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.392 0.615 . . . . 1.0 110.737 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 58.7 t -100.38 135.76 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 121.723 0.773 . . . . 1.0 109.423 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 53.4 m-85 -144.68 146.3 32.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.245 -0.889 . . . . 1.0 109.929 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.9 t -163.05 150.02 12.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.437 -0.802 . . . . 1.0 109.8 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -145.25 132.58 20.62 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.088 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.7 mp -83.0 118.63 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.45 107.05 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.8 122.3 29.69 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.5 t -129.08 134.98 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 1.0 109.902 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 CA-C-O 122.06 0.933 . . . . 1.0 109.931 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.554 1.113 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.92 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.21 -39.17 3.16 Favored 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 120.881 1.054 . . . . 1.0 112.417 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -100.51 133.83 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.588 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.9 p -137.26 123.06 20.0 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.4 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.6 mt -112.27 150.7 30.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.48 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.3 p -81.09 28.35 0.37 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.37 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -73.95 48.91 0.31 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -55.15 -26.24 37.31 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.193 0.52 . . . . 1.0 110.396 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -133.34 138.45 31.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-O 118.247 -0.883 . . . . 1.0 111.4 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -78.42 113.54 3.37 Favored 'Trans proline' 0 N--CA 1.51 2.468 0 CA-C-N 119.596 0.891 . . . . 1.0 111.642 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -166.96 99.39 0.54 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.78 146.83 16.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.733 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.93 -23.01 25.84 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -68.78 138.15 54.59 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.47 136.32 54.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.31 0.576 . . . . 1.0 109.622 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.84 148.1 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.234 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.5 m -96.35 114.11 25.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.816 -0.629 . . . . 1.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.24 122.77 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 m -128.63 132.66 48.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.33 0.586 . . . . 1.0 109.984 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.08 123.41 40.27 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.734 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -79.28 144.64 34.1 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.202 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.03 135.64 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -101.34 123.99 46.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.414 HD21 ' CB ' ' A' ' 32' ' ' ALA . 5.3 t-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.429 0.633 . . . . 1.0 110.103 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.183 0.516 . . . . 1.0 110.77 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -58.08 125.84 24.88 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.533 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' CB ' HD21 ' A' ' 26' ' ' ASN . . . -105.08 152.91 22.18 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.201 0.524 . . . . 1.0 110.107 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -147.22 -178.88 6.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.097 0.951 . . . . 1.0 109.741 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 47.83 59.24 4.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.832 -1.076 . . . . 1.0 111.223 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.86 84.66 2.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 CA-C-O 118.395 -0.812 . . . . 1.0 109.783 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.83 160.69 30.73 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 120.638 0.892 . . . . 1.0 111.724 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.82 141.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.031 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.43 129.09 42.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.499 -0.773 . . . . 1.0 109.536 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.51 146.32 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.724 0.773 . . . . 1.0 109.224 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -152.12 150.03 29.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.992 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tp -97.33 130.85 44.45 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.114 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.79 -153.55 17.45 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -118.72 143.63 33.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.36 -37.11 40.1 Favored 'Trans proline' 0 N--CA 1.521 3.142 0 CA-C-N 119.559 0.878 . . . . 1.0 113.275 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.57 99.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.783 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.91 8.69 1.42 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.235 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.31 74.2 0.55 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.89 163.99 13.98 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.125 -0.79 . . . . 1.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.79 132.97 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.211 0.529 . . . . 1.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.04 134.84 48.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.684 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -98.69 -36.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.577 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.84 172.84 41.01 Favored Glycine 0 N--CA 1.463 0.437 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.16 166.77 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.754 0.787 . . . . 1.0 110.294 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -161.17 117.14 2.18 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.95 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -76.62 136.52 39.2 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.9 mt -107.56 142.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.727 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 59' ' ' ILE . 95.8 p -105.02 -54.95 2.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.578 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -63.51 75.3 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.15 0.976 . . . . 1.0 110.967 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' SER . 49.7 mm -121.91 82.23 42.88 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 114.748 -1.115 . . . . 1.0 109.529 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 167.7 24.49 Favored 'Trans proline' 0 N--CA 1.506 2.219 0 C-N-CA 121.191 1.26 . . . . 1.0 111.844 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.95 137.73 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.323 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.23 13.84 73.64 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.93 -167.27 22.36 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.5 p -143.15 -174.32 4.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.297 0.57 . . . . 1.0 110.616 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.73 149.52 21.37 Favored Glycine 0 N--CA 1.477 1.382 0 N-CA-C 110.929 -0.869 . . . . 1.0 110.929 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.7 mt -138.68 124.61 19.95 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.278 1.037 . . . . 1.0 110.025 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.91 160.6 15.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.421 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -126.18 122.34 35.37 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.843 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.13 135.4 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 122.004 0.907 . . . . 1.0 109.043 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -99.77 139.09 35.93 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -143.01 143.37 31.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.143 0.973 . . . . 1.0 109.932 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -113.43 127.28 56.06 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.181 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 118.18 13.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.661 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 121.21 0.529 . . . . 1.0 109.916 -179.733 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.705 0 N-CA-C 110.621 -0.991 . . . . 1.0 110.621 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.55 63.14 13.82 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.66 166.54 19.69 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.888 1.726 . . . . 1.0 111.245 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.5 158.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 114.898 -1.047 . . . . 1.0 110.144 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -152.95 146.54 25.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.872 0.844 . . . . 1.0 109.746 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.49 144.33 34.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.886 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.3 t -131.74 138.63 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.66 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.59 135.17 28.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 118.785 -0.626 . . . . 1.0 110.17 179.253 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.2 m120 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -159.61 46.53 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.71 104.43 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -110.27 132.04 54.53 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.03 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 t -164.36 144.09 7.67 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.331 0.586 . . . . 1.0 110.139 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -133.55 132.23 40.67 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.514 0.673 . . . . 1.0 110.136 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -80.68 137.72 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.68 142.92 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.771 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.26 143.68 49.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.137 0.97 . . . . 1.0 110.061 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.43 137.83 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.293 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 N--CA 1.469 0.518 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.753 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 CA--C 1.562 1.429 0 CA-C-O 119.478 -0.296 . . . . 1.0 110.875 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.84 -24.14 40.64 Favored 'Trans proline' 0 N--CA 1.515 2.75 0 C-N-CA 121.976 1.784 . . . . 1.0 111.957 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.4 mt -124.27 130.93 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.328 0.585 . . . . 1.0 110.2 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.2 m -134.87 123.46 23.52 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.856 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.47 147.64 28.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.369 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.9 p -81.06 34.41 0.35 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -70.79 50.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.974 0.51 . . . . 1.0 110.209 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -51.83 -30.33 23.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.658 0.742 . . . . 1.0 110.523 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.5 p -137.16 140.7 31.9 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.261 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.97 113.95 3.52 Favored 'Trans proline' 0 N--CA 1.514 2.728 0 CA-C-N 119.231 0.761 . . . . 1.0 111.392 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.92 101.45 0.55 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.86 0.362 . . . . 1.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 1.4 pm0 -53.9 148.8 9.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.948 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.14 -23.7 16.85 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -69.68 144.1 52.95 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.46 137.55 46.49 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.561 0.696 . . . . 1.0 109.508 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.14 146.55 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.915 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -97.7 114.51 26.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.7 119.7 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -129.09 132.99 47.48 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.265 0.555 . . . . 1.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.06 128.22 55.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.152 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -84.5 119.34 25.05 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 t -108.26 113.21 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.497 0.665 . . . . 1.0 109.215 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 m -86.27 131.92 34.11 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.557 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.006 0.431 . . . . 1.0 109.844 -179.841 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 121.495 0.664 . . . . 1.0 110.598 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -66.01 117.22 8.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.738 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.14 152.65 22.16 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 34' ' ' ASN . 44.1 t-80 -139.91 169.04 18.44 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.518 0.675 . . . . 1.0 110.04 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.418 ' N ' ' CG ' ' A' ' 33' ' ' HIS . 80.0 m-20 50.24 62.52 2.63 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.738 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 t -113.97 82.81 7.17 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -80.39 169.5 17.12 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.638 1.559 . . . . 1.0 111.322 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.13 136.61 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.547 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.38 114.91 18.83 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.275 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 t -104.44 137.48 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.526 0.679 . . . . 1.0 109.307 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -146.71 127.11 14.0 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.131 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tp -85.93 124.33 32.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 -158.75 15.68 Favored Glycine 0 N--CA 1.476 1.348 0 N-CA-C 110.762 -0.935 . . . . 1.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.5 142.68 28.56 Favored Pre-proline 0 N--CA 1.491 1.62 0 CA-C-O 117.788 -1.101 . . . . 1.0 111.528 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.8 -38.8 38.42 Favored 'Trans proline' 0 N--CA 1.519 2.992 0 CA-C-N 120.079 1.064 . . . . 1.0 113.108 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.51 22.89 0.23 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.981 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -166.71 -73.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.921 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.63 -97.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.1 90.86 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.1 115.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.24 133.07 45.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.67 -46.11 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.64 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.15 165.8 35.45 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -155.49 167.43 30.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.367 0.603 . . . . 1.0 110.629 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -161.25 119.82 2.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.404 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 m -75.11 131.4 40.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -80.81 155.51 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.4 p -65.42 -51.96 56.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.602 0.715 . . . . 1.0 110.072 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -177.29 145.47 0.45 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.039 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.5 mt -114.56 117.29 42.85 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 117.571 -1.205 . . . . 1.0 110.686 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.13 162.25 41.19 Favored 'Trans proline' 0 N--CA 1.519 2.971 0 CA-C-N 120.286 1.138 . . . . 1.0 112.157 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.17 137.31 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.557 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.55 77.48 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.82 -167.9 14.69 Favored Glycine 0 N--CA 1.472 1.068 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -132.92 176.23 8.66 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.896 0.855 . . . . 1.0 110.364 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.41 124.42 0.94 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 115.098 -0.955 . . . . 1.0 110.783 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.76 160.15 37.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.05 0.929 . . . . 1.0 110.127 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.67 161.91 13.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.246 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.854 -1.066 . . . . 1.0 109.895 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -140.03 156.32 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.28 1.038 . . . . 1.0 109.169 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -123.32 141.72 51.69 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.956 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -140.8 137.56 33.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.991 0.9 . . . . 1.0 109.691 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -100.31 123.84 45.04 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.557 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.44 138.39 49.02 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.47 0.57 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.436 179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 N-CA-C 111.047 -0.821 . . . . 1.0 111.047 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -119.14 64.71 7.21 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -60.6 141.46 95.28 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.755 1.637 . . . . 1.0 111.734 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.7 t -98.49 147.02 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 115.349 -0.841 . . . . 1.0 109.862 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -135.38 138.88 43.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.037 0.923 . . . . 1.0 109.821 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.92 135.03 22.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.033 -0.985 . . . . 1.0 109.632 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 t -139.67 144.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.996 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.4 145.79 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.538 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 118.437 -0.792 . . . . 1.0 110.143 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 m120 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 110.23 -0.285 . . . . 1.0 110.23 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -167.32 44.38 0.05 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.873 0.368 . . . . 1.0 110.547 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.45 139.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.222 0.534 . . . . 1.0 109.789 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -147.9 153.39 39.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.123 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -165.09 147.04 7.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.125 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -142.14 133.01 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.8 mp -81.28 123.35 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.63 136.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.376 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -131.95 125.19 30.99 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.317 0.58 . . . . 1.0 109.927 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.09 137.05 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.771 0.796 . . . . 1.0 110.039 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.481 1.088 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.952 -179.689 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 CA--C 1.563 1.447 0 CA-C-O 118.314 -0.851 . . . . 1.0 110.918 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.47 -32.16 61.58 Favored 'Trans proline' 0 N--CA 1.516 2.806 0 C-N-CA 121.099 1.2 . . . . 1.0 112.603 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.95 130.1 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.202 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -134.22 121.76 21.81 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.475 0.655 . . . . 1.0 109.921 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.04 147.29 27.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.445 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -94.03 78.03 4.09 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.603 0.716 . . . . 1.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.44 58.89 0.69 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.444 1.098 . . . . 1.0 110.693 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.67 -33.72 56.26 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.743 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -126.93 132.74 24.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.903 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -81.13 105.78 1.68 Allowed 'Trans proline' 0 N--CA 1.511 2.518 0 CA-C-N 119.914 1.005 . . . . 1.0 111.438 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -169.42 117.32 0.62 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.206 0.527 . . . . 1.0 110.454 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.76 150.81 9.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.065 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.3 34.56 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -72.82 126.33 29.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.217 0.532 . . . . 1.0 109.815 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -65.03 131.54 46.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.662 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.8 pt -119.69 147.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.271 0.558 . . . . 1.0 109.741 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.9 m -94.5 121.14 35.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.701 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.4 t -100.27 121.59 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -123.99 134.5 53.45 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.603 0.716 . . . . 1.0 109.808 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.09 120.67 33.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.08 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.81 123.25 30.96 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.997 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -107.62 129.26 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.216 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 m -90.94 123.75 34.68 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.305 0.574 . . . . 1.0 110.856 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 19.1 mp0 -67.04 125.78 27.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.909 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.74 160.35 18.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 1.0 110.432 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -161.09 94.22 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 122.572 1.177 . . . . 1.0 109.33 178.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER 157.4 58.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.414 -1.266 . . . . 1.0 110.394 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.63 86.01 12.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.09 100.85 0.96 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.016 1.144 . . . . 1.0 111.269 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.97 143.02 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.759 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.15 120.21 26.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.935 0.494 . . . . 1.0 109.82 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.9 t -112.01 143.14 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.324 0.583 . . . . 1.0 109.582 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -151.98 126.01 9.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.102 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.55 128.54 34.95 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.643 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.61 -160.38 15.99 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -117.45 142.35 30.22 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.144 -0.932 . . . . 1.0 111.457 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.64 -40.95 46.48 Favored 'Trans proline' 0 N--CA 1.522 3.171 0 CA-C-N 119.688 0.924 . . . . 1.0 113.323 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.41 93.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.968 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -59.21 4.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.122 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.67 83.16 0.04 OUTLIER Glycine 0 N--CA 1.476 1.361 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.6 130.7 40.44 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.92 126.0 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.224 0.535 . . . . 1.0 109.786 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -68.48 122.14 17.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.824 -0.626 . . . . 1.0 109.926 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.16 -44.91 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.213 0.53 . . . . 1.0 109.94 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.56 168.53 37.98 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -158.16 169.99 23.27 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.618 0.723 . . . . 1.0 110.334 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -163.45 114.66 1.41 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.005 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -75.22 140.51 43.3 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.9 mm -78.63 142.09 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -66.62 -50.13 64.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.229 0.538 . . . . 1.0 110.579 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -147.3 130.33 16.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.759 0.79 . . . . 1.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 mt -117.71 108.47 42.88 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.982 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.95 159.88 44.08 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 CA-C-N 119.934 1.012 . . . . 1.0 111.667 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -70.57 145.52 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.499 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.26 1.86 29.95 Favored Glycine 0 N--CA 1.461 0.321 0 N-CA-C 110.385 -1.086 . . . . 1.0 110.385 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.95 -165.35 26.92 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -139.74 -173.42 3.62 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.388 0.613 . . . . 1.0 110.648 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.01 151.18 22.65 Favored Glycine 0 N--CA 1.477 1.408 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mt -132.54 152.59 51.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.291 1.043 . . . . 1.0 109.641 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.04 154.74 45.19 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.706 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -117.9 120.4 37.75 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.35 128.76 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.632 0.73 . . . . 1.0 109.269 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -99.29 140.04 34.05 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.848 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -137.98 121.88 17.71 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.981 0.896 . . . . 1.0 109.981 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -92.37 127.04 37.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.107 -0.951 . . . . 1.0 109.788 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.88 138.52 50.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.487 -0.485 . . . . 1.0 109.749 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.714 -179.373 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.823 0 N-CA-C 110.594 -1.003 . . . . 1.0 110.594 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.79 62.79 27.0 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.25 149.62 89.89 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.731 1.621 . . . . 1.0 111.309 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.6 t -103.75 114.33 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.72 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.61 147.32 30.79 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.852 0.834 . . . . 1.0 109.474 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.99 142.69 27.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.041 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.1 138.87 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.082 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -84.65 135.91 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.558 1.284 0 CA-C-O 117.759 -1.115 . . . . 1.0 111.558 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.824 -0.435 . . . . 1.0 109.824 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -155.06 26.39 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.418 0.287 . . . . 1.0 110.556 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.83 136.73 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -141.63 138.66 32.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.0 m -165.62 140.04 4.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.086 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -134.84 150.31 50.47 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.083 0.468 . . . . 1.0 110.444 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -88.76 133.05 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.53 138.61 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.84 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.33 155.99 48.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.779 0.799 . . . . 1.0 109.535 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.55 133.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 mt . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.789 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.326 -0.99 . . . . 1.0 108.326 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.6 t0 52.91 84.3 0.06 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.332 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.81 156.58 72.13 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 118.529 -0.748 . . . . 1.0 110.911 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -53.5 -28.64 45.88 Favored 'Trans proline' 0 N--CA 1.517 2.855 0 C-N-CA 121.592 1.528 . . . . 1.0 112.361 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.15 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.762 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 65.5 p -131.93 120.22 22.2 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.49 -0.777 . . . . 1.0 109.955 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 9' ' ' LYS . 60.4 mt -102.66 145.48 29.61 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.225 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.8 t -78.88 31.17 0.2 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.6 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 7' ' ' LEU . 80.8 tttt -72.98 49.35 0.24 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.584 0.707 . . . . 1.0 110.16 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -61.08 -40.49 93.89 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 p -117.17 89.86 31.94 Favored Pre-proline 0 N--CA 1.485 1.278 0 CA-C-N 115.321 -0.854 . . . . 1.0 110.708 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -46.47 111.13 0.33 Allowed 'Trans proline' 0 N--CA 1.523 3.221 0 C-N-CA 121.052 1.168 . . . . 1.0 113.256 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -162.48 109.37 1.27 Allowed 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.265 0.555 . . . . 1.0 110.432 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -55.68 142.68 33.22 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.782 -0.645 . . . . 1.0 110.112 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.1 18.23 63.37 Favored Glycine 0 N--CA 1.478 1.473 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -107.28 143.62 35.27 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.663 0.385 . . . . 1.0 110.233 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.17 130.95 40.07 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.15 144.68 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.909 -0.587 . . . . 1.0 109.987 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -89.3 112.96 24.16 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.6 t -96.22 115.51 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 83.1 p -129.53 134.83 47.97 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.371 0.605 . . . . 1.0 110.236 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -118.0 127.18 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.582 -0.735 . . . . 1.0 109.831 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -84.03 116.26 22.75 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.2 t -97.81 126.51 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.135 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -96.18 126.91 41.73 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 120.677 0.275 . . . . 1.0 110.284 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -82.81 108.06 15.89 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 1.0 109.749 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -98.33 -168.17 1.61 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.238 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.27 -122.79 6.87 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.774 -0.93 . . . . 1.0 110.774 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -167.39 12.06 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.553 0.216 . . . . 1.0 110.802 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.41 156.06 44.04 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.25 0.548 . . . . 1.0 110.613 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -58.05 119.33 6.6 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.363 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.08 149.74 21.69 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.888 0.375 . . . . 1.0 110.175 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -137.13 162.75 32.53 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 122.435 1.112 . . . . 1.0 109.797 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 53.83 67.57 0.99 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.604 -1.18 . . . . 1.0 110.405 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.43 82.58 24.88 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.579 -0.737 . . . . 1.0 109.273 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -80.17 175.27 10.49 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 120.75 0.966 . . . . 1.0 111.16 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 42.8 t -134.51 138.69 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 115.252 -0.886 . . . . 1.0 109.677 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -127.26 114.25 17.37 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.379 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.0 t -107.59 140.56 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.519 0.676 . . . . 1.0 109.233 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -145.56 130.24 18.02 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.407 -0.815 . . . . 1.0 110.048 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tp -84.31 125.59 32.41 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.781 -0.645 . . . . 1.0 109.99 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -159.65 17.06 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -108.59 143.32 27.26 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.736 -0.649 . . . . 1.0 111.467 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.12 -21.19 27.63 Favored 'Trans proline' 0 N--CA 1.516 2.812 0 C-N-CA 120.5 0.8 . . . . 1.0 111.789 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.3 -45.88 89.33 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.934 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -72.38 -69.59 0.39 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.136 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.02 77.42 0.03 OUTLIER Glycine 0 N--CA 1.472 1.046 0 N-CA-C 111.035 -0.826 . . . . 1.0 111.035 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.32 165.84 21.6 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.052 -0.819 . . . . 1.0 111.052 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.54 141.8 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.089 0.471 . . . . 1.0 110.516 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -73.83 134.17 43.29 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.757 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.3 mt -98.51 -42.13 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -179.7 168.75 39.37 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.675 -0.97 . . . . 1.0 110.675 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -153.96 166.19 33.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.506 0.67 . . . . 1.0 110.374 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -154.65 114.89 3.85 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.478 -0.783 . . . . 1.0 110.047 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -76.0 132.71 40.34 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.6 mt -86.46 148.54 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.5 t -62.24 -49.85 74.06 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.36 0.6 . . . . 1.0 110.465 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -176.25 146.77 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.293 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -118.31 124.16 28.8 Favored Pre-proline 0 N--CA 1.499 2.009 0 CA-C-O 117.924 -1.036 . . . . 1.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.04 163.15 39.07 Favored 'Trans proline' 0 N--CA 1.519 2.999 0 CA-C-N 119.844 0.98 . . . . 1.0 111.984 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.4 t -71.61 142.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.717 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.18 6.33 56.83 Favored Glycine 0 N--CA 1.465 0.627 0 N-CA-C 110.544 -1.023 . . . . 1.0 110.544 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.9 -166.74 21.54 Favored Glycine 0 N--CA 1.473 1.13 0 N-CA-C 110.481 -1.048 . . . . 1.0 110.481 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 p -146.2 152.42 39.19 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.274 0.559 . . . . 1.0 110.14 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.55 157.75 19.84 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 tt -142.39 113.72 7.75 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.501 0.667 . . . . 1.0 110.162 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.98 159.47 15.18 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.513 -0.767 . . . . 1.0 110.002 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -126.38 122.22 34.74 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.79 -0.641 . . . . 1.0 109.868 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.71 146.37 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 121.9 0.857 . . . . 1.0 109.55 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -119.84 142.29 48.77 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.216 -0.902 . . . . 1.0 110.033 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.4 t90 -144.5 145.2 31.73 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.012 0.911 . . . . 1.0 109.712 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -91.19 121.19 32.75 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.942 -1.026 . . . . 1.0 109.676 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.38 132.64 42.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t -170.82 119.64 0.53 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.951 0.405 . . . . 1.0 110.181 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -168.58 12.57 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.063 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -62.88 154.67 29.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.125 0.488 . . . . 1.0 110.461 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.39 13.21 1.22 Allowed 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.261 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 53.07 46.71 26.14 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.535 0.683 . . . . 1.0 110.675 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.52 145.1 5.91 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 111.068 -0.813 . . . . 1.0 111.068 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 55.33 67.55 1.0 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.652 0.263 . . . . 1.0 110.824 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.54 -17.39 32.14 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.332 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.03 37.16 0.24 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.917 0.389 . . . . 1.0 110.658 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -167.58 130.25 1.34 Allowed Pre-proline 0 CA--C 1.56 1.359 0 CA-C-O 118.087 -0.958 . . . . 1.0 111.418 179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 73.1 Cg_endo -71.26 -83.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.512 2.592 0 CA-C-N 119.831 0.975 . . . . 1.0 112.097 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.422 ' H ' ' HG2' ' A' ' 84' ' ' PRO . . . 83.72 11.96 78.56 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 110.608 -0.997 . . . . 1.0 110.608 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 86' ' ' VAL . 3.9 p -118.42 64.98 5.93 Favored Pre-proline 0 N--CA 1.48 1.047 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -68.81 175.45 7.27 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.983 1.789 . . . . 1.0 111.357 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.43 135.73 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.868 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -135.22 146.78 48.98 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.862 0.839 . . . . 1.0 109.721 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.72 143.02 28.42 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.929 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.8 t -135.42 140.13 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.652 0.739 . . . . 1.0 109.728 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.06 140.63 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 115.343 -0.844 . . . . 1.0 109.255 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -40.69 146.66 0.44 Allowed Pre-proline 0 CA--C 1.561 1.387 0 CA-C-O 118.143 -0.932 . . . . 1.0 111.767 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.81 109.59 2.55 Favored 'Trans proline' 0 N--CA 1.509 2.387 0 C-N-CA 120.8 1.0 . . . . 1.0 112.231 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -85.24 8.74 17.32 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.979 -0.378 . . . . 1.0 109.979 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -149.84 49.54 0.93 Allowed 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.954 0.407 . . . . 1.0 110.61 -179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 52.82 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.127 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.6 t -131.82 125.19 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 CA-C-O 121.79 0.805 . . . . 1.0 109.87 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -170.87 100.29 0.22 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.301 -0.863 . . . . 1.0 110.073 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -70.31 -60.81 2.06 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.069 -0.514 . . . . 1.0 109.852 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.5 t -44.66 -47.37 10.54 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.505 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.85 -72.42 0.12 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 120.993 -0.283 . . . . 1.0 110.406 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 105' ' ' ASN . 22.9 mtpp -42.75 -45.53 4.81 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 120.962 0.41 . . . . 1.0 111.222 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.03 -6.7 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.511 0.672 . . . . 1.0 111.745 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 103' ' ' LYS . 6.6 m120 -84.4 -38.22 20.52 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.935 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -95.28 46.6 1.11 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.364 0.666 . . . . 1.0 110.234 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 13.1 p -105.68 139.01 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.843 -0.617 . . . . 1.0 109.428 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 55.3 m-85 -145.33 143.24 30.04 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.023 -0.535 . . . . 1.0 110.146 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.4 p -170.54 143.36 2.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.875 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -143.74 147.28 33.97 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.187 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.569 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.6 mp -92.48 144.59 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.6 m -137.57 140.12 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.927 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.38 143.94 38.26 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.873 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.1 m -109.58 135.79 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 115.895 -0.593 . . . . 1.0 109.826 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.52 133.03 35.19 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.676 0.751 . . . . 1.0 109.063 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -130.17 101.73 5.92 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.342 -0.844 . . . . 1.0 109.671 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.417 ' ND1' ' N ' ' A' ' 117' ' ' HIS . 3.2 p-80 -165.63 171.66 12.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.226 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -149.53 152.32 35.35 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.182 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -69.07 123.1 20.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.622 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.441 ' O ' ' N ' ' A' ' 122' ' ' HIS . 64.0 m80 -79.53 -157.8 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 1.0 109.926 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 55.49 -82.89 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.992 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 2.5 p-80 . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 118.045 -0.979 . . . . 1.0 110.199 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -81.44 76.18 8.38 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.235 0.54 . . . . 1.0 109.874 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.32 151.72 81.13 Favored Pre-proline 0 CA--C 1.557 1.224 0 CA-C-N 115.748 -0.66 . . . . 1.0 110.735 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.26 -23.51 38.74 Favored 'Trans proline' 0 N--CA 1.51 2.451 0 C-N-CA 121.551 1.501 . . . . 1.0 111.737 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 78.0 mt -125.24 132.16 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.334 0.588 . . . . 1.0 110.269 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.3 m -133.62 121.95 22.78 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.047 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 mp -101.07 147.61 26.02 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.477 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.9 p -85.82 34.55 0.6 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.297 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -71.77 54.92 0.26 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.936 0.398 . . . . 1.0 110.261 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -52.14 -32.6 36.31 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.311 0.577 . . . . 1.0 110.434 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.9 p -134.85 139.26 31.72 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.638 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -79.33 115.62 3.48 Favored 'Trans proline' 0 N--CA 1.515 2.771 0 C-N-CA 120.522 0.815 . . . . 1.0 111.779 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -167.13 102.93 0.53 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.805 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -52.58 146.41 10.08 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.018 0.437 . . . . 1.0 110.642 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.91 -23.6 22.6 Favored Glycine 0 N--CA 1.476 1.301 0 N-CA-C 111.049 -0.82 . . . . 1.0 111.049 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -67.66 141.09 56.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.887 0.375 . . . . 1.0 110.014 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.94 133.85 47.74 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.547 -0.538 . . . . 1.0 109.547 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.1 pt -119.65 144.86 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 115.897 -0.592 . . . . 1.0 109.976 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.7 m -96.25 110.46 22.76 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.559 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.4 t -93.82 117.71 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 109.314 -0.624 . . . . 1.0 109.314 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 t -128.38 137.73 52.02 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.266 0.555 . . . . 1.0 110.286 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.56 123.51 40.75 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.253 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -77.63 116.05 17.88 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -95.22 121.86 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.6 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.1 m -108.72 122.73 47.74 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 120.993 0.425 . . . . 1.0 110.078 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -89.47 127.55 35.86 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.859 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.7 mtp85 -129.52 130.58 45.97 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.536 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.56 -109.82 0.32 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.928 -0.869 . . . . 1.0 110.928 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 30' ' ' ALA . . . -167.68 3.65 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.466 0.174 . . . . 1.0 110.846 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 29' ' ' ALA . . . -146.39 163.26 36.18 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.34 0.59 . . . . 1.0 110.584 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -66.96 121.18 14.96 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.671 -0.695 . . . . 1.0 109.887 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.89 154.0 18.47 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.115 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -142.71 171.0 14.64 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.484 0.659 . . . . 1.0 110.131 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 51.13 63.68 2.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.54 -0.754 . . . . 1.0 110.613 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.3 t -112.56 84.25 6.22 Favored Pre-proline 0 N--CA 1.482 1.164 0 CA-C-N 115.45 -0.796 . . . . 1.0 109.953 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -79.21 158.77 26.52 Favored 'Trans proline' 0 N--CA 1.503 2.076 0 C-N-CA 121.365 1.377 . . . . 1.0 111.518 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.51 135.99 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.358 -0.837 . . . . 1.0 109.842 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.05 115.09 17.94 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.47 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.2 m -107.83 140.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.796 0.807 . . . . 1.0 109.489 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -145.67 130.28 17.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.205 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 tp -84.65 125.94 32.93 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.692 -0.685 . . . . 1.0 110.01 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.96 -162.33 18.04 Favored Glycine 0 N--CA 1.479 1.502 0 N-CA-C 111.027 -0.829 . . . . 1.0 111.027 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -93.66 146.68 32.22 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 119.1 -0.476 . . . . 1.0 111.039 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.12 -12.18 29.95 Favored 'Trans proline' 0 N--CA 1.511 2.55 0 C-N-CA 120.679 0.919 . . . . 1.0 111.606 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.88 -44.29 86.59 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.02 0.438 . . . . 1.0 110.699 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -81.64 7.37 12.49 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.991 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.09 -9.35 47.2 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 110.854 -0.898 . . . . 1.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.31 177.77 0.21 Allowed Glycine 0 CA--C 1.534 1.28 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.74 135.92 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.921 0.391 . . . . 1.0 110.345 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.17 132.23 44.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.871 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.27 -42.67 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.641 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -169.48 155.72 26.11 Favored Glycine 0 N--CA 1.465 0.598 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -148.18 161.58 41.17 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.472 0.653 . . . . 1.0 110.48 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -160.99 114.11 1.97 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.571 -0.741 . . . . 1.0 110.111 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.9 m -82.62 140.55 33.12 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.6 mm -81.14 147.73 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.657 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 t -64.49 -46.28 83.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 1.0 110.54 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -166.5 137.07 3.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.657 -0.702 . . . . 1.0 110.596 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.1 mt -118.92 118.83 32.78 Favored Pre-proline 0 N--CA 1.494 1.739 0 CA-C-O 117.98 -1.009 . . . . 1.0 110.847 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.69 162.73 37.21 Favored 'Trans proline' 0 N--CA 1.511 2.531 0 CA-C-N 119.78 0.957 . . . . 1.0 111.693 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.11 137.71 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.409 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.41 16.44 77.36 Favored Glycine 0 CA--C 1.511 -0.204 0 N-CA-C 110.144 -1.182 . . . . 1.0 110.144 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.79 -169.08 17.52 Favored Glycine 0 N--CA 1.475 1.283 0 N-CA-C 110.315 -1.114 . . . . 1.0 110.315 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.0 p -140.17 -170.57 3.0 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.498 0.666 . . . . 1.0 110.634 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.63 147.2 18.72 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 110.448 -1.061 . . . . 1.0 110.448 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.6 114.66 19.66 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.426 0.631 . . . . 1.0 109.81 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.67 154.01 22.09 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.593 -0.73 . . . . 1.0 109.52 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -126.18 121.66 33.42 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.597 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -135.81 131.59 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.549 0.69 . . . . 1.0 109.49 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -110.73 138.66 46.84 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 115.423 -0.808 . . . . 1.0 109.93 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -138.73 133.71 32.58 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.912 0.863 . . . . 1.0 109.983 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -88.38 121.01 30.29 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 1.0 109.73 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.27 122.94 20.48 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -168.82 -167.36 0.75 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.1 0.476 . . . . 1.0 110.429 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 57.74 50.27 10.97 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.319 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -168.27 88.92 0.25 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.143 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -67.53 -32.34 73.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.401 0.62 . . . . 1.0 110.121 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 54.66 73.8 0.38 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.567 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.52 84.84 0.05 OUTLIER Glycine 0 CA--C 1.521 0.428 0 N-CA-C 110.722 -0.951 . . . . 1.0 110.722 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 51.53 88.37 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.812 0.339 . . . . 1.0 110.726 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.77 102.65 0.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.12 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.05 -169.96 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.871 -0.418 . . . . 1.0 109.871 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 39.1 71.07 1.2 Allowed Pre-proline 0 N--CA 1.486 1.348 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.255 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -50.14 -45.18 34.54 Favored 'Trans proline' 0 N--CA 1.511 2.536 0 C-N-CA 121.978 1.785 . . . . 1.0 112.834 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.65 80.38 0.14 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.8 t -117.05 82.29 13.53 Favored Pre-proline 0 N--CA 1.482 1.167 0 CA-C-O 118.474 -0.774 . . . . 1.0 109.234 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.82 160.81 33.93 Favored 'Trans proline' 0 N--CA 1.501 1.912 0 C-N-CA 121.848 1.698 . . . . 1.0 111.236 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -123.36 158.53 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.063 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.55 149.47 35.9 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.804 0.811 . . . . 1.0 110.075 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -149.05 136.39 20.14 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.272 -0.876 . . . . 1.0 109.948 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -138.06 144.15 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-O 121.702 0.763 . . . . 1.0 109.683 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.0 m -94.94 139.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.819 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -120.37 81.6 30.68 Favored Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 118.59 -0.719 . . . . 1.0 109.696 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -80.15 162.44 23.03 Favored 'Trans proline' 0 N--CA 1.503 2.063 0 C-N-CA 121.765 1.643 . . . . 1.0 111.346 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.39 21.08 0.5 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.284 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -144.07 40.89 1.38 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.593 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -55.9 96.48 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.461 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.2 -55.58 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.208 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.29 -176.33 2.5 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.465 0.65 . . . . 1.0 110.387 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -68.17 -64.17 0.91 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.509 -0.769 . . . . 1.0 110.086 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.9 t -47.38 -44.54 24.33 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.994 -0.548 . . . . 1.0 111.228 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.21 -70.39 0.2 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.315 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.541 ' C ' ' H ' ' A' ' 105' ' ' ASN . 36.7 ttpt -44.77 -40.71 6.29 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.273 0.559 . . . . 1.0 111.054 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.7 3.33 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.342 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.556 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.541 ' H ' ' C ' ' A' ' 103' ' ' LYS . 67.4 m-20 -94.9 32.6 1.63 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.888 -0.596 . . . . 1.0 109.615 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -161.46 42.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.178 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -111.9 146.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-O 121.156 0.503 . . . . 1.0 109.65 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -147.76 154.19 40.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.188 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.7 t -160.55 145.92 14.71 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.703 -0.68 . . . . 1.0 110.174 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -135.88 130.71 34.27 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.272 0.558 . . . . 1.0 110.228 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -80.95 128.42 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.718 -0.845 . . . . 1.0 108.718 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 37.6 t -132.21 138.83 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.742 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -130.63 110.22 11.23 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.006 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.5 p -89.83 137.22 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.732 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.95 133.89 35.09 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.309 0.576 . . . . 1.0 109.486 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -65.7 -35.66 81.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.955 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -150.67 155.85 40.16 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.34 0.59 . . . . 1.0 110.577 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -167.52 -13.6 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.676 -0.693 . . . . 1.0 110.392 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -80.73 24.85 0.46 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.241 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -62.08 -47.27 85.4 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.412 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -75.17 71.52 2.21 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.072 0.463 . . . . 1.0 110.105 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 117.957 -1.02 . . . . 1.0 110.273 -179.93 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtp . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -67.23 104.19 1.41 Allowed 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 109.658 -0.497 . . . . 1.0 109.658 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.1 mt -64.87 151.4 93.06 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 118.359 -0.829 . . . . 1.0 111.005 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -49.74 -21.51 5.79 Favored 'Trans proline' 0 N--CA 1.512 2.587 0 C-N-CA 121.831 1.687 . . . . 1.0 112.562 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.3 mt -121.51 132.74 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-N 115.536 -0.756 . . . . 1.0 110.077 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.7 p -134.51 122.3 22.23 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.266 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mp -106.86 147.14 30.11 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.418 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.0 t -81.81 36.39 0.44 Allowed 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.404 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -71.43 50.72 0.17 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.047 0.451 . . . . 1.0 110.714 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -56.19 -39.27 72.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.588 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.2 p -124.41 84.33 56.68 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 118.875 -0.583 . . . . 1.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -47.13 112.91 0.58 Allowed 'Trans proline' 0 N--CA 1.51 2.452 0 C-N-CA 121.9 1.734 . . . . 1.0 112.56 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -167.08 123.96 1.2 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.961 0.41 . . . . 1.0 110.592 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -58.68 147.19 33.73 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 1.0 110.448 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.58 -31.64 4.48 Favored Glycine 0 N--CA 1.474 1.212 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.79 133.6 50.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.863 0.363 . . . . 1.0 110.052 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 69.3 tt0 -68.19 136.54 53.77 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.792 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.7 pt -126.0 146.67 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.454 0.645 . . . . 1.0 110.426 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.0 m -92.79 112.26 24.16 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.616 -0.72 . . . . 1.0 109.704 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.09 117.75 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.74 -0.664 . . . . 1.0 109.848 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.2 m -129.42 136.79 50.38 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.349 0.595 . . . . 1.0 110.29 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.08 125.96 46.17 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.02 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 81.8 mtp180 -81.19 113.72 19.52 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.8 m -95.66 124.66 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.867 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.8 m -101.25 122.04 42.94 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.118 0.485 . . . . 1.0 110.015 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -91.77 122.56 34.43 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.559 0.695 . . . . 1.0 109.76 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.607 ' NH2' HD21 ' A' ' 106' ' ' ASN . 87.1 mtm180 -111.02 126.06 54.4 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.261 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 173.41 -137.37 4.07 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.16 10.98 0.21 Allowed 'General case' 0 N--CA 1.47 0.552 0 O-C-N 122.983 -0.128 . . . . 1.0 110.668 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.22 158.47 43.88 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.49 0.662 . . . . 1.0 110.52 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -61.1 117.14 5.16 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.451 -0.795 . . . . 1.0 110.175 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.86 151.43 22.85 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.049 0.452 . . . . 1.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -137.96 159.79 41.07 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 122.114 0.959 . . . . 1.0 109.817 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 53.46 65.79 1.41 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.797 -1.092 . . . . 1.0 110.474 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.4 t -113.32 83.34 6.53 Favored Pre-proline 0 N--CA 1.481 1.103 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -76.91 176.37 10.21 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 120.909 1.072 . . . . 1.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -150.34 145.75 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.025 -0.988 . . . . 1.0 109.986 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.97 132.57 43.61 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.974 -0.557 . . . . 1.0 109.507 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.07 144.93 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.43 0.633 . . . . 1.0 109.335 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.19 150.14 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.503 -0.772 . . . . 1.0 110.262 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.0 tp -99.47 127.21 45.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.046 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.96 -154.75 16.45 Favored Glycine 0 N--CA 1.481 1.653 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -116.35 143.86 31.93 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 119.112 -0.471 . . . . 1.0 111.257 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.58 -10.85 23.99 Favored 'Trans proline' 0 N--CA 1.511 2.508 0 C-N-CA 120.725 0.95 . . . . 1.0 111.58 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.17 86.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.828 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -80.69 -76.13 0.24 Allowed 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.134 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.86 78.2 0.05 OUTLIER Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.855 -0.898 . . . . 1.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.39 168.26 26.43 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 p -132.77 139.34 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 120.952 0.406 . . . . 1.0 110.487 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -74.71 136.97 41.8 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.096 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 79.5 mt -95.02 -41.74 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 179.72 171.08 42.28 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.2 ptp85 -150.32 162.63 40.15 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.761 0.791 . . . . 1.0 110.253 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -152.46 113.93 4.29 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.195 -0.912 . . . . 1.0 110.147 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 m -78.08 132.9 37.93 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.717 -0.475 . . . . 1.0 109.717 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 84.8 mt -89.57 150.77 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -63.33 -51.34 66.39 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.396 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -169.79 141.79 2.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.505 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.1 mt -113.97 124.03 31.72 Favored Pre-proline 0 N--CA 1.495 1.819 0 CA-C-O 117.978 -1.011 . . . . 1.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.16 160.17 45.9 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 120.87 1.047 . . . . 1.0 111.705 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.0 m -70.09 143.27 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.19 10.65 66.06 Favored Glycine 0 N--CA 1.468 0.78 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.83 -167.75 16.37 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.0 p -145.64 150.44 36.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.439 -0.38 . . . . 1.0 110.148 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.4 148.93 19.23 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 109.907 -1.277 . . . . 1.0 109.907 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.46 109.79 16.65 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.602 0.715 . . . . 1.0 109.75 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 154.35 18.83 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.351 -0.841 . . . . 1.0 109.893 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -132.45 123.03 25.87 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.282 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.8 t -137.08 135.11 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.457 -0.792 . . . . 1.0 109.506 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -103.41 138.8 39.65 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.731 -0.668 . . . . 1.0 110.031 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -139.77 132.46 28.94 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.627 0.727 . . . . 1.0 110.248 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -86.41 124.62 32.95 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.784 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.63 100.61 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.3 t -105.55 178.43 4.56 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.196 0.522 . . . . 1.0 110.26 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -156.23 170.0 23.25 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.519 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -151.12 141.29 22.23 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.667 -0.697 . . . . 1.0 110.324 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.87 107.57 9.29 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.278 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -169.17 104.21 0.38 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.44 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.25 106.87 0.01 OUTLIER Glycine 0 CA--C 1.528 0.856 0 N-CA-C 110.573 -1.011 . . . . 1.0 110.573 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -64.31 140.75 58.9 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.809 -0.441 . . . . 1.0 109.809 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -157.12 153.72 28.24 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.38 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.55 -76.7 0.08 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.086 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -77.1 144.47 71.74 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.542 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.69 -37.6 2.18 Favored 'Trans proline' 0 N--CA 1.511 2.552 0 C-N-CA 120.635 0.89 . . . . 1.0 111.661 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.07 79.29 0.14 Allowed Glycine 0 N--CA 1.47 0.965 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -119.14 65.03 7.38 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 118.818 -0.61 . . . . 1.0 109.524 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -62.96 147.85 94.12 Favored 'Trans proline' 0 N--CA 1.502 1.98 0 C-N-CA 122.228 1.952 . . . . 1.0 111.431 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.46 141.63 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 121.901 0.857 . . . . 1.0 109.807 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.68 151.83 51.86 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-O 122.317 1.055 . . . . 1.0 109.882 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.13 139.93 26.32 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.669 -1.15 . . . . 1.0 109.919 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.7 t -133.04 141.95 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 121.82 0.819 . . . . 1.0 110.034 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 m -100.11 136.61 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.697 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -46.85 143.49 4.31 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-O 118.182 -0.913 . . . . 1.0 111.729 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -73.62 140.87 30.2 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.612 1.542 . . . . 1.0 111.547 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -74.01 -42.41 60.39 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.355 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -171.2 76.31 0.06 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.312 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 50.59 60.93 3.5 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.144 0.497 . . . . 1.0 111.033 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 8.7 p -66.87 146.33 13.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.139 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.32 158.48 34.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 1.0 109.87 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -66.28 -65.0 0.73 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.045 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.1 p -43.28 -37.54 2.23 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.092 -0.503 . . . . 1.0 111.126 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -72.64 -56.51 5.2 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.777 -0.453 . . . . 1.0 109.777 178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.548 ' C ' ' H ' ' A' ' 105' ' ' ASN . 88.3 tttt -44.07 -38.39 3.58 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 121.298 0.57 . . . . 1.0 110.995 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.52 2.56 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.765 -0.652 . . . . 1.0 111.528 178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.548 ' H ' ' C ' ' A' ' 103' ' ' LYS . 86.7 m-20 -91.88 -34.62 14.45 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.002 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.607 HD21 ' NH2' ' A' ' 27' ' ' ARG . 80.8 m-20 -95.01 35.26 1.28 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.12 0.568 . . . . 1.0 110.36 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.21 137.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -146.23 147.99 32.02 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.273 0.558 . . . . 1.0 110.126 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 92.9 p -164.26 149.66 10.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.701 -0.681 . . . . 1.0 109.839 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -134.32 126.31 29.44 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.772 -0.649 . . . . 1.0 109.883 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.0 mm -85.1 101.6 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 m -86.87 144.25 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 109.739 -0.467 . . . . 1.0 109.739 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 ttmm -119.58 132.62 55.77 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.618 0.723 . . . . 1.0 110.034 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.27 135.83 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.495 -0.775 . . . . 1.0 110.175 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 mp -83.99 130.34 34.89 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.606 -0.724 . . . . 1.0 109.287 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -62.73 143.39 57.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.221 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -70.78 106.05 3.43 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.697 -0.482 . . . . 1.0 109.697 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -65.58 133.23 50.75 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -167.17 -42.5 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 53.7 98.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.692 -0.231 . . . . 1.0 110.648 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -56.93 116.45 3.2 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.672 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.406 ' H ' ' CD2' ' A' ' 122' ' ' HIS . 13.9 p80 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.643 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' O ' ' NH1' ' A' ' 23' ' ' ARG . 66.1 mtt . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 55.43 177.03 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.772 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.9 mp -73.81 153.34 89.18 Favored Pre-proline 0 CA--C 1.566 1.572 0 CA-C-O 118.402 -0.809 . . . . 1.0 111.069 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.14 -27.98 23.99 Favored 'Trans proline' 0 N--CA 1.519 2.984 0 C-N-CA 121.092 1.195 . . . . 1.0 112.775 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 79.2 mt -109.99 134.48 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.195 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.7 p -143.7 137.8 28.43 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.341 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.17 157.32 47.21 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.276 0.56 . . . . 1.0 110.396 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 m -84.02 113.42 21.0 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.813 -0.63 . . . . 1.0 109.702 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -145.9 52.1 1.16 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.032 0.444 . . . . 1.0 110.72 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -57.61 -43.18 84.54 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.463 0.649 . . . . 1.0 110.487 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 60.0 p -124.01 84.38 54.98 Favored Pre-proline 0 N--CA 1.485 1.323 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.169 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -48.43 122.06 7.2 Favored 'Trans proline' 0 N--CA 1.515 2.74 0 C-N-CA 121.348 1.365 . . . . 1.0 112.705 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -167.88 123.01 1.0 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.667 -0.242 . . . . 1.0 110.675 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -56.19 145.16 27.17 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.611 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.21 -26.7 6.69 Favored Glycine 0 N--CA 1.481 1.656 0 N-CA-C 111.357 -0.697 . . . . 1.0 111.357 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -69.63 140.4 53.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -73.73 137.28 43.9 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -132.31 147.94 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 115.806 -0.633 . . . . 1.0 110.161 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 35.7 m -94.64 141.4 28.65 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.725 -0.67 . . . . 1.0 109.418 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.0 126.89 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 p -137.0 128.53 28.5 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.496 0.665 . . . . 1.0 109.953 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.86 131.48 56.92 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.487 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.43 ' NH1' ' O ' ' A' ' 1' ' ' MET . 99.9 mtt180 -89.22 118.15 28.71 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.495 0.664 . . . . 1.0 109.498 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.32 132.97 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.784 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.431 HG21 ' HE ' ' A' ' 27' ' ' ARG . 90.2 m -100.66 127.81 46.93 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.124 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -88.92 121.05 30.89 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.636 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HE ' HG21 ' A' ' 25' ' ' THR . 23.4 mmt85 -113.83 132.46 55.87 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.193 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 168.51 -125.13 1.25 Allowed Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.712 -0.955 . . . . 1.0 110.712 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.67 5.83 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 120.787 0.327 . . . . 1.0 110.871 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.26 162.68 39.0 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.291 0.567 . . . . 1.0 110.422 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 24.7 mp0 -59.81 118.81 6.62 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.679 -0.691 . . . . 1.0 109.923 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.2 154.66 17.13 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.99 0.424 . . . . 1.0 110.082 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -144.94 175.1 10.46 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.752 0.787 . . . . 1.0 110.067 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 50.93 64.08 1.98 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.204 -0.907 . . . . 1.0 110.978 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.7 t -116.21 84.52 14.17 Favored Pre-proline 0 N--CA 1.489 1.486 0 CA-C-N 115.1 -0.955 . . . . 1.0 109.473 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -81.66 120.35 3.5 Favored 'Trans proline' 0 N--CA 1.5 1.889 0 C-N-CA 120.626 0.884 . . . . 1.0 111.579 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 t -87.35 141.33 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.647 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.24 115.65 17.95 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -108.61 144.15 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.62 0.724 . . . . 1.0 109.227 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -152.16 143.28 23.18 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.906 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tt -95.61 128.29 42.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.237 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.57 -158.36 17.23 Favored Glycine 0 N--CA 1.478 1.446 0 N-CA-C 110.784 -0.926 . . . . 1.0 110.784 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -103.32 144.23 28.21 Favored Pre-proline 0 N--CA 1.487 1.408 0 CA-C-O 118.404 -0.808 . . . . 1.0 111.461 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.54 -29.68 16.0 Favored 'Trans proline' 0 N--CA 1.516 2.824 0 C-N-CA 120.796 0.997 . . . . 1.0 111.808 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.55 -43.32 90.29 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -67.55 -70.46 0.25 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.238 0.542 . . . . 1.0 110.166 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.99 85.85 0.06 OUTLIER Glycine 0 N--CA 1.47 0.949 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.47 141.7 47.22 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -113.47 123.98 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-O 121.124 0.488 . . . . 1.0 109.821 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -67.36 125.08 24.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.643 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.36 -42.54 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 109.51 -0.552 . . . . 1.0 109.51 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.58 163.34 32.39 Favored Glycine 0 N--CA 1.462 0.417 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -150.35 163.98 36.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.508 0.67 . . . . 1.0 110.528 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -165.95 116.87 1.03 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.139 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.7 m -75.23 139.15 42.4 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.279 -0.637 . . . . 1.0 109.279 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.3 mm -78.55 148.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.698 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.5 m -63.84 -47.9 78.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.31 0.576 . . . . 1.0 110.418 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -168.51 136.26 2.1 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.674 -0.694 . . . . 1.0 110.385 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.9 mt -116.13 119.21 37.12 Favored Pre-proline 0 N--CA 1.499 2.0 0 CA-C-O 117.785 -1.102 . . . . 1.0 110.647 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.86 165.62 29.68 Favored 'Trans proline' 0 N--CA 1.518 2.966 0 CA-C-N 120.009 1.039 . . . . 1.0 111.993 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.73 139.89 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.003 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.49 19.83 73.11 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.529 -1.028 . . . . 1.0 110.529 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.83 -171.15 18.12 Favored Glycine 0 N--CA 1.477 1.433 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 29.8 p -143.68 149.81 37.77 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.806 0.336 . . . . 1.0 110.806 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.97 157.14 18.03 Favored Glycine 0 N--CA 1.469 0.868 0 N-CA-C 110.439 -1.064 . . . . 1.0 110.439 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.1 tp -150.46 139.33 20.89 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.932 0.872 . . . . 1.0 110.039 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -122.71 160.37 26.03 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.024 -0.989 . . . . 1.0 109.866 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -122.2 124.14 43.13 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.493 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.0 142.84 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 CA-C-O 121.761 0.791 . . . . 1.0 109.587 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -103.44 140.81 36.97 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 115.299 -0.864 . . . . 1.0 109.991 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 26.7 t90 -141.01 132.49 26.91 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.319 0.581 . . . . 1.0 109.931 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -88.04 124.54 33.85 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.695 -0.684 . . . . 1.0 109.388 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.06 130.22 42.28 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.8 t -158.67 173.87 15.92 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.373 0.606 . . . . 1.0 110.345 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -150.93 85.19 1.35 Allowed 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.985 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -67.36 131.98 46.78 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.916 -0.584 . . . . 1.0 109.854 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.0 tp 54.23 94.28 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 O-C-N 123.087 0.242 . . . . 1.0 110.635 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.1 -163.54 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.699 0.285 . . . . 1.0 110.417 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.13 -139.55 21.29 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 55.08 76.52 0.25 Allowed 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 117.177 0.489 . . . . 1.0 110.122 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 56.61 170.52 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.484 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.39 178.67 7.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.806 0.336 . . . . 1.0 110.18 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 60.53 145.53 0.06 OUTLIER Pre-proline 0 CA--C 1.564 1.49 0 CA-C-O 118.599 -0.715 . . . . 1.0 111.489 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -70.76 -55.0 0.16 Allowed 'Trans proline' 0 N--CA 1.516 2.832 0 CA-C-N 119.288 0.782 . . . . 1.0 111.997 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.38 78.34 0.15 Allowed Glycine 0 N--CA 1.47 0.951 0 N-CA-C 110.867 -0.893 . . . . 1.0 110.867 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -122.19 63.64 17.8 Favored Pre-proline 0 N--CA 1.482 1.14 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -64.22 -177.91 0.56 Allowed 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 121.676 1.584 . . . . 1.0 111.837 178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.89 158.38 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.399 -0.819 . . . . 1.0 110.331 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -153.11 148.0 26.46 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 122.026 0.917 . . . . 1.0 109.817 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -144.57 145.03 31.59 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.017 -0.992 . . . . 1.0 109.973 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -141.25 142.56 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 CA-C-O 121.419 0.628 . . . . 1.0 110.206 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.1 p -93.01 136.53 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.706 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -47.17 130.01 9.49 Favored Pre-proline 0 CA--C 1.555 1.135 0 CA-C-O 117.666 -1.159 . . . . 1.0 111.404 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.85 153.19 37.65 Favored 'Trans proline' 0 N--CA 1.503 2.078 0 CA-C-N 120.27 1.132 . . . . 1.0 112.03 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -93.57 18.85 9.3 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.673 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 60.5 t30 58.57 12.04 1.97 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.835 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -145.25 -10.96 0.55 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.87 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 99' ' ' ALA . 11.7 p -66.27 -27.4 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-O 120.893 0.378 . . . . 1.0 110.057 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 98' ' ' VAL . . . 74.46 161.47 0.24 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.847 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -81.01 -57.11 3.68 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.556 0.693 . . . . 1.0 110.518 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.1 p -40.82 -40.74 1.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.448 -0.797 . . . . 1.0 111.446 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -74.83 -50.41 17.21 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.966 0.413 . . . . 1.0 109.888 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.577 ' C ' ' H ' ' A' ' 105' ' ' ASN . 34.2 ttmt -45.04 -44.48 10.18 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.161 0.505 . . . . 1.0 110.636 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.69 -0.11 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.76 0 CA-C-O 121.486 0.66 . . . . 1.0 111.752 178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.577 ' H ' ' C ' ' A' ' 103' ' ' LYS . 57.0 t30 -89.53 -36.2 15.5 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.527 -0.76 . . . . 1.0 110.072 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.75 46.35 1.23 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.495 0.718 . . . . 1.0 110.999 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.62 136.08 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 115.517 -0.765 . . . . 1.0 109.336 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -143.99 145.47 32.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.462 -0.79 . . . . 1.0 109.832 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.8 t -165.42 147.82 7.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.576 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 ttt-85 -134.02 128.15 33.75 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.606 -0.725 . . . . 1.0 109.477 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 22.2 mm -81.09 132.61 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.515 -0.766 . . . . 1.0 109.27 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.6 p -149.18 142.91 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.989 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -134.73 149.45 50.46 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.502 0.668 . . . . 1.0 109.698 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.1 m -97.43 136.7 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.785 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -151.83 134.83 15.74 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.87 0.843 . . . . 1.0 110.042 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 118' ' ' HIS . 47.5 tp10 -167.78 92.7 0.37 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.076 -0.965 . . . . 1.0 109.371 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 66.31 -17.44 0.12 Allowed 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.858 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.568 ' H ' ' C ' ' A' ' 116' ' ' GLU . 49.9 t-80 56.2 177.65 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.365 -179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.529 ' H ' ' CG ' ' A' ' 118' ' ' HIS . 86.9 m-70 59.28 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.967 0.413 . . . . 1.0 110.69 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.475 ' N ' ' O ' ' A' ' 118' ' ' HIS . 81.4 t60 54.33 102.35 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.499 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.447 ' CG ' ' N ' ' A' ' 122' ' ' HIS . 82.4 t60 56.94 170.42 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.753 -0.203 . . . . 1.0 110.498 -179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.447 ' N ' ' CG ' ' A' ' 121' ' ' HIS . 57.0 t-80 . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 118.037 -0.982 . . . . 1.0 111.135 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtm . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 108.744 -0.836 . . . . 1.0 108.744 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -153.47 173.53 15.57 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.698 0.761 . . . . 1.0 109.986 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.25 147.21 98.97 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-N 115.279 -0.873 . . . . 1.0 111.373 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.08 -27.46 13.92 Favored 'Trans proline' 0 N--CA 1.51 2.47 0 C-N-CA 121.766 1.644 . . . . 1.0 111.742 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.85 130.96 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.221 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.4 m -132.66 122.69 25.04 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 116.011 -0.54 . . . . 1.0 109.941 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 65.0 mt -104.33 144.2 31.96 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.914 -0.585 . . . . 1.0 110.232 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.3 m -80.07 44.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.627 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.0 ptpp? -75.89 51.84 0.66 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.564 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.55 -45.25 92.37 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.238 0.542 . . . . 1.0 110.331 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 73.2 p -119.19 85.94 31.39 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 115.652 -0.704 . . . . 1.0 110.378 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -46.43 116.37 1.54 Allowed 'Trans proline' 0 N--CA 1.514 2.685 0 C-N-CA 121.524 1.483 . . . . 1.0 112.804 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -167.09 117.2 0.87 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.621 0.248 . . . . 1.0 110.508 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -55.95 146.32 22.59 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.03 0.443 . . . . 1.0 110.354 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.26 -26.19 8.2 Favored Glycine 0 N--CA 1.475 1.293 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -67.34 146.93 53.59 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.891 -0.411 . . . . 1.0 109.891 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -78.41 132.96 37.55 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.398 0.618 . . . . 1.0 109.651 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 36.5 pt -118.31 145.29 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.165 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 32.0 m -91.25 115.96 28.44 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.899 -0.592 . . . . 1.0 109.522 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.88 112.89 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.4 p -123.56 138.24 54.6 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.556 0.693 . . . . 1.0 110.18 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.16 124.67 47.38 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.374 -0.83 . . . . 1.0 110.033 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -85.76 113.22 21.77 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.926 -0.579 . . . . 1.0 109.719 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -92.71 117.85 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 116.011 -0.541 . . . . 1.0 109.616 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.7 m -89.75 125.31 35.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -103.34 111.66 24.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.903 0.859 . . . . 1.0 109.665 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -59.76 137.8 57.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.171 -0.922 . . . . 1.0 110.158 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.14 119.81 18.63 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 110.774 -0.93 . . . . 1.0 110.774 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -172.54 -78.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.905 -0.648 . . . . 1.0 109.796 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.59 149.21 40.44 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.477 0.656 . . . . 1.0 110.699 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -58.25 116.4 3.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.286 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -91.88 152.27 20.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.884 -0.413 . . . . 1.0 109.884 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -142.44 169.83 16.85 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.696 0.76 . . . . 1.0 110.049 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 49.48 62.25 2.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.716 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 25.5 t -113.47 82.69 6.25 Favored Pre-proline 0 N--CA 1.485 1.297 0 CA-C-N 115.749 -0.659 . . . . 1.0 109.381 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -80.35 112.39 2.75 Favored 'Trans proline' 0 N--CA 1.504 2.129 0 C-N-CA 121.201 1.267 . . . . 1.0 111.395 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -75.92 146.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.831 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -129.81 122.13 28.14 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.924 -0.398 . . . . 1.0 109.924 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.8 t -117.0 143.48 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-O 121.466 0.651 . . . . 1.0 109.704 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -156.14 132.6 10.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.519 -0.764 . . . . 1.0 110.171 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.3 mp -87.13 127.86 35.13 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.606 0.717 . . . . 1.0 109.697 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.31 -154.6 16.51 Favored Glycine 0 N--CA 1.469 0.879 0 N-CA-C 110.639 -0.984 . . . . 1.0 110.639 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -122.21 143.01 38.12 Favored Pre-proline 0 N--CA 1.49 1.563 0 CA-C-O 118.175 -0.916 . . . . 1.0 111.721 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.6 -39.57 46.23 Favored 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 120.782 0.988 . . . . 1.0 113.069 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 47' ' ' GLY . . . -60.78 -42.37 97.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.931 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -73.04 8.65 1.48 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.104 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 45' ' ' ALA . . . 66.77 72.89 0.7 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.98 163.35 25.22 Favored Glycine 0 N--CA 1.466 0.65 0 N-CA-C 110.933 -0.867 . . . . 1.0 110.933 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.0 p -135.14 141.4 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.233 0.539 . . . . 1.0 110.481 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -75.85 135.81 40.19 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.799 -0.637 . . . . 1.0 109.811 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.9 mt -103.15 -42.84 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.533 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.93 160.36 30.26 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 110.576 -1.01 . . . . 1.0 110.576 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -151.6 164.48 36.78 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.667 0.746 . . . . 1.0 110.406 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -154.51 115.94 4.1 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.355 -0.839 . . . . 1.0 110.358 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -77.0 133.91 39.0 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.343 -0.614 . . . . 1.0 109.343 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 mm -79.76 145.82 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.871 -0.604 . . . . 1.0 109.531 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.5 m -63.5 -49.33 73.97 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.693 0.759 . . . . 1.0 110.687 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -173.06 142.22 1.04 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.302 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.5 mt -122.98 120.45 27.53 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 118.03 -0.986 . . . . 1.0 111.145 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.12 166.82 28.53 Favored 'Trans proline' 0 N--CA 1.509 2.438 0 C-N-CA 120.85 1.033 . . . . 1.0 111.648 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.74 139.13 21.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.412 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.51 22.65 76.6 Favored Glycine 0 N--CA 1.462 0.387 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.54 -172.32 15.91 Favored Glycine 0 N--CA 1.474 1.174 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.2 p -139.9 -169.19 2.67 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.528 0.68 . . . . 1.0 110.672 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -141.44 150.91 22.27 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 110.468 -1.053 . . . . 1.0 110.468 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.89 114.92 15.24 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.847 0.832 . . . . 1.0 110.206 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.82 155.75 19.9 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.705 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -126.12 122.27 35.26 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.705 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 29.5 t -136.75 136.06 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 121.87 0.843 . . . . 1.0 109.323 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -108.4 140.66 41.37 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.114 -0.948 . . . . 1.0 109.946 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 31.2 t90 -141.67 135.76 30.21 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.95 0.881 . . . . 1.0 109.837 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -89.64 123.0 33.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 114.995 -1.002 . . . . 1.0 109.635 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.84 128.51 35.72 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.5 t -167.78 131.5 1.7 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.674 0.273 . . . . 1.0 110.318 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -147.1 -70.98 0.23 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.343 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' ALA . 1.3 ttmp? -164.53 151.18 11.02 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.332 0.587 . . . . 1.0 110.566 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.428 ' N ' HD12 ' A' ' 77' ' ' LEU . 9.6 mp -62.4 80.56 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.997 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 76' ' ' LYS . . . -84.98 177.04 8.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.751 -0.659 . . . . 1.0 109.848 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 179.83 136.8 2.81 Favored Glycine 0 N--CA 1.463 0.477 0 N-CA-C 110.615 -0.994 . . . . 1.0 110.615 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 53.73 97.67 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.609 0.242 . . . . 1.0 110.759 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.47 -171.12 1.6 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.283 0.563 . . . . 1.0 110.244 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.04 65.6 0.11 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.719 0.771 . . . . 1.0 110.408 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -165.92 96.13 0.78 Allowed Pre-proline 0 CA--C 1.55 0.972 0 CA-C-N 115.24 -0.891 . . . . 1.0 110.243 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -44.98 -83.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.513 2.632 0 C-N-CA 120.679 0.919 . . . . 1.0 113.336 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.77 11.01 78.01 Favored Glycine 0 N--CA 1.472 1.097 0 N-CA-C 110.893 -0.883 . . . . 1.0 110.893 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 t -113.44 68.93 1.37 Allowed Pre-proline 0 N--CA 1.484 1.244 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -73.57 -169.22 0.51 Allowed 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.081 1.187 . . . . 1.0 111.654 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 p -147.83 142.98 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 115.461 -0.79 . . . . 1.0 110.324 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -141.28 140.14 33.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.652 0.739 . . . . 1.0 109.747 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.7 141.6 26.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.32 -0.854 . . . . 1.0 109.95 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.4 t -140.75 143.72 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 115.69 -0.686 . . . . 1.0 109.996 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 p -87.98 142.71 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.581 -0.736 . . . . 1.0 109.533 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.2 146.31 97.97 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 119.055 -0.497 . . . . 1.0 110.213 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 96' ' ' ASN . 88.7 Cg_endo -74.47 170.63 19.82 Favored 'Trans proline' 0 N--CA 1.511 2.557 0 C-N-CA 121.13 1.22 . . . . 1.0 111.733 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -73.98 24.23 0.08 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.435 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 94' ' ' PRO . 41.4 t30 67.87 42.67 1.87 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.521 0.676 . . . . 1.0 110.499 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 67.7 mtp85 -133.97 -0.47 3.09 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.528 -0.76 . . . . 1.0 111.023 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t 54.74 102.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 116.673 -0.239 . . . . 1.0 110.563 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 101' ' ' SER . . . -158.26 107.98 2.07 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.023 0.44 . . . . 1.0 110.385 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -72.46 13.11 0.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.237 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 99' ' ' ALA . 53.1 m -87.56 -55.15 3.91 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.305 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.45 -41.54 89.91 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.511 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -59.0 -60.84 3.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.328 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.44 -38.8 30.79 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.113 0.482 . . . . 1.0 110.864 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.575 HD22 ' N ' ' A' ' 105' ' ' ASN . 0.9 OUTLIER -86.16 34.28 0.62 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.959 179.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -171.77 48.27 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.583 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.6 t -109.05 139.66 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-O 121.235 0.54 . . . . 1.0 109.868 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -144.9 143.81 30.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.746 -0.661 . . . . 1.0 110.243 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.6 t -171.18 137.04 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.414 0.626 . . . . 1.0 110.039 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -135.08 155.37 50.85 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.661 -0.699 . . . . 1.0 110.479 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.0 mm -83.36 123.12 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.089 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.3 t -91.21 103.87 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.041 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -88.44 102.7 15.15 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -106.9 127.91 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-O 121.335 0.588 . . . . 1.0 109.82 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 115' ' ' LEU . 10.0 mp -89.18 176.73 6.84 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.72 0.771 . . . . 1.0 109.136 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -169.32 43.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.303 -0.862 . . . . 1.0 110.164 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -164.1 108.14 0.97 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.339 0.59 . . . . 1.0 110.151 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -149.54 159.59 44.18 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.096 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.565 ' CG ' ' H ' ' A' ' 120' ' ' HIS . 51.0 t60 -167.25 -138.06 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.269 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.565 ' H ' ' CG ' ' A' ' 119' ' ' HIS . 90.4 m-70 52.16 67.75 0.92 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.462 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -167.36 11.76 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.632 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 118.065 -0.969 . . . . 1.0 111.404 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.3 ttm . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -67.73 126.74 30.35 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 35.2 mt -65.63 144.39 98.89 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-O 118.678 -0.677 . . . . 1.0 111.087 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.94 -27.32 20.98 Favored 'Trans proline' 0 N--CA 1.515 2.753 0 C-N-CA 121.492 1.461 . . . . 1.0 111.992 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.25 132.7 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.067 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.2 t -133.15 127.83 34.73 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.229 0.538 . . . . 1.0 110.227 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.487 HD22 HD12 ' A' ' 18' ' ' ILE . 16.2 mt -108.61 144.04 36.86 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.275 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.1 t -76.74 36.15 0.16 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.844 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 7' ' ' LEU . 36.8 tttp -74.05 48.74 0.32 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.672 0.749 . . . . 1.0 110.235 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -60.14 -41.61 93.08 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.451 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 61.1 p -116.06 87.49 19.3 Favored Pre-proline 0 N--CA 1.486 1.336 0 CA-C-N 115.261 -0.881 . . . . 1.0 110.477 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -48.03 115.31 1.44 Allowed 'Trans proline' 0 N--CA 1.516 2.84 0 C-N-CA 121.051 1.167 . . . . 1.0 113.076 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -169.09 116.42 0.63 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.627 -0.26 . . . . 1.0 110.466 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -55.8 145.71 23.61 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.502 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.52 -25.98 8.71 Favored Glycine 0 N--CA 1.477 1.421 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -65.77 144.03 57.13 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -77.77 137.04 38.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.48 0.657 . . . . 1.0 109.516 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.487 HD12 HD22 ' A' ' 7' ' ' LEU . 33.5 pt -124.05 145.6 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.399 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 20.1 m -87.56 113.62 23.41 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.1 t -93.07 113.24 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 N-CA-C 109.421 -0.585 . . . . 1.0 109.421 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 t -130.1 135.19 47.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.576 0.703 . . . . 1.0 110.141 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 126.2 48.88 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.02 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -81.87 111.4 18.05 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.351 -0.611 . . . . 1.0 109.351 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.6 p -89.62 124.99 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.564 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.3 m -98.09 124.52 42.66 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -75.61 106.38 7.14 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.358 0.599 . . . . 1.0 109.647 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -122.5 119.0 29.63 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.128 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 176.76 -99.5 0.13 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 30' ' ' ALA . . . -169.45 -6.34 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.658 0.266 . . . . 1.0 111.016 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' H ' ' H ' ' A' ' 29' ' ' ALA . . . -152.07 174.6 13.49 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.3 0.571 . . . . 1.0 110.549 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -62.1 126.95 29.11 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.579 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -78.54 135.88 37.42 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.532 ' O ' ' C ' ' A' ' 34' ' ' ASN . 33.6 m170 -105.9 169.71 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.087 0.946 . . . . 1.0 109.73 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' C ' ' O ' ' A' ' 33' ' ' HIS . 4.3 p30 16.73 84.5 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.906 -1.043 . . . . 1.0 111.454 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.6 t -112.44 80.9 3.75 Favored Pre-proline 0 N--CA 1.483 1.211 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.109 -178.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -83.57 102.8 1.04 Allowed 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 120.386 0.724 . . . . 1.0 111.352 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.0 p -74.46 149.42 7.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.01 129.46 40.14 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -121.37 143.98 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 121.5 0.667 . . . . 1.0 109.501 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -152.86 128.39 10.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.7 tt -81.52 127.64 33.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.12 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.79 -155.33 17.12 Favored Glycine 0 N--CA 1.476 1.361 0 N-CA-C 110.714 -0.955 . . . . 1.0 110.714 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -121.34 143.72 38.21 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.325 -0.845 . . . . 1.0 111.503 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.59 -30.11 15.57 Favored 'Trans proline' 0 N--CA 1.517 2.904 0 CA-C-N 119.684 0.923 . . . . 1.0 113.166 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.37 87.61 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.729 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.16 -52.36 64.13 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.324 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.49 -4.08 0.26 Allowed Glycine 0 N--CA 1.473 1.123 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.34 98.84 0.01 OUTLIER Glycine 0 CA--C 1.53 1.029 0 N-CA-C 111.096 -0.802 . . . . 1.0 111.096 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.1 t -81.41 114.43 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 109.827 -0.434 . . . . 1.0 109.827 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' CD ' HH22 ' A' ' 53' ' ' ARG . 63.5 tt0 -74.46 112.69 10.89 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.671 -0.492 . . . . 1.0 109.671 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.9 -46.2 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 176.24 42.47 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 110.734 -0.947 . . . . 1.0 110.734 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.428 HH22 ' CD ' ' A' ' 50' ' ' GLU . 9.5 ptp85 -147.85 160.88 42.28 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.726 0.774 . . . . 1.0 110.457 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -146.07 113.7 6.38 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.198 -0.91 . . . . 1.0 109.893 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.9 m -84.98 130.25 34.66 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.0 mm -82.7 145.77 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.079 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.9 p -62.42 -46.58 87.94 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.121 0.486 . . . . 1.0 110.421 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -169.09 137.53 2.0 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.472 0.653 . . . . 1.0 109.9 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.0 mt -115.91 119.14 37.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 CA-C-O 118.393 -0.813 . . . . 1.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.43 168.71 24.18 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 CA-C-N 119.592 0.89 . . . . 1.0 112.302 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -72.12 141.23 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.808 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.91 13.5 59.51 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.597 -1.001 . . . . 1.0 110.597 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.95 -175.44 19.4 Favored Glycine 0 N--CA 1.477 1.393 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.5 p -143.09 150.91 40.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.882 -0.159 . . . . 1.0 110.864 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.82 158.19 21.32 Favored Glycine 0 N--CA 1.464 0.557 0 N-CA-C 110.21 -1.156 . . . . 1.0 110.21 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.24 110.84 16.64 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.9 0.857 . . . . 1.0 109.906 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.47 154.81 18.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.088 -0.96 . . . . 1.0 110.339 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.2 ptt-85 -141.47 123.59 15.53 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.842 0.829 . . . . 1.0 110.594 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.05 135.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.145 -0.934 . . . . 1.0 109.428 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -92.6 137.1 32.66 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.597 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.6 t90 -139.65 131.02 26.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 1.0 109.639 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -97.26 123.9 41.19 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.003 -0.999 . . . . 1.0 109.482 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 147.09 53.25 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.561 -0.533 . . . . 1.0 109.561 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.0 p -139.18 -162.85 1.38 Allowed 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.433 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 68.7 ttt-85 53.72 83.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.875 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -80.57 129.05 34.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.08 0.467 . . . . 1.0 109.945 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.4 tt -165.66 116.66 1.07 Allowed 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.619 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -136.11 138.71 42.33 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.989 -0.551 . . . . 1.0 110.752 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 175.5 -106.81 0.23 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 111.294 -0.722 . . . . 1.0 111.294 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -62.81 -33.6 75.54 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.94 0.4 . . . . 1.0 110.331 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 52.95 36.82 22.89 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.332 0.587 . . . . 1.0 110.977 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.78 -30.23 71.3 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.656 -0.702 . . . . 1.0 110.665 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -152.09 145.42 17.59 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-N 115.84 -0.618 . . . . 1.0 111.321 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 85' ' ' GLY . 71.1 Cg_endo -69.42 -67.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.516 2.828 0 CA-C-N 118.798 0.606 . . . . 1.0 112.316 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.401 ' H ' ' HG2' ' A' ' 84' ' ' PRO . . . 79.05 73.82 1.1 Allowed Glycine 0 N--CA 1.466 0.67 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 86' ' ' VAL . 11.8 p -165.44 60.47 0.69 Allowed Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -76.98 163.34 31.09 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.943 1.762 . . . . 1.0 111.141 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.1 t -130.24 134.33 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 121.433 0.635 . . . . 1.0 109.787 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -128.46 148.23 50.72 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.996 0.903 . . . . 1.0 109.937 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.98 146.75 31.12 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.969 -1.014 . . . . 1.0 110.102 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.42 141.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.512 0.672 . . . . 1.0 110.156 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.7 t -86.83 137.5 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.547 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -41.55 145.56 0.64 Allowed Pre-proline 0 N--CA 1.484 1.229 0 CA-C-O 117.951 -1.023 . . . . 1.0 111.547 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.18 129.21 14.76 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 120.997 1.132 . . . . 1.0 111.913 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.37 -34.98 79.19 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.284 0.564 . . . . 1.0 110.161 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 98' ' ' VAL . 52.8 t30 -161.75 78.11 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.65 -0.705 . . . . 1.0 110.084 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 58.74 -74.38 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.617 -0.719 . . . . 1.0 110.862 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 96' ' ' ASN . 40.9 t -55.92 144.12 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.393 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -166.71 -4.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.376 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -52.77 -22.45 5.32 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.554 0.216 . . . . 1.0 110.475 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 38.0 t -89.17 -56.24 3.35 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.605 0.362 . . . . 1.0 110.024 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.22 -33.83 71.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.393 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -59.16 -60.62 3.58 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.13 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.25 -44.42 79.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.629 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -63.61 -53.4 52.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.673 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -90.56 51.58 2.03 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.155 0.502 . . . . 1.0 110.661 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.9 p -101.87 134.88 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.716 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -142.84 136.4 28.7 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.426 0.631 . . . . 1.0 109.736 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.6 m -158.48 145.14 17.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.527 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -144.11 127.2 16.53 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.717 -0.674 . . . . 1.0 109.974 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.9 mp -88.75 147.24 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 108.671 -0.863 . . . . 1.0 108.671 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.0 m -136.32 140.9 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-N 115.202 -0.908 . . . . 1.0 109.842 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -95.51 142.49 27.8 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.71 -0.677 . . . . 1.0 109.798 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.7 136.32 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-O 121.324 0.583 . . . . 1.0 110.203 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tp -105.42 133.43 50.19 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.707 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -160.33 91.33 0.92 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.795 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -168.15 96.44 0.42 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.495 -0.775 . . . . 1.0 109.882 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.415 ' N ' ' ND1' ' A' ' 118' ' ' HIS . 0.0 OUTLIER -164.27 170.84 15.69 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.295 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -65.02 111.57 2.94 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.101 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -67.09 142.29 57.17 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.879 0.371 . . . . 1.0 110.072 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -65.97 -39.36 90.3 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.128 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 72.8 m80 . . . . . 0 N--CA 1.473 0.715 0 CA-C-O 118.058 -0.972 . . . . 1.0 109.719 -179.834 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 mtt . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.186 -0.672 . . . . 1.0 109.186 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.24 151.86 39.28 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.172 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 mp -62.48 151.83 82.01 Favored Pre-proline 0 CA--C 1.558 1.282 0 CA-C-O 118.336 -0.84 . . . . 1.0 111.115 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.47 -29.33 77.63 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.643 1.562 . . . . 1.0 112.339 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 83.9 mt -111.99 135.94 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.209 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.4 t -148.23 138.98 23.0 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.493 -0.776 . . . . 1.0 110.382 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.07 163.27 33.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.543 -0.753 . . . . 1.0 110.72 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.3 t -84.02 114.69 21.9 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.508 -0.769 . . . . 1.0 109.971 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.86 50.19 1.19 Allowed 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.834 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -56.77 -43.79 81.18 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.717 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 63.0 p -123.19 84.93 51.52 Favored Pre-proline 0 N--CA 1.485 1.285 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.251 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_exo -49.27 123.33 9.98 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 121.584 1.523 . . . . 1.0 112.2 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -168.15 123.7 1.0 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.397 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -56.85 146.21 27.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.599 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.16 -27.54 6.09 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 110.994 -0.843 . . . . 1.0 110.994 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.54 141.25 55.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.881 -0.415 . . . . 1.0 109.881 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -74.76 143.28 44.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.681 0.753 . . . . 1.0 109.745 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 24.7 pt -132.73 148.5 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 115.322 -0.854 . . . . 1.0 110.046 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -89.35 112.51 23.62 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.366 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.4 t -94.02 118.33 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 N-CA-C 109.478 -0.564 . . . . 1.0 109.478 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.4 m -130.79 133.99 46.46 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.442 0.639 . . . . 1.0 110.479 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -119.57 128.26 53.74 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.109 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.43 119.72 26.99 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 1.0 109.573 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.1 m -103.74 126.73 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.765 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 55.0 m -88.81 125.17 34.78 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.02 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -83.24 115.0 21.76 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.239 0.542 . . . . 1.0 110.133 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -108.43 104.59 13.97 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.056 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -175.39 143.88 6.93 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.758 -0.937 . . . . 1.0 110.758 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.75 8.44 6.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.802 0.334 . . . . 1.0 110.246 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.5 165.93 31.73 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.386 0.612 . . . . 1.0 110.556 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -56.63 120.19 7.38 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.462 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.84 152.95 18.2 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.101 0.476 . . . . 1.0 109.828 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -146.15 173.31 12.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.876 0.846 . . . . 1.0 109.836 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.4 m120 48.63 59.45 4.36 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.086 -0.961 . . . . 1.0 110.857 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.5 t -111.44 87.33 7.64 Favored Pre-proline 0 N--CA 1.488 1.457 0 CA-C-O 118.578 -0.725 . . . . 1.0 109.749 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.52 173.4 14.54 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 C-N-CA 120.836 1.024 . . . . 1.0 111.478 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -149.58 144.42 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.071 -0.968 . . . . 1.0 109.92 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.1 133.06 43.88 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.537 -0.756 . . . . 1.0 109.528 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.1 146.06 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.635 0.731 . . . . 1.0 109.283 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -154.95 141.89 19.18 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.822 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.592 HD23 ' N ' ' A' ' 42' ' ' GLY . 1.6 tt -96.62 130.22 43.87 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.925 -0.579 . . . . 1.0 109.545 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.592 ' N ' HD23 ' A' ' 41' ' ' LEU . . . 118.94 -153.04 17.09 Favored Glycine 0 N--CA 1.475 1.284 0 N-CA-C 110.498 -1.041 . . . . 1.0 110.498 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -126.01 140.03 35.82 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-O 118.175 -0.917 . . . . 1.0 111.575 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -51.04 -36.15 53.25 Favored 'Trans proline' 0 N--CA 1.517 2.888 0 C-N-CA 120.74 0.96 . . . . 1.0 112.923 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.13 -46.48 89.49 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.885 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -65.77 -75.32 0.09 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.889 -0.596 . . . . 1.0 110.193 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.42 67.79 0.04 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.88 151.64 51.16 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 110.804 -0.918 . . . . 1.0 110.804 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.72 138.0 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 121.286 0.565 . . . . 1.0 110.403 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -67.93 136.13 53.51 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.766 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.0 mt -101.52 -38.95 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 115.528 -0.76 . . . . 1.0 109.531 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.01 164.16 34.04 Favored Glycine 0 N--CA 1.462 0.433 0 N-CA-C 110.654 -0.978 . . . . 1.0 110.654 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -149.35 162.17 40.6 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.967 0.889 . . . . 1.0 110.264 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -155.05 118.79 4.55 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.036 -0.983 . . . . 1.0 110.162 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.1 m -79.1 133.3 36.77 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.23 0.538 . . . . 1.0 109.591 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 59' ' ' ILE . 60.8 mt -108.52 145.57 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 109.164 -0.68 . . . . 1.0 109.164 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.8 t -109.47 -56.35 2.31 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.417 -0.811 . . . . 1.0 110.628 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 15.3 tpt85 -64.92 79.28 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.467 -0.788 . . . . 1.0 111.316 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.522 HD11 ' HB ' ' A' ' 56' ' ' ILE . 30.3 mt -122.85 86.9 50.36 Favored Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 118.237 -0.887 . . . . 1.0 110.558 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.66 163.7 35.29 Favored 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.59 1.526 . . . . 1.0 111.746 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.8 m -69.09 142.7 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.445 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.3 14.41 68.9 Favored Glycine 0 CA--C 1.518 0.27 0 N-CA-C 110.222 -1.151 . . . . 1.0 110.222 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.04 -167.68 18.91 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 110.355 -1.098 . . . . 1.0 110.355 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.1 p -146.33 151.06 36.9 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.255 0.55 . . . . 1.0 110.253 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.64 151.85 19.81 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.062 -1.215 . . . . 1.0 110.062 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.52 116.52 16.04 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.746 0.784 . . . . 1.0 110.109 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -105.95 156.0 18.8 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.837 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -125.54 124.17 40.72 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.944 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 t -138.21 140.64 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 CA-C-N 115.252 -0.885 . . . . 1.0 109.482 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -106.3 140.21 39.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.311 -0.859 . . . . 1.0 109.709 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.3 t90 -141.64 134.23 28.39 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.974 0.893 . . . . 1.0 109.839 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -102.34 127.56 49.29 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 114.991 -1.004 . . . . 1.0 109.986 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 141.88 53.27 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.0 p -119.1 138.4 52.91 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.204 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -167.62 43.57 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.934 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -75.55 138.91 41.81 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.585 0.707 . . . . 1.0 109.227 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 47.17 79.24 0.06 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.382 -0.826 . . . . 1.0 110.951 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 80' ' ' ARG . . . -71.21 146.45 49.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.213 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.12 29.34 1.63 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 110.568 -1.013 . . . . 1.0 110.568 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.433 ' H ' ' C ' ' A' ' 78' ' ' ALA . 77.3 mtm-85 52.73 16.78 0.72 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.57 0.7 . . . . 1.0 110.811 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.28 -169.89 2.77 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.45 -0.796 . . . . 1.0 109.996 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -166.01 85.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.681 -0.691 . . . . 1.0 110.168 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 84' ' ' PRO . 34.5 m120 -151.57 76.51 7.51 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.598 -0.728 . . . . 1.0 109.603 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 83' ' ' ASN . 74.2 Cg_exo -52.8 -146.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.51 2.449 0 C-N-CA 122.185 1.924 . . . . 1.0 112.459 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.82 82.08 1.4 Allowed Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.5 m -119.45 65.26 8.45 Favored Pre-proline 0 N--CA 1.481 1.089 0 N-CA-C 108.617 -0.882 . . . . 1.0 108.617 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.4 -179.55 1.21 Allowed 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.129 1.886 . . . . 1.0 110.94 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.7 m -138.66 157.59 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 115.077 -0.965 . . . . 1.0 110.173 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -147.11 145.77 29.71 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.465 -0.788 . . . . 1.0 109.925 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.18 142.36 32.69 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.254 -0.884 . . . . 1.0 110.109 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.13 136.54 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.64 0.734 . . . . 1.0 110.088 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.7 p -91.63 138.37 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.666 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -49.81 134.04 20.75 Favored Pre-proline 0 CA--C 1.558 1.278 0 CA-C-O 117.917 -1.04 . . . . 1.0 111.184 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.42 148.47 48.62 Favored 'Trans proline' 0 N--CA 1.506 2.254 0 C-N-CA 121.16 1.24 . . . . 1.0 111.668 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -72.49 -42.39 64.91 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.178 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -168.81 47.14 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.773 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 50.16 70.42 0.51 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.831 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 47.1 t -65.34 -79.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.148 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -169.83 161.27 8.99 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.12 0.486 . . . . 1.0 110.434 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -62.84 -66.38 0.55 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.304 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.3 p -46.32 -39.78 10.71 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 115.787 -0.642 . . . . 1.0 111.098 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -61.64 -71.53 0.15 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.243 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.576 ' C ' ' H ' ' A' ' 105' ' ' ASN . 90.7 mttt -45.64 -41.54 10.37 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.793 0.33 . . . . 1.0 110.642 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.8 3.92 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 121.182 0.515 . . . . 1.0 111.586 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 103' ' ' LYS . 90.2 m-20 -89.06 -35.44 16.34 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.832 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -93.29 47.53 1.26 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-O 121.392 0.615 . . . . 1.0 110.737 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' O ' ' CD1' ' A' ' 108' ' ' PHE . 58.7 t -100.38 135.76 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-O 121.723 0.773 . . . . 1.0 109.423 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 107' ' ' VAL . 53.4 m-85 -144.68 146.3 32.16 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.245 -0.889 . . . . 1.0 109.929 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 41.9 t -163.05 150.02 12.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.437 -0.802 . . . . 1.0 109.8 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -145.25 132.58 20.62 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.088 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.63 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.7 mp -83.0 118.63 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.933 -0.765 . . . . 1.0 108.933 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.6 t -96.45 107.05 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.8 122.3 29.69 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.5 t -129.08 134.98 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.667 0.746 . . . . 1.0 109.902 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.06 179.48 7.71 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.06 0.933 . . . . 1.0 109.931 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -140.88 147.81 39.5 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.018 -0.992 . . . . 1.0 110.352 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -74.38 90.98 2.18 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.701 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -60.97 -48.76 80.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.367 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -64.63 80.88 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.135 0.493 . . . . 1.0 110.057 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -60.75 -40.47 92.58 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.125 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -67.01 119.13 11.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.101 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 69.8 m80 . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.283 179.781 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.5 mmm . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 54.22 -177.87 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.781 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.2 mp -64.65 144.31 98.75 Favored Pre-proline 0 CA--C 1.554 1.113 0 CA-C-O 118.483 -0.77 . . . . 1.0 110.92 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.21 -39.17 3.16 Favored 'Trans proline' 0 N--CA 1.513 2.642 0 C-N-CA 120.881 1.054 . . . . 1.0 112.417 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -100.51 133.83 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.588 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 45.9 p -137.26 123.06 20.0 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.722 -0.672 . . . . 1.0 110.4 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.6 mt -112.27 150.7 30.58 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.48 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.3 p -81.09 28.35 0.37 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.821 -0.627 . . . . 1.0 110.37 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -73.95 48.91 0.31 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 109.986 -0.376 . . . . 1.0 109.986 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -55.15 -26.24 37.31 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.193 0.52 . . . . 1.0 110.396 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 t -133.34 138.45 31.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 CA-C-O 118.247 -0.883 . . . . 1.0 111.4 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -78.42 113.54 3.37 Favored 'Trans proline' 0 N--CA 1.51 2.468 0 CA-C-N 119.596 0.891 . . . . 1.0 111.642 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -166.96 99.39 0.54 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.67 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -54.78 146.83 16.18 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.733 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.93 -23.01 25.84 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 110.755 -0.938 . . . . 1.0 110.755 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -68.78 138.15 54.59 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 109.742 -0.466 . . . . 1.0 109.742 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.47 136.32 54.45 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.31 0.576 . . . . 1.0 109.622 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.4 pt -125.84 148.1 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.234 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.5 m -96.35 114.11 25.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.816 -0.629 . . . . 1.0 109.41 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.24 122.77 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.459 -0.571 . . . . 1.0 109.459 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 m -128.63 132.66 48.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.33 0.586 . . . . 1.0 109.984 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.08 123.41 40.27 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.734 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -79.28 144.64 34.1 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.202 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.03 135.64 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 110.117 -0.327 . . . . 1.0 110.117 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.7 m -101.34 123.99 46.32 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.414 HD21 ' CB ' ' A' ' 32' ' ' ALA . 5.3 t-20 -82.06 119.79 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.429 0.633 . . . . 1.0 110.103 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -108.95 95.9 5.95 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.523 -0.762 . . . . 1.0 109.981 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -171.91 137.13 4.14 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.96 -0.856 . . . . 1.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.87 11.27 1.12 Allowed 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.723 0.297 . . . . 1.0 110.446 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.9 165.48 30.52 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.183 0.516 . . . . 1.0 110.77 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -58.08 125.84 24.88 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.533 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' CB ' HD21 ' A' ' 26' ' ' ASN . . . -105.08 152.91 22.18 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.201 0.524 . . . . 1.0 110.107 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 48.1 m80 -147.22 -178.88 6.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 122.097 0.951 . . . . 1.0 109.741 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 47.83 59.24 4.32 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 114.832 -1.076 . . . . 1.0 111.223 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.6 t -107.86 84.66 2.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 CA-C-O 118.395 -0.812 . . . . 1.0 109.783 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -77.83 160.69 30.73 Favored 'Trans proline' 0 N--CA 1.504 2.127 0 C-N-CA 120.638 0.892 . . . . 1.0 111.724 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -139.82 141.31 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.031 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.43 129.09 42.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.499 -0.773 . . . . 1.0 109.536 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.51 146.32 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.724 0.773 . . . . 1.0 109.224 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -152.12 150.03 29.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.992 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.3 tp -97.33 130.85 44.45 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.114 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.79 -153.55 17.45 Favored Glycine 0 N--CA 1.476 1.366 0 N-CA-C 110.382 -1.087 . . . . 1.0 110.382 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -118.72 143.63 33.92 Favored Pre-proline 0 N--CA 1.488 1.445 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.301 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -49.36 -37.11 40.1 Favored 'Trans proline' 0 N--CA 1.521 3.142 0 CA-C-N 119.559 0.878 . . . . 1.0 113.275 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.57 99.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.783 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.91 8.69 1.42 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.235 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 66.31 74.2 0.55 Allowed Glycine 0 N--CA 1.465 0.619 0 N-CA-C 110.868 -0.893 . . . . 1.0 110.868 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -59.89 163.99 13.98 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 111.125 -0.79 . . . . 1.0 111.125 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.4 p -128.79 132.97 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.211 0.529 . . . . 1.0 110.337 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -70.04 134.84 48.68 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.841 -0.618 . . . . 1.0 109.684 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 73.2 mt -98.69 -36.15 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.577 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.84 172.84 41.01 Favored Glycine 0 N--CA 1.463 0.437 0 N-CA-C 110.601 -0.999 . . . . 1.0 110.601 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -154.16 166.77 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.754 0.787 . . . . 1.0 110.294 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -161.17 117.14 2.18 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.95 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.4 m -76.62 136.52 39.2 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.9 mt -107.56 142.23 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 CA-C-N 115.927 -0.578 . . . . 1.0 109.727 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 59' ' ' ILE . 95.8 p -105.02 -54.95 2.4 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.578 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -63.51 75.3 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 122.15 0.976 . . . . 1.0 110.967 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.451 ' N ' ' O ' ' A' ' 57' ' ' SER . 49.7 mm -121.91 82.23 42.88 Favored Pre-proline 0 N--CA 1.491 1.58 0 CA-C-N 114.748 -1.115 . . . . 1.0 109.529 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.13 167.7 24.49 Favored 'Trans proline' 0 N--CA 1.506 2.219 0 C-N-CA 121.191 1.26 . . . . 1.0 111.844 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 28.7 m -67.95 137.73 24.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 1.0 110.323 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.23 13.84 73.64 Favored Glycine 0 C--N 1.33 0.195 0 N-CA-C 110.239 -1.144 . . . . 1.0 110.239 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.93 -167.27 22.36 Favored Glycine 0 N--CA 1.472 1.094 0 N-CA-C 110.465 -1.054 . . . . 1.0 110.465 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 37.5 p -143.15 -174.32 4.16 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.297 0.57 . . . . 1.0 110.616 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.73 149.52 21.37 Favored Glycine 0 N--CA 1.477 1.382 0 N-CA-C 110.929 -0.869 . . . . 1.0 110.929 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.7 mt -138.68 124.61 19.95 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-O 122.278 1.037 . . . . 1.0 110.025 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -107.91 160.6 15.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 114.677 -1.147 . . . . 1.0 109.421 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -126.18 122.34 35.37 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 115.387 -0.824 . . . . 1.0 109.843 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.8 t -137.13 135.4 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 122.004 0.907 . . . . 1.0 109.043 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.0 mp0 -99.77 139.09 35.93 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.972 -1.013 . . . . 1.0 109.827 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 30.3 t90 -143.01 143.37 31.88 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.143 0.973 . . . . 1.0 109.932 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -113.43 127.28 56.06 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 114.829 -1.078 . . . . 1.0 110.181 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 118.18 13.69 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.891 -0.595 . . . . 1.0 109.661 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.1 p -105.23 119.19 38.45 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 121.21 0.529 . . . . 1.0 109.916 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.513 HH12 ' CB ' ' A' ' 84' ' ' PRO . 41.5 ttm180 -170.61 116.3 0.48 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.089 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -133.89 93.85 3.17 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.263 0.554 . . . . 1.0 110.062 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.8 mt -105.18 -161.33 0.81 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.788 -0.642 . . . . 1.0 109.97 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.0 65.84 0.19 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.637 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 178.1 -159.89 25.78 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -63.58 172.41 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.792 0.33 . . . . 1.0 110.559 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -167.3 126.93 1.41 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.64 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -169.07 20.14 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.646 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -152.69 55.75 1.56 Allowed Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.513 ' CB ' HH12 ' A' ' 75' ' ' ARG . 53.2 Cg_endo -64.71 -67.1 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 121.356 1.371 . . . . 1.0 111.719 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.21 79.71 0.16 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.621 -0.991 . . . . 1.0 110.621 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.55 63.14 13.82 Favored Pre-proline 0 N--CA 1.482 1.13 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.66 166.54 19.69 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.888 1.726 . . . . 1.0 111.245 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.5 158.79 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 CA-C-N 114.898 -1.047 . . . . 1.0 110.144 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -152.95 146.54 25.05 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.872 0.844 . . . . 1.0 109.746 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.49 144.33 34.31 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.886 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 50.3 t -131.74 138.63 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.66 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.3 t -93.59 135.17 28.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.262 -0.881 . . . . 1.0 109.71 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -125.37 80.47 65.3 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-O 118.785 -0.626 . . . . 1.0 110.17 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.5 178.3 0.47 Allowed 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 121.803 1.669 . . . . 1.0 111.847 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -64.7 -40.05 94.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.093 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -110.13 66.17 0.63 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.034 0.533 . . . . 1.0 110.659 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -64.37 97.74 0.21 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.006 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.2 160.17 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-O 121.789 0.804 . . . . 1.0 110.078 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 57.95 107.25 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.151 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -71.1 -64.32 0.93 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.52 0.676 . . . . 1.0 110.072 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.5 p -41.48 -32.18 0.32 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 115.617 -0.72 . . . . 1.0 111.269 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -67.35 -63.05 1.14 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.543 ' C ' ' H ' ' A' ' 105' ' ' ASN . 23.4 ttpp -43.33 -41.73 4.19 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.125 0.488 . . . . 1.0 111.025 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.46 0.17 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.89 -0.595 . . . . 1.0 111.564 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.543 ' H ' ' C ' ' A' ' 103' ' ' LYS . 9.2 m120 -95.36 32.58 1.73 Allowed 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.679 -0.692 . . . . 1.0 109.671 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -159.61 46.53 0.27 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 110.088 -0.338 . . . . 1.0 110.088 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.71 104.43 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 109.246 -0.65 . . . . 1.0 109.246 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -110.27 132.04 54.53 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.03 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.3 t -164.36 144.09 7.67 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.331 0.586 . . . . 1.0 110.139 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -133.55 132.23 40.67 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.514 0.673 . . . . 1.0 110.136 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -80.68 137.72 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.492 -0.929 . . . . 1.0 108.492 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.68 142.92 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.771 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -121.26 143.68 49.03 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.137 0.97 . . . . 1.0 110.061 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.0 p -122.43 137.83 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.293 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -149.54 136.28 19.45 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.663 -0.699 . . . . 1.0 109.753 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -166.57 141.42 4.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.928 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -75.92 131.99 39.99 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -66.74 127.03 30.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 52.04 90.4 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.637 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -60.95 -42.14 97.66 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.134 0.492 . . . . 1.0 110.289 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.432 ' CG ' ' N ' ' A' ' 122' ' ' HIS . 81.0 t60 56.51 170.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.652 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.432 ' N ' ' CG ' ' A' ' 121' ' ' HIS . 50.9 t-80 . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.192 -0.909 . . . . 1.0 109.508 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 108.69 -0.855 . . . . 1.0 108.69 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 63.65 23.87 13.71 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.228 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.04 152.28 68.19 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.875 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.84 -24.14 40.64 Favored 'Trans proline' 0 N--CA 1.515 2.75 0 C-N-CA 121.976 1.784 . . . . 1.0 111.957 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 80.4 mt -124.27 130.93 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.328 0.585 . . . . 1.0 110.2 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.2 m -134.87 123.46 23.52 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.635 -0.711 . . . . 1.0 109.856 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mp -105.47 147.64 28.07 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.369 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.9 p -81.06 34.41 0.35 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.24 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -70.79 50.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 122.974 0.51 . . . . 1.0 110.209 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -51.83 -30.33 23.0 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.658 0.742 . . . . 1.0 110.523 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.5 p -137.16 140.7 31.9 Favored Pre-proline 0 N--CA 1.486 1.347 0 CA-C-N 115.352 -0.84 . . . . 1.0 111.261 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.97 113.95 3.52 Favored 'Trans proline' 0 N--CA 1.514 2.728 0 CA-C-N 119.231 0.761 . . . . 1.0 111.392 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -166.92 101.45 0.55 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 120.86 0.362 . . . . 1.0 110.938 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.539 ' H ' ' CD ' ' A' ' 14' ' ' GLU . 1.4 pm0 -53.9 148.8 9.81 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.948 179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.14 -23.7 16.85 Favored Glycine 0 N--CA 1.474 1.195 0 N-CA-C 110.97 -0.852 . . . . 1.0 110.97 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -69.68 144.1 52.95 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.46 137.55 46.49 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.561 0.696 . . . . 1.0 109.508 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.7 pt -123.14 146.55 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.915 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.7 m -97.7 114.51 26.5 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.179 -0.675 . . . . 1.0 109.179 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.7 119.7 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.5 m -129.09 132.99 47.48 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.265 0.555 . . . . 1.0 110.028 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.06 128.22 55.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.152 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -84.5 119.34 25.05 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.2 t -108.26 113.21 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 121.497 0.665 . . . . 1.0 109.215 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.4 m -86.27 131.92 34.11 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.518 -0.765 . . . . 1.0 109.557 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -86.79 107.18 18.16 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.006 0.431 . . . . 1.0 109.844 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -97.72 -159.34 0.73 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.319 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.47 -130.69 11.41 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.557 -1.017 . . . . 1.0 110.557 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.47 21.18 0.06 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.864 0.364 . . . . 1.0 110.684 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -142.44 154.66 44.76 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.495 0.664 . . . . 1.0 110.598 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -66.01 117.22 8.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.738 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -87.14 152.65 22.16 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.418 ' CG ' ' N ' ' A' ' 34' ' ' ASN . 44.1 t-80 -139.91 169.04 18.44 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.518 0.675 . . . . 1.0 110.04 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.418 ' N ' ' CG ' ' A' ' 33' ' ' HIS . 80.0 m-20 50.24 62.52 2.63 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.433 -0.803 . . . . 1.0 110.738 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.7 t -113.97 82.81 7.17 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -80.39 169.5 17.12 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 121.638 1.559 . . . . 1.0 111.322 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.13 136.61 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 115.189 -0.914 . . . . 1.0 109.547 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.38 114.91 18.83 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.746 -0.661 . . . . 1.0 109.275 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.0 t -104.44 137.48 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.526 0.679 . . . . 1.0 109.307 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -146.71 127.11 14.0 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.131 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tp -85.93 124.33 32.27 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.877 -0.416 . . . . 1.0 109.877 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 120.93 -158.75 15.68 Favored Glycine 0 N--CA 1.476 1.348 0 N-CA-C 110.762 -0.935 . . . . 1.0 110.762 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -114.5 142.68 28.56 Favored Pre-proline 0 N--CA 1.491 1.62 0 CA-C-O 117.788 -1.101 . . . . 1.0 111.528 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -48.8 -38.8 38.42 Favored 'Trans proline' 0 N--CA 1.519 2.992 0 CA-C-N 120.079 1.064 . . . . 1.0 113.108 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.51 22.89 0.23 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.981 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -166.71 -73.91 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.921 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.63 -97.33 0.01 OUTLIER Glycine 0 CA--C 1.533 1.184 0 N-CA-C 111.181 -0.768 . . . . 1.0 111.181 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.1 90.86 Favored Glycine 0 CA--C 1.532 1.128 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -106.1 115.33 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 109.99 -0.374 . . . . 1.0 109.99 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.24 133.07 45.83 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 109.798 -0.445 . . . . 1.0 109.798 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.67 -46.11 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 115.964 -0.562 . . . . 1.0 109.64 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.15 165.8 35.45 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -155.49 167.43 30.41 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.367 0.603 . . . . 1.0 110.629 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -161.25 119.82 2.45 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.404 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 m -75.11 131.4 40.49 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 68.0 mt -80.81 155.51 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.4 p -65.42 -51.96 56.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.602 0.715 . . . . 1.0 110.072 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -177.29 145.47 0.45 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.283 -0.871 . . . . 1.0 110.039 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.5 mt -114.56 117.29 42.85 Favored Pre-proline 0 N--CA 1.495 1.781 0 CA-C-O 117.571 -1.205 . . . . 1.0 110.686 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.13 162.25 41.19 Favored 'Trans proline' 0 N--CA 1.519 2.971 0 CA-C-N 120.286 1.138 . . . . 1.0 112.157 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 25.7 t -70.17 137.31 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.557 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.47 16.55 77.48 Favored Glycine 0 N--CA 1.463 0.49 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.82 -167.9 14.69 Favored Glycine 0 N--CA 1.472 1.068 0 N-CA-C 110.554 -1.018 . . . . 1.0 110.554 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 59.4 p -132.92 176.23 8.66 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.896 0.855 . . . . 1.0 110.364 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -177.41 124.42 0.94 Allowed Glycine 0 N--CA 1.474 1.182 0 CA-C-N 115.098 -0.955 . . . . 1.0 110.783 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.76 160.15 37.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.05 0.929 . . . . 1.0 110.127 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.67 161.91 13.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.874 -1.057 . . . . 1.0 109.246 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -121.1 123.35 42.11 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.854 -1.066 . . . . 1.0 109.895 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -140.03 156.32 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.28 1.038 . . . . 1.0 109.169 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -123.32 141.72 51.69 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.956 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -140.8 137.56 33.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.991 0.9 . . . . 1.0 109.691 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -100.31 123.84 45.04 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.557 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.44 138.39 49.02 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 t -166.36 150.23 7.48 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.436 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -167.77 84.21 0.21 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.166 -0.47 . . . . 1.0 109.879 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -70.82 126.51 29.79 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.703 -0.481 . . . . 1.0 109.703 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 tp -162.72 120.98 2.09 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.319 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.79 -41.16 96.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.129 -0.323 . . . . 1.0 110.129 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.48 156.46 48.58 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.796 -0.922 . . . . 1.0 110.796 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -62.53 -165.28 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.951 0.405 . . . . 1.0 110.68 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -163.69 156.0 17.62 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.431 0.634 . . . . 1.0 110.399 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -168.32 26.63 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.631 0.729 . . . . 1.0 110.714 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -165.61 97.44 0.79 Allowed Pre-proline 0 CA--C 1.556 1.211 0 CA-C-O 117.577 -1.201 . . . . 1.0 110.065 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.69 -80.56 0.01 OUTLIER 'Trans proline' 0 N--CA 1.512 2.575 0 CA-C-N 120.283 1.137 . . . . 1.0 112.065 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.83 79.58 0.13 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.282 -0.961 . . . . 1.0 111.047 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -119.14 64.71 7.21 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.873 -0.788 . . . . 1.0 108.873 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -60.6 141.46 95.28 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 121.755 1.637 . . . . 1.0 111.734 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.7 t -98.49 147.02 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 115.349 -0.841 . . . . 1.0 109.862 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -135.38 138.88 43.74 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 122.037 0.923 . . . . 1.0 109.821 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.92 135.03 22.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.033 -0.985 . . . . 1.0 109.632 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 t -139.67 144.41 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.996 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.4 145.79 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-N 115.809 -0.632 . . . . 1.0 109.538 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -136.35 87.33 22.51 Favored Pre-proline 0 N--CA 1.482 1.162 0 CA-C-O 118.437 -0.792 . . . . 1.0 110.143 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.51 -60.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.511 2.528 0 C-N-CA 121.936 1.757 . . . . 1.0 112.35 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -91.83 21.12 5.06 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 116.299 -0.409 . . . . 1.0 110.343 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 60.21 97.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.209 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 54.46 88.7 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.668 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 48.1 t -78.75 -76.51 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.005 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -168.58 158.29 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.413 0.625 . . . . 1.0 110.49 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.79 -4.87 1.08 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.479 -0.782 . . . . 1.0 110.683 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -87.16 -56.51 3.34 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.831 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -62.52 -44.31 96.67 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.611 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -54.82 -59.62 4.48 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.394 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -52.21 -36.17 51.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.537 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -79.01 23.94 0.33 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.23 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -167.32 44.38 0.05 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.873 0.368 . . . . 1.0 110.547 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.6 p -111.45 139.91 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 CA-C-O 121.222 0.534 . . . . 1.0 109.789 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -147.9 153.39 39.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.123 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.3 m -165.09 147.04 7.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.125 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -142.14 133.01 25.75 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.211 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.8 mp -81.28 123.35 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 108.569 -0.9 . . . . 1.0 108.569 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.63 136.01 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.376 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -131.95 125.19 30.99 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.317 0.58 . . . . 1.0 109.927 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.09 137.05 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.771 0.796 . . . . 1.0 110.039 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 86.0 mt -125.06 126.32 45.2 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.259 -0.882 . . . . 1.0 109.952 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -81.38 -27.59 34.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.121 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -69.79 164.22 24.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.64 0.733 . . . . 1.0 109.808 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.433 ' C ' ' H ' ' A' ' 120' ' ' HIS . 1.1 t60 54.68 86.58 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.291 -0.868 . . . . 1.0 110.533 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -75.53 15.66 0.45 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.176 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.433 ' H ' ' C ' ' A' ' 118' ' ' HIS . 94.0 m-70 53.34 -173.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.495 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 54.44 16.63 1.33 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.164 0.507 . . . . 1.0 111.051 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 117.979 -1.01 . . . . 1.0 110.517 -179.712 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.777 -0.823 . . . . 1.0 108.777 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -169.2 77.15 0.1 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.99 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -69.59 139.97 89.32 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 118.314 -0.851 . . . . 1.0 110.918 -178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -53.47 -32.16 61.58 Favored 'Trans proline' 0 N--CA 1.516 2.806 0 C-N-CA 121.099 1.2 . . . . 1.0 112.603 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 81.8 mt -111.95 130.1 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 115.307 -0.86 . . . . 1.0 110.202 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.9 m -134.22 121.76 21.81 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.475 0.655 . . . . 1.0 109.921 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.04 147.29 27.15 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.445 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.2 t -94.03 78.03 4.09 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.603 0.716 . . . . 1.0 110.193 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.44 58.89 0.69 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.444 1.098 . . . . 1.0 110.693 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.67 -33.72 56.26 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.743 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.4 t -126.93 132.74 24.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 117.928 -1.034 . . . . 1.0 110.903 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -81.13 105.78 1.68 Allowed 'Trans proline' 0 N--CA 1.511 2.518 0 CA-C-N 119.914 1.005 . . . . 1.0 111.438 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -169.42 117.32 0.62 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.206 0.527 . . . . 1.0 110.454 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -54.76 150.81 9.19 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.065 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.8 -22.3 34.56 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -72.82 126.33 29.67 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.217 0.532 . . . . 1.0 109.815 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -65.03 131.54 46.84 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.847 -0.615 . . . . 1.0 109.662 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.8 pt -119.69 147.1 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-O 121.271 0.558 . . . . 1.0 109.741 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.9 m -94.5 121.14 35.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.701 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.4 t -100.27 121.59 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 CA-C-N 116.008 -0.542 . . . . 1.0 109.598 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -123.99 134.5 53.45 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 121.603 0.716 . . . . 1.0 109.808 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.09 120.67 33.05 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.449 -0.796 . . . . 1.0 110.08 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -85.81 123.25 30.96 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.948 -0.569 . . . . 1.0 109.997 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -107.62 129.26 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.216 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.8 m -90.94 123.75 34.68 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.094 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -74.0 115.43 13.46 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.935 -0.394 . . . . 1.0 109.935 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -114.3 96.75 5.94 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.028 0.442 . . . . 1.0 110.05 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -167.86 152.97 21.86 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.788 -0.925 . . . . 1.0 110.788 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -80.75 2.0 27.97 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.572 -0.314 . . . . 1.0 110.301 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.51 169.82 20.04 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.305 0.574 . . . . 1.0 110.856 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 19.1 mp0 -67.04 125.78 27.09 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.787 -0.642 . . . . 1.0 109.909 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -113.74 160.35 18.75 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 1.0 110.432 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -161.09 94.22 1.0 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 122.572 1.177 . . . . 1.0 109.33 178.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 33' ' ' HIS . 0.8 OUTLIER 157.4 58.13 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 114.414 -1.266 . . . . 1.0 110.394 179.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.63 86.01 12.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.09 100.85 0.96 Allowed 'Trans proline' 0 N--CA 1.505 2.173 0 C-N-CA 121.016 1.144 . . . . 1.0 111.269 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 p -69.97 143.02 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.759 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.15 120.21 26.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.935 0.494 . . . . 1.0 109.82 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.9 t -112.01 143.14 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.324 0.583 . . . . 1.0 109.582 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -151.98 126.01 9.16 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.668 -0.696 . . . . 1.0 110.102 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.6 tp -76.55 128.54 34.95 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.994 -0.548 . . . . 1.0 109.643 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.61 -160.38 15.99 Favored Glycine 0 N--CA 1.476 1.363 0 N-CA-C 110.996 -0.842 . . . . 1.0 110.996 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -117.45 142.35 30.22 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-O 118.144 -0.932 . . . . 1.0 111.457 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -49.64 -40.95 46.48 Favored 'Trans proline' 0 N--CA 1.522 3.171 0 CA-C-N 119.688 0.924 . . . . 1.0 113.323 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.81 -43.41 93.24 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.968 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.59 -59.21 4.55 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.122 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 152.67 83.16 0.04 OUTLIER Glycine 0 N--CA 1.476 1.361 0 N-CA-C 111.025 -0.83 . . . . 1.0 111.025 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.6 130.7 40.44 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.7 t -111.92 126.0 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 CA-C-O 121.224 0.535 . . . . 1.0 109.786 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -68.48 122.14 17.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.824 -0.626 . . . . 1.0 109.926 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.16 -44.91 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-O 121.213 0.53 . . . . 1.0 109.94 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.56 168.53 37.98 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -158.16 169.99 23.27 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.618 0.723 . . . . 1.0 110.334 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -163.45 114.66 1.41 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.005 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.6 m -75.22 140.51 43.3 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.9 mm -78.63 142.09 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.862 -0.422 . . . . 1.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.0 m -66.62 -50.13 64.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.229 0.538 . . . . 1.0 110.579 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -147.3 130.33 16.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.759 0.79 . . . . 1.0 110.206 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 mt -117.71 108.47 42.88 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-O 117.994 -1.003 . . . . 1.0 110.982 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.95 159.88 44.08 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 CA-C-N 119.934 1.012 . . . . 1.0 111.667 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -70.57 145.52 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.499 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.26 1.86 29.95 Favored Glycine 0 N--CA 1.461 0.321 0 N-CA-C 110.385 -1.086 . . . . 1.0 110.385 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.95 -165.35 26.92 Favored Glycine 0 N--CA 1.47 0.905 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 27.0 p -139.74 -173.42 3.62 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.388 0.613 . . . . 1.0 110.648 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.01 151.18 22.65 Favored Glycine 0 N--CA 1.477 1.408 0 N-CA-C 110.57 -1.012 . . . . 1.0 110.57 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mt -132.54 152.59 51.53 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.291 1.043 . . . . 1.0 109.641 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.04 154.74 45.19 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.664 -1.153 . . . . 1.0 109.706 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -117.9 120.4 37.75 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.43 -0.804 . . . . 1.0 109.701 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.1 t -134.35 128.76 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.632 0.73 . . . . 1.0 109.269 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -99.29 140.04 34.05 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.356 -0.838 . . . . 1.0 109.848 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -137.98 121.88 17.71 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.981 0.896 . . . . 1.0 109.981 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -92.37 127.04 37.71 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.107 -0.951 . . . . 1.0 109.788 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.88 138.52 50.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.487 -0.485 . . . . 1.0 109.749 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 75' ' ' ARG . 4.4 t -147.56 -174.68 4.6 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.714 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.408 ' N ' ' OG1' ' A' ' 74' ' ' THR . 21.9 mmt85 56.26 12.68 1.04 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.416 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.4 145.23 35.07 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.789 0.805 . . . . 1.0 110.455 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.8 tp -169.11 -81.51 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.12 -0.945 . . . . 1.0 109.851 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.14 -47.52 76.8 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.832 0.348 . . . . 1.0 110.984 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.55 44.04 90.88 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 111.062 -0.815 . . . . 1.0 111.062 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -64.4 -38.03 89.6 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.116 0.484 . . . . 1.0 110.451 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -168.41 37.91 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.43 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.47 -160.02 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.597 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -130.57 86.02 54.3 Favored Pre-proline 0 N--CA 1.483 1.182 0 CA-C-O 118.758 -0.639 . . . . 1.0 110.053 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -49.62 -174.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.508 2.345 0 C-N-CA 122.076 1.85 . . . . 1.0 112.486 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.3 81.24 1.45 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.594 -1.003 . . . . 1.0 110.594 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.9 m -123.79 62.79 27.0 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 108.782 -0.821 . . . . 1.0 108.782 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.25 149.62 89.89 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 121.731 1.621 . . . . 1.0 111.309 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.6 t -103.75 114.33 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.72 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -107.61 147.32 30.79 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.852 0.834 . . . . 1.0 109.474 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -146.99 142.69 27.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.181 -0.918 . . . . 1.0 110.041 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.4 t -133.1 138.87 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.082 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -84.65 135.91 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.966 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -44.03 163.7 0.17 Allowed Pre-proline 0 CA--C 1.558 1.284 0 CA-C-O 117.759 -1.115 . . . . 1.0 111.558 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.57 129.59 32.84 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 120.935 1.09 . . . . 1.0 112.296 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -88.68 25.54 1.71 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.068 0.547 . . . . 1.0 110.1 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 71.38 -4.37 1.86 Allowed 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.561 0.696 . . . . 1.0 110.455 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 70.4 mmt-85 -133.15 81.24 1.92 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.431 -0.804 . . . . 1.0 110.303 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.4 t -61.43 119.95 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 115.933 -0.576 . . . . 1.0 109.883 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -172.28 140.62 1.15 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.217 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -68.58 -61.1 1.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.944 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.3 m -41.82 -48.99 4.43 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.585 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -65.96 -63.31 1.11 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 110.173 -0.306 . . . . 1.0 110.173 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 105' ' ' ASN . 37.8 ttpt -46.24 -49.8 16.76 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.222 0.534 . . . . 1.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -49.74 -11.29 0.05 Allowed 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.734 -0.667 . . . . 1.0 111.635 178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 103' ' ' LYS . 27.1 m-20 -102.23 26.39 7.78 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.824 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -155.06 26.39 0.42 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.418 0.287 . . . . 1.0 110.556 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.3 t -102.83 136.73 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 109.443 -0.577 . . . . 1.0 109.443 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -141.63 138.66 32.71 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.35 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.0 m -165.62 140.04 4.73 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.086 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -134.84 150.31 50.47 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-O 121.083 0.468 . . . . 1.0 110.444 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.5 mp -88.76 133.05 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 108.885 -0.783 . . . . 1.0 108.885 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -142.53 138.61 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.84 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -138.33 155.99 48.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.779 0.799 . . . . 1.0 109.535 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 30.6 m -126.55 133.82 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.032 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.1 mt -91.3 115.82 28.34 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -76.87 -65.38 0.95 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.735 -0.666 . . . . 1.0 109.946 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -77.85 152.76 33.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.019 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -64.58 133.09 51.57 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.138 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.0 t60 -65.62 -42.53 91.46 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.992 0.425 . . . . 1.0 110.017 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -62.52 98.33 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.377 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -65.37 -43.11 91.8 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.087 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 118.04 -0.981 . . . . 1.0 110.601 -179.968 . . . . . . . . 0 0 . 1 stop_ save_